<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Arch Microbiol</journal-id><journal-title-group><journal-title>Archives of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">0302-8933</issn><issn pub-type="epub">1432-072X</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">11045635</article-id><article-id pub-id-type="pmid">38662051</article-id>
<article-id pub-id-type="publisher-id">3948</article-id><article-id pub-id-type="doi">10.1007/s00203-024-03948-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Bacteriocins: potentials and prospects in health and agrifood systems</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8084-2387</contrib-id><name><surname>Reuben</surname><given-names>Rine Christopher</given-names></name><address><email>reubenrine@yahoo.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3709-1690</contrib-id><name><surname>Torres</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0553yr311</institution-id><institution-id institution-id-type="GRID">grid.119021.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 6969</institution-id><institution>Area of Biochemistry and Molecular Biology, OneHealth-UR Research Group, </institution><institution>University of La Rioja, </institution></institution-wrap>26006 Logro&#x000f1;o, Spain </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by Yusuf Akhter.</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>206</volume><issue>5</issue><elocation-id>233</elocation-id><history><date date-type="received"><day>2</day><month>2</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>3</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Bacteriocins are highly diverse, abundant, and heterogeneous antimicrobial peptides that are ribosomally synthesized by bacteria and archaea. Since their discovery about a century ago, there has been a growing interest in bacteriocin research and applications. This is mainly due to their high antimicrobial properties, narrow or broad spectrum of activity, specificity, low cytotoxicity, and stability. Though initially used to improve food quality and safety, bacteriocins are now globally exploited for innovative applications in human, animal, and food systems as sustainable alternatives to antibiotics. Bacteriocins have the potential to beneficially modulate microbiota, providing viable microbiome-based solutions for the treatment, management, and non-invasive bio-diagnosis of infectious and non-infectious diseases. The use of bacteriocins holds great promise in the modulation of food microbiomes, antimicrobial food packaging, bio-sanitizers and antibiofilm, pre/post-harvest biocontrol, functional food, growth promotion, and sustainable aquaculture. This can undoubtedly improve food security, safety, and quality globally. This review highlights the current trends in bacteriocin research, especially the increasing research outputs and funding, which we believe may proportionate the soaring global interest in bacteriocins. The use of cutting-edge technologies, such as bioengineering, can further enhance the exploitation of bacteriocins for innovative applications in human, animal, and food systems.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00203-024-03948-y.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bacteriocin</kwd><kwd>Antimicrobial agents</kwd><kwd>Microbiome</kwd><kwd>Health</kwd><kwd>Food</kwd><kwd>Antimicrobial resistance</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010665</institution-id><institution>H2020 Marie Sk&#x00142;odowska-Curie Actions</institution></institution-wrap></funding-source><award-id>101034288</award-id><award-id>101034288</award-id><principal-award-recipient><name><surname>Reuben</surname><given-names>Rine Christopher</given-names></name><name><surname>Torres</surname><given-names>Carmen</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Universidad de la Rioja</institution></funding-source></award-group><open-access><p>Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Antimicrobial resistance (AMR) has risen as one of the major public health challenges in recent times. While the discovery of antibiotics revolutionized modern medicine making them the most successful therapeutic agents to be widely used against bacterial infections, the overuse and misuse of antibiotics have resulted in the emergence of antibiotic-resistant bacteria (Alonso et al. <xref ref-type="bibr" rid="CR22">2017</xref>; Torres et al. <xref ref-type="bibr" rid="CR554">2018</xref>; Baquero et al. <xref ref-type="bibr" rid="CR53">2021</xref>). Regardless of the appropriateness of antibiotics use, routine use of antibiotics at the individual and/or community level exerts immense selective pressure which drives bacterial evolution and the development and acquisition of resistant determinants (Bloom et al. <xref ref-type="bibr" rid="CR81">2018</xref>; Baquero et al. <xref ref-type="bibr" rid="CR53">2021</xref>). Importantly, antibiotic use in human and veterinary medicine and food production is increasing, and this may likely continue into the coming years as unrestrained antibiotic access rises in resource-limited countries (CDC <xref ref-type="bibr" rid="CR107">2018</xref>; Hussain et al. <xref ref-type="bibr" rid="CR267">2020</xref>; Gupta <xref ref-type="bibr" rid="CR237">2022</xref>). The surge and continuous spread of antibiotic-resistant bacteria and the diminished potency of commercially available antimicrobials and therapeutics necessitate a concerted approach to the search for novel and potent antimicrobials that may become alternatives to available antibiotics. Unless the enigma of widespread AMR and associated public health concerns are urgently prioritized and mitigated, global health and economic burdens will continue to worsen.</p><p id="Par3">Over the past decades, there has been growing interest and research exploring several emerging antimicrobial compounds, including antimicrobial peptides, nanomedicines, probiotics, postbiotics, phytochemicals, bacteriophages, etc. as alternatives to antibiotics (Reuben et al. <xref ref-type="bibr" rid="CR461">2019</xref>, <xref ref-type="bibr" rid="CR462">2020</xref>; Wang et al. <xref ref-type="bibr" rid="CR583">2020a</xref>; Mba and Nweze <xref ref-type="bibr" rid="CR364">2022</xref>; Anyaegbunam et al. <xref ref-type="bibr" rid="CR32">2022</xref>; Field et al. <xref ref-type="bibr" rid="CR194">2023</xref>; Ye et al. <xref ref-type="bibr" rid="CR605">2023</xref>; Baquero et al. <xref ref-type="bibr" rid="CR54">2024</xref>). Interestingly, ribosomally synthesized peptides of bacterial origin have received increased attention and hold great potential as valuable antimicrobial compounds against a broad spectrum of multi-drug resistant (MDR) pathogens as well as therapeutic agents for the treatment of several diseases (Lynch et al. <xref ref-type="bibr" rid="CR350">2019</xref>; Magana et al. <xref ref-type="bibr" rid="CR352">2020</xref>; Mba and Nweze <xref ref-type="bibr" rid="CR364">2022</xref>; Telhig et al. <xref ref-type="bibr" rid="CR545">2022</xref>; Garc&#x000ed;a-Vela et al. <xref ref-type="bibr" rid="CR207">2023</xref>). Bacteriocins, which are antimicrobial peptides synthesized by bacteria have attracted increasing interest due to their high antimicrobial activities, stability, and low toxicity (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Lynch et al. <xref ref-type="bibr" rid="CR350">2019</xref>; Deslouches et al. <xref ref-type="bibr" rid="CR152">2020</xref>; Wiman et al. <xref ref-type="bibr" rid="CR589">2023</xref>). The majority of bacteria synthesize at least one known or unknown bacteriocin (Riley and Wertz <xref ref-type="bibr" rid="CR471">2002</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>). While the ecological function of bacteriocins is yet to be fully elucidated, they are believed to help bacteria outcompete other members of the community, modulate the competitive landscape through direct or exclusive antagonisms, and also serve as signaling molecules (Dobson et al. <xref ref-type="bibr" rid="CR158">2012</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>).</p><p id="Par4">Bacteriocins are structurally diverse and encoded by highly variable and complex biosynthetic gene clusters that evolve rapidly (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>; Ye et al. <xref ref-type="bibr" rid="CR605">2023</xref>). The high antimicrobial activity, diversity, low toxicity, stability, and therapeutic benefits of bacteriocins have prompted a soaring multi-sectorial and transdisciplinary interest in their search, characterization, and broad applications either as (i) antimicrobial/therapeutic compounds for the treatment and prevention of human and animal diseases, (ii) food additives for the inhibition of foodborne pathogens or spoilage organisms, (iii) feed supplements for growth promotion in animal production, or (iv) microbiome-based interventions for the modulation of the gut, reproductive tract, respiratory tract, skin, and food microbiomes (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Jayaraman et al. <xref ref-type="bibr" rid="CR279">2013</xref>; Campion et al. <xref ref-type="bibr" rid="CR97">2013</xref>; Vieco-Saiz et al. <xref ref-type="bibr" rid="CR572">2019</xref>; Sarika et al. <xref ref-type="bibr" rid="CR497">2019</xref>; Liu et al. <xref ref-type="bibr" rid="CR342">2020</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>; Bos&#x000e1;k et al. <xref ref-type="bibr" rid="CR87">2021</xref>; Saur et al. <xref ref-type="bibr" rid="CR501">2021</xref>; Polak et al. <xref ref-type="bibr" rid="CR440">2021</xref>). Bacteriocins have a high potential for medico- and techno-economic use in biomedicine and agri-food systems, thus depicting their relevance and prospects across the One Health continuum.</p><p id="Par5">From a cross-disciplinary and multisectoral perspective, several bacteriocins from both Gram-negative and Gram-positive bacteria are being explored. Some of these bacteriocins have shown great potential and prospects for field applications. Bacteriocin research has evolved from basic characterization to high-throughput identification and applications in multiple systems. The increasingly comprehensive scientific reports of multi-sourced (and novel) bacteriocins as well as their impacts on human and animal health, food quality and safety, [micro]ecological landscapes, and industry necessitate their unified compilation and synthesis. Furthermore, bacteriocin research and bibliographies are often disjointed in a &#x02018;stand-alone&#x02019; manner seldom without a nexus linking them across disciplines. Understanding the current bacteriocin research across disciplines will inform concerted future research direction which may further foster interdisciplinary perspectives and collaborations. To this end, this review carefully assessed and compiled significant advances and emerging roles of bacteriocins and related innovations within the One Health continuum. Furthermore, we provided a comprehensive cross-disciplinary, multisectoral, and up-to-date potential and prospects of bacteriocins applications and bibliometrics in the human, animal, and food systems.</p></sec><sec id="Sec2"><title>Advances in the biology, classification, and sources of bacteriocins</title><p id="Par6">Bacteriocins have been generally defined as ribosomally synthesized antimicrobial peptide molecules that can either be enzymatically modified or remain unaltered (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Johnson et al. <xref ref-type="bibr" rid="CR284">2018</xref>; Simons et al. <xref ref-type="bibr" rid="CR520">2020</xref>; Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>). They are abundant and highly diverse with widespread synthesis among different groups of bacteria (Riley and Wertz <xref ref-type="bibr" rid="CR471">2002</xref>; Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Fern&#x000e1;ndez-Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR187">2023c</xref>). It has been suggested that 30% to 99% of Archaea and bacterial species synthesize one or more bacteriocins (Klaenhammer <xref ref-type="bibr" rid="CR309">1988</xref>; Riley <xref ref-type="bibr" rid="CR469">1998</xref>). Typically, bacteriocins have a narrow spectrum of bactericidal or bacteriostatic activity against taxonomically related bacteria (O&#x02019;Connor et al. <xref ref-type="bibr" rid="CR406">2018</xref>; Simons et al. <xref ref-type="bibr" rid="CR520">2020</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>), but occasionally they can have a broad spectrum of activity against unrelated bacteria (Cotter et al. <xref ref-type="bibr" rid="CR130">2005</xref>; Mills et al. <xref ref-type="bibr" rid="CR375">2011</xref>; Silva et al. <xref ref-type="bibr" rid="CR519">2018</xref>). The biosynthetic mechanisms for these antimicrobial peptides are relatively simple and often encoded in transferable elements such as plasmids and transposons (Klaenhammer <xref ref-type="bibr" rid="CR310">1993</xref>; And and Hoover <xref ref-type="bibr" rid="CR30">2003</xref>; Fern&#x000e1;ndez-Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR186">2023b</xref>). Bacteriocins are synthesized as biologically inactive precursor peptides harboring an N-terminal leader sequence (Kanmani et al. <xref ref-type="bibr" rid="CR295">2013</xref>; Liu et al. <xref ref-type="bibr" rid="CR344">2023</xref>). These precursor peptides are often detached from the leader peptide and exported outside the cell after post-translational modifications (PTMs) (Riley and Wertz <xref ref-type="bibr" rid="CR471">2002</xref>; Mokoena <xref ref-type="bibr" rid="CR381">2017</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Bacteriocinogenic bacteria have developed mechanisms to protect themselves from being killed by the bacteriocins they produce. These mechanisms include using efflux pumps to export bacteriocins from inside the cells to the outside, synthesizing self-immunity proteins, or using both mechanisms in some instances (Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Ben Lagha et al. <xref ref-type="bibr" rid="CR66">2017</xref>; Bountra et al. <xref ref-type="bibr" rid="CR89">2017</xref>).</p><p id="Par7">The function of bacteriocins depends on the recognition of specific receptors and ionic interactions with the hydrophobic surface molecules of target cells (Soliman et al. <xref ref-type="bibr" rid="CR525">2010</xref>; Todorov et al. <xref ref-type="bibr" rid="CR551">2022</xref>; &#x0015a;mia&#x00142;ek-Bartyzel et al. <xref ref-type="bibr" rid="CR523">2023</xref>). This is typically considered the initial step of the antimicrobial mechanism of action exerted by bacteriocins. To infiltrate the cell membrane and compromise cellular integrity, bacteriocins must effectively recognize these receptors and also express physicochemical interactions with the target cells. For example, receptors like mannose phosphotransferase and lipid II are primarily recognized by class II, unmodified bacteriocins (such as pediocin PA-1 and enterocin CRL35) and class I, post-translationally modified bacteriocins (RiPPs) (such as nisin and mutacin 1140), respectively (Grein et al. <xref ref-type="bibr" rid="CR230">2019</xref>; Wang et al. <xref ref-type="bibr" rid="CR585">2020c</xref>; Zhu et al. <xref ref-type="bibr" rid="CR623">2022</xref>). These intricate interactions between bacteriocins and target cells are often influenced by various physicochemical factors such as temperature, pH, and other chemical constituents. These factors also affect cell membrane integrity and physiological conditions, which consequently impact bacteriocin interactions with specific receptors or directly with the cell membrane (Todorov et al. <xref ref-type="bibr" rid="CR551">2022</xref>). Depending on their primary structure and complexity, bacteriocins exert antimicrobial activity through distinct mechanisms of action on susceptible microbial strains. Some bacteriocins cause cell lysis by inhibiting cell wall synthesis or forming pores in the cell membrane. Others act inside the target cells, inhibiting protein production and gene expression (Dobson et al. <xref ref-type="bibr" rid="CR158">2012</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>).</p><p id="Par8">Since the discovery of bacteriocins about a century ago, there has been an increasing number of characterized and identified bacteriocins. These bacteriocins are heterogeneous and highly diverse, possessing a wide range of complexities, structures, sizes, mechanisms of action, spectra of activity, and target cells. To better collate and understand the structural and functional diversities of bacteriocins, some integrated open-access databases and tools have been developed. These include antiSMASH 2.0 [<ext-link ext-link-type="uri" xlink:href="http://antismash.secondarymetabolites.org/">http://antismash.secondarymetabolites.org/</ext-link> (Blin et al. <xref ref-type="bibr" rid="CR80">2013</xref>)], BAGEL3 [<ext-link ext-link-type="uri" xlink:href="http://bagel.molgenrug.nl/">http://bagel.molgenrug.nl/</ext-link> (van Heel et al. <xref ref-type="bibr" rid="CR566">2013</xref>)], ADAM, [<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.cs.ntou.edu.tw/ADAM">http://bioinformatics.cs.ntou.edu.tw/ADAM</ext-link> (Lee et al. <xref ref-type="bibr" rid="CR335">2015</xref>)], BACTIBASE, [<ext-link ext-link-type="uri" xlink:href="http://bactibase.hammamilab.org">http://bactibase.hammamilab.org</ext-link> (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>)], NucleBact [<ext-link ext-link-type="uri" xlink:href="https://pubmlst.org/projects/nuclebact">https://pubmlst.org/projects/nuclebact</ext-link> (Sharp et al. <xref ref-type="bibr" rid="CR516">2017</xref>)], LABiocin [<ext-link ext-link-type="uri" xlink:href="https://bio.tools/LABiocin_database">https://bio.tools/LABiocin_database</ext-link> (Kassaa et al. <xref ref-type="bibr" rid="CR296">2019</xref>)], BUR&#x02014;bacteriocins database URMITE [<ext-link ext-link-type="uri" xlink:href="https://drissifatima.wixsite.com/bacteriocins">https://drissifatima.wixsite.com/bacteriocins</ext-link> (Drissi et al. <xref ref-type="bibr" rid="CR163">2015</xref>)], Bacteriocin (<ext-link ext-link-type="uri" xlink:href="https://aapep.bocsci.com/">https://aapep.bocsci.com/</ext-link>), and Syngulon (<ext-link ext-link-type="uri" xlink:href="https://syngulon.com/">https://syngulon.com/</ext-link>). Following the first bacteriocin classification by Klaenhammer (<xref ref-type="bibr" rid="CR310">1993</xref>), several classifications have been proposed and used in recent years. Due to the advent of cutting-edge high throughput technologies and new developments in bacteriocins&#x02019; structures, functions, and mechanisms of action, the classification of bacteriocins progressively evolved, undergoing continuous modification. These classification systems primarily hinge on multiple factors such as physical properties, chemical structure, molecular composition, size, stability, mechanism of action, post-translational modification, microbial target, organism producing them, and cell wall type (Klaenhammer <xref ref-type="bibr" rid="CR310">1993</xref>; Dobson et al. <xref ref-type="bibr" rid="CR158">2012</xref>; Arnison et al. <xref ref-type="bibr" rid="CR36">2013</xref>; Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Alvarez-Sieiro et al. <xref ref-type="bibr" rid="CR24">2016</xref>; Johnson et al. <xref ref-type="bibr" rid="CR284">2018</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>).</p><p id="Par9">Building on the previous classification (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>) and recent advances in ribosomally synthesized and post-translationally modified peptides (RiPPs), the latest and updated classification system proposed by Soltani et al. (<xref ref-type="bibr" rid="CR526">2021a</xref>) suggests two large classes of bacteriocins. Class I, also referred to as RiPPs have molecular masses&#x02009;&#x0003c;&#x02009;5&#x000a0;kDa and contain post-translational modifications (PTMs). Class I is subdivided into 12 subclasses, including lanthipeptides, sactipeptides, linear azole(ine)-containing peptides (LAP), circular peptides, glycocins, nucleotide peptides, lasso peptides, siderophore peptides, and Bottromycins from both Gram-positive and Gram-negative bacteria (Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>; Norris and Patchett <xref ref-type="bibr" rid="CR403">2016</xref>; Mills et al. <xref ref-type="bibr" rid="CR376">2017</xref>). Additionally, thiopeptides and linaridins from Actinobacteria (Bagley et al. <xref ref-type="bibr" rid="CR43">2005</xref>; Claesen and Bibb <xref ref-type="bibr" rid="CR120">2010</xref>), and cyanobactins produced by different cyanobacteria (Martins and Vasconcelos <xref ref-type="bibr" rid="CR361">2015</xref>; Martins et al. <xref ref-type="bibr" rid="CR362">2018</xref>) are subclasses of class I bacteriocin. Class II bacteriocins, also known as unmodified bacteriocins, have molecular masses&#x02009;&#x0003c;&#x02009;10&#x000a0;kDa and are subdivided into three subclasses: pediocin-like bacteriocins (single peptides containing the YGNGV consensus sequence), two peptides bacteriocins (containing two or more unmodified peptides), and non-pediocin-like bacteriocins (unmodified linear single peptides devoid of the YGNGV) (Mills et al. <xref ref-type="bibr" rid="CR376">2017</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Generally, the PTMs make class I bacteriocins more stable to extreme pHs, high temperatures, or proteolysis than class II bacteriocins. However, the presence of disulfide bridges in class II bacteriocins relatively increases their stability (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Updated classification of bacteriocins based on post-translationally modified and unmodified peptides (Adopted from Mills et al. <xref ref-type="bibr" rid="CR376">2017</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>)</p></caption><graphic xlink:href="203_2024_3948_Fig1_HTML" id="MO1"/></fig></p><p id="Par10">Bacteriocins are abundant and heterogeneous in nature. Bacteriocin-producing bacteria can be found in both conventional and unconventional sources. While the human gut is considered a conventional source of bacteriocinogenic bacteria, unconventional sources include soil, water, foods/food products, animal guts, and the vagina and nose of animals and humans (Ryan et al. <xref ref-type="bibr" rid="CR480">2008</xref>; Vera Pingitore et al. <xref ref-type="bibr" rid="CR571">2009</xref>; Lo Verso et al. <xref ref-type="bibr" rid="CR345">2018</xref>; Zieli&#x00144;ska and Kolo&#x0017c;yn-Krajewska <xref ref-type="bibr" rid="CR625">2018</xref>; Fuochi et al. <xref ref-type="bibr" rid="CR203">2019</xref>; Reuben et al. <xref ref-type="bibr" rid="CR462">2020</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>; Fern&#x000e1;ndez-Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR185">2023a</xref>, <xref ref-type="bibr" rid="CR186">b</xref>, <xref ref-type="bibr" rid="CR188">c</xref>, <xref ref-type="bibr" rid="CR189">d</xref>; Navarro et al. <xref ref-type="bibr" rid="CR396">2023</xref>). Common bacteriocin-producing bacteria in humans include <italic>Enterococcus</italic>, <italic>Escherichia coli</italic>, <italic>Lactobacillus</italic>, <italic>Lactococcus</italic>, <italic>Pediococcus</italic>, <italic>Staphylococcus</italic>, and <italic>Streptococcus</italic> (Ryan et al. <xref ref-type="bibr" rid="CR480">2008</xref>; Lakshminarayanan et al. <xref ref-type="bibr" rid="CR325">2013</xref>; Zalewska et al. <xref ref-type="bibr" rid="CR614">2018</xref>; Laux et al. <xref ref-type="bibr" rid="CR329">2019</xref>; Kassem et al. <xref ref-type="bibr" rid="CR297">2021</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>). These bacteria not only act as the first line of defense against invading pathogens, but their bacteriocins also play a role in enhancing the immune system (Zipperer et al. <xref ref-type="bibr" rid="CR627">2016</xref>; O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR411">2019</xref>).</p><p id="Par11">Interestingly, most of the bacteriocins that have been successfully characterized and identified are produced by lactic acid bacteria (LAB), which are frequently found in milk and dairy products. LAB is a diverse group of bacteria that has garnered significant interest due to their widely recognized safety status, known as &#x02018;Generally Recognized as Safe&#x02019; (GRAS) and &#x02018;Qualified Presumption of Safety&#x02019; (QPS) status (Reuben et al. <xref ref-type="bibr" rid="CR462">2020</xref>; Zimina et al. <xref ref-type="bibr" rid="CR626">2020</xref>). Some well-known bacteriocinogenic bacteria commonly found in dairy products include <italic>Lactococcus lactis</italic> and <italic>Lactobacillus plantarum</italic> (found in camel, cow, and goat milk), <italic>Lactobacillus kefiranofaciens</italic> and <italic>L. plantarum</italic> (found in cheese and kefir), and <italic>Lactobacillus brevis</italic>, <italic>Enterococcus</italic> spp., and <italic>Streptococcus thermophilus</italic> (found in other dairy products) (Reuben et al. <xref ref-type="bibr" rid="CR462">2020</xref>; Zimina et al. <xref ref-type="bibr" rid="CR626">2020</xref>; Benkirane et al. <xref ref-type="bibr" rid="CR72">2022</xref>). <italic>Lactobacillus acidophilus</italic> is commonly isolated from yogurt and fermented soy products as a bacteriocin-producing bacterium, while <italic>Bifidobacterium lacti</italic>s and <italic>Brevibacillus brevis</italic> are most commonly found in raw milk (Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>). In milk products, <italic>Lactobacillus</italic>, <italic>Lactococcus</italic>, and <italic>Streptococcus</italic> are the predominant bacteriocin-producing bacteria.</p><p id="Par12">From fermented raw or cooked meat products, <italic>Lactobacillus brevis</italic>, <italic>Lactobacillus curvatus</italic>, <italic>Lactobacillus fermentum</italic>, <italic>Lactobacillus plantarum</italic> subsp. <italic>plantarum</italic>, <italic>Enterococcus faecium</italic> UAM1, <italic>Pediococcus pentosaceus</italic>, and <italic>P. accidilactici</italic> are widely isolated bacteriocinogenic bacteria (Aymerich et al. <xref ref-type="bibr" rid="CR41">2011</xref>; Zieli&#x00144;ska and Kolo&#x0017c;yn-Krajewska <xref ref-type="bibr" rid="CR625">2018</xref>; Khorshidian et al. <xref ref-type="bibr" rid="CR303">2021</xref>; Garc&#x000ed;a-L&#x000f3;pez et al. <xref ref-type="bibr" rid="CR206">2023</xref>; Kaveh et al. <xref ref-type="bibr" rid="CR299">2023</xref>). These bacteria exhibit inhibitory activity against major foodborne pathogens including <italic>Aeromonas hydrophila</italic>, <italic>Listeria monocytogenes</italic>, and <italic>Staphylococcus aureus</italic>, thereby preventing their growth in meat products (Winkowski and Montville <xref ref-type="bibr" rid="CR590">1992</xref>; Khan et al. <xref ref-type="bibr" rid="CR300">2016</xref>). <italic>E</italic>. <italic>faecium</italic> HL7, <italic>L</italic>. <italic>plantarum</italic>, and <italic>L</italic>. <italic>brevis</italic> LAP2 are commonly associated with fish and seafood (Vijayabaskar and Somasundaram <xref ref-type="bibr" rid="CR573">2008</xref>; G&#x000f3;mez-Sala et al. <xref ref-type="bibr" rid="CR223">2015</xref>; Ring&#x000f8; et al. <xref ref-type="bibr" rid="CR472">2018</xref>), while <italic>L</italic>. <italic>brevis</italic>, <italic>L. paracasei</italic>, <italic>L. pentosus</italic>, <italic>L. fermentum</italic>, <italic>L. plantarum</italic>, <italic>Weissella</italic>, <italic>Pediococcus</italic>, and <italic>Enterococcus durans</italic> are known bacteriocin-producing bacteria found in fruits and vegetables (Knorr <xref ref-type="bibr" rid="CR312">1998</xref>; Linares-Morales et al. <xref ref-type="bibr" rid="CR340">2020</xref>). Soil is another extensively studied unconventional source of bacteriocinogenic bacteria. Many bacteriocins obtained from soilborne bacteria and rhizosphere exhibit inhibitory and biocidal activity against phytopathogens, pests, and insects, making them useful for plant protection as well as biopesticides, bioinsecticides, and growth stimulants (Lv et al. <xref ref-type="bibr" rid="CR349">2017</xref>; Zimina et al. <xref ref-type="bibr" rid="CR626">2020</xref>). Soil bacteria, including <italic>Pseudomonas putida</italic> BW11M1, <italic>Bacillus subtilis</italic> 14B, and <italic>Clavibacter michiganensis</italic> subsp. michiganensis (<italic>Cmm</italic>) produce bacteriocin putidacin, Bac 14B, and michiganin A which have inhibitory activity against <italic>P. putida</italic> GR12-2R3, <italic>Agrobacter tumefaciens</italic>, and <italic>C. michiganensis</italic> subsp. <italic>Sepedonicus</italic>, the etiological agents of plant diseases. Similarly, <italic>Bacillus clausii</italic> GM17 produces bacteriocin Bac GM17 which has broad-spectrum antifungal and antibacterial activity against multiple phytopathogens (Zimina et al. <xref ref-type="bibr" rid="CR626">2020</xref>). Recently, our group characterized and identified different bacteriocins of staphylococcal origin from multiple sources including humans, food, migratory birds, pets, wild animals, and the environment (Fern&#x000e1;ndez-Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR183">2022a</xref>, <xref ref-type="bibr" rid="CR184">b</xref>, <xref ref-type="bibr" rid="CR185">2023a</xref>; <xref ref-type="bibr" rid="CR186">b</xref>).</p></sec><sec id="Sec3"><title>Trends in bacteriocins research: a bibliometrics perspective</title><p id="Par13">To fully comprehend the current direction of bacteriocin research, we conducted a bibliometric analysis to identify the prevalent research trends and gaps in the field as well as future research perspectives. In August 2023, we conducted a comprehensive literature search on the Web of Science core collection database (<ext-link ext-link-type="uri" xlink:href="http://www.webofscience.com/">http://www.webofscience.com/</ext-link>) using the keyword &#x02018;bacteriocin&#x02019; to identify relevant bacteriocin-based publications. We included articles published in 16 different languages until August 2023 for our synthesis (Table <xref rid="MOESM1" ref-type="media">S1</xref>). In total, there were 8303 publications with 270,493 citations recorded in the Web of Science (WoS) core collection between 1958 to August 2023. Throughout this period, we observed a relatively steady increase in the number of articles and citations, with a notable spike in 2021 (articles&#x02009;=&#x02009;474; citations&#x02009;=&#x02009;23,638) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). It is worth mentioning that the last decade has seen an unprecedented exponential increase in bacteriocin-related research, nearly doubling the total research output of previous decades. Given the utilization of advanced technologies in bacteriocin research and the growing global interest and acceptance of bacteriocins in recent years, this trend is not surprising.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Bibliometric indices of bacteriocin-related publications and citations</p></caption><graphic xlink:href="203_2024_3948_Fig2_HTML" id="MO2"/></fig></p><p id="Par14">There is a wide geographical spread of bacteriocin-related research outputs, spanning 127 countries or regions around the world. The United States, China, and Spain are leading with 1238 (14.907%), 716 (8.621%), and 605 (7.285%) publications respectively, while 26 other countries have over 100 publications each (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Interestingly, the top regions leading in bacteriocin-related research outputs are North America, Europe, and Asia which are known to have highly industrialized economies. The dominance of these countries can be rationalized by the public perception and national/regional approval of certain bacteriocins for commercial use. For example, the European Union (EU) approved the use of Nisin (E 234) as a food additive in various food categories in the EU under Directive 83/463/EEC, Directive 95/2/EC in 1988, and EU Annex II of Regulation (EC)&#x000a0;1333/2008 in 2006, following its safety evaluation by the European Food Safety Authority expert panel (European Food Safety Authority (EFSA) <xref ref-type="bibr" rid="CR173">2006</xref>). Similarly, the Food and Drug Administration of the USA approved the use of nisin as an antimicrobial agent in 1988 (and later amended at 59 FR 14364, Mar. 28, 1994; 68 FR 24879, May 9, 2003; and 88 FR 17724, Mar. 24, 2023) (<ext-link ext-link-type="uri" xlink:href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=184.1538">https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=184.1538</ext-link>), and it was given the GRAS status for use in processed food (Cotter et al. <xref ref-type="bibr" rid="CR130">2005</xref>; Shin et al. <xref ref-type="bibr" rid="CR518">2016</xref>). The periods of these approvals coincided with the rise in antimicrobial resistance to commercially available antimicrobials and concerns about the use of in-fed antimicrobials in livestock production (European Commission <xref ref-type="bibr" rid="CR172">2005</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Country-specific bacteriocins-related research outputs (top 50)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Countries/Regions</th><th align="left">Record count</th><th align="left">% of 8303</th></tr></thead><tbody><tr><td align="left">USA</td><td align="left">1238</td><td char="." align="char">14.91</td></tr><tr><td align="left">China</td><td align="left">715</td><td char="." align="char">8.611</td></tr><tr><td align="left">Spain</td><td align="left">605</td><td char="." align="char">7.287</td></tr><tr><td align="left">India</td><td align="left">522</td><td char="." align="char">6.287</td></tr><tr><td align="left">France</td><td align="left">500</td><td char="." align="char">6.022</td></tr><tr><td align="left">Brazil</td><td align="left">478</td><td char="." align="char">5.757</td></tr><tr><td align="left">Japan</td><td align="left">431</td><td char="." align="char">5.191</td></tr><tr><td align="left">Canada</td><td align="left">418</td><td char="." align="char">5.034</td></tr><tr><td align="left">Germany</td><td align="left">331</td><td char="." align="char">3.987</td></tr><tr><td align="left">South korea</td><td align="left">318</td><td char="." align="char">3.83</td></tr><tr><td align="left">Ireland</td><td align="left">281</td><td char="." align="char">3.384</td></tr><tr><td align="left">Norway</td><td align="left">280</td><td char="." align="char">3.372</td></tr><tr><td align="left">Italy</td><td align="left">278</td><td char="." align="char">3.348</td></tr><tr><td align="left">England</td><td align="left">236</td><td char="." align="char">2.842</td></tr><tr><td align="left">The Netherlands</td><td align="left">204</td><td char="." align="char">2.457</td></tr><tr><td align="left">Argentina</td><td align="left">196</td><td char="." align="char">2.361</td></tr><tr><td align="left">Belgium</td><td align="left">191</td><td char="." align="char">2.3</td></tr><tr><td align="left">Turkey</td><td align="left">163</td><td char="." align="char">1.963</td></tr><tr><td align="left">Iran</td><td align="left">144</td><td char="." align="char">1.734</td></tr><tr><td align="left">Egypt</td><td align="left">135</td><td char="." align="char">1.626</td></tr><tr><td align="left">South africa</td><td align="left">135</td><td char="." align="char">1.626</td></tr><tr><td align="left">Thailand</td><td align="left">135</td><td char="." align="char">1.626</td></tr><tr><td align="left">Slovakia</td><td align="left">131</td><td char="." align="char">1.578</td></tr><tr><td align="left">Australia</td><td align="left">126</td><td char="." align="char">1.518</td></tr><tr><td align="left">New Zealand</td><td align="left">126</td><td char="." align="char">1.518</td></tr><tr><td align="left">Denmark</td><td align="left">108</td><td char="." align="char">1.301</td></tr><tr><td align="left">Pakistan</td><td align="left">108</td><td char="." align="char">1.301</td></tr><tr><td align="left">Russia</td><td align="left">106</td><td char="." align="char">1.277</td></tr><tr><td align="left">Malaysia</td><td align="left">105</td><td char="." align="char">1.265</td></tr><tr><td align="left">Poland</td><td align="left">98</td><td char="." align="char">1.18</td></tr><tr><td align="left">Portugal</td><td align="left">98</td><td char="." align="char">1.18</td></tr><tr><td align="left">Tunisia</td><td align="left">92</td><td char="." align="char">1.108</td></tr><tr><td align="left">Mexico</td><td align="left">90</td><td char="." align="char">1.084</td></tr><tr><td align="left">Greece</td><td align="left">86</td><td char="." align="char">1.036</td></tr><tr><td align="left">Czech Republic</td><td align="left">83</td><td char="." align="char">1.000</td></tr><tr><td align="left">Switzerland</td><td align="left">80</td><td char="." align="char">0.964</td></tr><tr><td align="left">Taiwan</td><td align="left">64</td><td char="." align="char">0.771</td></tr><tr><td align="left">Indonesia</td><td align="left">59</td><td char="." align="char">0.711</td></tr><tr><td align="left">Finland</td><td align="left">57</td><td char="." align="char">0.686</td></tr><tr><td align="left">Bulgaria</td><td align="left">53</td><td char="." align="char">0.638</td></tr><tr><td align="left">Saudi Arabia</td><td align="left">52</td><td char="." align="char">0.626</td></tr><tr><td align="left">Scotland</td><td align="left">48</td><td char="." align="char">0.578</td></tr><tr><td align="left">Serbia</td><td align="left">47</td><td char="." align="char">0.566</td></tr><tr><td align="left">Nigeria</td><td align="left">46</td><td char="." align="char">0.554</td></tr><tr><td align="left">Slovenia</td><td align="left">46</td><td char="." align="char">0.554</td></tr><tr><td align="left">Algeria</td><td align="left">43</td><td char="." align="char">0.518</td></tr><tr><td align="left">Sweden</td><td align="left">43</td><td char="." align="char">0.518</td></tr><tr><td align="left">Chile</td><td align="left">40</td><td char="." align="char">0.482</td></tr><tr><td align="left">Israel</td><td align="left">34</td><td char="." align="char">0.409</td></tr><tr><td align="left">Morocco</td><td align="left">34</td><td char="." align="char">0.409</td></tr></tbody></table></table-wrap></p><p id="Par15">The categorization of publications related to bacteriocins, according to disciplines and specialties demonstrates the broad and multidisciplinary nature of bacteriocin research and applications in various fields, including the One Health systems. Out of the 8303 publications, 45.1% (3749), 30.3% (2513), and 23.6% (1958) were categorized under microbiology, biotechnology and applied microbiology, and food science and technology, respectively. Other disciplines that have significant bacteriocin-related research outputs, with over 100 publications, include pharmacology and pharmacy, biochemistry and molecular biology, agriculture, infectious diseases, immunology, nutrition and dietetics, plant sciences, chemistry, veterinary sciences, dentistry and oral medicine, and multidisciplinary sciences (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Microbiology is the discipline with the highest number of research outputs, which is expected since bacteriocins are microbial products. Therefore, most microbiological research focuses on characterizing, synthesizing, and identifying (novel) bacteriocins from various microorganisms isolated from both conventional and unconventional sources. Biotechnology and applied microbiology, as well as food science and technology, are also prominent research areas in bacteriocins-related publications, highlighting the dynamic and diverse biotechnological applications of bacteriocins and their increasing use in food production (Gharsallaoui et al. <xref ref-type="bibr" rid="CR213">2016</xref>; Chandrakasan et al. <xref ref-type="bibr" rid="CR109">2019</xref>). Furthermore, emerging areas with bacteriocin-related publications include obstetrics and gynecology, dermatology, oncology, soil science, nanoscience and nanotechnology, neurosciences, entomology, and agronomy. To further support the categorization of bacteriocin-associated research outputs, we examined the intra-discipline citations at both the meso- and micro-scale. Our findings revealed that inflammatory bowel diseases and infections (3325), bacteriology (787), antibiotics and antimicrobials (345), dentistry and oral medicine (236), and plant pathology (187) were the specialized areas with the highest number of citations (Figure <xref rid="MOESM1" ref-type="media">S1</xref>).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>TreeMap representation of bacteriocin-related publications across disciplines</p></caption><graphic xlink:href="203_2024_3948_Fig3_HTML" id="MO3"/></fig></p><p id="Par16">While Elsevier (1723), Springer Nature (1202), Wiley (914), the American Society for Microbiology (905), and MDPI (323) are the publishers with the most bacteriocin-related publications, the United States Department of Health and Human Services (HHS), the National Institutes of Health<italic> (</italic>NIH), National Natural Science Foundation of China (NSFC), the Brazilian National Council for Scientific and Technological Development (CNPQ), and the Spanish Government are among the leading funding agencies for bacteriocin research (Tables S2 and S3). There is a global spread of funding for bacteriocin research. This demonstrates the willingness of funding agencies across different regions of the world to support bacteriocin research. Finally, among the 17 Sustainable Development Goals (SDGs), 7277, 172, 123, 63, and 46 bacteriocin-related research outputs primarily align with Goal 3: Good Health and Well-being, Goal 2: Zero Hunger, Goal 15: Life on Land, Goal 13: Climate Action, and Goal 12: Responsible Consumption and Production (Table S4). While there are a few bacteriocin research outputs that align with several other SDGs, this highlights the potential of bacteriocins in promoting global peace and prosperity for both people and the planet, both now and in the future (<ext-link ext-link-type="uri" xlink:href="https://sdgs.un.org/goals">https://sdgs.un.org/goals</ext-link>).</p></sec><sec id="Sec4"><title>Bacteriocins vs. viable [probiotics/protective cultures] cells: mitigating emerging concerns</title><p id="Par17">Most bacteriocin-producing bacteria, especially (foodborne) LAB and gut commensals are widely used as probiotics or protective cultures in food production and as supplements for animals and humans. Bacteriocin production has long been recognized as an important trait in probiotics or protective cultures (Corr et al. <xref ref-type="bibr" rid="CR127">2007</xref>; Dobson et al. <xref ref-type="bibr" rid="CR158">2012</xref>; Cotter et al. <xref ref-type="bibr" rid="CR131">2013</xref>). Although the exact ecological function of bacteriocins is not fully understood, it is believed that they play a significant role in the functionality of probiotics within their host. Functioning as colonizing peptides, bacteriocins facilitate the colonization and dominance of a producing [probiotic] strain into an already established niche (Riley and Wertz <xref ref-type="bibr" rid="CR471">2002</xref>; Anjana <xref ref-type="bibr" rid="CR31">2022</xref>). These promising advantages exerted by bacteriocins are attributed to their biofunctional properties and structural diversity (Zhu et al. <xref ref-type="bibr" rid="CR624">2023</xref>; Wang et al. <xref ref-type="bibr" rid="CR587">2023</xref>). Current research focuses on exploring the underlying bioactivity of bacteriocins in the development of novel probiotics for broad and newer applications in biomedicine and the agri-food industry. Under different conditions, probiotic-derived bacteriocins are often evaluated and used alone or in combination with the producing strains (Umair et al. <xref ref-type="bibr" rid="CR561">2022</xref>; Hussien et al. <xref ref-type="bibr" rid="CR268">2022</xref>; Ahn et al. <xref ref-type="bibr" rid="CR13">2023</xref>; Mihailovskaya et al. <xref ref-type="bibr" rid="CR373">2023</xref>; Yu et al. <xref ref-type="bibr" rid="CR611">2023</xref>). Bacteriocins can directly inhibit pathogens and other competing microorganisms (Majeed et al. <xref ref-type="bibr" rid="CR355">2011</xref>; Simons et al. <xref ref-type="bibr" rid="CR520">2020</xref>) or modulate the composition and diversity of microbial communities and the host immune system through signaling mechanisms (Cz&#x000e1;r&#x000e1;n et al. <xref ref-type="bibr" rid="CR136">2002</xref>; Di Cagno et al. <xref ref-type="bibr" rid="CR154">2007</xref>; Chikindas et al. <xref ref-type="bibr" rid="CR115">2018</xref>). For example, vancomycin-resistant enterococci (VRE) were successfully controlled using pediocin PA-1-producing <italic>P. acidilactici</italic> MM33. Conversely, no effect was recorded using the non-pediocin PA-1 producing <italic>P. acidilactici</italic> MM33 strain (Millette et al. <xref ref-type="bibr" rid="CR374">2008</xref>). In separate studies, novel bacteriocins such as cerein B4080, cerein 7B, bacteriocin AS-48, garvicin KS, and micrococcin P1 were studied and proposed as promising alternatives for the treatment of skin and soft tissue infections caused by multidrug-resistant <italic>Staphylococcus aureus</italic> (Ovchinnikov et al. <xref ref-type="bibr" rid="CR420">2020</xref>; Vel&#x000e1;zquez-Su&#x000e1;rez et al. <xref ref-type="bibr" rid="CR570">2021</xref>; Jaumaux et al. <xref ref-type="bibr" rid="CR278">2023</xref>). Like probiotics, the antimicrobial properties of bacteriocins are pathogen-specific and activity-dependent (Tran et al. <xref ref-type="bibr" rid="CR555">2023</xref>; Zhu et al. <xref ref-type="bibr" rid="CR624">2023</xref>). Similarly, oral administration of bacteriocin (ABP118) producing <italic>L. salivarius</italic> UCC118 reportedly controlled <italic>L. monocytogenes</italic> infection than the non-ABP118 producing strain of <italic>L. salivarius</italic> UCC118 (Corr et al. <xref ref-type="bibr" rid="CR127">2007</xref>). Therefore, assessing the antimicrobial profiles of bacteriocins against multiple pathogens under different conditions is a prerequisite for their selection in the treatment of antibiotic-resistant pathogens in clinical settings.</p><p id="Par18">The common and primary denominator in probiotics and protective cultures is the viability of the cells. Both probiotics and protective cultures essentially consist of live or viable cells specifically selected to confer desired benefits when used in adequate amounts (Hill et al. <xref ref-type="bibr" rid="CR250">2014</xref>; Hammami et al. <xref ref-type="bibr" rid="CR241">2019</xref>; Fischer and Titgemeyer <xref ref-type="bibr" rid="CR195">2023</xref>). However, emerging evidence demonstrates their viability as a non-essential precursor for exerting the desired beneficial properties. Some non-viable components from probiotics and protective cultures, such as bacteriocins and postbiotics, can exude comparable beneficial properties (Raman et al. <xref ref-type="bibr" rid="CR452">2016</xref>; Hammami et al. <xref ref-type="bibr" rid="CR241">2019</xref>; Homayouni Rad et al. <xref ref-type="bibr" rid="CR256">2021</xref>; Mack et al. <xref ref-type="bibr" rid="CR351">2022</xref>; Liang and Xing <xref ref-type="bibr" rid="CR338">2023</xref>; Teng et al. <xref ref-type="bibr" rid="CR547">2023</xref>). Bacteriocins are highly diverse and often outperform viable cells in terms of safety, bioavailability, absorption, distribution, and metabolism while maintaining cognate bioactivities (Ng et al. <xref ref-type="bibr" rid="CR400">2020</xref>; Todorov et al. <xref ref-type="bibr" rid="CR551">2022</xref>; Liang and Xing <xref ref-type="bibr" rid="CR338">2023</xref>).</p><p id="Par19">In recent decades, there have been overwhelming concerns associated with the use of probiotics and protective cultures, particularly regarding the acquisition and distribution of undesired genes, such as antibiotic resistance and virulence. In most cases, microbial strains used as probiotics or protective cultures are generally benign and pose no risk. However, untoward conditions, especially horizontal transfer directly or indirectly predispose them to acquire or spread antibiotic resistance and virulence genes among the commensal microbiota (and opportunistic pathogens) inhabiting the same niche (Imperial and Ibana <xref ref-type="bibr" rid="CR271">2016</xref>; Costa et al. <xref ref-type="bibr" rid="CR129">2018</xref>; Kothari et al. <xref ref-type="bibr" rid="CR316">2019</xref>). Human or animal microbiota is believed to be a trove of numerous [functional] genes, including antibiotic resistance genes which can be easily shared or transferred between resident and transient bacteria (e.g., probiotics and pathogens) (Kothari et al. <xref ref-type="bibr" rid="CR316">2019</xref>). Several studies have extensively documented the transfer of undesirable genes between the resident microbiota (in the gut or food) and the strains used as probiotics or protective cultures (Hu et al. <xref ref-type="bibr" rid="CR263">2013</xref>; Aarts and Margolles <xref ref-type="bibr" rid="CR1">2014</xref>; Abriouel et al. <xref ref-type="bibr" rid="CR7">2015</xref>; Wolfe <xref ref-type="bibr" rid="CR593">2023</xref>; Sada et al. <xref ref-type="bibr" rid="CR483">2024</xref>). Other concerns associated with the use of probiotics and protective cultures include deleterious metabolic activities and imbalances, the eruption of excessive immune responses, persistent microbial colonization that disrupts the normal microbiota, septicemia, and localized or systemic infections (Spano et al. <xref ref-type="bibr" rid="CR531">2010</xref>; Doron and Snydman <xref ref-type="bibr" rid="CR160">2015</xref>; Pararajasingam and Uwagwu <xref ref-type="bibr" rid="CR425">2017</xref>; Costa et al. <xref ref-type="bibr" rid="CR129">2018</xref>; Kim et al. <xref ref-type="bibr" rid="CR305">2018</xref>; Sada et al. <xref ref-type="bibr" rid="CR483">2024</xref>).</p><p id="Par20">The concerns associated with the use of live cells necessitate the use of bacteriocins, which may be safer for application in multiple systems. Since most microbial strains used as probiotics or protective cultures produce known (or unknown) bacteriocins or bacteriocin-like inhibitory substances (BLIS) that exert similar beneficial effects as the viable strains, it is believed that researchers may sooner than expected preferably explore the use of bacteriocins to mitigate the concerns associated with the use of viable cells. Bacteriocins seem to pose little or no risks for use within animal, human, and food systems while exerting their heterogeneous beneficial effects. Therefore, they may be the most preferred choice for broad applications earlier than anticipated. To fully understand the risks associated with the use of viable cells and to establish the preference for bacteriocin applications in real-life situations, more comprehensive studies using experimental evolution across multiple systems are required.</p></sec><sec id="Sec5"><title>Applications of bacteriocins</title><p id="Par21">As the science of bacteriocins steadily progresses, their areas of application are increasing proportionately, encompassing previously unknown areas. Since their discovery, bacteriocins have been used to improve food production, preservation, and safety in the food industry. However, their potential has now extended to various fields, including biotechnology, ecology, pharmaceuticals, agriculture, clinical settings, and veterinary medicine. Bacteriocins offer sustainable solutions to a wide range of scientific problems. Here, we critically evaluated and compiled the significant advances and emerging roles of bacteriocins as well as the latest bacteriocin-related innovations aimed at harnessing their heterogeneous potential and prospects for multisectoral applications in health and agrifood systems. Table <xref rid="Tab2" ref-type="table">2</xref> summarizes some bacteriocins with potential applications in different systems.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Bacteriocins with potential applications</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Microbiome modulation</th></tr><tr><th align="left">Effect</th><th align="left">Model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Nisin Z</td><td align="left"><italic>Lactococcus lactis</italic></td><td align="left">Reduction of enteric pathogens</td><td align="left">Mouse</td><td align="left">Millette et al. (<xref ref-type="bibr" rid="CR374">2008</xref>)</td></tr><tr><td align="left"><italic>Nisin</italic></td><td align="left"><italic>L. lactis</italic></td><td align="left">Modulation of microbiome-brain-gut axis neurochemicals</td><td align="left">Mice</td><td align="left">Jia et al. (<xref ref-type="bibr" rid="CR280">2018</xref>)</td></tr><tr><td align="left"><italic>Nisin Z</italic></td><td align="left"><italic>L. lactis</italic></td><td align="left">Reduction of intestinal colonization of vancomycin-resistant enterococci (VRE) and Immunomodulatory effect</td><td align="left">Murine</td><td align="left">Millette et al. (<xref ref-type="bibr" rid="CR374">2008</xref>)</td></tr><tr><td align="left">Nisin P</td><td align="left"><italic>L. lacti</italic>s SMN003</td><td align="left">Reduction of <italic>S. aureus</italic> and regulation of cytokine concentration to reduce uterine inflammation in rats</td><td align="left">Rat</td><td align="left">Dabour et al. (<xref ref-type="bibr" rid="CR138">2009</xref>)</td></tr><tr><td align="left"><italic>Nisin</italic></td><td align="left"><italic>L. lactis</italic></td><td align="left">Control of meningitis, sepsis, and pneumonia</td><td align="left">In vitro and mouse</td><td align="left">Goldstein (<xref ref-type="bibr" rid="CR220">1998</xref>)</td></tr><tr><td align="left">Nisin A</td><td align="left"><italic>L. lactis</italic></td><td align="left">Decrease the levels of IL-6, IL-8, and TNF-&#x003b1; and the growth of bacteria wound</td><td align="left">Ex vivo</td><td align="left">Mouritzen et al. (<xref ref-type="bibr" rid="CR386">2019</xref>)</td></tr><tr><td align="left">Sakacin A (SakA), pediocin PA-1 (PedPA-1), enterocins P, Q and L50 (enterocins), plantaricins EF and JK (plantaricins) and garvicin ML (GarML)</td><td align="left">Multiple bacteriocinogenic strains</td><td align="left">Modulation of the abundance of gut microbiota and structure</td><td align="left">Mice</td><td align="left">Umu et al. (<xref ref-type="bibr" rid="CR562">2016</xref>)</td></tr><tr><td align="left">Bactofencin A</td><td align="left"><italic>Lactobacillus salivarius</italic> DPC6502</td><td align="left">Modulation of gut microbial populations</td><td align="left">Simulated colon</td><td align="left">Guinane et al. (<xref ref-type="bibr" rid="CR234">2016</xref>)</td></tr><tr><td align="left">Bactofencin A</td><td align="left"><italic>L. salivarius</italic></td><td align="left">Reduction of <italic>Listeria</italic> and staphylococcal counts</td><td align="left">In vitro</td><td align="left">O&#x02019;Connor et al. (<xref ref-type="bibr" rid="CR406">2018</xref>)</td></tr><tr><td align="left"><italic>Bactofencin A</italic></td><td align="left"><italic>L. salivariu</italic>s DPC6502</td><td align="left">Increase relative abundances of <italic>Bifidobacterium</italic> and <italic>Streptococcus</italic> while lowering the abundances of <italic>Blautia</italic> and <italic>Clostridium</italic> spp.</td><td align="left">Mice</td><td align="left">Sun et al. (<xref ref-type="bibr" rid="CR540">2020</xref>)</td></tr><tr><td align="left">Lacticin3147</td><td align="left"><italic>L. lactis</italic> DPC3147</td><td align="left">Reduction of <italic>Clostridium difficile</italic> associated diarrhea (CDAD)</td><td align="left">In vitro</td><td align="left">Rea et al. (<xref ref-type="bibr" rid="CR456">2007</xref>)</td></tr><tr><td align="left"><italic>Lactocin 160</italic></td><td align="left"><italic>L. rhamnosus</italic></td><td align="left">Control <italic>Escherichia coli</italic> and <italic>Bordetella pertussis</italic></td><td align="left">In vitro</td><td align="left">Belfiore et al. (<xref ref-type="bibr" rid="CR65">2007</xref>)</td></tr><tr><td align="left">Bacteriocin Abp118</td><td align="left"><italic>L. salivarius</italic></td><td align="left">Reduction of Listeriosis</td><td align="left">Murine and pigs</td><td align="left">Riboulet-Bisson et al. (<xref ref-type="bibr" rid="CR467">2012</xref>)</td></tr><tr><td align="left">Bacteriocin OR-7</td><td align="left"><italic>L. salivarius</italic> NRRLB</td><td align="left">Reduction of <italic>Campylobacter jejuni</italic> counts</td><td align="left">Chicken</td><td align="left">Ilinskaya et al. (<xref ref-type="bibr" rid="CR270">2017</xref>)</td></tr><tr><td align="left">Erwinaocin NA4</td><td align="left"><italic>Erwinia carotovora</italic> NA4</td><td align="left">Reduction of coliphage</td><td align="left">In vitro</td><td align="left">Dey et al. (<xref ref-type="bibr" rid="CR153">2021</xref>)</td></tr><tr><td align="left">Pediocin PA1</td><td align="left"><italic>Pediococcus acidilactici</italic></td><td align="left">Control listeriosis</td><td align="left">Mouse</td><td align="left">Dabour et al. (<xref ref-type="bibr" rid="CR138">2009</xref>)</td></tr><tr><td align="left">Pediocin AcH</td><td align="left"><italic>P. acidilactici</italic></td><td align="left">Reduction of enteric pathogens</td><td align="left">Mouse</td><td align="left">Millette et al. (<xref ref-type="bibr" rid="CR374">2008</xref>)</td></tr><tr><td align="left">Enterocin A/P</td><td align="left"><italic>Enterococcus faecium</italic> P13</td><td align="left">Modulation of gut microbiota, improving growth and immune response</td><td align="left">Rabbit</td><td align="left">Pog&#x000e1;ny Simonov&#x000e1; et al. (<xref ref-type="bibr" rid="CR439">2022</xref>)</td></tr><tr><td align="left">Microcin M</td><td align="left"><italic>Escherichia coli</italic> MC4100</td><td align="left">Inhibition of intestinal pathogenic bacteria and reduction of intestinal inflammation</td><td align="left">Mice</td><td align="left">Sassone-Corsi et al. (<xref ref-type="bibr" rid="CR498">2016</xref>)</td></tr><tr><td align="left">Microcin J25</td><td align="left"><italic>E. coli</italic></td><td align="left">Modulation of porcine microbiota composition and metabolome</td><td align="left">PolyFermS in vitro continuous fermentation</td><td align="left">Naimi et al. (<xref ref-type="bibr" rid="CR393">2022</xref>)</td></tr><tr><td align="left">Microcin J25</td><td align="left"><italic>E. coli</italic></td><td align="left">Improve intestinal microbiota and inflammation of broiler and mouse caused by <italic>Salmonella</italic> and Enterotoxigenic<italic> E. coli</italic></td><td align="left">Broiler and mouse</td><td align="left">Yu et al. (<xref ref-type="bibr" rid="CR609">2018</xref>), Wang et al. (<xref ref-type="bibr" rid="CR584">2020b</xref>)</td></tr><tr><td align="left">Gassericin A</td><td align="left"><italic>L. gasseri</italic> LA39</td><td align="left">Increase relative abundances of beneficial lactic acid bacteria, promote fluid absorption, and decrease diarrhoea</td><td align="left">Early weaned piglets</td><td align="left">Hu et al. (<xref ref-type="bibr" rid="CR265">2018</xref>)</td></tr><tr><td align="left">Lmo2776</td><td align="left"><italic>Listeria monocytogenes</italic></td><td align="left">Target the commensal <italic>Prevotella copri</italic> and modulation of intestinal infection</td><td align="left">Mice</td><td align="left">Rolhion et al. (<xref ref-type="bibr" rid="CR477">2019</xref>)</td></tr><tr><td align="left">Salivaricin LHM</td><td align="left"><italic>L. salivarius</italic></td><td align="left">Antibacterial, immunomodulatory, and antibiofilm</td><td align="left">Simulated urinary tract infection</td><td align="left">Mahdi et al. (<xref ref-type="bibr" rid="CR354">2019</xref>)</td></tr><tr><td align="left">Plantaricin EF</td><td align="left"><italic>L. plantarum</italic></td><td align="left">Intestinal microbial modulation, maintains epithelial barrier integrity, reduction of obesity and fat inflammation</td><td align="left">In vitro and mice</td><td align="left">Heeney et al. (<xref ref-type="bibr" rid="CR245">2019</xref>)</td></tr><tr><td align="left">Sublancin</td><td align="left"><italic>Bacillus subtilis</italic> 800</td><td align="left">Protection against methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) and enhancement of macrophage function</td><td align="left">Mice</td><td align="left">Wang et al. (<xref ref-type="bibr" rid="CR579">2018</xref>, <xref ref-type="bibr" rid="CR581">2019b</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Bacterial infections</th></tr><tr><th align="left">Target microorganism</th><th align="left">Model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Bacteriocin C2-1</td><td align="left"><italic>Ligilactobacillus salivarius</italic> C2-1</td><td align="left"><italic>Listeria monocytogenes</italic> CICC 21633</td><td align="left">In vitro</td><td align="left">Mu et al. (<xref ref-type="bibr" rid="CR388">2024</xref>)</td></tr><tr><td align="left">Lactocin AL705</td><td align="left"><italic>L. curvatus</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">In vitro</td><td align="left">Melian et al. (<xref ref-type="bibr" rid="CR371">2019</xref>)</td></tr><tr><td align="left">Lactocin 160</td><td align="left"><italic>L. Rhamnosus</italic></td><td align="left"><italic>Gardnerella vaginalis</italic>, <italic>Bacillus pertussis</italic></td><td align="left">In epivaginal</td><td align="left">Turovskiy et al. (<xref ref-type="bibr" rid="CR557">2009</xref>)</td></tr><tr><td align="left">Lacticin NK34</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>S. aureus/S. simulans</italic></td><td align="left">Mice</td><td align="left">Kim et al. (<xref ref-type="bibr" rid="CR304">2010</xref>)</td></tr><tr><td align="left">Thiostrepton</td><td align="left"><italic>Streptomyces</italic> spp.</td><td align="left"><italic>Mycobacterium abscessus</italic></td><td align="left">In vitro and zebrafish (FDA approved)</td><td align="left">Rodnina et al. (<xref ref-type="bibr" rid="CR475">1999</xref>), Kim et al. (<xref ref-type="bibr" rid="CR306">2019</xref>)</td></tr><tr><td align="left">Thuricin CD</td><td align="left"><italic>Bacillus thuringiensis</italic> DPC 6431</td><td align="left"><italic>Clostridium difficile</italic>, <italic>L. monocytogenes</italic></td><td align="left">In vitro and mice</td><td align="left">Rea et al. (<xref ref-type="bibr" rid="CR457">2010</xref>, <xref ref-type="bibr" rid="CR458">2014</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L</italic>. <italic>lactis</italic></td><td align="left"><italic>Staphylococcus aureus</italic>, <italic>C. difficile</italic></td><td align="left">In vitro, mice and rat (FDA approved)</td><td align="left">Brand et al. (<xref ref-type="bibr" rid="CR90">2010</xref>), Lay et al. (<xref ref-type="bibr" rid="CR331">2016</xref>)</td></tr><tr><td align="left">Nisin F</td><td align="left"><italic>L. lactis</italic> subsp. <italic>lactis</italic></td><td align="left"><italic>S. aureus</italic></td><td align="left">Immunosuppressed Wistar rat</td><td align="left">De Kwaadsteniet et al. (<xref ref-type="bibr" rid="CR148">2009</xref>)</td></tr><tr><td align="left">Nisin V</td><td align="left"><italic>L. lactis</italic> NZ9700</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">BALB/c mice</td><td align="left">Campion et al. (<xref ref-type="bibr" rid="CR97">2013</xref>)</td></tr><tr><td align="left">Mutacin B-Ny266</td><td align="left"><italic>S. mutans</italic></td><td align="left"><italic>S. aureus</italic>, <italic>Neisseria</italic>, <italic>Helicobacter</italic></td><td align="left">In vitro and mice</td><td align="left">Mota-Meira et al. (<xref ref-type="bibr" rid="CR384">2000</xref>, <xref ref-type="bibr" rid="CR385">2005</xref>)</td></tr><tr><td align="left">Mersacidin</td><td align="left"><italic>Bacillus</italic> spp. HIL-Y85/54728</td><td align="left">Methicillin-resistant <italic>S. aureus</italic> (MRSA)</td><td align="left">In vitro and mice</td><td align="left">Br&#x000f6;tz et al. (<xref ref-type="bibr" rid="CR92">1998</xref>), Kruszewska et al. (<xref ref-type="bibr" rid="CR319">2004</xref>)</td></tr><tr><td align="left">Mersacidin</td><td align="left"><italic>Bacillus</italic> spp. strain HIL Y-85</td><td align="left">MRSA</td><td align="left"><italic>BALB/cA</italic> mice</td><td align="left">Kruszewska et al. (<xref ref-type="bibr" rid="CR319">2004</xref>)</td></tr><tr><td align="left">Plantaricin NC8 &#x003b1;&#x003b2; (PLNC8 &#x003b1;&#x003b2;)</td><td align="left"><italic>L. plantarum</italic></td><td align="left"><italic>Staphylococcus</italic> spp.,<italic> Porphyromonas gingivalis</italic></td><td align="left">In vitro</td><td align="left">Bengtsson et al. (<xref ref-type="bibr" rid="CR70">2020</xref>)</td></tr><tr><td align="left">R-pyocins</td><td align="left"><italic>P. aeruginosa</italic></td><td align="left"><italic>Pseudomonas aeruginosa</italic></td><td align="left">In vitro</td><td align="left">Redero et al. (<xref ref-type="bibr" rid="CR459">2018</xref>)</td></tr><tr><td align="left">Lassomycin</td><td align="left"><italic>Lentzea kentuckyensis</italic></td><td align="left"><italic>Mycobacterium tuberculosis</italic></td><td align="left">In vitro</td><td align="left">Gavrish et al. (<xref ref-type="bibr" rid="CR210">2014</xref>)</td></tr><tr><td align="left">Enterocin AS-48</td><td align="left"><italic>E. faecalis</italic></td><td align="left"><italic>M. tuberculosis</italic></td><td align="left">In vitro and macrophages</td><td align="left">Aguilar-P&#x000e9;rez et al. (<xref ref-type="bibr" rid="CR10">2018</xref>), Cebri&#x000e1;n et al. (<xref ref-type="bibr" rid="CR105">2019</xref>)</td></tr><tr><td align="left">Durancin 61A</td><td align="left"><italic>E. durans</italic> 61A</td><td align="left"><italic>C. difficile</italic>, vancomycin-resistant enterococci, MRSA, <italic>L. innocua</italic></td><td align="left">In vitro</td><td align="left">Hanchi et al. (<xref ref-type="bibr" rid="CR242">2016</xref>, <xref ref-type="bibr" rid="CR243">2017</xref>)</td></tr><tr><td align="left">Ruminococcin C</td><td align="left"><italic>Ruminococcus gnavus</italic> E1</td><td align="left">Pathogenic clostridia and MDR strains</td><td align="left">In vitro</td><td align="left">Chiumento et al. (<xref ref-type="bibr" rid="CR116">2019</xref>), Balty et al. (<xref ref-type="bibr" rid="CR50">2019</xref>)</td></tr><tr><td align="left">Gallidermin/epidermin</td><td align="left"><italic>S. gallinarum</italic></td><td align="left"><italic>S. epidermidis</italic>, <italic>S. aureus</italic></td><td align="left">In vitro</td><td align="left">Bengtsson et al. (<xref ref-type="bibr" rid="CR69">2018</xref>)</td></tr><tr><td align="left">Haemocin type B</td><td align="left"><italic>Haemophilus haemolyticus</italic></td><td align="left"><italic>Haemophilus influenza</italic></td><td align="left">In vitro</td><td align="left">Latham et al. (<xref ref-type="bibr" rid="CR328">2017</xref>)</td></tr><tr><td align="left">Gassericin E</td><td align="left"><italic>L. gasseri</italic> EV1461</td><td align="left">Pathogens associated with vaginosis</td><td align="left">In vitro</td><td align="left">Maldonado-Barrag&#x000e1;n et al. (<xref ref-type="bibr" rid="CR356">2016</xref>)</td></tr><tr><td align="left">ABP-118</td><td align="left"><italic>Lactobacillus salivarius</italic> UCC118</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Mouse</td><td align="left">Corr et al. (<xref ref-type="bibr" rid="CR127">2007</xref>)</td></tr><tr><td align="left">Colicin E1 and Ib</td><td align="left"><italic>E. coli</italic> H22</td><td align="left"><italic>E. coli</italic> and <italic>Enterobacter</italic> spp.</td><td align="left">Mouse</td><td align="left">Cursino et al. (<xref ref-type="bibr" rid="CR134">2006</xref>)</td></tr><tr><td align="left">Colicin FY</td><td align="left"><italic>E. coli</italic></td><td align="left"><italic>Yersinia enterocolitica</italic></td><td align="left">Mice</td><td align="left">Bos&#x000e1;k et al. (<xref ref-type="bibr" rid="CR85">2012</xref>, <xref ref-type="bibr" rid="CR86">2018</xref>)</td></tr><tr><td align="left">Microcin C7</td><td align="left"><italic>E. coli</italic> H22</td><td align="left"><italic>Shigella flexneri</italic></td><td align="left">Mouse</td><td align="left">Cursino et al. (<xref ref-type="bibr" rid="CR134">2006</xref>)</td></tr><tr><td align="left">Microcin B17</td><td align="left"><italic>E. coli Nissle</italic> 1917</td><td align="left"><italic>Salmonella</italic> Typhimurium, <italic>S. flexneri</italic>, <italic>E. coli</italic></td><td align="left">Infants and toddlers</td><td align="left">Henker et al. (<xref ref-type="bibr" rid="CR248">2007</xref>)</td></tr><tr><td align="left">Micrcoccin P1</td><td align="left"><italic>Staphylococcus</italic> spp.</td><td align="left">MRSA</td><td align="left">In vitro</td><td align="left">Fern&#x000e1;ndez-Fern&#x000e1;ndez et al. (<xref ref-type="bibr" rid="CR187">2023c</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>L. casei</italic> L26</td><td align="left"><italic>E. coli</italic> O111, <italic>L. monocytogenes</italic></td><td align="left">Mouse</td><td align="left">Su et al. (<xref ref-type="bibr" rid="CR537">2007</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>L. johnsonii</italic> La1</td><td align="left"><italic>Helicobacter pylori</italic></td><td align="left">Children and adults</td><td align="left">Gotteland (<xref ref-type="bibr" rid="CR225">2003</xref>), Cruchet et al. (<xref ref-type="bibr" rid="CR133">2003</xref>)</td></tr><tr><td align="left">Salivaricin</td><td align="left"><italic>S. salivarius</italic> CRL1328</td><td align="left"><italic>Enterococcus</italic> spp., <italic>Neisseria gonorrhoeae</italic></td><td align="left">In vitro</td><td align="left">Juarez Tom&#x000e1;s et al. (<xref ref-type="bibr" rid="CR288">2002</xref>)</td></tr><tr><td align="left">Salivaricin A &#x00026; B</td><td align="left"><italic>S. salivarius</italic> K12</td><td align="left"><italic>Streptococcus sobrinus</italic>, <italic>S. mutans</italic></td><td align="left">Children and adults</td><td align="left">Burton et al. (<xref ref-type="bibr" rid="CR95">2006b</xref>), Dierksen et al. (<xref ref-type="bibr" rid="CR155">2007</xref>)</td></tr><tr><td align="left">Salivaricin B</td><td align="left"><italic>S. salivarius</italic> K12</td><td align="left"><italic>Micrococcus luteus; S. anginosis; Eubacterium saburreum</italic></td><td align="left">Humans</td><td align="left">Burton et al. (<xref ref-type="bibr" rid="CR94">2006a</xref>)</td></tr><tr><td align="left">Salivaricin</td><td align="left"><italic>S. salivarius</italic> K12</td><td align="left"><italic>S. pyogenes</italic></td><td align="left">Children</td><td align="left">Walls et al. (<xref ref-type="bibr" rid="CR577">2003</xref>)</td></tr><tr><td align="left">ESL5</td><td align="left"><italic>E. faecalis</italic> SL-5</td><td align="left"><italic>Propionibacterium acnes</italic></td><td align="left">In vitro and human</td><td align="left">Kang et al. (<xref ref-type="bibr" rid="CR294">2009</xref>)</td></tr><tr><td align="left">Diffocin</td><td align="left"><italic>C. difficile CD4</italic></td><td align="left"><italic>C. difficile</italic></td><td align="left">In vitro and mice</td><td align="left">Gebhart et al. (<xref ref-type="bibr" rid="CR211">2015</xref>), K&#x000e5;hrstr&#x000f6;m (<xref ref-type="bibr" rid="CR292">2015</xref>)</td></tr><tr><td align="left">Subtilosin</td><td align="left"><italic>B. subtilis</italic></td><td align="left"><italic>Gardnerella vaginalis</italic>, <italic>L. monocytogenes</italic>, <italic>S. agalactiae</italic></td><td align="left">In epivaginal</td><td align="left">Sutyak et al. (<xref ref-type="bibr" rid="CR542">2008a</xref>, <xref ref-type="bibr" rid="CR543">b</xref>)</td></tr><tr><td align="left">Laterosporulin10</td><td align="left"><italic>B. laterosporus</italic> SKDU10</td><td align="left"><italic>S. aureus</italic>, <italic>M. smegmatis</italic></td><td align="left">In vitro and macrophages</td><td align="left">Baindara et al. (<xref ref-type="bibr" rid="CR45">2016</xref>)</td></tr><tr><td align="left">NVB333 lanthipeptide</td><td align="left"><italic>Actinoplanes liguriae</italic> NCIMB41362</td><td align="left"><italic>S.aureus</italic></td><td align="left">In vitro and mice</td><td align="left">Boakes et al. (<xref ref-type="bibr" rid="CR82">2016</xref>)</td></tr><tr><td align="left">Pediocin PA-1</td><td align="left"><italic>P. acidilactici</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Mouse</td><td align="left">Dabour et al. (<xref ref-type="bibr" rid="CR138">2009</xref>)</td></tr><tr><td align="left">Bacteriocins ST651ea, ST7119ea, and ST7319ea</td><td align="left"><italic>E. faecium</italic> ST651ea, ST7119ea, and ST7319ea</td><td align="left"><italic>L. monocytogenes</italic> and vancomycin-resistant enterococci</td><td align="left">Simulated gastrointestinal tract</td><td align="left">Fugaban et al. (<xref ref-type="bibr" rid="CR201">2021a</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Antiviral agents</th></tr><tr><th align="left">Target virus</th><th align="left">Model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Bacteriocin-like inhibitory substances</td><td align="left"><italic>Enterococcus faecium</italic> CM019</td><td align="left">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</td><td align="left">Vero-E6 cells</td><td align="left">Bahy et al. (<xref ref-type="bibr" rid="CR44">2023</xref>)</td></tr><tr><td align="left">Labyrinthopeptin A1</td><td align="left"><italic>Actinomadura namibiensis</italic> DSM 6313</td><td align="left">Human immunodeficiency virus (HIV), Herpes simplex virus (HSV), dengue virus, and Zika virus</td><td align="left">In vitro</td><td align="left">F&#x000e9;rir et al. (<xref ref-type="bibr" rid="CR180">2014</xref>)</td></tr><tr><td align="left">Mundticin ST4SA</td><td align="left"><italic>E. mundtii</italic> ST4V</td><td align="left">HSV-1, HSV-2, Measles virus, and poliovirus</td><td align="left">In vitro</td><td align="left">Todorov et al. (<xref ref-type="bibr" rid="CR549">2005</xref>)</td></tr><tr><td align="left">Subtilosin</td><td align="left"><italic>B. subtilis</italic></td><td align="left">HSV-1 and HSV-2</td><td align="left">In vitro</td><td align="left">Quintana et al. (<xref ref-type="bibr" rid="CR449">2014</xref>)</td></tr><tr><td align="left">Subtilosin</td><td align="left"><italic>B. amyloliquefaciens</italic></td><td align="left">HSV-1</td><td align="left">In vitro</td><td align="left">Torres et al. (<xref ref-type="bibr" rid="CR553">2013</xref>)</td></tr><tr><td align="left">Enterocin AAR-74</td><td align="left"><italic>E. faecalis</italic></td><td align="left">Coliphage HSA</td><td align="left">In vitro</td><td align="left">Qureshi et al. (<xref ref-type="bibr" rid="CR450">2006</xref>)</td></tr><tr><td align="left">Enterocin B</td><td align="left"><italic>E. faecium</italic> L3</td><td align="left">Influenza A virus subtype H3N2, H1N1</td><td align="left">In vitro and mouse</td><td align="left">Ermolenko et al. (<xref ref-type="bibr" rid="CR168">2019</xref>)</td></tr><tr><td align="left">Enterocin CRL35</td><td align="left"><italic>E. faecium</italic> CRL3</td><td align="left">HSV-1 and HSV-2</td><td align="left">In vitro</td><td align="left">Wachsman et al. (<xref ref-type="bibr" rid="CR576">2003</xref>)</td></tr><tr><td align="left">Enterocin CRL35</td><td align="left"><italic>E. mundtii</italic></td><td align="left">Herpesviruses</td><td align="left">Vero and BHK-21 cells</td><td align="left">Wachsman et al. (<xref ref-type="bibr" rid="CR575">1999</xref>)</td></tr><tr><td align="left">Enterocin ST5Ha</td><td align="left"><italic>E. faecium</italic> ST5Ha</td><td align="left">HSV-1</td><td align="left">In vitro</td><td align="left">Todorov et al. (<xref ref-type="bibr" rid="CR550">2010</xref>)</td></tr><tr><td align="left">Enterocin AAR-71</td><td align="left"><italic>E. faecalis</italic></td><td align="left">Coliphage HSA</td><td align="left">In vitro</td><td align="left">Qureshi et al. (<xref ref-type="bibr" rid="CR450">2006</xref>)</td></tr><tr><td align="left">Unnamed bacteriocins</td><td align="left"><italic>L. lactis</italic> subsp. Lactis and<italic> E. durans</italic></td><td align="left">HSV-1 and poliovirus (PV-1)</td><td align="left">Vero cells</td><td align="left">Cavicchioli et al. (<xref ref-type="bibr" rid="CR104">2018</xref>)</td></tr><tr><td align="left">Unnamed bacteriocins</td><td align="left"><italic>L. delbrueckii</italic></td><td align="left">Influenza viruses (H7N7 and H7N1)</td><td align="left">In vitro</td><td align="left">Serkedjieva et al. (<xref ref-type="bibr" rid="CR510">2000</xref>)</td></tr><tr><td align="left">Erwiniocin NA4</td><td align="left"><italic>Erwinia carotovora</italic> NA4</td><td align="left">Coliphage HSA</td><td align="left">In vitro</td><td align="left">Qureshi et al. (<xref ref-type="bibr" rid="CR450">2006</xref>)</td></tr><tr><td align="left">Staphylococcin 188</td><td align="left"><italic>S. aureus</italic> AB188</td><td align="left">New castle disease virus (NCDV), poliovirus</td><td align="left">In vitro and in vivo</td><td align="left">Saeed et al. (<xref ref-type="bibr" rid="CR484">2007</xref>)</td></tr><tr><td align="left">Erwinaocin NA4</td><td align="left"><italic>E. carotovora</italic> NA4</td><td align="left">Coliphage</td><td align="left">In vitro</td><td align="left">Dey et al. (<xref ref-type="bibr" rid="CR153">2021</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Anticancers</th></tr><tr><th align="left">Target cancer cell lines</th><th align="left">Model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Laterosporulin 10</td><td align="left"><italic>B. laterosporus</italic> SKDU10</td><td align="left">MCF-7, HEK293T, HT1080, HeLa and H1299 cells</td><td align="left">In vitro</td><td align="left">Baindara et al. (<xref ref-type="bibr" rid="CR46">2017</xref>)</td></tr><tr><td align="left">Microcin E492</td><td align="left"><italic>K. pneumoniae</italic></td><td align="left">Human cell lines</td><td align="left">In vitro</td><td align="left">Hetz et al. (<xref ref-type="bibr" rid="CR249">2002</xref>)</td></tr><tr><td align="left">Microcin E492</td><td align="left"><italic>K. pneumoniae</italic></td><td align="left">Human colorectal cancer cells</td><td align="left">In vivo SW480 and SW620 zebrafish xenograft</td><td align="left">Varas et al. (<xref ref-type="bibr" rid="CR568">2020</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left">Human asterocytoma cell line (SW1088), head and neck squamous cell carcinoma (HNSCC)</td><td align="left">In vitro</td><td align="left">Joo et al. (<xref ref-type="bibr" rid="CR285">2012</xref>), Zainodini et al. (<xref ref-type="bibr" rid="CR613">2018</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left">Colon cancer cell line</td><td align="left">In vitro</td><td align="left">Ahmadi et al. (<xref ref-type="bibr" rid="CR12">2017</xref>)</td></tr><tr><td align="left">Nisin A</td><td align="left"><italic>L. lactis</italic></td><td align="left">Head and neck squamous cell carcinoma (HNSCC)</td><td align="left">In vitro</td><td align="left">Shin et al. (<xref ref-type="bibr" rid="CR518">2016</xref>)</td></tr><tr><td align="left">Plantaricin P1053</td><td align="left"><italic>L. plantarum</italic> PBS067</td><td align="left">Cancerogenic epithelial intestinal cell lines</td><td align="left">In vitro</td><td align="left">De Giani et al. (<xref ref-type="bibr" rid="CR147">2019</xref>)</td></tr><tr><td align="left">Plantaricin A</td><td align="left"><italic>L. plantarum</italic> C11</td><td align="left">GH4, Reh, Jurkat, PC12, N2A</td><td align="left">In vitro</td><td align="left">Sand et al. (<xref ref-type="bibr" rid="CR493">2013</xref>)</td></tr><tr><td align="left">Enterocin LNS18</td><td align="left"><italic>Enterococcus thailandicus</italic></td><td align="left">HepG2 cell lines</td><td align="left">In vitro</td><td align="left">Al-Madboly et al. (<xref ref-type="bibr" rid="CR21">2020</xref>)</td></tr><tr><td align="left">Pediocin K2a2-3</td><td align="left"><italic>P. acidilactici</italic> K2a2-3</td><td align="left">Human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells</td><td align="left">In vitro</td><td align="left">Villarante et al. (<xref ref-type="bibr" rid="CR574">2011</xref>)</td></tr><tr><td align="left">Pediocin CP2</td><td align="left"><italic>P. acidilactici</italic> CP2 MTCC501</td><td align="left">HeLa, MCF-7, HepG2, murine myeloma (Sp2/0-Ag 14)</td><td align="left">In vitro</td><td align="left">Kumar (<xref ref-type="bibr" rid="CR320">2012</xref>)</td></tr><tr><td align="left">Duramycin</td><td align="left"><italic>S. cinnamoneus</italic></td><td align="left">AsPC-1, Caco-2, Colo320, CT116, JJN3, Lovo, MCF-7, (Rodrigues et al. 2019) MDA-B-231, MIA PaCa-2</td><td align="left">In vitro</td><td align="left">Broughton et al. (<xref ref-type="bibr" rid="CR93">2016</xref>)</td></tr><tr><td align="left">Pep27anal2</td><td align="left"><italic>S. pneumoniae</italic></td><td align="left">Jurkat, HL-60, AML-2, MCF-7, SNU-601</td><td align="left">In vitro</td><td align="left">Lee et al. (<xref ref-type="bibr" rid="CR334">2005</xref>), Sung et al. (<xref ref-type="bibr" rid="CR541">2007</xref>)</td></tr><tr><td align="left">Bovicin HC5</td><td align="left"><italic>S. bovis</italic> HC5</td><td align="left">MCF-7, HepG2 mammalian cell lines</td><td align="left">In vitro</td><td align="left">Mantovani et al. (<xref ref-type="bibr" rid="CR357">2002</xref>), Paiva et al. (<xref ref-type="bibr" rid="CR423">2012</xref>)</td></tr><tr><td align="left">p28</td><td align="left"><italic>Pseudomonas aeruginosa</italic> PAO1</td><td align="left">MCF-7, HCT-116, UISO-MEL-23, MNE-MB-231, p53wt (Mel-29), U87, LN229</td><td align="left">In vitro</td><td align="left">Yamada et al. (<xref ref-type="bibr" rid="CR602">2009</xref>), Mehta et al. (<xref ref-type="bibr" rid="CR369">2011</xref>)</td></tr><tr><td align="left">Pyocin S2</td><td align="left"><italic>P. aeruginosa</italic> 42A</td><td align="left">HepG2, Im9, murine tumor (mKS-A TU-7), human fetal foreskin fibroblast (HFFF)</td><td align="left">In vitro</td><td align="left">Abdi-Ali et al. (<xref ref-type="bibr" rid="CR3">2004</xref>)</td></tr><tr><td align="left">Colicin E3</td><td align="left"><italic>E. coli</italic></td><td align="left">P388, HeLa, HS913T</td><td align="left">In vitro</td><td align="left">Kohoutova et al. (<xref ref-type="bibr" rid="CR313">2014</xref>)</td></tr><tr><td align="left">Sungsanpin</td><td align="left"><italic>Streptomyces</italic> spp.</td><td align="left">Human lung cancer cell line A549</td><td align="left">In vitro</td><td align="left">Um et al. (<xref ref-type="bibr" rid="CR560">2013</xref>)</td></tr><tr><td align="left">Chaxapeptin</td><td align="left"><italic>S. leeuwenhoekii</italic> C58</td><td align="left">Human lung cancer cell line A549</td><td align="left">In vitro</td><td align="left">Elsayed et al. (<xref ref-type="bibr" rid="CR167">2015</xref>)</td></tr><tr><td align="left">Thiostrepton</td><td align="left"><italic>S. aureus</italic></td><td align="left">Breast cancer cell lines, endometriosis</td><td align="left">Rat</td><td align="left">Kwok et al. (<xref ref-type="bibr" rid="CR324">2008</xref>), Jin et al. (<xref ref-type="bibr" rid="CR283">2019</xref>), Kongsema et al. (<xref ref-type="bibr" rid="CR315">2019</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Food preservation, safety, and quality</th></tr><tr><th align="left">Target microorganism</th><th align="left">Food/model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Colicins (GRN 676, GRN 593)</td><td align="left"><italic>E. coli</italic></td><td align="left"><italic>E. coli</italic>, <italic>P. aeruginosa</italic>, <italic>Salmonella</italic> spp.</td><td align="left">Meat, fruits, and vegetables</td><td align="left">Hahn-L&#x000f6;bmann et al. (<xref ref-type="bibr" rid="CR238">2019</xref>)</td></tr><tr><td align="left">Sakacin P</td><td align="left"><italic>L. sakei</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Beef and salmon</td><td align="left">Teneva-Angelova et al. (<xref ref-type="bibr" rid="CR546">2018</xref>)</td></tr><tr><td align="left">Sakacin</td><td align="left"><italic>Lactobacillus sakei</italic> subsp. <italic>sakei</italic> 2a</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Cheese</td><td align="left">Martinez et al. (<xref ref-type="bibr" rid="CR360">2015</xref>)</td></tr><tr><td align="left">Salmocins</td><td align="left"><italic>Salmonella</italic> spp.</td><td align="left"><italic>S. enterica</italic></td><td align="left">Red meat</td><td align="left">Schneider et al. (<xref ref-type="bibr" rid="CR506">2018</xref>)</td></tr><tr><td align="left">Divergicin M35</td><td align="left"><italic>Carnobacterium divergens</italic> M35</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Smoked fish</td><td align="left">Benabbou et al. (<xref ref-type="bibr" rid="CR68">2020</xref>)</td></tr><tr><td align="left">Lactocin 705, Lactocin AL705</td><td align="left"><italic>Lactobacillus curvatus</italic> CRL705</td><td align="left"><italic>B. thermosphacta</italic>,<italic> L. innocua</italic></td><td align="left">Vacuum-packed meat</td><td align="left">Castellano and Vignolo (<xref ref-type="bibr" rid="CR103">2006</xref>)</td></tr><tr><td align="left">Lactoccin BZ</td><td align="left"><italic>Lactococus lactis</italic></td><td align="left"><italic>L. innocua</italic></td><td align="left">fresh beef</td><td align="left">Y&#x00131;ld&#x00131;r&#x00131;m et al. (<xref ref-type="bibr" rid="CR606">2016</xref>)</td></tr><tr><td align="left">Enterocin K2B1</td><td align="left"><italic>E. faecalis</italic> K2B1</td><td align="left">Foodborne pathogens</td><td align="left">Dairy products</td><td align="left">Alang et al. (<xref ref-type="bibr" rid="CR17">2020</xref>)</td></tr><tr><td align="left">Enterocin AS-48</td><td align="left"><italic>Enterococcus faecalis</italic></td><td align="left">Endogenous staphylococci</td><td align="left">Sardines</td><td align="left">Ananou et al. (<xref ref-type="bibr" rid="CR28">2014</xref>)</td></tr><tr><td align="left">Enterocin LD3 and Plantaricin LD4</td><td align="left"><italic>E. faecium</italic> LD3 <italic>and L. plantarum</italic> LD4</td><td align="left"><italic>S. aureus</italic> subsp. <italic>aureus</italic> ATCC25923, <italic>Salmonella enterica</italic> subsp<italic>. enterica serovar</italic> Typhimurium ATCC13311, <italic>Proteus mirabilis</italic> ATCC43071, <italic>P. aeruginosa</italic> ATCC27853, and <italic>E. coli</italic> ATCC25922</td><td align="left">In vitro</td><td align="left">Sheoran and Tiwari (<xref ref-type="bibr" rid="CR517">2021</xref>)</td></tr><tr><td align="left">Aureocin A70</td><td align="left"><italic>S. aureus</italic> A70</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Dairy products</td><td align="left">Carlin Fagundes et al. (<xref ref-type="bibr" rid="CR99">2016</xref>)</td></tr><tr><td align="left">Psicolin 126, carnocyclin A</td><td align="left"><italic>Carnobacterium maltoaromaticum</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Ready-to-eat meat products</td><td align="left">Liu et al. (<xref ref-type="bibr" rid="CR341">2008</xref>)</td></tr><tr><td align="left">Variacin</td><td align="left"><italic>Kocuria varians</italic> NCC 1482</td><td align="left"><italic>B. cereus</italic></td><td align="left">Dairy food</td><td align="left">O&#x02019;Mahony et al. (<xref ref-type="bibr" rid="CR408">2001</xref>)</td></tr><tr><td align="left">Lacticin 481</td><td align="left"><italic>L. lactis</italic> L3A21M1</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Fresh cheese</td><td align="left">Ribeiro et al. (<xref ref-type="bibr" rid="CR466">2016</xref>)</td></tr><tr><td align="left">Lacticin 3147</td><td align="left"><italic>L. lactis</italic> subsp. <italic>lactis</italic> DPC3147</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Cottage cheese and yogurt</td><td align="left">Morgan et al. (<xref ref-type="bibr" rid="CR383">2001</xref>)</td></tr><tr><td align="left">Reuterin</td><td align="left"><italic>L. reuteri</italic> INIA PRO 137</td><td align="left"><italic>L. monocytogenes</italic> and <italic>S. aureus</italic></td><td align="left">skim milk</td><td align="left">Arqu&#x000e9;s et al. (<xref ref-type="bibr" rid="CR37">2011</xref>)</td></tr><tr><td align="left">Gassericins A and T</td><td align="left"><italic>L. gasseri</italic> LA39 and LA158</td><td align="left"><italic>B. cereus</italic></td><td align="left">Custard cream</td><td align="left">Arakawa et al. (<xref ref-type="bibr" rid="CR34">2009</xref>)</td></tr><tr><td align="left">Bovicin HC5</td><td align="left"><italic>S. bovis</italic> HC5</td><td align="left"><italic>Clostridium tyrobutyricum</italic></td><td align="left">Mango pulp</td><td align="left">de Carvalho et al. (<xref ref-type="bibr" rid="CR144">2007</xref>)</td></tr><tr><td align="left">Ent35-MccV</td><td align="left"><italic>E. coli</italic> BL21</td><td align="left"><italic>E. coli</italic> and<italic> L. monocytogenes</italic></td><td align="left">Skim milk</td><td align="left">Acu&#x000f1;a et al. (<xref ref-type="bibr" rid="CR9">2015</xref>)</td></tr><tr><td align="left">Bacteriocin GP1</td><td align="left"><italic>L. rhamnosus</italic> GP1</td><td align="left"><italic>Staphylococcus</italic> spp., <italic>Aeromonas</italic> spp., <italic>Lactobacillus</italic> spp., <italic>Pseudomonas</italic> spp., <italic>Vibrio</italic> spp.</td><td align="left">Fish</td><td align="left">Sarika et al. (<xref ref-type="bibr" rid="CR497">2019</xref>)</td></tr><tr><td align="left">Bacteriocins ST3522BG and ST3633BG</td><td align="left"><italic>P. acidilactici</italic> ST3522BG and <italic>P. pentosaceus</italic> ST3633BG</td><td align="left"><italic>Listeria</italic> spp.</td><td align="left">Silage fermentation models system</td><td align="left">Fugaban et al. (<xref ref-type="bibr" rid="CR202">2021b</xref>)</td></tr><tr><td align="left">Bacteriocin BM1829</td><td align="left"><italic>Companilactobacillus crustorum</italic> MN047</td><td align="left"><italic>E. coli</italic> and <italic>S. aureus</italic></td><td align="left">Beef</td><td align="left">Yan et al. (<xref ref-type="bibr" rid="CR603">2021</xref>)</td></tr><tr><td align="left">Bacteriocin Sak-59</td><td align="left"><italic>L. sakei</italic> B-RKM 0559</td><td align="left"><italic>L. monocytogenes</italic>, <italic>S. aureus</italic>, and pathogenic strains of <italic>Serratia marcescens</italic> and<italic> E. coli</italic></td><td align="left">Meat spoilage bacteria</td><td align="left">Abitayeva et al. (<xref ref-type="bibr" rid="CR5">2021</xref>)</td></tr><tr><td align="left">Bacteriocins ST20Kc and ST41Kc</td><td align="left"><italic>E. faecium</italic> ST20Kc and ST41Kc</td><td align="left"><italic>L. monocytogenes</italic> and vancomycin-resistant enterococci</td><td align="left">Kimchi</td><td align="left">Valledor et al. (<xref ref-type="bibr" rid="CR565">2022</xref>)</td></tr><tr><td align="left">Bacteriocin 32Y</td><td align="left"><italic>L. curvatus</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Pork and beef</td><td align="left">G&#x000e1;lvez et al. (<xref ref-type="bibr" rid="CR204">2007</xref>)</td></tr><tr><td align="left">Bacteriocin RSQ04</td><td align="left"><italic>L. lactis</italic> CGMCC20699</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Model food system</td><td align="left">Xiang et al. (<xref ref-type="bibr" rid="CR600">2022</xref>)</td></tr><tr><td align="left">Bacteriocin OS1</td><td align="left"><italic>E. hirae</italic> OS1</td><td align="left"><italic>Listeria</italic> spp.</td><td align="left">In vitro</td><td align="left">Siragusa (<xref ref-type="bibr" rid="CR521">1992</xref>)</td></tr><tr><td align="left">Pyocin QDD1</td><td align="left"><italic>P. aeruginosa</italic> QDD1</td><td align="left"><italic>S. aureus</italic> and<italic> B. cereus</italic></td><td align="left">In vitro</td><td align="left">Doshi et al. (<xref ref-type="bibr" rid="CR161">2022</xref>)</td></tr><tr><td align="left">Nisin (Nisaplin<sup>&#x000ae;</sup>)</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>S. aureus</italic></td><td align="left">Minas frescal cheese</td><td align="left">Felicio et al. (<xref ref-type="bibr" rid="CR178">2015</xref>)</td></tr><tr><td align="left">Nisin Z</td><td align="left"><italic>L. lactis</italic> W8</td><td align="left"><italic>Enterococcus italicus</italic>, <italic>E. mundtii</italic>, <italic>E. faecalis</italic>, <italic>B. thuringiensis</italic>, <italic>B. cereus</italic>, <italic>L. paracasei</italic>, <italic>Acinetobacter</italic> spp., <italic>Pseudomonas fluorescens</italic> and<italic> Enterobacter aerogenes</italic></td><td align="left">Skim and whole-fat milk</td><td align="left">Mitra et al. (<xref ref-type="bibr" rid="CR379">2011</xref>)</td></tr><tr><td align="left">Nisin Z and A and lacticin 481</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Cottage cheese</td><td align="left">Dal Bello et al. (<xref ref-type="bibr" rid="CR140">2012</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic> N5764</td><td align="left"><italic>S. aureus</italic> and <italic>L. monocytogenes</italic></td><td align="left">Cow milk</td><td align="left">Alves et al. (<xref ref-type="bibr" rid="CR25">2016</xref>)</td></tr><tr><td align="left">Micrococcin P1</td><td align="left"><italic>S. equorum</italic> WS 2733</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Soft cheese</td><td align="left">Carnio et al. (<xref ref-type="bibr" rid="CR101">2000</xref>)</td></tr><tr><td align="left">AMA-K, Leucocin K7</td><td align="left"><italic>L. plantarum</italic> AMA-K</td><td align="left"><italic>K. pneumoniae</italic>, <italic>Listeria</italic> spp., <italic>Enterococcus</italic> spp.,<italic> E. coli</italic></td><td align="left">Amasi (fermented milk product)</td><td align="left">Todorov (<xref ref-type="bibr" rid="CR548">2008</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Antimicrobial food packaging</th></tr><tr><th align="left">Target microorganism</th><th align="left">Food/model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>S. aureus</italic>, <italic>L. monocytogenes</italic></td><td align="left">Cellulose films&#x02009;+&#x02009;minimally processed mangoes</td><td align="left">Barbosa et al. (<xref ref-type="bibr" rid="CR57">2013</xref>)</td></tr><tr><td align="left">Nisin Z</td><td align="left"><italic>L. lactis</italic> subsp. lactis I8-7-3</td><td align="left"><italic>Salmonella typhimurium</italic>, <italic>S. enteriditis</italic>, <italic>S. aureus</italic>, <italic>L. monocytogenes</italic>, <italic>E. coli</italic></td><td align="left">Pullulan films&#x02009;+&#x02009;fresh and ready to eat muscle foods</td><td align="left">Pattanayaiying et al. (<xref ref-type="bibr" rid="CR428">2015</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>E. coli</italic> O157:H7, <italic>Salmonella</italic> spp.</td><td align="left">Stainless steel</td><td align="left">Phongphakdee and Nitisinprasert (<xref ref-type="bibr" rid="CR434">2015</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>Micrococcus luteus</italic> ATCC 10240</td><td align="left">Ethylene-<italic>co</italic>-vinyl acetate (EVA) film</td><td align="left">(Scaffaro et al. <xref ref-type="bibr" rid="CR503">2011</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>S. aureus</italic> and<italic> E. coli</italic></td><td align="left">Poly(vinyl alcohol) films</td><td align="left">Hrabalikova et al. (<xref ref-type="bibr" rid="CR262">2016</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>E. coli</italic> O157:H7, <italic>Salmonella</italic>, and<italic> L. monocytogenes</italic></td><td align="left">Fresh cut cantaloupe/rind</td><td align="left">Ukuku et al. (<xref ref-type="bibr" rid="CR559">2015</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Starch/halloysite/nanocomposite films&#x02009;+&#x02009;soft cheese</td><td align="left">Meira et al. (<xref ref-type="bibr" rid="CR370">2016</xref>)</td></tr><tr><td align="left">Nisin and lacticin 3147</td><td align="left">L. lactis subsp. lactis HP</td><td align="left"><italic>L. lactis</italic> subsp. <italic>lactis</italic>, <italic>S. aureus</italic>, and<italic> L. innocua</italic></td><td align="left">Polyamide and polyethylene pouches&#x02009;+&#x02009;cheese</td><td align="left">Scannell et al. (<xref ref-type="bibr" rid="CR504">2000</xref>)</td></tr><tr><td align="left">Sakacin A</td><td align="left"><italic>L. sakei</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Polyethylene coated paper sheets&#x02009;+&#x02009;meat</td><td align="left">Barbiroli et al. (<xref ref-type="bibr" rid="CR56">2017</xref>)</td></tr><tr><td align="left">Curvacin A</td><td align="left"><italic>L. sakei</italic> CRL1862</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Stainless steel Polytetrafluoroethylene surfaces (PTFE)</td><td align="left">P&#x000e9;rez-Ibarreche et al. (<xref ref-type="bibr" rid="CR433">2016</xref>)</td></tr><tr><td align="left">Lacticin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>L. helveticus</italic> and <italic>Brochothrix thermosphacta</italic></td><td align="left">Polyethylene based plastic film&#x02009;+&#x02009;meat</td><td align="left">Siragusa et al. (<xref ref-type="bibr" rid="CR522">1999</xref>)</td></tr><tr><td align="left">Divergicin M35</td><td align="left"><italic>Carnobacterium divergens M35</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Chitosan film&#x02009;+&#x02009;smoked fish</td><td align="left">Benabbou et al. (<xref ref-type="bibr" rid="CR68">2020</xref>)</td></tr><tr><td align="left">Bacteriocin 7293</td><td align="left"><italic>Weissella hellenica</italic> BCC 729</td><td align="left">Gram-positive and Gram-negative food borne pathogens</td><td align="left">PLA/SP biocomposite film&#x02009;+&#x02009;pangasius fish fillets</td><td align="left">Woraprayote et al. (<xref ref-type="bibr" rid="CR596">2018</xref>)</td></tr><tr><td align="left">Plantaricin BM-1</td><td align="left"><italic>L. plantarum</italic> BM-1</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Polyethylene</td><td align="left">Zhang et al. (<xref ref-type="bibr" rid="CR615">2017</xref>)</td></tr><tr><td align="left">Enterocin B3A-B3B</td><td align="left"><italic>E. faecalis</italic> B3A-B3B</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Stainless steel</td><td align="left">Al-Seraih et al. (<xref ref-type="bibr" rid="CR23">2017</xref>)</td></tr><tr><td align="left">Pediocin</td><td align="left"><italic>P. acidilactici</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Plastic bags and cellulose casings&#x02009;+&#x02009;meat</td><td align="left">Ming et al. (<xref ref-type="bibr" rid="CR377">1997</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Antibiofilm and sanitizers</th></tr><tr><th align="left">Target microorganism/biofilm former</th><th align="left">Model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Gallidermin</td><td align="left"><italic>S. gallinarum</italic></td><td align="left"><italic>S. aureus</italic> and <italic>S. epidermidis</italic></td><td align="left">Medical implants</td><td align="left">Saising et al. (<xref ref-type="bibr" rid="CR487">2012</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>L. monocytogenes</italic> 4032</td><td align="left">Stainless steel and polypropylen</td><td align="left">Sa&#x000e1; Ibusquiza et al. (<xref ref-type="bibr" rid="CR482">2011</xref>)</td></tr><tr><td align="left">Nisin, enterocin DD14, colistin combination</td><td align="left"><italic>L. lactis</italic> and <italic>E. faecalis</italic> 14</td><td align="left"><italic>E. coli</italic> CIP54127, <italic>E. coli</italic> 184 (mcr-1+), and <italic>E. col</italic>i (mcr-1)</td><td align="left">In vitro</td><td align="left">Al Atya et al. (<xref ref-type="bibr" rid="CR14">2016a</xref>)</td></tr><tr><td align="left">Lacticin 3147</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>S. mutans</italic></td><td align="left">In vitro oral biofilm model</td><td align="left">Corbin et al. (<xref ref-type="bibr" rid="CR126">2011</xref>)</td></tr><tr><td align="left">Bacteriocins 4356 and 8014</td><td align="left"><italic>L. acidophilus</italic> ATCC 4356 and <italic>L. plantarum</italic> ATCC 8014</td><td align="left"><italic>Serratia marcescens</italic></td><td align="left">In vitro</td><td align="left">Vahedi Shahandashti et al. (<xref ref-type="bibr" rid="CR564">2016</xref>)</td></tr><tr><td align="left">Hyicin 4244</td><td align="left"><italic>Staphylococcus hyicus</italic> 4244</td><td align="left">14 <italic>Staphylococcus</italic> strains from human infections or bovine mastitis</td><td align="left">In vitro</td><td align="left">Duarte et al. (<xref ref-type="bibr" rid="CR165">2018</xref>)</td></tr><tr><td align="left">Licheniocin 50.2</td><td align="left"><italic>L. lactis</italic> subsp. lactis biovar. diacetylactis BGBU1-4</td><td align="left"><italic>L. monocytogenes</italic>, coagulase-negative staphylococci</td><td align="left">In vitro</td><td align="left">Cirkovic et al. (<xref ref-type="bibr" rid="CR119">2016</xref>)</td></tr><tr><td align="left">Sonorensin</td><td align="left"><italic>Bacillus sonorensis</italic> MT93</td><td align="left"><italic>L. monocytogene</italic>s and <italic>S. aureus</italic></td><td align="left">Polyethylene film coated meat and tomatoes</td><td align="left">Chopra et al. (<xref ref-type="bibr" rid="CR117">2015</xref>)</td></tr><tr><td align="left">Enterocin AS-48</td><td align="left"><italic>E. faecalis</italic> A-48-32</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">In vitro</td><td align="left">Caballero G&#x000f3;mez et al. (<xref ref-type="bibr" rid="CR96">2013</xref>)</td></tr><tr><td align="left">Enterocin AS-48 with benzalkonium chloride, polyhexamethylene guanidium chloride and triclosan</td><td align="left"><italic>E. faecalis</italic> A-48-32</td><td align="left">MRSA and MSSA</td><td align="left">In vitro</td><td align="left">Caballero G&#x000f3;mez et al. (<xref ref-type="bibr" rid="CR96">2013</xref>)</td></tr><tr><td align="left">Enterocin AS-48 with biocides</td><td align="left"><italic>E. faecalis</italic> A-48-32</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">In vitro</td><td align="left">G&#x000f3;mez et al. (<xref ref-type="bibr" rid="CR222">2012</xref>)</td></tr><tr><td align="left">Enterocin DD93, DD28</td><td align="left"><italic>E. faecalis</italic> DD28 and <italic>E. faecalis</italic> DD93</td><td align="left">MRSA</td><td align="left">In vitro, stainless steel, and glace devices</td><td align="left">Al Atya et al. (<xref ref-type="bibr" rid="CR15">2016b</xref>)</td></tr><tr><td align="left">Enterocin B3A-B3B</td><td align="left"><italic>E. faecalis</italic> B3A-B3B</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Stainless steel</td><td align="left">Al-Seraih et al. (<xref ref-type="bibr" rid="CR23">2017</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>L. fermentum 97</italic></td><td align="left"><italic>S. epidermidis</italic>, enterotoxigenic enterobacteria</td><td align="left">In vitro</td><td align="left">Rybalchenko et al. (<xref ref-type="bibr" rid="CR481">2015</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>Citrobacter freundii</italic></td><td align="left"><italic>Citrobacter</italic>, <italic>K. pneumoniae</italic>, <italic>E. coli</italic></td><td align="left">In vitro</td><td align="left">Shanks et al. (<xref ref-type="bibr" rid="CR513">2012</xref>)</td></tr><tr><td align="left">Curvacin A</td><td align="left"><italic>L. sakei</italic> CRL1862</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Stainless steel, polytetrafluoroethylene surfaces (PTFE)</td><td align="left">P&#x000e9;rez-Ibarreche et al. (<xref ref-type="bibr" rid="CR433">2016</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Aquaculture/aquatic product</th></tr><tr><th align="left">Target microorganism</th><th align="left">Application/model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">CAMT2</td><td align="left"><italic>Bacillus amyloliquefaciens</italic> ZJHD3-06</td><td align="left"><italic>L. monocytogenes</italic>, <italic>S. aureus</italic></td><td align="left"><italic>Epinephelus areolatus</italic></td><td align="left">An et al. (<xref ref-type="bibr" rid="CR27">2015</xref>)</td></tr><tr><td align="left">Coagulin L1208</td><td align="left"><italic>B. coagulans</italic> L1208</td><td align="left"><italic>E. coli</italic>, <italic>Shewanella putrefaciens</italic>,<italic> S. aureus</italic></td><td align="left"><italic>Pseudosciaena croce</italic></td><td align="left">Fu et al. (<xref ref-type="bibr" rid="CR200">2018</xref>)</td></tr><tr><td align="left">Mundticin KS</td><td align="left"><italic>E. mundtii</italic> Tw56</td><td align="left"><italic>P. aeruginosa</italic>,<italic> S. putrefaciens</italic></td><td align="left"><italic>Odontesthes platensis</italic></td><td align="left">Schelegueda et al. (<xref ref-type="bibr" rid="CR505">2015</xref>)</td></tr><tr><td align="left">BacALP7</td><td align="left"><italic>E. faecium</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Shellfish</td><td align="left">Pinto et al. (<xref ref-type="bibr" rid="CR437">2009</xref>)</td></tr><tr><td align="left">Nisin Z</td><td align="left"><italic>L. lactis</italic> ssp. Lactis</td><td align="left"><italic>Streptococcus iniae</italic></td><td align="left"><italic>Oxyeleotris lineolata</italic></td><td align="left">Wright (<xref ref-type="bibr" rid="CR599">2017</xref>)</td></tr><tr><td align="left">Nisin Z</td><td align="left"><italic>L. lactis</italic> TW34</td><td align="left"><italic>L. garvieae</italic></td><td align="left"><italic>Odontesthes platensis</italic></td><td align="left">Sequeiros et al. (<xref ref-type="bibr" rid="CR509">2015</xref>)</td></tr><tr><td align="left">Nisin</td><td align="left"><italic>L. lactis</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left"><italic>Litopenaeus vannamei</italic></td><td align="left">Zhao et al. (<xref ref-type="bibr" rid="CR620">2020</xref>)</td></tr><tr><td align="left">Plantaricin FGC-12</td><td align="left"><italic>L. plantarum</italic> FGC-12</td><td align="left"><italic>V. parahaemolyticus</italic></td><td align="left">Golden carp</td><td align="left">Chen et al. (<xref ref-type="bibr" rid="CR110">2019</xref>)</td></tr><tr><td align="left">Weissellicin 110</td><td align="left"><italic>Weissella cibaria</italic></td><td align="left"><italic>L. sakei</italic> JCM 1157</td><td align="left">Plaa-Som, a Fermented Fish Product</td><td align="left">Srionnual et al. (<xref ref-type="bibr" rid="CR532">2007</xref>)</td></tr><tr><td align="left">Enterocin MC13</td><td align="left"><italic>E. faecium</italic> MC13</td><td align="left"><italic>L. monocytogenes</italic>, <italic>V. parahaemolyticus</italic>, and <italic>V. vulnificus</italic></td><td align="left"><italic>Mugil cephalus</italic></td><td align="left">Satish Kumar et al. (<xref ref-type="bibr" rid="CR499">2011</xref>)</td></tr><tr><td align="left">Pentocin JL-1</td><td align="left"><italic>L. pentosus</italic></td><td align="left"><italic>S. aureus</italic></td><td align="left"><italic>Chiloscyllim punctatum</italic></td><td align="left">Jiang et al. (<xref ref-type="bibr" rid="CR281">2017</xref>)</td></tr><tr><td align="left">PE-ZYB1</td><td align="left"><italic>P. Pentosaceus</italic> Zy-B</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left"><italic>Mimachlamys nobilis</italic></td><td align="left">Zhang et al. (<xref ref-type="bibr" rid="CR617">2020</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>P. acidilactici</italic></td><td align="left"><italic>L. monocytogenes</italic></td><td align="left"><italic>Tilapia</italic> sp., Catla catla, Cyprinus carpio</td><td align="left">Sudarsanan and Thangappan (<xref ref-type="bibr" rid="CR539">2017</xref>)</td></tr><tr><td align="left">Bacteriocin 7293</td><td align="left"><italic>W. hellenica</italic> BCC 7293</td><td align="left"><italic>L. monocytogenes</italic>, <italic>S. aureus</italic>, <italic>A. hydrophila</italic>, <italic>E. coli</italic>, <italic>P. aeruginosa</italic>, <italic>S.</italic> Typhimurium</td><td align="left"><italic>Pangasius bocourti</italic></td><td align="left">Woraprayote et al. (<xref ref-type="bibr" rid="CR596">2018</xref>)</td></tr><tr><td align="left">Bacteriocin KTH0-1S</td><td align="left"><italic>L. lactis</italic> KTH0-1S</td><td align="left"><italic>S. aureus</italic></td><td align="left">Fermented shrimp</td><td align="left">Saelao et al. (<xref ref-type="bibr" rid="CR485">2017</xref>)</td></tr><tr><td align="left">Bacteriocin PSY2</td><td align="left"><italic>L. lactis</italic> strain PSY2</td><td align="left">Spoilage Gram-positive and Gram-negative bacteria</td><td align="left">Perch</td><td align="left">Sarika et al. (<xref ref-type="bibr" rid="CR496">2012</xref>)</td></tr><tr><td align="left">Bacteriocin CN-25</td><td align="left"><italic>E. faecium</italic> CN-25</td><td align="left"><italic>L. monocytogenes</italic></td><td align="left">Fermented fish roe</td><td align="left">du Toit et al. (<xref ref-type="bibr" rid="CR164">2000</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Bacteriocin</th><th align="left" rowspan="2">Producer</th><th align="left" colspan="3">Plant diseases</th></tr><tr><th align="left">Target phytopathogen</th><th align="left">Application/model</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">Gluconacin</td><td align="left"><italic>Gluconacetobacter diazotrophicus</italic> strain PAL5</td><td align="left"><italic>Xanthomonas axonopodis</italic> pv<italic>. vasculorum</italic>, <italic>Acidovorax avenae</italic> subsp<italic>. avenae</italic>, <italic>Pseudomonas syringae</italic> pv<italic>. syringae</italic>, <italic>Xanthomonas vasicola</italic> pv<italic>. vasculorum</italic></td><td align="left">In vitro</td><td align="left">Oliveira et al. (<xref ref-type="bibr" rid="CR413">2018</xref>)</td></tr><tr><td align="left">Amylocyclicin</td><td align="left"><italic>B. amyloliquefaciens</italic> FZB42</td><td align="left"><italic>Ralstonia solanacearum</italic> and<italic> X. campestris</italic></td><td align="left">In vitro</td><td align="left">Scholz et al. (<xref ref-type="bibr" rid="CR508">2014</xref>)</td></tr><tr><td align="left">Enterocin UNAD 046</td><td align="left"><italic>E. faecalis</italic></td><td align="left"><italic>Botryodiplodia theobromae</italic>, <italic>Aspergillus niger</italic>, <italic>Pythium ultimum</italic>, <italic>Penicillium expansum</italic>, and<italic> Fusarium oxysporum</italic></td><td align="left">In vitro</td><td align="left">David and Onifade (<xref ref-type="bibr" rid="CR143">2018</xref>)</td></tr><tr><td align="left">Putidacin L1 (PL1)</td><td align="left"><italic>Pseudomonas putida</italic></td><td align="left"><italic>P. syringae</italic></td><td align="left">In vitro</td><td align="left">Rooney et al. (<xref ref-type="bibr" rid="CR478">2020</xref>)</td></tr><tr><td align="left">Tailocins</td><td align="left"><italic>Pseudomonas fluorescens</italic> SF4c</td><td align="left"><italic>X. vesicatoria</italic> Xcv Bv5-4a</td><td align="left">Tomato fruits</td><td align="left">Pr&#x000ed;ncipe et al. (<xref ref-type="bibr" rid="CR442">2018</xref>)</td></tr><tr><td align="left">Syringacin M</td><td align="left"><italic>Pseudomonas syringae</italic> pv. <italic>tomato</italic> DC3000</td><td align="left"><italic>P.&#x000a0;syringae</italic></td><td align="left"><italic>Arabidopsis</italic> and tomato plants</td><td align="left">Li et al. (<xref ref-type="bibr" rid="CR337">2020</xref>)</td></tr><tr><td align="left">Plantazolicin</td><td align="left"><italic>B. amyloliquefaciens</italic> subsp. Plantarum FZB42</td><td align="left"><italic>B. anthracis</italic> and <italic>nematodes</italic></td><td align="left">Plant roots</td><td align="left">Chowdhury et al. (<xref ref-type="bibr" rid="CR118">2015</xref>)</td></tr><tr><td align="left">Carocin D</td><td align="left"><italic>P. carotovorum</italic> subsp. Carotovorum</td><td align="left"><italic>P. carotovorum</italic> subsp. Carotovorum</td><td align="left">In vitro</td><td align="left">Grinter et al. (<xref ref-type="bibr" rid="CR233">2012</xref>)</td></tr><tr><td align="left">Kenyacin 404, Entomocin 420, Tolworthcin 524, Morricin 269, Kurstacin 287</td><td align="left"><italic>B. thurigiensis</italic></td><td align="left"><italic>F. oxysporum</italic>, <italic>Rhizopus</italic> sp., <italic>Mucor rouxi</italic>, <italic>Trichoderma</italic> spp<italic>.</italic>, <italic>A. nodulans</italic>, <italic>F. graminis</italic>,</td><td align="left">In vitro</td><td align="left">Salazar-Marroqu&#x000ed;n et al. (<xref ref-type="bibr" rid="CR489">2016</xref>)</td></tr><tr><td align="left">BLIS RC-2</td><td align="left"><italic>B. amyloliquefaciens</italic> RC-2</td><td align="left"><italic>X. campestris pv.</italic> Campestris,<italic>C. dematium</italic>, <italic>R. necatrix</italic>, <italic>P. oryzae</italic>,<italic> A. tumefaciens</italic></td><td align="left">In vitro</td><td align="left">Abriouel et al. (<xref ref-type="bibr" rid="CR6">2011</xref>)</td></tr><tr><td align="left">Bacteriocin LlpA</td><td align="left"><italic>Pseudomonas</italic> sp. strain BW11M1</td><td align="left"><italic>P. fluorescens</italic> Pf-5, <italic>P. tolaasii</italic></td><td align="left">In vitro</td><td align="left">Parret et al. (<xref ref-type="bibr" rid="CR426">2005</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>B. gladioli</italic></td><td align="left"><italic>Tatumella ptyseos</italic></td><td align="left">In vitro and in planta</td><td align="left">Mar&#x000ed;n-Cevada et al. (<xref ref-type="bibr" rid="CR358">2012</xref>)</td></tr><tr><td align="left">Unnamed bacteriocin</td><td align="left"><italic>P. syringae</italic> pv. Ciccaronei</td><td align="left"><italic>P. syringae</italic> subsp. Savastanoi</td><td align="left">In vitro and in planta</td><td align="left">Lavermicocca et al. (<xref ref-type="bibr" rid="CR330">2002</xref>)</td></tr><tr><td align="left">BL8</td><td align="left"><italic>B. thuringiensis</italic> subsp. Tochigiensis HD868</td><td align="left"><italic>Cryphonectria parasitica</italic>, <italic>F. oxysporum</italic>, <italic>Penicillium digitatum</italic>, <italic>A. niger</italic>, <italic>A. fumigatus</italic>,<italic> A. flavus</italic></td><td align="left">In vitro</td><td align="left">Subramanian and Smith (<xref ref-type="bibr" rid="CR538">2015</xref>)</td></tr></tbody></table></table-wrap></p><sec id="Sec6"><title>Modulation of microbiomes</title><p id="Par22">The microbiota is crucial and necessary for maintaining homeostasis, the host defense system, disease prevention, and overall health and well-being. The composition and diversity of the microbiota vary depending on localized regions (e.g., oral, nasal, respiratory, gut, and skin) and consist of highly diverse and&#x000a0;complex communities with specialized autochthonous bacteria (Berg et al. 2020; Anjana <xref ref-type="bibr" rid="CR31">2022</xref>; Baquero et al. <xref ref-type="bibr" rid="CR52">2019</xref>; Zheng et al. <xref ref-type="bibr" rid="CR622">2023</xref>; Ormaasen et al. <xref ref-type="bibr" rid="CR418">2023</xref>; Reuben et al. <xref ref-type="bibr" rid="CR465">2023</xref>; P&#x000e9;rez-Cobas et al. <xref ref-type="bibr" rid="CR432">2023</xref>; Ferraz <xref ref-type="bibr" rid="CR190">2023</xref>). Dysbiosis of the microbiota often leads to physiological dysfunction, dysregulation, and diseases (Hou et al. <xref ref-type="bibr" rid="CR260">2022</xref>). Numerous studies have highlighted the indiscriminate impact of antibiotics on the microbiota, resulting in dysbiosis and perturbations of microbial composition and diversity that predispose the host to metabolic and immune system disorders (Francino <xref ref-type="bibr" rid="CR199">2015</xref>; Sanchez-Rodriguez et al. <xref ref-type="bibr" rid="CR492">2020</xref>; Hou et al. <xref ref-type="bibr" rid="CR260">2022</xref>). Unlike antibiotics, bacteriocins have a narrow spectrum of activity, are highly specific, and can inhibit pathogens without disrupting host-microbiota homeostasis or causing detrimental effects. Bacteriocins that can promote beneficial shifts in the abundance, composition, and diversity of the microbiota may provide sustainable and valuable microbiome-based solutions for the treatment of infectious and non-infectious microbiome-related diseases resulting from microbiota dysbiosis.</p><p id="Par23">Furthermore, bacteriocin production by most bacteria can be seen as a strategy to modulate the microbiome (Pu et al. <xref ref-type="bibr" rid="CR445">2022</xref>; O&#x02019;Reilly et al. <xref ref-type="bibr" rid="CR409">2023</xref>; R&#x000ed;os Colombo et al. <xref ref-type="bibr" rid="CR473">2023</xref>; Rani and Tiwari <xref ref-type="bibr" rid="CR454">2023</xref>; Puls et al. <xref ref-type="bibr" rid="CR446">2024</xref>). Bacteriocins can either prevent invasion by allochthonous bacteria (competitors or pathogens) or stimulate the immune system to prevent oxidative stress and inflammation (Dahiya et al. <xref ref-type="bibr" rid="CR139">2017</xref>; B&#x000e4;uerl et al. <xref ref-type="bibr" rid="CR62">2017</xref>; Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>; Rani and Tiwari <xref ref-type="bibr" rid="CR454">2023</xref>; Puls et al. <xref ref-type="bibr" rid="CR446">2024</xref>). In another instance, bacteriocin-producing bacteria can invade and colonize communities predominantly populated by susceptible strains (Riley and Gordon <xref ref-type="bibr" rid="CR470">1999</xref>; Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>). Bacterial interactions within the microbiota are characterized by both competition (antagonism) and cooperation (mutualism), which require a delicate balance for overall microbiota functioning and cohesion (Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>; P&#x000e9;rez-Cobas et al. <xref ref-type="bibr" rid="CR432">2023</xref>). However, the mechanisms regulating the integration and modulation of bacteriocins in this complex multifactorial meshwork remain a black box.</p><p id="Par24">Although the roles of bacteriocins in microbiome modulation and the maintenance of homeostasis and host health are limited, extensive metagenomic analysis substantially revealed the omnipresence of bacteriocin biosynthetic gene clusters across human microbiomes (Donia et al. <xref ref-type="bibr" rid="CR159">2014</xref>; Aleti et al. <xref ref-type="bibr" rid="CR20">2019</xref>; Naimi et al. <xref ref-type="bibr" rid="CR393">2022</xref>). In a study, several bacteriocins, including garvicin ML (GarML), plantaricins EF and JK (plantaricins), enterocins P, Q, and L50 (enterocins), pediocin PA-1 (PedPA-1), and sakacin A (SakA) were reported to beneficially modulate the gut microbiota in mice (Umu et al. <xref ref-type="bibr" rid="CR562">2016</xref>). While these bacteriocins differ greatly in terms of physicochemical properties and inhibition spectrum, their administration had a favorable impact on the microbiota, resulting in changes at the taxonomic level, increased abundance of LAB, and a decrease in Enterococcaceae, clostridia, and staphylococci. Recent studies showed that nisin, lacticin 3147, pediocin PA1, and bactofencin A separately modulated gut microbiota, resulting in subtle and beneficial alterations in pigs, Simplified Human Intestinal Microbiota (SIHUMI), and simulated colon models (R&#x000ed;os Colombo et al. <xref ref-type="bibr" rid="CR473">2023</xref>; O&#x02019;Reilly et al. <xref ref-type="bibr" rid="CR409">2023</xref>; Pu et al. <xref ref-type="bibr" rid="CR445">2022</xref>; Guinane et al. <xref ref-type="bibr" rid="CR234">2016</xref>). Bactofencin A increased the relative abundances of <italic>Bifidobacterium</italic> and <italic>Streptococcus</italic> while lowering the abundances of <italic>Blautia</italic> and <italic>Clostridium</italic> spp. (Arboleya et al. <xref ref-type="bibr" rid="CR35">2016</xref>; Sun et al. <xref ref-type="bibr" rid="CR540">2020</xref>). <italic>Bifidobacterium</italic> spp. are considered important microbes in healthy microbiota and are associated with probiotic properties. Mice fed with bacteriocin-producing <italic>L. salivarius</italic> UCC118 for eight weeks showed changes in gut microbiota compared to those fed with non-bacteriocin-producing variants (Murphy et al. <xref ref-type="bibr" rid="CR391">2013</xref>). Treatment with bacteriocin-producing <italic>L. salivarius</italic> UCC118 significantly increased <italic>Proteobacteria</italic> and <italic>Bacteroides</italic> while decreasing Actinobacteria. Similarly, the assessment of <italic>L. salivarius</italic> bacteriocin, bactofencin A, in a simulated gut microbiota system showed significant microbiota modulation in both the bactofencin A-producing strain and bactofencin A treatments compared with the non-bactofencin A producing mutant (Guinane et al. <xref ref-type="bibr" rid="CR234">2016</xref>). Bacteriocin production subtly changes the community structure of the gut microbiota at the taxonomic level, maintaining a beneficial and desirable microbiota (Guinane et al. <xref ref-type="bibr" rid="CR234">2016</xref>; Garcia-Gutierrez et al. <xref ref-type="bibr" rid="CR205">2019</xref>; O&#x02019;Connor et al. <xref ref-type="bibr" rid="CR407">2020</xref>). In the same manner, Naimi et al. (<xref ref-type="bibr" rid="CR393">2022</xref>) recently reported the subtle beneficial modulatory effect of Microcin J25 (MccJ25) or reuterin on the overall colon microbiota diversity and metabolome of swine.</p><p id="Par25">Within the oral cavity, some strains of <italic>S. mutans</italic> produce bacteriocins called mutacins which modulate the oral microbiome by inhibiting phylogenetically related plaque-forming strains (Gillor et al. <xref ref-type="bibr" rid="CR217">2008</xref>). There is a positive correlation between the production of bacteriocins by <italic>S. mutans</italic> and their ability to colonize the oral cavity (Hillman et al. <xref ref-type="bibr" rid="CR251">1987</xref>, <xref ref-type="bibr" rid="CR252">2000</xref>). <italic>S. salivarius</italic> K12, a commensal of the oral cavity often produces bacteriocins called salivaricins A and B. The presence of <italic>S. salivarius</italic> K12 which produces salivaricins A and B has been shown to modulate the oral and throat microbiomes, preventing the invasion of oral pathogens such as <italic>S. pyogenes</italic> and reducing throat infections (Brook <xref ref-type="bibr" rid="CR91">2005</xref>; Horz et al. <xref ref-type="bibr" rid="CR257">2007</xref>). Similarly, the consumption of milk containing a strain of <italic>S. salivarius</italic> 20P5, which produces salivaricin A, positively modulates the oral microbiota of children by significantly increasing the production and antagonistic activity of salivaricin A and providing immunity against <italic>S. pyogenes</italic> infection (Walls et al. <xref ref-type="bibr" rid="CR577">2003</xref>). Bacteriocin-producing <italic>Lactobacillus</italic> spp. including <italic>L. gasseri</italic>, <italic>L. crispatus</italic>, <italic>L. jensenii</italic>, and <italic>L. iners</italic>, are dominant in the vagina microbiota of healthy women (V&#x000e1;squez et al. <xref ref-type="bibr" rid="CR569">2002</xref>; Pendharkar et al. <xref ref-type="bibr" rid="CR429">2023</xref>). In contrast, women with bacterial vaginosis have a distinct vaginal microbiota characterized predominantly by <italic>Mycoplasma hominis</italic>, <italic>Gardnerella vaginalis</italic>, <italic>Bacteroides</italic>, <italic>Mobiluncus</italic>, <italic>Peptostreptococcus</italic>, and <italic>Prevotella</italic> spp., along with lower densities of lactobacilli (O&#x02019;Brien <xref ref-type="bibr" rid="CR404">2005</xref>; Falagas et al. <xref ref-type="bibr" rid="CR174">2007</xref>; Turovskiy et al. <xref ref-type="bibr" rid="CR557">2009</xref>). The vaginal microbiota is often modulated by bacteriocin-producing lactobacilli, which typically antagonize pathogens, especially <italic>G. vaginalis</italic> and <italic>Candida</italic> spp. (Kaewsrichan et al. <xref ref-type="bibr" rid="CR291">2006</xref>; G&#x000fc;nther et al. <xref ref-type="bibr" rid="CR236">2022</xref>).</p><p id="Par26">The skin microbiome consists of a highly diverse array of microorganisms involved in complex but balanced multifactorial interactions with the host and external environment (Carmona-Cruz et al. <xref ref-type="bibr" rid="CR100">2022</xref>; Nicholas-Haizelden et al. <xref ref-type="bibr" rid="CR401">2023</xref>; Glatthardt et al. <xref ref-type="bibr" rid="CR218">2024</xref>). Any imbalance (dysbiosis) in the structure and composition of the skin microbiota often results in skin infections/diseases such as acne, impetigo, atopic dermatitis, and psoriasis (Grice <xref ref-type="bibr" rid="CR231">2014</xref>; O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR411">2019</xref>; Carmona-Cruz et al. <xref ref-type="bibr" rid="CR100">2022</xref>; Richter and Wohlrab <xref ref-type="bibr" rid="CR468">2023</xref>; Sato et al. <xref ref-type="bibr" rid="CR500">2023</xref>; Puls et al. <xref ref-type="bibr" rid="CR446">2024</xref>). Bacteriocins have been used to selectively modulate and restore the skin microbial balance (eubiosis) in situations of dysbiosis caused by pathogen colonization and environmental perturbation (O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR411">2019</xref>; Ovchinnikov et al. <xref ref-type="bibr" rid="CR420">2020</xref>; Soltani et al. <xref ref-type="bibr" rid="CR529">2022b</xref>; Alessandrini et al. <xref ref-type="bibr" rid="CR19">2023</xref>; Jaumaux et al. <xref ref-type="bibr" rid="CR278">2023</xref>). Lugdunin, a cyclic peptide bacteriocin facilitates the restoration of skin microbial balance while inhibiting different etiological agents of skin infections, especially MRSA and other Gram-positive bacteria (Bitschar et al. <xref ref-type="bibr" rid="CR78">2019</xref>; Krauss et al. <xref ref-type="bibr" rid="CR317">2020</xref>; Barber and Zhang <xref ref-type="bibr" rid="CR55">2021</xref>; Bier and Schittek <xref ref-type="bibr" rid="CR76">2021</xref>). Lugdunin is believed to exert microbiome modulatory activity by stimulating the expression of different cutaneous antimicrobial peptides and recruiting phagocytic neutrophils and monocytes (Bitschar et al. <xref ref-type="bibr" rid="CR78">2019</xref>; Krauss et al. <xref ref-type="bibr" rid="CR317">2020</xref>; Saur et al. <xref ref-type="bibr" rid="CR501">2021</xref>; Hirsch et al. <xref ref-type="bibr" rid="CR253">2024</xref>). Lugdunin also inhibits colonizing skin pathogens by disrupting the transmembrane pH gradient, which likely leads to protein denaturation and a reduction in proton motive force, obstructing cellular respiration (Krulwich et al. <xref ref-type="bibr" rid="CR318">2011</xref>; Farha et al. <xref ref-type="bibr" rid="CR175">2013</xref>; Barber and Zhang <xref ref-type="bibr" rid="CR55">2021</xref>). Similarly, two recently discovered bacteriocins, cerein B4080 and cerein 7B, reportedly enhance skin microbiome eubiosis by selectively promoting the growth of skin commensals while inhibiting pathogens (Jaumaux et al. <xref ref-type="bibr" rid="CR278">2023</xref>). By preserving skin commensals through competitive exclusion/inhibition of pathogens, bacteriocins could beneficially modulate the skin microbiome while limiting the emergence and spread of superbugs within the skin ecosystem, thereby reducing skin infections (Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>; Soltani et al. <xref ref-type="bibr" rid="CR529">2022b</xref>; Jaumaux et al. <xref ref-type="bibr" rid="CR278">2023</xref>). Other bacteriocins that show high potential for application in skin microbiome modulation include garvicin KS, nisin Z, bactofencin A, pediocin PA-1, subtilosin, microcin J25, micrococcin P1, subtilin, bacteriocin A37, and reuterin (Joseph et al. <xref ref-type="bibr" rid="CR286">2013</xref>; O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR411">2019</xref>; Ovchinnikov et al. <xref ref-type="bibr" rid="CR420">2020</xref>; Heilbronner et al. <xref ref-type="bibr" rid="CR246">2021</xref>; Soltani et al. <xref ref-type="bibr" rid="CR529">2022b</xref>; Alessandrini et al. <xref ref-type="bibr" rid="CR19">2023</xref>; Puls et al. <xref ref-type="bibr" rid="CR446">2024</xref>). There is a need to further explore the mechanisms of activity and pharmacological benefits of promising skin-relevant bacteriocins for their suitability in clinical application and commercialization.</p><p id="Par27">Bacteriocins have also been used to modulate food microbiota to improve organoleptic properties, quality, and microbiological safety. The growing knowledge of the structure and function of food microbiota now influences their modulation towards desirable functions and beneficial outcomes. Food microbiota are often modulated through the regulation of abiotic factors or by using specific microorganisms and/or their products, such as bacteriocins (And and Hoover <xref ref-type="bibr" rid="CR30">2003</xref>; Walsh et al. <xref ref-type="bibr" rid="CR578">2023</xref>). The latter involves the use of various forms of bacteriocins, whether purified or semi-purified, and/or bacteriocin-producing strains to modulate food microbiota (O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR410">2003</xref>; Ramu et al. <xref ref-type="bibr" rid="CR453">2015</xref>; Silva et al. <xref ref-type="bibr" rid="CR519">2018</xref>). It has been demonstrated that the microbiota of fermented foods (e.g., cheese and kefir) can be modulated, making them useful models for shaping food microbiota (Wolfe et al. <xref ref-type="bibr" rid="CR594">2014</xref>; Bonham et al. <xref ref-type="bibr" rid="CR84">2017</xref>; Wolfe <xref ref-type="bibr" rid="CR592">2018</xref>; Blasche et al. <xref ref-type="bibr" rid="CR79">2021</xref>; Walsh et al. <xref ref-type="bibr" rid="CR578">2023</xref>). The application of bacteriocins or bacteriocin-producing strains as starter or protective cultures in dairy products can confer numerous advantages during food processing. They can modulate the food microbiota by accelerating ripening, as is the case with cheese (&#x000c1;vila et al. <xref ref-type="bibr" rid="CR40">2005</xref>; Martinez et al. <xref ref-type="bibr" rid="CR360">2015</xref>), or reduce the growth of adventitious non-starter lactic acid bacteria (NSLAB) and other non-starter microbiota in fermented foods (Oumer et al. <xref ref-type="bibr" rid="CR419">2001</xref>; O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR410">2003</xref>), or inhibit invasion by environmental or spoilage organisms (Mu&#x000f1;oz et al. <xref ref-type="bibr" rid="CR389">2004</xref>, <xref ref-type="bibr" rid="CR390">2007</xref>), or significantly reduce the growth of foodborne pathogens (Carnio et al. <xref ref-type="bibr" rid="CR101">2000</xref>; Aspri et al. <xref ref-type="bibr" rid="CR38">2017</xref>; Kondrotiene et al. <xref ref-type="bibr" rid="CR314">2018</xref>), or accelerate enzyme release and activities (O&#x02019;Sullivan et al. <xref ref-type="bibr" rid="CR410">2003</xref>), or enhance fermentation (Oumer et al. <xref ref-type="bibr" rid="CR419">2001</xref>). Additionally, bacteriocin production has been detected in LAB bacteria recovered from wine during malolactic fermentation, especially among <italic>L. plantarum</italic> strains (Navarro et al. <xref ref-type="bibr" rid="CR395">2000</xref>; Rojo-Bezares et al. <xref ref-type="bibr" rid="CR476">2008</xref>; D&#x000ed;ez et al. <xref ref-type="bibr" rid="CR156">2012</xref>). During vinification, bacteriocin production could be an important characteristic to consider when selecting LAB as starters for malolactic fermentation. Furthermore, bacteriocins produced by LAB have significant potential for use as biocontrol agents against foodborne and spoilage organisms as well as biopreservatives throughout the enological processes (D&#x000ed;ez et al. <xref ref-type="bibr" rid="CR156">2012</xref>; D&#x000fc;ndar <xref ref-type="bibr" rid="CR166">2016</xref>; Fern&#x000e1;ndez-P&#x000e9;rez et al. <xref ref-type="bibr" rid="CR189">2018</xref>).</p></sec><sec id="Sec7"><title>Medical and pharmaceutical applications</title><p id="Par28">The emergence and spread of infectious diseases, especially those caused by antimicrobial-resistant pathogens, and the increasing morbidity and mortality due to non-communicable diseases like diabetes and cancer pose major threats to global health (PAHO/WHO <xref ref-type="bibr" rid="CR424">2019</xref>; WHO <xref ref-type="bibr" rid="CR597">2021</xref>). Due to their high antimicrobial activity against a wide range of pathogens, safety, biocompatibility, unique mechanisms of action, biodegradability, high specificity, and nanomolar range, bacteriocins exert desirable heterogeneous traits relevant for medical application (Naveen and Kalaivani <xref ref-type="bibr" rid="CR397">2018</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>; Le et al. <xref ref-type="bibr" rid="CR332">2021</xref>, <xref ref-type="bibr" rid="CR333">2023</xref>; Reinseth et al. <xref ref-type="bibr" rid="CR460">2024</xref>; Rossi et al. <xref ref-type="bibr" rid="CR479">2024</xref>). The potential of bacteriocins in medicine has been demonstrated through various in vitro, ex vivo, and in vivo experiments, with some undergoing clinical evaluation. However, concerns have risen regarding solubility, stability, bioavailability, sensitivity to proteolytic enzymes, high cost, and the challenges of large-scale purification and production for general use, which often limit the direct use of bacteriocins in clinical studies and hinder their industrial production and commercialization (B&#x000f6;ttger et al. <xref ref-type="bibr" rid="CR88">2017</xref>; Mathur et al. <xref ref-type="bibr" rid="CR363">2018</xref>; Hols et al. <xref ref-type="bibr" rid="CR255">2019</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Nevertheless, due to the unique and diverse medical potentials exhibited by bacteriocins, further investigations involving cutting-edge bioengineering techniques can be conducted to address these concerns and improve their properties and large-scale production for general medical use.</p><sec id="Sec8"><title>Inhibition of pathogens: viable alternatives to antibiotics</title><p id="Par29">Since the discovery of antibiotics, they have played a significant role in the prevention and treatment of animal and human diseases. However, the emergence and increasing spread of multi- and extensive-drug-resistant superbugs necessitate the urgent use of novel, suitable, and sustainable strategies for infection control, treatment, and addressing AMR concerns. Bacteriocins show great promise as sustainable alternatives to currently available antibiotics. Numerous studies have described the unique mechanisms of action and potency of different bacteriocins against a broad range of superbugs (Bastos et al. <xref ref-type="bibr" rid="CR60">2009</xref>, <xref ref-type="bibr" rid="CR61">2015</xref>; Svetoch et al. <xref ref-type="bibr" rid="CR544">2009</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Goodarzi et al. <xref ref-type="bibr" rid="CR224">2020</xref>; Ovchinnikov et al. <xref ref-type="bibr" rid="CR421">2021</xref>; Ben&#x000ed;tez-Chao et al. <xref ref-type="bibr" rid="CR71">2021</xref>; Sharma et al. <xref ref-type="bibr" rid="CR515">2022</xref>; Soltani et al. 2022a; Barman et al. <xref ref-type="bibr" rid="CR59">2023</xref>; Ghapanvari et al. <xref ref-type="bibr" rid="CR212">2022</xref>; Bahy et al. <xref ref-type="bibr" rid="CR44">2023</xref>; Ibraheim et al. <xref ref-type="bibr" rid="CR269">2023</xref>; Wolden et al. <xref ref-type="bibr" rid="CR591">2023</xref>; Reinseth et al. <xref ref-type="bibr" rid="CR460">2024</xref>). Over the years, many studies have reported the antimicrobial properties of various bacteriocins against clinically important pathogens responsible for respiratory tract, nosocomial, dental, skin, and gastrointestinal tract infections. Bacteriocins have also been shown to have inhibitory effects on multidrug-resistant pathogens including <italic>C. difficile</italic>, vancomycin-resistant <italic>Enterococcus</italic> (VRE), methicillin-resistant <italic>S. aureus</italic> (MRSA), <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Haemophilus influenza</italic>, <italic>Listeria</italic> spp., <italic>Salmonella</italic> spp., <italic>Enterobacter</italic> spp., <italic>Acinetobacter</italic> spp. and others (Oman and van der Donk <xref ref-type="bibr" rid="CR414">2009</xref>; Lay et al. <xref ref-type="bibr" rid="CR331">2016</xref>; Hanchi et al. <xref ref-type="bibr" rid="CR243">2017</xref>; Yu et al. <xref ref-type="bibr" rid="CR610">2019</xref>; Vel&#x000e1;zquez-Su&#x000e1;rez et al. <xref ref-type="bibr" rid="CR570">2021</xref>; Ghapanvari et al. <xref ref-type="bibr" rid="CR212">2022</xref>; Bahy et al. <xref ref-type="bibr" rid="CR44">2023</xref>; Le et al. <xref ref-type="bibr" rid="CR333">2023</xref>; Alattar et al. <xref ref-type="bibr" rid="CR18">2024</xref>; Mu et al. <xref ref-type="bibr" rid="CR388">2024</xref>; Reinseth et al. <xref ref-type="bibr" rid="CR460">2024</xref>). Recently, Ying et al. (<xref ref-type="bibr" rid="CR607">2024</xref>) and Wolden et al. (<xref ref-type="bibr" rid="CR591">2023</xref>) separately identified novel bacteriocins, bacteriocin XJS01 and romsacin (produced by <italic>Lactobacillus salivarius</italic> and <italic>Staphylococcus haemolyticus</italic>) which showed broad-spectrum activity against Gram-positive World Health Organization (WHO) priority pathogens such as VRE (<italic>E. faecium</italic>) and MRSA. Additionally, romsacin also eradicated the biofilms of VRE, MRSA, <italic>Staphylococcus epidermidis</italic>, and <italic>S. haemolyticus</italic>.</p><p id="Par30">Nosocomial infections are mostly caused by MDR <italic>E</italic>. <italic>coli</italic>, enterococci, <italic>P. aeruginosa</italic>,<italic> Acinetobacter baumannii</italic>, <italic>K. pneumoniae</italic>, pneumococci, <italic>S. aureus</italic>, and <italic>Proteus</italic> spp. (Ghodhbane et al. <xref ref-type="bibr" rid="CR215">2015</xref>; Khan et al. <xref ref-type="bibr" rid="CR301">2017</xref>; Le et al. <xref ref-type="bibr" rid="CR332">2021</xref>; Rossi et al. <xref ref-type="bibr" rid="CR479">2024</xref>). Lacticin 3147, klebicin, and nisin A have shown high inhibitory activity against multiple nosocomial pathogens including MRSA and VRE (Piper et al. <xref ref-type="bibr" rid="CR438">2009</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Alattar et al. <xref ref-type="bibr" rid="CR18">2024</xref>; Zhao et al. <xref ref-type="bibr" rid="CR621">2024</xref>). These bacteriocins also exhibit significant antagonism against pathogens in the kidney, liver, and spleen. In an in vivo study involving <italic>S. aureus</italic> Xen 29 infected mice, subcutaneous treatment with lacticin 3147 prevented the systemic spread of the pathogen, indicating the potential of lacticin 3147 as a biotherapeutic in real-life applications (Piper et al. <xref ref-type="bibr" rid="CR438">2009</xref>). Pumilicin 4, a bacteriocin produced by <italic>Bacillus pumilus</italic>, has shown remarkable inhibitory activity against MRSA, VRE, and several Gram-positive bacteria (Aunpad and Na-Bangchang <xref ref-type="bibr" rid="CR39">2007</xref>). This demonstrates the potential of the use of Pumilicin 4 in the management of infections caused by MRSA, VRE, and other susceptible Gram-positive pathogenic bacteria. Similarly, planosporicin, a bacteriocin produced by <italic>Planomonospora</italic> spp. DSM14920, has shown activity against <italic>S. pyogenes</italic>, <italic>S. pneumoniae</italic>, and <italic>S. aureus</italic> (Aunpad and Na-Bangchang <xref ref-type="bibr" rid="CR39">2007</xref>). Jab&#x000e9;s et al. (<xref ref-type="bibr" rid="CR277">2011</xref>) and Mota-Meira et al. (<xref ref-type="bibr" rid="CR385">2005</xref>) separately demonstrated high in vitro and in vivo inhibitory activities of bacteriocins NAI-107, mutacin B-Ny266, and microbisporicin against MDR pathogens. Additionally, the activity of microcin J25, a bacteriocin produced by <italic>E. coli</italic> against multidrug-resistant Enterobacteriaceae has also been reported (Telhig et al. <xref ref-type="bibr" rid="CR545">2022</xref>).</p><p id="Par31">The growth of major pathogenic bacteria including <italic>H. influenzae</italic>, <italic>Pasteurella multocida</italic>, <italic>Mycobacterium tuberculosis</italic>, <italic>P. aeruginosa</italic>, or <italic>Moraxella catarrhalis</italic>, responsible for various respiratory tract infections (RTIs) such as rhinitis, pneumonia, otitis, and tuberculosis were reportedly inhibited by different bacteriocins (mutacin B-Ny266, bacteriocin L23, lantibiotic MU1140, nisin F, and Mersacidin) under in vivo conditions in mice and Wistar Rats models and in vitro models (Kruszewska et al. <xref ref-type="bibr" rid="CR319">2004</xref>; Mota-Meira et al. <xref ref-type="bibr" rid="CR385">2005</xref>; Pascual et al. <xref ref-type="bibr" rid="CR427">2008</xref>; De Kwaadsteniet et al. <xref ref-type="bibr" rid="CR148">2009</xref>; Ghobrial et al. <xref ref-type="bibr" rid="CR214">2009</xref>; Le et al. <xref ref-type="bibr" rid="CR333">2023</xref>; Martin et al. <xref ref-type="bibr" rid="CR359">2023</xref>; Zhao et al. <xref ref-type="bibr" rid="CR621">2024</xref>). The activities of these bacteriocins under varied in vivo conditions, including immunosuppression, were observed to have no toxicity to the bronchi, trachea, lungs, or haematology of the evaluated animals. Similarly, purified salivaricin D and mutacin 1140 have shown antagonism against known RTI pathogens, <italic>P. aeruginosa</italic>, <italic>S. aureus</italic>, and <italic>S. pneumoniae</italic> (Ghobrial et al. <xref ref-type="bibr" rid="CR214">2009</xref>; Birri et al. <xref ref-type="bibr" rid="CR77">2012</xref>). Multiple in vitro and in vivo (mice and macrophages) anti-tubercular activities of various bacteriocins (e.g. lacticin 3147, nisin, laterosporulin10, and enterocin AS-48) have been tested against different strains of <italic>M. tuberculosis</italic> with favorable outcomes (Sosunov et al. <xref ref-type="bibr" rid="CR530">2007</xref>; de Kwaadsteniet et al. <xref ref-type="bibr" rid="CR145">2010</xref>; Carroll et al. <xref ref-type="bibr" rid="CR102">2010</xref>; Aguilar-P&#x000e9;rez et al. <xref ref-type="bibr" rid="CR10">2018</xref>)<italic>.</italic> Furthermore, variants of bioengineered nisin S, T, and V tested against <italic>M. tuberculosis</italic> (H37Ra), <italic>M. avium</italic> subsp. <italic>Paratuberculosis</italic> (ATCC 19698), <italic>M. avium</italic> subsp. <italic>Hominissuis</italic> (CIT05/03), and <italic>M. kansasii</italic> (CIT11/06) showed more significant inhibitory activities compared to parent nisin (Carroll et al. <xref ref-type="bibr" rid="CR102">2010</xref>). Among the bioengineered nisin variants, nisin S showed the most potent antagonism. Latham et al. (<xref ref-type="bibr" rid="CR328">2017</xref>) also reported narrow-spectrum activity against nontypeable <italic>Haemophilus influenzae</italic> (NTHi) by a novel bacteriocin produced by <italic>Haemophilus haemolyticus</italic>. Their findings suggest that the novel bacteriocin or bacteriocinogenic strains of <italic>H. haemolyticus</italic> have the potential to reduce NTHi colonization and respiratory tract infection caused by NTHi.</p><p id="Par32">Topical evaluation of bacteriocins has successfully been reported against oral and skin diseases, and breastfeeding women with mastitis (Fern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR181">2008</xref>; Kang et al. <xref ref-type="bibr" rid="CR294">2009</xref>; Tong et al. <xref ref-type="bibr" rid="CR552">2014</xref>). Etiological agents of these diseases especially <italic>Propionibacterium acnes</italic>, <italic>P. aeruginosa</italic>, <italic>S. aureus</italic>, <italic>S. epidermidis</italic>, <italic>L. monocytogene</italic>s, <italic>B. subtilis</italic>, and <italic>B. cereus</italic> were controlled using bacteriocins such as nisin, lactocyclicin Q, subpeptin JM4B and hiracin JM79 (S&#x000e1;nchez et al. <xref ref-type="bibr" rid="CR491">2007</xref>; Kang et al. <xref ref-type="bibr" rid="CR294">2009</xref>; Sawa et al. <xref ref-type="bibr" rid="CR502">2009</xref>; Izquierdo et al. <xref ref-type="bibr" rid="CR276">2009</xref>; Ovchinnikov et al. <xref ref-type="bibr" rid="CR420">2020</xref>; Barman et al. <xref ref-type="bibr" rid="CR59">2023</xref>). Similarly, bacteriocins or bacteriocin-based formulas have been topically used for the treatment and prevention of mastitis and intramammary infections in animals Bennett et al. <xref ref-type="bibr" rid="CR73">2021</xref>; <xref ref-type="bibr" rid="CR74">2022</xref>; Heinzinger et al. <xref ref-type="bibr" rid="CR247">2023</xref>; Raheel et al. <xref ref-type="bibr" rid="CR451">2023</xref>). Several studies have reported the potency of different bacteriocins against pathogenic bacteria responsible for dental infections, vaginosis, gastric ulcers, gastroenteritis, etc. (Howell et al. <xref ref-type="bibr" rid="CR261">1993</xref>; Dover et al. <xref ref-type="bibr" rid="CR162">2007</xref>; Miyauchi et al. <xref ref-type="bibr" rid="CR380">2012</xref>; Kaewnopparat et al. <xref ref-type="bibr" rid="CR290">2013</xref>; van Staden et al. <xref ref-type="bibr" rid="CR567">2016</xref>; Cebri&#x000e1;n et al. <xref ref-type="bibr" rid="CR105">2019</xref>; Ovchinnikov et al. <xref ref-type="bibr" rid="CR420">2020</xref>, <xref ref-type="bibr" rid="CR421">2021</xref>; Goodarzi et al. <xref ref-type="bibr" rid="CR224">2020</xref>; Ben&#x000ed;tez-Chao et al. <xref ref-type="bibr" rid="CR71">2021</xref>; Sharma et al. <xref ref-type="bibr" rid="CR515">2022</xref>; Barman et al. <xref ref-type="bibr" rid="CR59">2023</xref>; Alessandrini et al. <xref ref-type="bibr" rid="CR19">2023</xref>).</p></sec><sec id="Sec9"><title>Potential antiviral agents</title><p id="Par33">Apart from antibacterial properties exhibited by bacteriocins, several bacteriocins also possess antiviral activities against different viruses. While working with bacteriocins produced by <italic>E. faecium</italic> CRL35, (Wachsman et al. <xref ref-type="bibr" rid="CR575">1999</xref>) first described the antiviral activity of enterocin CRL35 against Herpes simplex viruses (HSV-1 and HSV-2). Enterocin CRL35 interferes with intracellular viral multiplication and inhibits viral late stages of replication (Wachsman et al. <xref ref-type="bibr" rid="CR576">2003</xref>; Al Kassaa et al. <xref ref-type="bibr" rid="CR16">2014</xref>). Similarly, enterocin ST4V and enterocin ST5Ha produced by <italic>E. mundtii</italic> ST4V and <italic>E. faecium</italic> ST5Ha, respectively, have shown high potency against HSV-1 and HSV-2 (Wachsman et al. <xref ref-type="bibr" rid="CR576">2003</xref>; Todorov et al. <xref ref-type="bibr" rid="CR549">2005</xref>). Bacteriocins produced by <italic>L. curvatus</italic> and <italic>L. delbrueckii</italic> subsp. <italic>Bulgaricus</italic> have shown antiviral properties against murine norovirus (MNV) and influenza virus (H1N1) (Serkedjieva et al. <xref ref-type="bibr" rid="CR510">2000</xref>; Lange-Starke et al. <xref ref-type="bibr" rid="CR326">2014</xref>). Non-LAB bacteriocins including Subtilosin A, erwiniocin NA4, and staphylococcin 188 produced by <italic>B. subtilis</italic>, <italic>E. carotovora</italic> NA4, and <italic>S. aureus</italic> AB188 independently showed inhibitory activities against HSV-1 (Torres et al. <xref ref-type="bibr" rid="CR553">2013</xref>), influenza, Newcastle disease, and coliphage HSA viruses (Qureshi et al. <xref ref-type="bibr" rid="CR450">2006</xref>; Saeed et al. <xref ref-type="bibr" rid="CR484">2007</xref>), respectively. Likewise, <italic>Actinomadura namibiensis</italic> DSM 6313 secretes bacteriocin, Labyrinthopeptin A1 (LabyA1) with antiviral activity against HSV and human immunodeficiency virus type 1 (HIV-1) (F&#x000e9;rir et al. <xref ref-type="bibr" rid="CR179">2013</xref>). LabyA1 inhibited intracellular transmission of HIV-1 between infected and noninfected CD4&#x02009;+&#x02009;T cells. Lee et al. (<xref ref-type="bibr" rid="CR336">2016</xref>) similarly demonstrated the antiviral inhibitory activity of Micrococcin P1. In their study, they reported that Micrococcin P1, a naturally occurring macrocyclic peptide efficiently inhibited the attachment, entry, and cell-to-cell transmission of all hepatitis C virus (HCV) genotypes.</p><p id="Par34">In a recent study, bacteriocin-like inhibitory substances produced by <italic>E</italic><italic><underline>.</underline></italic><italic> faecium</italic> CM019 isolated from Egyptian dairy products showed broad-spectrum antimicrobial activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and several Gram-positive bacteria activity (Bahy et al. <xref ref-type="bibr" rid="CR44">2023</xref>). Generally, the antiviral mechanisms and pharmacodynamics of bacteriocins against viruses are yet to be fully elucidated. However, it is believed that bacteriocins interfere with viral key determinants responsible for viral replication (Wachsman et al. <xref ref-type="bibr" rid="CR576">2003</xref>). Further studies are required to decipher the mechanisms of action and pharmacodynamics of bacteriocins against different viruses, especially those emerging with high virulence.</p></sec><sec id="Sec10"><title>Potential non-invasive bio-diagnostic tool</title><p id="Par35">Emerging reports show the great potential of bacteriocins as valuable tools for bioanalytical purposes in medicine, largely due to their precision, specificity, and in vivo recognition in biological systems. Different studies have demonstrated the labeling of bacteriocins using specific organic probes, fluorescent, or radioactive markers (Imran et al. <xref ref-type="bibr" rid="CR272">2013</xref>; Deng et al. <xref ref-type="bibr" rid="CR150">2020</xref>; Escobar et al. <xref ref-type="bibr" rid="CR169">2023</xref>). Through visualization with fluorescence ratio imaging microscopy, a labeled bacteriocin, fluorescent nisin Z, was able to precisely detect three pathogenic listerial strains: <italic>L. monocytogenes</italic> CIP 82110, <italic>L. ivanovii</italic> CIP 12510, and <italic>L. innocua</italic> CIP 12511 (Imran et al. <xref ref-type="bibr" rid="CR272">2013</xref>). Additionally, the mechanism of antilisterial action using the labeled nisin was demonstrated. Technetium-99&#x000a0;m (<sup>99m</sup>Tc)&#x02013;duramycin a bacteriocin which is known to have high specificity and affinity towards phosphatidylethanolamine was used to identify apoptotic and necrotic cells (Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>). The combinatorial use of sodium iodide symporter (NIS) and <sup>99m</sup>Tc-duramycin single-photon emission computed tomography (SPECT) imaging has proven effective in monitoring the spread of oncolytic virotherapy (OV) and determining the absence or presence of therapeutic-associated cell death (Zhang et al. <xref ref-type="bibr" rid="CR616">2019</xref>).</p><p id="Par36">Recent advances in bacteriocin and peptide-based diagnosis, detection, and monitoring of pathogens have been increasingly developed for application in clinical and food systems with remarkable success. Various bacteriocins such as warnericin RK, leucocin, leucocin A, pediocin PA1, and curvacin A, have been used for the detection and monitoring of pathogens including bacteria and viruses, in clinical settings and the food system (Etayash et al. <xref ref-type="bibr" rid="CR170">2014a</xref>, <xref ref-type="bibr" rid="CR171">b</xref>; Azmi et al. <xref ref-type="bibr" rid="CR42">2015</xref>; Islam et al. <xref ref-type="bibr" rid="CR274">2021</xref>, <xref ref-type="bibr" rid="CR275">2022</xref>; Escobar et al. <xref ref-type="bibr" rid="CR169">2023</xref>). These advances show the potential application of bacteriocins not only as noninvasive diagnostic tools for the diagnosis and prognosis of both infectious and non-infectious diseases but also for the identification of individuals predisposed to chronic diseases or secondary infections. Additionally, the use of peptide-based biosensors could offer promising, rapid, and highly sensitive alternatives for pathogen detection and food monitoring in agrifood systems.</p></sec><sec id="Sec11"><title>Potential as anticancer agents</title><p id="Par37">Globally, cancer remains one of the most severe, life-threatening, and difficult-to-treat diseases, resulting from the spread of uncontrollable proliferation of cells. The use of conventional cancer treatments, especially chemotherapy, radiotherapy, and surgery, often results in more devastating side effects and is still unable to curb the rising cases of cancer-associated morbidity and mortality (Naveen and Kalaivani <xref ref-type="bibr" rid="CR397">2018</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>). A paradigm shift in cancer treatment approaches, including the use of innovative, safe, and sustainable solutions with no severe side effects is imperative. Interestingly, several bacteriocins have demonstrated varying degrees of anticancer activity (Hoskin and Ramamoorthy <xref ref-type="bibr" rid="CR258">2008</xref>; Kaur and Kaur <xref ref-type="bibr" rid="CR298">2015</xref>; Baindara et al. <xref ref-type="bibr" rid="CR47">2018</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>). Due to the differences between the membranes of cancerous and healthy cells, bacteriocins can identify and selectively destroy cancer cells (Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>). Unlike healthy cells, which have outer membranes with neutral charged ions, the outer membrane of cancer cells upregulates the expressions of O-glycosylated mucins and phosphatidylserine (Yoon et al. <xref ref-type="bibr" rid="CR608">1996</xref>; Dobrzy&#x00144;ska et al. <xref ref-type="bibr" rid="CR157">2005</xref>) and becomes negatively charged. The negatively charged cell membranes of cancer cells trigger electrostatic interactions in the presence of [positively charged] bacteriocins (Hammami et al. <xref ref-type="bibr" rid="CR240">2010</xref>; Baindara et al. <xref ref-type="bibr" rid="CR47">2018</xref>; Meade et al. <xref ref-type="bibr" rid="CR368">2020</xref>; Ananou et al. <xref ref-type="bibr" rid="CR29">2020</xref>). The inhibitory activity of bacteriocins against cancer cells is primarily based on membrane permeabilization, which is mainly due to the amphiphilic and cationic nature of bacteriocins (Kaur and Kaur <xref ref-type="bibr" rid="CR298">2015</xref>; Perez et al. <xref ref-type="bibr" rid="CR431">2018</xref>). Ahmadi et al. (<xref ref-type="bibr" rid="CR12">2017</xref>) reported antiproliferative activity of nisin against colon cancer SW480&#x000a0;cells. Nisin ZP induced anticancer activity, resulting in a high level of apoptosis in squamous cell carcinoma (HNSCC cells) with no histological damage, necrosis, fibrosis, or inflammation even after prolonged exposure to nisin ZP (Kamarajan et al. <xref ref-type="bibr" rid="CR293">2015</xref>). Similarly, nisin has shown activity in the control of oral cancer as well as in head and neck squamous cell carcinoma in in vivo mice studies (Lopetuso et al. <xref ref-type="bibr" rid="CR347">2019</xref>). Purified colicin, microcin, pediocin, and pyocin have also demonstrated high inhibitory activities in xenograft mouse models and neoplastic cell lines (Shin et al. <xref ref-type="bibr" rid="CR518">2016</xref>). Microcin E492, produced by <italic>K. pneumoniae</italic>, exhibits anticancer properties against breast and colorectal cancer cells through the induction of apoptosis and necrosis in some human cell lines (Hetz et al. <xref ref-type="bibr" rid="CR249">2002</xref>).</p><p id="Par38">In recent years, several bacteriocins, including Laterosporulin10, Enterocin 12a, nisin A, Fermenticin HV6b, colicins, and Enterocin LNS18, have shown anticancer properties against various types of cancers in different cancer cell models (Baindara et al. <xref ref-type="bibr" rid="CR46">2017</xref>; Norouzi et al. <xref ref-type="bibr" rid="CR402">2018</xref>; Al-Madboly et al. <xref ref-type="bibr" rid="CR21">2020</xref>; Hosseini et al. <xref ref-type="bibr" rid="CR259">2020</xref>; Soleimanpour et al. <xref ref-type="bibr" rid="CR524">2020</xref>; Sharma et al. <xref ref-type="bibr" rid="CR514">2021</xref>; Balcik-Ercin and Sever <xref ref-type="bibr" rid="CR48">2022</xref>; Molujin et al. <xref ref-type="bibr" rid="CR382">2022</xref>; Ye et al. <xref ref-type="bibr" rid="CR605">2023</xref>). These bacteriocins often exhibit anticancer activities against human cell lines or in vivo, with minimal activity towards non-cancerous cells. Several studies have confirmed the anticancer potential of bacteriocins. However, more in vivo studies are necessary to fully elucidate and validate the clinical potency of bacteriocins as anticancer therapeutic agents.</p></sec></sec><sec id="Sec100"><title>Food applications</title><p id="Par39">The application of bacteriocins in the food system has been extensively studied since their discovery. Bacteriocins are naturally synthesized and ready-to-use, without color, taste, odor, or impact on the sensory properties of food. They also demonstrate stability at high temperatures and low pH, making them increasingly important in the food sector (Perez et al. <xref ref-type="bibr" rid="CR430">2014</xref>; Abbasiliasi et al. <xref ref-type="bibr" rid="CR2">2017</xref>; Yang et al. <xref ref-type="bibr" rid="CR604">2018</xref>; Sanguyo et al. <xref ref-type="bibr" rid="CR494">2021</xref>; Shafique et al. <xref ref-type="bibr" rid="CR512">2022</xref>; Field et al. <xref ref-type="bibr" rid="CR194">2023</xref>; Yu et al. <xref ref-type="bibr" rid="CR611">2023</xref>). The suitability of bacteriocins for extensive application in the food system leverages several beneficial aspects of food production. Bacteriocins are able to (a) decrease the risk of transmission of foodborne or zoonotic pathogens and food poisoning, (b) improve the shelf life of food, (c) decrease economic losses due to disease outbreaks, food spoilage, and recalls, (d) preserve the nutritional value of food through the reduction of the intensity of physical treatments, (e) decrease processing costs and time, (f) provide a safe and sustainable alternative preservation approach for ready-to-eat and "novel&#x0201d; food, and (g) provide extra protection during temperature abuse episodes (G&#x000e1;lvez et al. <xref ref-type="bibr" rid="CR204">2007</xref>; Hu et al. <xref ref-type="bibr" rid="CR264">2014</xref>; Darbandi et al. <xref ref-type="bibr" rid="CR141">2022</xref>). While various aspects of bacteriocin applications within the food system, including food preservation, fermentation, and protective culture, have been extensively reviewed (Deegan et al. <xref ref-type="bibr" rid="CR149">2006</xref>; Zacharof and Lovitt <xref ref-type="bibr" rid="CR612">2012</xref>; Perez et al. <xref ref-type="bibr" rid="CR430">2014</xref>; Bali et al. <xref ref-type="bibr" rid="CR49">2016</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Lopetuso et al. <xref ref-type="bibr" rid="CR347">2019</xref>), we provide additional updates on the emerging and relevant potential of bacteriocin use in the food system.</p><sec id="Sec200"><title>Potential in antimicrobial food packaging</title><p id="Par40">Despite the application of advanced technologies in the food industry, excessive economic loss as a result of microbial contamination and spoilage continue to constitute a major challenge globally. The application of antimicrobial agents, including bacteriocins, in antimicrobial packaging is specifically suitable for mitigating the risk of microbial contamination. The use of bacteriocin-coated packaging films to inhibit and control food spoilage has attracted considerable attention the recent years. These bacteriocins can either be directly coated onto the packaging film surface or incorporated into the matrix of the packaging film (Woraprayote et al. <xref ref-type="bibr" rid="CR595">2016</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Benabbou et al. <xref ref-type="bibr" rid="CR68">2020</xref>). However, it is important to understand both the physicochemical properties and the mechanism(s) of action of the selected bacteriocin(s) for such use (O&#x02019;Connor et al. <xref ref-type="bibr" rid="CR405">2015</xref>). Active bacteriocin coating serves to protect food products by continuously interacting with the packaged food and modifying the internal environmental conditions within the required shelf life (Gumienna and G&#x000f3;rna <xref ref-type="bibr" rid="CR235">2021</xref>). In most instances, bacteriocins improve food quality by maintaining microbiological safety, improving nutritional and sensory properties, and extending shelf life (Santos et al. <xref ref-type="bibr" rid="CR495">2018</xref>; Mousavi Khaneghah et al. <xref ref-type="bibr" rid="CR387">2018</xref>; Sanguyo et al. <xref ref-type="bibr" rid="CR494">2021</xref>; Shafique et al. <xref ref-type="bibr" rid="CR512">2022</xref>; Yu et al. <xref ref-type="bibr" rid="CR611">2023</xref>). Food packaging films or polymers incorporated with bacteriocins directly inhibit the growth of microorganisms on the food surface, where most of the microbial food spoilage or contamination occurs (Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Gumienna and G&#x000f3;rna <xref ref-type="bibr" rid="CR235">2021</xref>; Rivera-Hern&#x000e1;ndez et al. <xref ref-type="bibr" rid="CR474">2021</xref>). Interestingly, most bacteriocins retain their antimicrobial activity during food processing. Their viability is not impacted by changes in temperature, sterilization, pasteurization, or other processing techniques (Santos et al. <xref ref-type="bibr" rid="CR495">2018</xref>; Gumienna and G&#x000f3;rna <xref ref-type="bibr" rid="CR235">2021</xref>). The growing consumer demand for safe, natural, and chemical-free food has enabled food industries to explore the use of bacteriocins in food packaging, among other applications. Active bacteriocin-coated materials are highly promising sustainable solutions to enhance food safety and shelf life while retarding food contamination and spoilage.</p><p id="Par41">For example, a polyethylene-based packaging film infused with plantaricin BM-1 produced by <italic>L. plantarum</italic> BM-1 showed antilisterial activity against <italic>L. monocytogenes</italic> for at least 120&#x000a0;days at room temperature (Zhang et al. <xref ref-type="bibr" rid="CR615">2017</xref>). Woraprayote et al. (<xref ref-type="bibr" rid="CR596">2018</xref>) also demonstrated the inhibitory activity of <italic>Weissella hellenica</italic>-produced bacteriocin 7293 impregnated onto a biocomposite film (PLA/SP) with pangasius fish fillets against various foodborne pathogens, including <italic>A. hydrophila</italic>, <italic>S. aureus</italic>, <italic>L. monocytogenes</italic>, <italic>P. aeruginosa</italic>, and <italic>S. typhimurium.</italic> The adsorption of nisin on a wide variety of packaging films with antimicrobial activities has been successfully reported on polypropylene, ethylene vinyl acetate, polyethylene, polyvinyl chloride, acrylics, polyamide, and polyester. Nisin-incorporated coatings for poultry products have also been documented (Appendini and Hotchkiss <xref ref-type="bibr" rid="CR33">2002</xref>; Scaffaro et al. <xref ref-type="bibr" rid="CR503">2011</xref>; Tumbarski et al. <xref ref-type="bibr" rid="CR556">2018</xref>). Polyamide and polyethylene pouches coated with nisin preparation (Nisaplin<sup>&#x000ae;</sup>) and lacticin 3147 significantly reduced <italic>L. lactis</italic> subsp. <italic>lactis</italic>, <italic>S. aureus</italic>, and <italic>L. innocua</italic> during the storage of vacuum-packed cheese (Scannell et al. <xref ref-type="bibr" rid="CR504">2000</xref>). Pediocin coated on plastic bags and cellulose casings completely inhibited <italic>L. monocytogenes</italic> in meats during 3&#x000a0;months of storage at refrigeration temperature (Ming et al. <xref ref-type="bibr" rid="CR377">1997</xref>). Benabbou et al. (<xref ref-type="bibr" rid="CR68">2020</xref>) also reported the antimicrobial properties of biocompatible and biodegradable chitosan films incorporated with divergicin M35 for the biocontrol of <italic>Listeria</italic> spp. in foods, especially minimally processed products, and ready-to-eat food. The success observed in these studies highlights the potential of bacteriocins in antimicrobial packaging by effectively inhibiting or limiting the growth of spoilage and pathogenic microorganisms in packaged food.</p></sec><sec id="Sec300"><title>Potential as antibiofilm and sanitizers</title><p id="Par42">Microorganisms mostly exist as sessile communities, known as biofilms, enclosed in an extracellular matrix typically composed of extracellular DNA, lipids, polysaccharides, etc. (Flemming et al. <xref ref-type="bibr" rid="CR196">2016</xref>). Biofilm formation by microorganisms in the food system makes them resistant to antimicrobials and difficult to remove from food production facilities, surfaces, and environments (Mathur et al. <xref ref-type="bibr" rid="CR363">2018</xref>). Many biofilm-forming species in the food industry are known human pathogens that can cause metal corrosion, changes in organoleptic properties of food, and disease (Colagiorgi et al. <xref ref-type="bibr" rid="CR122">2017</xref>; Kirtonia et al. <xref ref-type="bibr" rid="CR307">2021</xref>). Biofilms are commonly found on surfaces such as tanks, pipelines, glass, polyethylene, polypropylene, rubber, packaging tools, and wood (Kirtonia et al. <xref ref-type="bibr" rid="CR307">2021</xref>). Recently, the use of bacteriocins as antibiofilm agents in the food industry has been widely reported (Mathur et al. <xref ref-type="bibr" rid="CR363">2018</xref>; Kirtonia et al. <xref ref-type="bibr" rid="CR307">2021</xref>; Jiang et al. <xref ref-type="bibr" rid="CR282">2022</xref>; Zhang et al. <xref ref-type="bibr" rid="CR618">2022a</xref>, <xref ref-type="bibr" rid="CR619">b</xref>). In a study by Bolocan et al. (<xref ref-type="bibr" rid="CR83">2017</xref>), several bacteriocins including, subtilomycin, nisin Z, and lichenicidin demonstrated high antibiofilm activity against <italic>L. monocytogenes</italic> biofilms. These bacteriocins also significantly decreased the viability of already formed biofilms. Another study showed that nisin at the concentration of 4000&#x000a0;IU/ml reduced biofilm formation by 87, 57, and 30% for <italic>Salmonella</italic> Enteriditis, <italic>L. monocytogenes</italic>, and <italic>S. aureus</italic>, respectively (Mahdavi et al. <xref ref-type="bibr" rid="CR353">2007</xref>). Bacteriocin sonorensin exhibited inhibitory activity against <italic>S. aureus</italic> biofilms (Chopra et al. <xref ref-type="bibr" rid="CR117">2015</xref>). From their study, the inhibitory property of sonorensin was attributed to increased membrane permeability in <italic>S. aureus</italic>. Biofilms formed by fourteen <italic>Staphylococcus</italic> strains were inhibited by hyicin 4244, a circular sactibiotic secreted by <italic>S. hyicus</italic> 4244 (Duarte et al. <xref ref-type="bibr" rid="CR165">2018</xref>). Hyicin 4244 decreased biofilm-forming ability, number of cells, cellular viability, and proliferation of sessile cells within already formed biofilm.</p><p id="Par43">While the combination of nisin with enterocin B3A-B3B resulted in a 2-log decrease in <italic>L. monocytogenes</italic> biofilms on the surface of stainless steel within 24&#x000a0;h, nisin mixed with ethanol however resulted in a 5-log reduction of <italic>Salmonella</italic> and <italic>E. coli</italic> biofilms on stainless steel surfaces within 15&#x000a0;min (Phongphakdee and Nitisinprasert <xref ref-type="bibr" rid="CR434">2015</xref>; Al-Seraih et al. <xref ref-type="bibr" rid="CR23">2017</xref>). Industrial application of bacteriocins as antibiofilm agents or sanitizers may require a longer period to achieve significant bacterial reduction. However, bacteriocin combination with other antimicrobials can result in rapid bacterial reduction and biofilms clearance. Further studies are needed to explore the potential of bacteriocins as antibiofilm agents in the food industry, focusing on unraveling their mechanism of action and spectrum of activity.</p></sec></sec><sec id="Sec400"><title>Agriculture and veterinary medicine</title><p id="Par44">Antibiotics have been routinely used in agriculture, either for treating or preventing animal diseases or as growth promoters. This practice has significantly contributed to the increased emergence and spread of antimicrobial-resistant pathogens from animals to humans (Ben Lagha et al. <xref ref-type="bibr" rid="CR66">2017</xref>). To address the issue of AMR in animal production, many countries have prohibited antibiotic use as growth promoters in animal production (European Commission <xref ref-type="bibr" rid="CR172">2005</xref>; AccessScience Editors <xref ref-type="bibr" rid="CR8">2017</xref>; Prescott <xref ref-type="bibr" rid="CR441">2019</xref>; Field et al. <xref ref-type="bibr" rid="CR194">2023</xref>; WOAH <xref ref-type="bibr" rid="CR598">2023</xref>). Therefore, the application of bacteriocins and/or bacteriocin-producing strains as growth promoters, prophylaxis, or therapeutics in agriculture has been considered viable and sustainable alternatives to antibiotics.</p><sec id="Sec500"><title>Potential as prophylactic and therapeutic agents</title><p id="Par45">Dairy animals often suffer from mastitis, which is an inflammation of the mammary gland resulting in considerable economic losses due to reduced milk quantity and quality. Mastitis is predominantly caused by <italic>S. aureus</italic>, <italic>S. dysgalactiae</italic>, <italic>S. uberis</italic>, <italic>Mycoplasma</italic> spp., and <italic>E. coli</italic> (Cheng and Han <xref ref-type="bibr" rid="CR111">2020</xref>). Several bacteriocins, including lacticin 3147 and nisin, have been shown to inhibit the etiological agents of mastitis, especially <italic>S. agalactiae</italic> and <italic>S. aureus</italic> in dairy cattle (Cao et al. <xref ref-type="bibr" rid="CR98">2007</xref>; Pieterse et al. <xref ref-type="bibr" rid="CR436">2010b</xref>; Klostermann et al. <xref ref-type="bibr" rid="CR311">2010</xref>; Field et al. <xref ref-type="bibr" rid="CR193">2021</xref>; Bennett et al. <xref ref-type="bibr" rid="CR73">2021</xref>; <xref ref-type="bibr" rid="CR74">2022</xref>; Heinzinger et al. <xref ref-type="bibr" rid="CR247">2023</xref>; Raheel et al. <xref ref-type="bibr" rid="CR451">2023</xref>). The United States FDA has approved the general use of a nisin-based preparation, Wipe Out<sup>&#x000ae;</sup> Dairy Wipes (Immucell, Portland, ME, USA), for mastitis control in lactating dairy cows. Klostermann et al. (<xref ref-type="bibr" rid="CR311">2010</xref>) demonstrated the efficacy of lacticin 3147 in eliminating mastitis-causing <italic>S. uberis</italic>, <italic>S. dysgalactiae</italic>, and <italic>S. aureus</italic> after a 10-min teat dip treatment. Other bacteriocins, such as aureocins A70, A53, epilancin K7, entomocin, Pep5, kurstacin 287, bacteriocin ST91KM, uberolysin, nisin U, kenyacin 404, and epidermin, have shown anti-mastitis effects against <italic>S. aureus</italic> and <italic>S. agalactiae</italic> (Barboza-Corona et al. <xref ref-type="bibr" rid="CR58">2009</xref>; Pieterse et al. <xref ref-type="bibr" rid="CR435">2010a</xref>; Salvucci et al. <xref ref-type="bibr" rid="CR490">2012</xref>).</p><p id="Par46">Microcin J25 has been used for <italic>Salmonella</italic> control in poultry (Stavric and D&#x02019;Aoust <xref ref-type="bibr" rid="CR533">1993</xref>; Ben Said et al. <xref ref-type="bibr" rid="CR67">2020</xref>; Baquero et al. <xref ref-type="bibr" rid="CR54">2024</xref>). Divercin AS7, a bacteriocin produced by <italic>Carnobacterium divergens</italic> AS7 has been effective in controlling <italic>S. enterica</italic> Typhimurium, <italic>Campylobacter</italic> spp., and <italic>C. perfringens</italic> in both poultry and swine (Gillor et al. <xref ref-type="bibr" rid="CR216">2004</xref>; Stern et al. <xref ref-type="bibr" rid="CR536">2005</xref>; Udompijitkul et al. <xref ref-type="bibr" rid="CR558">2012</xref>). Our recent studies have demonstrated the antagonistic and pathogen-reducing activity of plantaricin EF producing-<italic>L. plantarum</italic>, alone and in combination with other potential probiotic strains against enterobacteria in poultry (Reuben et al. <xref ref-type="bibr" rid="CR464">2022</xref>) as well as other zoonotic pathogens such as <italic>Salmonella</italic> Typhimurium, <italic>S.</italic> Enteritidis, <italic>E. coli</italic> O157: H7, <italic>E. faecalis</italic>, and <italic>L. monocytogenes</italic> (Reuben et al. <xref ref-type="bibr" rid="CR462">2020</xref>). In another study involving boilers challenged with <italic>Pasteurella multocida</italic>, we found that dietary supplementation with novel multistrain probiotics containing plantaricin EF-producing <italic>L. plantarum</italic> attenuated mortality, clinical manifestations, and inflammatory reactions associated with <italic>P. multocida</italic>-induced fowl cholera (Reuben et al. <xref ref-type="bibr" rid="CR463">2021</xref>). Furthermore, the abundance of gut enterobacteria and <italic>P. multocida</italic> was also significantly reduced in birds supplemented with the multistrain probiotics containing plantaricin EF-producing <italic>L. plantarum.</italic> Similarly, the therapeutic potential of bacteriocin and a strain of bacteriocin producing <italic>L. plantarum</italic> was investigated on broilers experimentally infected with <italic>E. coli</italic> (Ogunbanwo et al. <xref ref-type="bibr" rid="CR412">2004</xref>). Treatment with bacteriocin or the producing <italic>L. plantarum</italic> strain reduced <italic>E. coli</italic>-associated infections and improved the overall health and well-being of the birds.</p></sec><sec id="Sec600"><title>Potential as growth promoters</title><p id="Par47">The prohibition of antibiotic use as growth promoters in animal production has created a void that must be filled with equally potent, safe, and sustainable alternatives. Bacteriocins and their producing strains have emerged as widely accepted and suitable growth promoters in animal production. Several studies have demonstrated the growth promotion effects of bacteriocins and bacteriocin-producing strains in various animal species including poultry, cattle, and swine (Gillor et al. <xref ref-type="bibr" rid="CR216">2004</xref>; Cutler et al. <xref ref-type="bibr" rid="CR135">2007</xref>; McAllister et al. <xref ref-type="bibr" rid="CR365">2011</xref>; J&#x000f3;zefiak et al. <xref ref-type="bibr" rid="CR287">2013</xref>; Reuben et al. <xref ref-type="bibr" rid="CR463">2021</xref>, <xref ref-type="bibr" rid="CR464">2022</xref>; Soltani et al. <xref ref-type="bibr" rid="CR528">2022a</xref>; Zhang et al. <xref ref-type="bibr" rid="CR618">2022a</xref>, <xref ref-type="bibr" rid="CR619">b</xref>; Field et al. <xref ref-type="bibr" rid="CR194">2023</xref>).</p><p id="Par48">The dietary supplementation with colicin E1 improved growth performance and significantly reduced F18-positive enterotoxigenic <italic>E. coli</italic>-associated postweaning diarrhea in piglets (Cutler et al. <xref ref-type="bibr" rid="CR135">2007</xref>). Supplementation with <italic>L. salivarius</italic> Bacteriocin Abp118 induced intestinal microbiota modulation, leading to increased growth performance and feed conversion efficiency in pigs (Riboulet-Bisson et al. <xref ref-type="bibr" rid="CR467">2012</xref>). Grilli et al. (<xref ref-type="bibr" rid="CR232">2009</xref>) observed improved growth performance in <italic>C. perfringens</italic> infected broiler chickens supplemented with pediocin A alone or in combination with the producing strain. Similarly, the inclusion of nisin in the diet of broiler chickens beneficially modulated gut microbiota and significantly enhanced feed conversion and growth performance (J&#x000f3;zefiak et al. <xref ref-type="bibr" rid="CR287">2013</xref>). Supplementation with plantaricin EF-producing <italic>L. plantarum</italic>, alone or in combination with other probiotic strains including <italic>E. faecium</italic> C14 and <italic>P. pentosaceus</italic> I13, improved haemato&#x02010;biochemical parameters, intestinal health, and growth in broilers (Reuben et al. <xref ref-type="bibr" rid="CR464">2022</xref>). Dietary supplementation of broiler feed with bacteriocin microcin J25 significantly improved performance, intestinal microbiota composition, and diversity, while reducing systemic inflammatory markers and levels of faecal <italic>E. coli</italic> and <italic>Salmonella</italic> (Wang et al. <xref ref-type="bibr" rid="CR584">2020b</xref>). These studies demonstrate the potential of bacteriocins or bacteriocinogenic strains as viable alternatives to antibiotics for growth promotion in animals.</p></sec><sec id="Sec700"><title>Potential in sustainable aquaculture</title><p id="Par49">The aquaculture supply chain is continuously exposed to multiple physical, chemical, and biological hazards, especially a wide range of pathogenic organisms. This impacts the quality and safety of aquaculture and its products. Minimizing microbiological hazards often involves the use of antibiotics, which enhances the selective pressure for the emergence and spread of superbugs and drug residues in both aquaculture products and their environment (Gillor et al. <xref ref-type="bibr" rid="CR217">2008</xref>; Wang et al. <xref ref-type="bibr" rid="CR580">2019a</xref>; Stentiford et al. <xref ref-type="bibr" rid="CR535">2022</xref>). However, in recent years, substantial attention has been given to the use of bacteriocins in aquaculture mostly for aquaculture processing and disease mitigation, improvement of water quality, and enhancement of sensory quality and shelf life (Wang et al. <xref ref-type="bibr" rid="CR580">2019a</xref>). Bacteriocin cloning and heterogeneous expressions from producing strains have demonstrated great potential in designing robust microbial cell factories capable of producing potent bacteriocins (Xu et al. <xref ref-type="bibr" rid="CR601">2019</xref>; Feito et al. <xref ref-type="bibr" rid="CR177">2023</xref>). Through this advancement, Feito et al. (<xref ref-type="bibr" rid="CR176">2022</xref>) and Contente et al. (<xref ref-type="bibr" rid="CR125">2023</xref>) engineered a recombinant multi-bacteriocinogenic strain (<italic>L. cremoris</italic> WA2-67) to produce three bacteriocins: garvicin A, Q, and nisin Z. The three recombinant bacteriocins, especially nisin Z, beneficially enhanced immune functions and growth performance while inhibiting pathogen colonization in rainbow trout (<italic>Oncorhynchus mykiss</italic>, Walbaum) (Contente et al. <xref ref-type="bibr" rid="CR125">2023</xref>). Bacteriocin-like substances (BLS) obtained by co-cultures of <italic>E. faecium</italic> MU8 with <italic>Aeromonas veronii</italic> showed significant antimicrobial activity against major pathogens of <italic>Nile tilapia</italic>, including <italic>Aeromonas jandaei</italic> and <italic>A. veronii</italic> (Promrug et al. <xref ref-type="bibr" rid="CR443">2023</xref>). Bacteriocin production through co-cultures of Gram-negative-inducing strains with Gram-positive bacteriocin-producing strains is now used to increase bacteriocin biosynthesis and yields (Liu et al. <xref ref-type="bibr" rid="CR343">2021</xref>; Promrug et al. <xref ref-type="bibr" rid="CR443">2023</xref>).</p><p id="Par50">Bacteriocins such as enteromycin F4-9 and MC13, produced from <italic>E. faecalis</italic> F4-9 and <italic>E. faecium</italic> MC13 respectively, have shown broad inhibitory activity against both Gram-negative and Gram-positive bacterial pathogens of aquatic animals, including <italic>E. coli</italic> JM109, <italic>A. hydrophila</italic>, <italic>Vibrio harveyi</italic>, and <italic>V. parahaemolyticus</italic> (Pinto et al. <xref ref-type="bibr" rid="CR437">2009</xref>). Bacteriocin produced by <italic>A. media</italic> strain A199 has controlled <italic>V. tubiashii</italic>-infected Pacific oyster larvae (Gibson et al. 1998) and significantly reduced mortality due to saprolegniosis in eels (Lategan and Gibson <xref ref-type="bibr" rid="CR327">2003</xref>). The dietary inclusion of bacteriocin NPUST1 produced by <italic>Paenibacillus ehimensis</italic> NPUST1 reduced the counts of <italic>S. iniae</italic> and <italic>A. hydrophila</italic> and improved the growth performance of <italic>Oreochromis niloticus</italic> (Nile tilapia) (Chen et al. <xref ref-type="bibr" rid="CR110">2019</xref>). Plantaricin FGC-12 applied to Whiteleg shrimp (<italic>Penaeus vannamei</italic>) inhibited <italic>V. parahaemolyticus</italic> by causing cell wall perforation (Hu et al. <xref ref-type="bibr" rid="CR263">2013</xref>).</p><p id="Par51">Furthermore, bacteriocin-like substances obtained from LAB associated with the gut of <italic>Mugil cephalus</italic> L (grey mullet) improved water quality, inhibited the growth of <italic>L. garvieae</italic> and reduced microbial-associated morbidity and mortality in aquatic animals (Lin et al. <xref ref-type="bibr" rid="CR339">2013</xref>). In addition to their pathogen inhibitory properties, bacteriocins also improve the sensory properties and shelf life of aquatic products (Cortesi et al. <xref ref-type="bibr" rid="CR128">2009</xref>; Alzamora et al. <xref ref-type="bibr" rid="CR26">2012</xref>).</p></sec><sec id="Sec800"><title>Potential as plant growth promoters</title><p id="Par52">So far, only bacteriocins of <italic>Bacillus</italic> spp. have been extensively studied and mostly used in plant production (Nazari and Smith <xref ref-type="bibr" rid="CR398">2020</xref>; Negash and Tsehai <xref ref-type="bibr" rid="CR399">2020</xref>). Bacteriocins bacthuricin F4 and thuricin 17 are produced by different <italic>B. thuringiensis</italic> strains, especially <italic>B. thuringiensis</italic> BF4 and NEB17. These bacteriocins, along with bacteriocin C85 secreted by <italic>B. cereus</italic> UW85, have been reported to possess growth promotion properties in plants (Negash and Tsehai <xref ref-type="bibr" rid="CR399">2020</xref>). Applying a cocktail containing the combination of the 3 bacteriocins and their producing strains increased photosynthesis by 6%, plant dry weight by 15%, root nodulation by 21%, and leaf area in corn, soybean, and tomato plants when compared with controls. These bacteriocins exhibit bacteriocidal and bacteriostatic activities that promote disease resistance in plants.</p><p id="Par53">Mirzaee et al. (<xref ref-type="bibr" rid="CR378">2021</xref>) recently reported that plant-produced bacteriocins inhibit different plant pathogens while conferring resistance to diseases in tomatoes. Furthermore, other bacteriocins such as amylocyclicin, Bac 14B, Bac-GM17, putidacin, and cerein 8A have been used for both antimicrobial activity and growth promotion in plants (Cherif et al. <xref ref-type="bibr" rid="CR112">2001</xref>, <xref ref-type="bibr" rid="CR113">2008</xref>; Hammami et al. <xref ref-type="bibr" rid="CR239">2009</xref>; Prudent et al. <xref ref-type="bibr" rid="CR444">2015</xref>).</p></sec></sec></sec><sec id="Sec20"><title>Commercialization of bacteriocins: patent and market perspectives</title><p id="Par54">While the current report of the World Intellectual Property Organization (WIPO) (<ext-link ext-link-type="uri" xlink:href="https://www.wipo.int/portal/en/index.html">https://www.wipo.int/portal/en/index.html</ext-link>) shows 1127 bacteriocins-related patent applications published, the Espacenet and Lens global patent search engines (<ext-link ext-link-type="uri" xlink:href="https://www.epo.org/">https://www.epo.org/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://about.lens.org/">https://about.lens.org/</ext-link>) report 10,790 and 10,846 patents, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Over the past three decades, there has been a consistent increase in bacteriocin-related patent publications, filings, and approvals. The leading countries in patent applications are the USA, China, Canada, the Republic of Korea, Japan, and Australia. The top applicants include Colgate Palmolive Co, Unilever Plc, Unilever Nv, University of California, Coca-Cola Co, Chr Hansen As, and US Agriculture (Figures S2 and S3). The fascinating properties of bacteriocins contribute to their widespread acceptance and market potential.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Bacteriocin patent publication, filing, and approval</p></caption><graphic xlink:href="203_2024_3948_Fig4_HTML" id="MO4"/></fig></p><p id="Par55">In 1969, the Food and Agriculture Organization/World Health Organization (FAO/WHO) of the United Nations approved the general use of nisin as a food preservative. Subsequently, the European Union (Directive 83/463/EEC; Directive 95/2/EC), United States (FDA 21CFR), and Canada [Health Canada (NOP/ADP-0028)] granted similar approvals in 1983, 1988, and 2017, respectively. Although most commercially available bacteriocins especially nisin (Nisaplin&#x02122;, Biosafe&#x02122;, Oralpeace&#x02122;), leucocin A (Bactoferm&#x02122; B-SF-43), sakacin (Bactoferm&#x02122; B-2, BactofermTM B-FM), and pediocin PA-1 (Microgard&#x02122;, Alta 2341), are primarily used as food preservatives (Daba and Elkhateeb <xref ref-type="bibr" rid="CR137">2020</xref>; Cesa-Luna et al. <xref ref-type="bibr" rid="CR108">2021</xref>; Naskar and Kim <xref ref-type="bibr" rid="CR394">2021</xref>), others such as colicins and salmocins, intended for use as antibacterial agents, have received FDA approval (Hahn-L&#x000f6;bmann et al. <xref ref-type="bibr" rid="CR238">2019</xref>). In 2019, the FDA approved five bacteriocin preparations including, SalE1a, SalE1b, SalE2, SalE3, and SalE7 (Nomad Bioscience GmbH) for use as antimicrobial agents on meat, poultry, fish, and egg products (<ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/media/135524/download">https://www.fda.gov/media/135524/download</ext-link>) The five bacteriocins were derived from non-typhoidal bacteriocinogenic <italic>Salmonella</italic> strains, and can be used individually or in combination. Duramycin (Moli1901) (AOP Orphan Pharmaceuticals AG), a commercially available bacteriocin, has been used in patients for the treatment of cystic fibrosis in humans (Grasemann et al. <xref ref-type="bibr" rid="CR229">2007</xref>; Steiner et al. <xref ref-type="bibr" rid="CR534">2008</xref>). Similarly, Delvo<sup>&#x000ae;</sup> Nis (DSM, Delft, Netherlands), Nisin Z<sup>&#x000ae;</sup> (Handary, Brussel, Belgium), and Nisaplin<sup>&#x000ae;</sup> (Danisco, Copenhagen, Denmark) have been approved for commercial use (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>).</p><p id="Par56">Bacteriocin-producing protective cultures, such as <italic>C. divergens</italic> M35, <italic>Leuconostoc carnosum</italic> 4010 (Danisco, HOLDBAC<sup>&#x000ae;</sup>) and <italic>C. maltaromaticum</italic> CB1 have been approved by several countries for use in the food industry (<ext-link ext-link-type="uri" xlink:href="https://members.wto.org/crnattachments/2017/SPS/CAN/17_0131_00_e.pdf">https://members.wto.org/crnattachments/2017/SPS/CAN/17_0131_00_e.pdf</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/food-nutrition/public-involvement-partnerships/use-microbiological-preparation-carnobacterium-maltaromaticum-strain-certain-ready-meat-poultry-products/document.html">https://www.canada.ca/en/health-canada/services/food-nutrition/public-involvement-partnerships/use-microbiological-preparation-carnobacterium-maltaromaticum-strain-certain-ready-meat-poultry-products/document.html</ext-link>). Nisin-based commercially available bacteriocins approved by the USDA, Teatseal<sup>&#x000ae;</sup> (Zoetis, USA), Wipe-Out<sup>&#x000ae;</sup> Dairy Wipes and Mast Out<sup>&#x000ae;</sup> (Immucell Corporation, USA) are commonly used as anti-mastitis agents in dairy cows (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Additionally, nisin-incorporated soy-derived packaging films have been commercialized as an antimicrobial food package to inhibit <italic>Listeria</italic> (Ahmad et al. <xref ref-type="bibr" rid="CR11">2017</xref>). Several bacteriocin products, including sakacin (Bactoferm FLC<sup>&#x000ae;</sup>, Chr. Hansen, H&#x000f8;rsholm, Denmark), NVB302, Moli1901 (<italic>Actinoplanes liguriae</italic> NCIMB41362), mutacin 1140 (<italic>S. mutans</italic> JH1000), pediocin (Fargo 23, Quest International, B.V.), and NAI-107 (<italic>Microbispora corallina</italic>), are currently at various phases of clinical trials for subsequent use in health and agrifood systems (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>; Cesa-Luna et al. <xref ref-type="bibr" rid="CR108">2021</xref>).</p></sec><sec id="Sec21"><title>Challenges and limitations of bacteriocin application and future research</title><p id="Par57">Despite increasing research on bacteriocin discovery, characterization, and application over the past decades, only a few have been commercially applied. While bacteriocins are generally believed to be safe, concerns about their cytotoxicity against eukaryotic cells, stability, immunogenicity, development of resistance, unpredictable biofunctions, and high production costs have raised doubts about their application. These concerns necessitate extensive safety evaluations of each bacteriocin before final approval and use in health and agrifood systems.</p><p id="Par58">Several reports have demonstrated the safety and non-cytotoxicity of bacteriocins; however, others have shown varying (low) degrees of cytotoxicity in both in vitro and in vivo experiments (Pulse et al. <xref ref-type="bibr" rid="CR447">2019</xref>; Ba&#x000f1;os et al. <xref ref-type="bibr" rid="CR51">2019</xref>; Cebri&#x000e1;n et al. <xref ref-type="bibr" rid="CR105">2019</xref>, <xref ref-type="bibr" rid="CR106">2023</xref>; Wang et al. <xref ref-type="bibr" rid="CR586">2022</xref>; Abdille et al. <xref ref-type="bibr" rid="CR4">2022</xref>; Heinzinger et al. <xref ref-type="bibr" rid="CR247">2023</xref>). The minimal cytotoxicity observed in most studies was due to significantly higher concentrations of bacteriocins and prolonged experimental exposure, beyond the required minimum inhibitory concentrations (MIC) for pathogen inhibition or food protection. At significantly higher concentrations (above the MIC), bacteriocin PA166 showed minimal cytotoxicity on Vero and NR8383 cells, as well as in the mouse infection model (Wang et al. <xref ref-type="bibr" rid="CR586">2022</xref>). Similarly, enterocin AS-48, bacteriocin OG716, and dermaseptin only exhibited mild cytotoxicity with prolonged treatment or at significantly higher concentrations in Golden Syrian hamsters, B2 BALB/c mice, and Albino Wistar rats (Pulse et al. <xref ref-type="bibr" rid="CR447">2019</xref>; Ba&#x000f1;os et al. <xref ref-type="bibr" rid="CR51">2019</xref>; Abdille et al. <xref ref-type="bibr" rid="CR4">2022</xref>). Additionally, cytolysin, a bacteriocin produced by <italic>E. faecalis</italic>, showed broad cytotoxicity to various cell lines, including intestinal epithelial cells, leucocytes, erythrocytes, and human retinal cells (Coburn and Gilmore <xref ref-type="bibr" rid="CR121">2003</xref>; Cox et al. <xref ref-type="bibr" rid="CR132">2005</xref><italic>).</italic> It is important to note that the cytotoxicity of bacteriocins can be influenced by factors such as purity, concentration, the specific mammalian cell line or experimental model used, and host-associated factors (e.g., in vivo experiments) (Cavicchioli et al. <xref ref-type="bibr" rid="CR104">2018</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>; Cebri&#x000e1;n et al. <xref ref-type="bibr" rid="CR106">2023</xref>). Certain eukaryotic cell lines may be more sensitive to particular bacteriocins than others, with differences attributed to cell type, composition of cell membranes, permeability, and hydrophobicity (Das and Goyal <xref ref-type="bibr" rid="CR142">2014</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>; Abdille et al. <xref ref-type="bibr" rid="CR4">2022</xref>).</p><p id="Par59">Physiological and physicochemical parameters can influence the stability and bioactivity of bacteriocins in the host or food matrix. Several reports have shown rapid inactivation or enzymatic degradation of bacteriocins produced in situ, orally ingested, or applied to food matrices (De Vuyst and Leroy <xref ref-type="bibr" rid="CR146">2007</xref>; Fernandez et al. <xref ref-type="bibr" rid="CR182">2013</xref>; Md Sidek et al. <xref ref-type="bibr" rid="CR367">2018</xref>; Holcapkova et al. <xref ref-type="bibr" rid="CR254">2018</xref>; Flynn et al. <xref ref-type="bibr" rid="CR197">2019</xref>, <xref ref-type="bibr" rid="CR198">2022</xref>; Soltani et al. <xref ref-type="bibr" rid="CR527">2021b</xref>). Despite their potential for applications in clinical and agrifood systems, class II bacteriocins are highly sensitive to proteolytic enzymes, which reduces their bioactivity when used (Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). For instance, pediocin PA-1, nisin A, and microcin J25 were inactivated or degraded when exposed to intestinal contents and proteolytic enzymes (Kheadr et al. <xref ref-type="bibr" rid="CR302">2010</xref>; Gough et al. <xref ref-type="bibr" rid="CR226">2017</xref>; Naimi et al. <xref ref-type="bibr" rid="CR392">2018</xref>). However, through encapsulation and bioengineering, microcin J25 or nisin showed some stability in the presence of proteolytic enzymes and under intestinal conditions (Field et al. <xref ref-type="bibr" rid="CR191">2015</xref>, <xref ref-type="bibr" rid="CR192">2019</xref>). Engineering bacteriocins can help create resistant bacteriocin derivatives that can withstand harsh gut conditions and enzymatic degradation while maintaining their bioactivity. Additionally, systems like encapsulation and coating have been developed to protect and precisely deliver bacteriocins to the intended site of action or within specific food matrices, allowing them to exert their biological functions (Gomaa et al. <xref ref-type="bibr" rid="CR221">2017</xref>; Gough et al. <xref ref-type="bibr" rid="CR227">2018</xref>; Holcapkova et al. <xref ref-type="bibr" rid="CR254">2018</xref>; Flynn et al. <xref ref-type="bibr" rid="CR197">2019</xref>, <xref ref-type="bibr" rid="CR198">2022</xref>).</p><p id="Par60">To avoid any sudden or unexpected immune responses, the immunogenicity of bacteriocins should be carefully examined, especially when intended for use in humans and animals. Generally, several bacteriocins, including pyocins S2, S5, AP41, and L1, bacteriocins LR14, TSU4, JCM1132, and P34, plantaricin E/F, mutacin 1140, microbisporicin, actagardine, and duramycin have been reported to be non-immunogenic in in vivo studies (McCaughey et al. <xref ref-type="bibr" rid="CR366">2016</xref>; Ongey et al. <xref ref-type="bibr" rid="CR416">2017</xref>; Sahoo et al. <xref ref-type="bibr" rid="CR486">2017</xref>; Hanny et al. <xref ref-type="bibr" rid="CR244">2019</xref>; Wang et al. <xref ref-type="bibr" rid="CR582">2019c</xref>). However, prolonged administration of some bacteriocins, such as pyocin S5 and Nisaplin<sup>&#x000ae;</sup>, has been shown to elicit mild immunogenicity (de Pablo et al. <xref ref-type="bibr" rid="CR422">1999</xref>; Scholl and Martin <xref ref-type="bibr" rid="CR507">2008</xref>; McCaughey et al. <xref ref-type="bibr" rid="CR366">2016</xref>). Furthermore, some bacteriocins have also displayed unique and unpredictable properties, expressing both bacteriocin and virulence factors. Listeriolysin S (LLS) and pneumocins exhibit both virulence and bacteriocin properties and are highly expressed in the gut of orally infected mice (Quereda et al. <xref ref-type="bibr" rid="CR448">2016</xref>; Wholey et al. <xref ref-type="bibr" rid="CR588">2019</xref>). Both LLS and pneumocins are antibiotic-induced and can alter the host intestinal microbiome, enhancing intestinal colonization with <italic>L. monocytogenes</italic> and <italic>S. pneumoniae</italic> (Kjos et al. <xref ref-type="bibr" rid="CR308">2016</xref>; Quereda et al. <xref ref-type="bibr" rid="CR448">2016</xref>; Wholey et al. <xref ref-type="bibr" rid="CR588">2019</xref>). Bacteriocins may exert different sudden and unpredictable effects when used in humans and animals. Therefore, their immunogenicity and other emerging co-bioactive properties such as virulence factors should be elucidated before use.</p><p id="Par61">Another major challenge of bacteriocin application in health and agrifood systems is their low yields and high cost of large-scale industrial production, purification, and prolonged storage. For commercial and economic purposes, bacteriocins need to be produced in large and sufficient quantities. For research purposes, crude, unpurified, and concentrated bacteriocins are often produced using costly and complex media that are mostly not food or pharmaceutical-grade (Garsa et al. <xref ref-type="bibr" rid="CR209">2014</xref>; Abbasiliasi et al. <xref ref-type="bibr" rid="CR2">2017</xref>; Johnson et al. <xref ref-type="bibr" rid="CR284">2018</xref>). The bottleneck for efficient and commercial production of bacteriocins is the need for complex media that optimally support the metabolism and auxotrophies of the producing strains (Ongey and Neubauer <xref ref-type="bibr" rid="CR415">2016</xref>; Goldbeck et al. <xref ref-type="bibr" rid="CR219">2021</xref>). Additionally, industrial-level purification and biopreservation of bacteriocins is another limitation for commercial-scale bacteriocin production. In most cases, laboratory-based purification protocols are usually not suitable at the industrial scale mostly due to the high cost of the purification processes (Garsa et al. <xref ref-type="bibr" rid="CR209">2014</xref>; Mesa-Pereira et al. <xref ref-type="bibr" rid="CR372">2018</xref>; Juturu and Wu <xref ref-type="bibr" rid="CR289">2018</xref>). Nevertheless, chemical synthesis has been recently proposed as a viable alternative for the industrial-scale production of bacteriocins (B&#x000e9;dard and Biron <xref ref-type="bibr" rid="CR63">2018</xref>; B&#x000e9;dard et al. <xref ref-type="bibr" rid="CR64">2018</xref>; Desiderato et al. <xref ref-type="bibr" rid="CR151">2023</xref>; Sevim and G&#x000fc;ne&#x0015f; Altunta&#x0015f; <xref ref-type="bibr" rid="CR511">2024</xref>). Industrial and large-scale production of active bacteriocins using chemical synthesis would further enhance the use of bioengineering and consequently, improve stability, spectra of antimicrobial activity, and pharmacological properties of bacteriocins in humans and agrifood systems (B&#x000e9;dard et al. <xref ref-type="bibr" rid="CR64">2018</xref>; Kuniyoshi et al. <xref ref-type="bibr" rid="CR323">2022</xref>; Garc&#x000ed;a-Vela et al. <xref ref-type="bibr" rid="CR208">2024</xref>). Efficient and cost-effective production and purification processes are essential for wider applications in health and agrifood systems. Additional research is necessary to further develop economical and low-cost production and purification processes of highly promising bacteriocins.</p><p id="Par62">Finally, like other conventional antimicrobials, persistent exposure to bacteriocins can lead to the development of resistance in target bacteria. Bacteriocin resistance has been demonstrated for divercin V41, mesenterocin, leucocin A, pediocin and pediocin-like bacteriocins, lacticin 3147, lysostaphin, nisin, pyocin S2, mesenterocin, mundticin KS, etc. (Sakayori et al. <xref ref-type="bibr" rid="CR488">2003</xref>; Opsata et al. <xref ref-type="bibr" rid="CR417">2010</xref>; Collins et al. <xref ref-type="bibr" rid="CR124">2012</xref>; Inglis et al. <xref ref-type="bibr" rid="CR273">2016</xref>; L&#x000f3;pez-Gonz&#x000e1;lez et al. <xref ref-type="bibr" rid="CR348">2018</xref>; Bhattacharya et al. <xref ref-type="bibr" rid="CR75">2019</xref>; Gradisteanu Pircalabioru et al. <xref ref-type="bibr" rid="CR228">2021</xref>). So far, bacteriocin resistance has been mostly studied in in vitro and model systems and can either be acquired (emerged from previously susceptible strains) or innate (naturally inherent in taxonomically related strains) (Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Bacteriocin resistance mechanisms can include impermeability due to changes in cellular surfaces, enzymatic inactivation, changes in the antimicrobial peptide targets, entrapment by secreted molecules that can bind and neutralize bacteriocins, chemical modifications in membrane lipid composition, D-alanylation of teichoic acid, cellular filamentation, efflux pumps, and capsule synthesis to avoid contact with bacteriocins (Sakayori et al. <xref ref-type="bibr" rid="CR488">2003</xref>; Chifiriuc et al. <xref ref-type="bibr" rid="CR114">2014</xref>; Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Kumariya et al. <xref ref-type="bibr" rid="CR321">2015</xref>, <xref ref-type="bibr" rid="CR322">2019</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Rasch and Kn&#x000f8;chel (<xref ref-type="bibr" rid="CR455">1998</xref>) and Collins et al. (<xref ref-type="bibr" rid="CR123">2010</xref>) separately reported up to 5.2 and 8.0% resistance of multi-sourced <italic>L. monocytogenes</italic> to pediocin PA-1 and pediocin-like bacteriocins respectively. The instances and mechanisms of bacteriocin resistance have been extensively reviewed (Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Gradisteanu Pircalabioru et al. <xref ref-type="bibr" rid="CR228">2021</xref>; Soltani et al. <xref ref-type="bibr" rid="CR526">2021a</xref>). Some target microbial strains have developed multiple mechanisms of resistance which can be synchronously displayed against specific bacteriocins (Vadyvaloo et al. <xref ref-type="bibr" rid="CR563">2002</xref>; Lohans and Vederas <xref ref-type="bibr" rid="CR346">2012</xref>; Bastos et al. <xref ref-type="bibr" rid="CR61">2015</xref>; Kumariya et al. <xref ref-type="bibr" rid="CR321">2015</xref>). This can therefore lead to the emergence of bacteriocin-resistant phenotypes, which may constitute an additional burden to the rising antimicrobial resistance menace. Understanding these resistance mechanisms and developing countermeasures can significantly enhance the clinical application of bacteriocins. Additional research is needed to address these challenges and further develop safe, economical, and low-cost production and purification processes for bacteriocins.</p></sec><sec id="Sec22"><title>Conclusion and prospects</title><p id="Par63">The exacerbating global crisis of the emergence and spread of pathogens, antimicrobial resistance, dearth of novel antimicrobials, and the implementation of strict antibiotic-limiting policies in many countries necessitate a comprehensive approach to identify and apply widely accepted, potent, and safe alternative antimicrobials. Bacteriocins have invaluable and heterogeneous properties that make them suitable for use in human, animal, and food systems for disease prevention and treatment, microbiome modulation, growth promotion, and enhancing food quality, safety, and organoleptic properties, among other benefits.</p><p id="Par64">Through bibliometric analyses, we have identified several prevailing trends in bacteriocin research. Firstly, there has been a significant increase in annual research outputs, which we believe reflects the growing global interest in bacteriocins. Secondly, we have observed a multidisciplinary participation in bacteriocin research, with contributions from various fields. Additionally, we have found that funding for bacteriocin research is relatively evenly distributed worldwide. The countries leading in bacteriocin-related research outputs are spread across the Northern and Southern Hemispheres. The majority of these research outputs are published by reputable publishes such as Elsevier, Springer Nature, Wiley, and the American Society of Microbiology. Interestingly, while bacteriocins research is primarily focused on microbiology, biotechnology, and food science, we have also discovered a significant number of outputs in emerging areas such as plant science, virology, polymer science, and biophysics. This suggests that bacteriocins may have applications in previously unknown fields, and we anticipate further research and applications in these areas in the coming years.</p><p id="Par65">Harnessing the ubiquitous nature of bacteriocins could help in their exploitation for broad applications in innovative areas of the human, animal, and food systems. The food system is benefiting immensely from commercially available bacteriocins. However, the scope of bacteriocin applications in the food system could be expanded in areas such as [fermented] food microbiota modulation, antimicrobial packaging/coating, biosanitizers, antibiofilm, pre/post-harvest biocontrol, and functional food.</p><p id="Par66">Furthermore, the use of bacteriocins in the modulation of human and animal microbiota can beneficially improve the composition, diversity, and richness of the microbiota, fostering health and well-being. Bacteriocin modulatory activity can provide a viable microbiome-based solution for the treatment and management of microbiome-associated diseases. Bacteriocins also have the potential for non-invasive bio-diagnosis and could be used for diagnosing both infectious and non-infectious diseases, thus complementing conventional diagnostic tools. In terms of agriculture, the growth-promoting effect of bacteriocins in both plants and animals would undoubtedly improve food security, safety, and quality, as well as promote sustainable agriculture and mitigate concerns associated with antibiotic use.</p><p id="Par67">Through vigorous research, it is necessary to increase the potency and applications of bacteriocins in humans, using innovative approaches such as bioengineering, computational methods, artificial intelligence, nanotechnology, machine learning, microscopy techniques, chemistry, metabolic activity-based assays, and pharmacodynamics. These approaches will facilitate optimal and industrial-scale production of safe bacteriocins for general use.</p></sec><sec sec-type="supplementary-material"><sec id="Sec23"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="203_2024_3948_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 312 KB)</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>All authors contributed to the study's conception and design. Rine Christopher Reuben carried out literature search and analysis, wrote the first draft of the manuscript, and acquired funding. Carmen Torres organized the presentation of tables and figures, revised the manuscript draft, supervised the study, and acquired the funding together with Rine Christopher Reuben. The final manuscript was read and approved by all the authors.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This project has received funding from the European Union&#x02019;s Horizon 2020 research and innovation programme under the Marie Sk&#x00142;odowska-Curie Grant agreement No 101034288.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data supporting the findings of this study are available within the paper.</p></notes><notes><title>Declarations</title><notes id="FPar2" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par69">The authors have no relevant financial or non-financial interests to disclose.</p></notes><notes id="FPar3"><title>Ethics approval</title><p id="Par70">No ethical approval is required.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarts</surname><given-names>H</given-names></name><name><surname>Margolles</surname><given-names>A</given-names></name></person-group><article-title>Antibiotic resistance genes in food and gut (non-pathogenic) bacteria. Bad genes in good bugs</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>754</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00754</pub-id><?supplied-pmid 25620961?><pub-id pub-id-type="pmid">25620961</pub-id>
</element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasiliasi</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>JS</given-names></name><name><surname>Tengku Ibrahim</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Fermentation factors influencing the production of bacteriocins by lactic acid bacteria: a review</article-title><source>RSC Adv</source><year>2017</year><volume>7</volume><fpage>29395</fpage><lpage>29420</lpage><pub-id pub-id-type="doi">10.1039/C6RA24579J</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdi-Ali</surname><given-names>A</given-names></name><name><surname>Worobec</surname><given-names>EA</given-names></name><name><surname>Deezagi</surname><given-names>A</given-names></name><name><surname>Malekzadeh</surname><given-names>F</given-names></name></person-group><article-title>Cytotoxic effects of pyocin S2 produced by <italic>Pseudomonas aeruginosa</italic> on the growth of three human cell lines</article-title><source>Can J Microbiol</source><year>2004</year><volume>50</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1139/w04-019</pub-id><?supplied-pmid 15213746?><pub-id pub-id-type="pmid">15213746</pub-id>
</element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdille</surname><given-names>AA</given-names></name><name><surname>Kitimu</surname><given-names>SR</given-names></name><name><surname>Ndubi</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Sub-acute and sub-chronic toxicity assessment of the antimicrobial peptide dermaseptin B2 on biochemical, haematological and histopathological parameters in BALB/c mice and albino Wistar rats</article-title><source>Heliyon</source><year>2022</year><volume>8</volume><fpage>e12124</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2022.e12124</pub-id><?supplied-pmid 36561696?><pub-id pub-id-type="pmid">36561696</pub-id>
</element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abitayeva</surname><given-names>GK</given-names></name><name><surname>Urazova</surname><given-names>MS</given-names></name><name><surname>Abilkhadirov</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Characterization of a new bacteriocin-like inhibitory peptide produced by <italic>Lactobacillus sakei</italic> B-RKM 0559</article-title><source>Biotechnol Lett</source><year>2021</year><volume>43</volume><fpage>2243</fpage><lpage>2257</lpage><pub-id pub-id-type="doi">10.1007/s10529-021-03193-z</pub-id><?supplied-pmid 34652635?><pub-id pub-id-type="pmid">34652635</pub-id>
</element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>Franz</surname><given-names>CMAP</given-names></name><name><surname>Ben Omar</surname><given-names>N</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>A</given-names></name></person-group><article-title>Diversity and applications of <italic>Bacillus</italic> bacteriocins</article-title><source>FEMS Microbiol Rev</source><year>2011</year><volume>35</volume><fpage>201</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2010.00244.x</pub-id><?supplied-pmid 20695901?><pub-id pub-id-type="pmid">20695901</pub-id>
</element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>Casado Mu&#x000f1;oz</surname><given-names>MDC</given-names></name><name><surname>Lavilla Lerma</surname><given-names>L</given-names></name><etal/></person-group><article-title>New insights in antibiotic resistance of <italic>Lactobacillus</italic> species from fermented foods</article-title><source>Food Res Int</source><year>2015</year><volume>78</volume><fpage>465</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2015.09.016</pub-id><?supplied-pmid 28433315?><pub-id pub-id-type="pmid">28433315</pub-id>
</element-citation></ref><ref id="CR8"><mixed-citation publication-type="other">AccessScience Editors (2017) U.S. bans antibiotics use for enhancing growth in livestock. McGraw-Hill Professional. 10.1036/1097-8542.br0125171</mixed-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acu&#x000f1;a</surname><given-names>L</given-names></name><name><surname>Corbalan</surname><given-names>NS</given-names></name><name><surname>Fernandez-No</surname><given-names>IC</given-names></name><etal/></person-group><article-title>Inhibitory effect of the hybrid bacteriocin Ent35-MccV on the growth of <italic>Escherichia coli</italic> and <italic>Listeria monocytogenes</italic> in model and food systems</article-title><source>Food Bioprocess Technol</source><year>2015</year><volume>8</volume><fpage>1063</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1007/s11947-015-1469-0</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-P&#x000e9;rez</surname><given-names>C</given-names></name><name><surname>Gracia</surname><given-names>B</given-names></name><name><surname>Rodrigues</surname><given-names>L</given-names></name><etal/></person-group><article-title>Synergy between circular bacteriocin AS-48 and ethambutol against <italic>Mycobacterium tuberculosis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2018</year><volume>62</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1128/AAC.00359-18</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>V</given-names></name><name><surname>Khan</surname><given-names>MS</given-names></name><name><surname>Jamal</surname><given-names>QMS</given-names></name><etal/></person-group><article-title>Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation</article-title><source>Int J Antimicrob Agents</source><year>2017</year><volume>49</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2016.08.016</pub-id><?supplied-pmid 27773497?><pub-id pub-id-type="pmid">27773497</pub-id>
</element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>S</given-names></name><name><surname>Ghollasi</surname><given-names>M</given-names></name><name><surname>Hosseini</surname><given-names>HM</given-names></name></person-group><article-title>The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells</article-title><source>Microb Pathog</source><year>2017</year><volume>111</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.08.037</pub-id><?supplied-pmid 28867631?><pub-id pub-id-type="pmid">28867631</pub-id>
</element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><etal/></person-group><article-title>Evaluation of probiotic and anti-inflammatory properties of bacteriocinogenic <italic>Pediococcus acidilactici</italic> HW01 and <italic>Leuconostoc citreum</italic> HW02 from malted barley</article-title><source>Chem Biol Technol Agric</source><year>2023</year><volume>10</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s40538-023-00425-4</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Atya</surname><given-names>AK</given-names></name><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>Kempf</surname><given-names>I</given-names></name><etal/></person-group><article-title>Effects of colistin and bacteriocins combinations on the in vitro growth of <italic>Escherichia coli</italic> strains from swine origin</article-title><source>Probiotics Antimicrob Proteins</source><year>2016</year><volume>8</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1007/s12602-016-9227-9</pub-id><?supplied-pmid 27557837?><pub-id pub-id-type="pmid">27557837</pub-id>
</element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Atya</surname><given-names>AK</given-names></name><name><surname>Belguesmia</surname><given-names>Y</given-names></name><name><surname>Chataigne</surname><given-names>G</given-names></name><etal/></person-group><article-title>Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>817</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.00817</pub-id><?supplied-pmid 27303396?><pub-id pub-id-type="pmid">27303396</pub-id>
</element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Kassaa</surname><given-names>I</given-names></name><name><surname>Hober</surname><given-names>D</given-names></name><name><surname>Hamze</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiviral potential of lactic acid bacteria and their bacteriocins</article-title><source>Probiotics Antimicrob Proteins</source><year>2014</year><volume>6</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1007/s12602-014-9162-6</pub-id><?supplied-pmid 24880436?><pub-id pub-id-type="pmid">24880436</pub-id>
</element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alang</surname><given-names>H</given-names></name><name><surname>Kusnadi</surname><given-names>J</given-names></name><name><surname>Ardyati</surname><given-names>T</given-names></name><name><surname>Suharjono</surname></name></person-group><article-title>Optimization and characterization of enterocin <italic>Enterococcus faecalis</italic> K2B1 isolated from Toraja&#x02019;s Belang Buffalo Milk, South Sulawesi, Indonesia</article-title><source>Biodiversitas</source><year>2020</year><volume>21</volume><fpage>1236</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.13057/biodiv/d210351</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alattar</surname><given-names>N</given-names></name><name><surname>Tawfeeq</surname><given-names>H</given-names></name><name><surname>Omran</surname><given-names>A</given-names></name></person-group><article-title>Antibacterial and antibiofilm activity of klebicin crude extract on clinical isolates of <italic>Salmonella</italic> and <italic>Enterobacter</italic></article-title><source>Wrld Acd Sci</source><year>2024</year><volume>6</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.3892/wasj.2024.222</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessandrini</surname><given-names>G</given-names></name><name><surname>Mercuri</surname><given-names>SR</given-names></name><name><surname>Martella</surname><given-names>A</given-names></name><etal/></person-group><article-title>Topical application of bacteriocins from <italic>Bacillus subtilis</italic> promotes <italic>Staphylococcus aureus</italic> decolonization in acneic skin and improves the clinical appearance of mild-to-moderate acne</article-title><source>Postepy Dermatol Alergol</source><year>2023</year><volume>40</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.5114/ada.2022.124108</pub-id><?supplied-pmid 36909897?><pub-id pub-id-type="pmid">36909897</pub-id>
</element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aleti</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>JL</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identification of the bacterial biosynthetic gene clusters of the oral microbiome illuminates the unexplored social language of bacteria during health and disease</article-title><source>Mbio</source><year>2019</year><pub-id pub-id-type="doi">10.1128/mBio.00321-19</pub-id><?supplied-pmid 30992349?><pub-id pub-id-type="pmid">30992349</pub-id>
</element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Madboly</surname><given-names>LA</given-names></name><name><surname>El-Deeb</surname><given-names>NM</given-names></name><name><surname>Kabbash</surname><given-names>A</given-names></name><etal/></person-group><article-title>Purification, characterization, identification, and anticancer activity of a circular bacteriocin from <italic>Enterococcus thailandicus</italic></article-title><source>Front Bioeng Biotechnol</source><year>2020</year><volume>8</volume><fpage>450</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2020.00450</pub-id><?supplied-pmid 32656185?><pub-id pub-id-type="pmid">32656185</pub-id>
</element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>CA</given-names></name><name><surname>Zarazaga</surname><given-names>M</given-names></name><name><surname>Ben Sallem</surname><given-names>R</given-names></name><etal/></person-group><article-title>Antibiotic resistance in <italic>Escherichia coli</italic> in husbandry animals: the African perspective</article-title><source>Lett Appl Microbiol</source><year>2017</year><volume>64</volume><fpage>318</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1111/lam.12724</pub-id><?supplied-pmid 28208218?><pub-id pub-id-type="pmid">28208218</pub-id>
</element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Seraih</surname><given-names>A</given-names></name><name><surname>Belguesmia</surname><given-names>Y</given-names></name><name><surname>Baah</surname><given-names>J</given-names></name><etal/></person-group><article-title>Enterocin B3A&#x02013;B3B produced by LAB collected from infant faeces: potential utilization in the food industry for <italic>Listeria monocytogenes</italic> biofilm management</article-title><source>Antonie Van Leeuwenhoek</source><year>2017</year><volume>110</volume><fpage>205</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1007/s10482-016-0791-5</pub-id><?supplied-pmid 27878401?><pub-id pub-id-type="pmid">27878401</pub-id>
</element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Sieiro</surname><given-names>P</given-names></name><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M</given-names></name><name><surname>Mu</surname><given-names>D</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name></person-group><article-title>Bacteriocins of lactic acid bacteria: extending the family</article-title><source>Appl Microbiol Biotechnol</source><year>2016</year><volume>100</volume><fpage>2939</fpage><lpage>2951</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7343-9</pub-id><?supplied-pmid 26860942?><pub-id pub-id-type="pmid">26860942</pub-id>
</element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>FCB</given-names></name><name><surname>Barbosa</surname><given-names>LN</given-names></name><name><surname>Andrade</surname><given-names>BFMT</given-names></name><etal/></person-group><article-title>Short communication: inhibitory activities of the lantibiotic nisin combined with phenolic compounds against <italic>Staphylococcus aureus</italic> and <italic>Listeria monocytogenes</italic> in cow milk</article-title><source>J Dairy Sci</source><year>2016</year><volume>99</volume><fpage>1831</fpage><lpage>1836</lpage><pub-id pub-id-type="doi">10.3168/jds.2015-10025</pub-id><?supplied-pmid 26774728?><pub-id pub-id-type="pmid">26774728</pub-id>
</element-citation></ref><ref id="CR26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alzamora</surname><given-names>SM</given-names></name><name><surname>Welti-Chanes</surname><given-names>J</given-names></name><name><surname>Guerrero</surname><given-names>SN</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>PL</given-names></name></person-group><person-group person-group-type="editor"><name><surname>McElhatton</surname><given-names>A</given-names></name><name><surname>do Amaral Sobral</surname><given-names>PJ</given-names></name></person-group><article-title>Rational use of novel technologies: a comparative analysis of the performance of several new food preservation technologies for microbial inactivation</article-title><source>Novel technologies in food science</source><year>2012</year><publisher-loc>New York</publisher-loc><publisher-name>Springer New York</publisher-name><fpage>235</fpage><lpage>260</lpage></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Purification and characterization of a novel bacteriocin CAMT2 produced by <italic>Bacillus amyloliquefaciens</italic> isolated from marine fish <italic>Epinephelus areolatus</italic></article-title><source>Food Control</source><year>2015</year><volume>51</volume><fpage>278</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2014.11.038</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ananou</surname><given-names>S</given-names></name><name><surname>Zentar</surname><given-names>H</given-names></name><name><surname>Mart&#x000ed;nez-Bueno</surname><given-names>M</given-names></name><etal/></person-group><article-title>The impact of enterocin AS-48 on the shelf-life and safety of sardines (<italic>Sardina pilchardus</italic>) under different storage conditions</article-title><source>Food Microbiol</source><year>2014</year><volume>44</volume><fpage>185</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2014.06.008</pub-id><?supplied-pmid 25084662?><pub-id pub-id-type="pmid">25084662</pub-id>
</element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ananou</surname><given-names>S</given-names></name><name><surname>Lotfi</surname><given-names>S</given-names></name><name><surname>Azdad</surname><given-names>O</given-names></name><name><surname>Nzoyikorera</surname><given-names>N</given-names></name></person-group><article-title>Production, recovery and characterization of an enterocin with anti-listerial activity produced by <italic>Enterococcus hirae</italic> OS1</article-title><source>Appl Food Biotechnol</source><year>2020</year><volume>7</volume><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.22037/afb.v7i2.27582</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>And</surname><given-names>HC</given-names></name><name><surname>Hoover</surname><given-names>DG</given-names></name></person-group><article-title>Bacteriocins and their food applications</article-title><source>Comp Rev Food Sci Food Safety</source><year>2003</year><volume>2</volume><fpage>82</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1111/j.1541-4337.2003.tb00016.x</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjana</surname><given-names>TSK</given-names></name></person-group><article-title>Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota</article-title><source>Front Cell Infect Microbiol</source><year>2022</year><volume>12</volume><fpage>851140</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.851140</pub-id><?supplied-pmid 35651753?><pub-id pub-id-type="pmid">35651753</pub-id>
</element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anyaegbunam</surname><given-names>NJ</given-names></name><name><surname>Anekpo</surname><given-names>CC</given-names></name><name><surname>Anyaegbunam</surname><given-names>ZKG</given-names></name><etal/></person-group><article-title>The resurgence of phage-based therapy in the era of increasing antibiotic resistance: from research progress to challenges and prospects</article-title><source>Microbiol Res</source><year>2022</year><volume>264</volume><fpage>127155</fpage><pub-id pub-id-type="doi">10.1016/j.micres.2022.127155</pub-id><?supplied-pmid 35969943?><pub-id pub-id-type="pmid">35969943</pub-id>
</element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appendini</surname><given-names>P</given-names></name><name><surname>Hotchkiss</surname><given-names>JH</given-names></name></person-group><article-title>Review of antimicrobial food packaging</article-title><source>Innov Food Sci Emerg Technol</source><year>2002</year><volume>3</volume><fpage>113</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/S1466-8564(02)00012-7</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>K</given-names></name><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Iioka</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of gassericins A and T, bacteriocins produced by <italic>Lactobacillus gasseri</italic>, with glycine on custard cream preservation</article-title><source>J Dairy Sci</source><year>2009</year><volume>92</volume><fpage>2365</fpage><lpage>2372</lpage><pub-id pub-id-type="doi">10.3168/jds.2008-1240</pub-id><?supplied-pmid 19447968?><pub-id pub-id-type="pmid">19447968</pub-id>
</element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arboleya</surname><given-names>S</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Ryan</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Bosom buddies: the symbiotic relationship between infants and <italic>Bifidobacterium longum</italic> ssp. <italic>longum</italic> and ssp. <italic>infantis</italic>. Genetic and probiotic features</article-title><source>Annu Rev Food Sci Technol</source><year>2016</year><volume>7</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1146/annurev-food-041715-033151</pub-id><?supplied-pmid 26934170?><pub-id pub-id-type="pmid">26934170</pub-id>
</element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnison</surname><given-names>PG</given-names></name><name><surname>Bibb</surname><given-names>MJ</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name><etal/></person-group><article-title>Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature</article-title><source>Nat Prod Rep</source><year>2013</year><volume>30</volume><fpage>108</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1039/c2np20085f</pub-id><?supplied-pmid 23165928?><pub-id pub-id-type="pmid">23165928</pub-id>
</element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arqu&#x000e9;s</surname><given-names>JL</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>E</given-names></name><name><surname>Nu&#x000f1;ez</surname><given-names>M</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name></person-group><article-title>Combined effect of reuterin and lactic acid bacteria bacteriocins on the inactivation of food-borne pathogens in milk</article-title><source>Food Control</source><year>2011</year><volume>22</volume><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2010.09.027</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspri</surname><given-names>M</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Field</surname><given-names>D</given-names></name><etal/></person-group><article-title>Application of bacteriocin-producing <italic>Enterococcus faecium</italic> isolated from donkey milk, in the bio-control of <italic>Listeria monocytogenes</italic> in fresh whey cheese</article-title><source>Int Dairy J</source><year>2017</year><volume>73</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2017.04.008</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aunpad</surname><given-names>R</given-names></name><name><surname>Na-Bangchang</surname><given-names>K</given-names></name></person-group><article-title>Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria <italic>Bacillus pumilus</italic> strain WAPB4</article-title><source>Curr Microbiol</source><year>2007</year><volume>55</volume><fpage>308</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1007/s00284-006-0632-2</pub-id><?supplied-pmid 17700984?><pub-id pub-id-type="pmid">17700984</pub-id>
</element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c1;vila</surname><given-names>M</given-names></name><name><surname>Garde</surname><given-names>S</given-names></name><name><surname>Gaya</surname><given-names>P</given-names></name><etal/></person-group><article-title>Influence of a bacteriocin-producing lactic culture on proteolysis and texture of Hisp&#x000e1;nico cheese</article-title><source>Int Dairy J</source><year>2005</year><volume>15</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2004.06.009</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Aymerich</surname><given-names>T</given-names></name><name><surname>Garriga</surname><given-names>M</given-names></name><name><surname>Monfort</surname><given-names>J</given-names></name></person-group><article-title>Applications of protective cultures, bacteriocins and bacteriophages in fermented meat products</article-title><source>Protective cultures, antimicrobial metabolites and bacteriophages for food and beverage biopreservation</source><year>2011</year><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>297</fpage><lpage>323</lpage></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azmi</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Stiles</surname><given-names>M</given-names></name><etal/></person-group><article-title>Detection of Listeria monocytogenes with short peptide fragments from class IIa bacteriocins as recognition elements</article-title><source>ACS Comb Sci</source><year>2015</year><volume>17</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1021/co500079k</pub-id><?supplied-pmid 25548942?><pub-id pub-id-type="pmid">25548942</pub-id>
</element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagley</surname><given-names>MC</given-names></name><name><surname>Dale</surname><given-names>JW</given-names></name><name><surname>Merritt</surname><given-names>EA</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name></person-group><article-title>Thiopeptide antibiotics</article-title><source>Chem Rev</source><year>2005</year><volume>105</volume><fpage>685</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1021/cr0300441</pub-id><?supplied-pmid 15700961?><pub-id pub-id-type="pmid">15700961</pub-id>
</element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahy</surname><given-names>R</given-names></name><name><surname>Emara</surname><given-names>M</given-names></name><name><surname>Elalem</surname><given-names>N</given-names></name><etal/></person-group><article-title>A new bacteriocin- like-inhibitory substance from Egyptian dairy products isolated from <italic>Enterococcus faecium</italic> with anti-SARS-CoV-2 activity</article-title><source>Process Biochem</source><year>2023</year><volume>134</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2023.10.023</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baindara</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Ranjan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Laterosporulin10: a novel defensin like Class IId bacteriocin from <italic>Brevibacillus</italic> sp. strain SKDU10 with inhibitory activity against microbial pathogens</article-title><source>Microbiology (Reading, Engl)</source><year>2016</year><volume>162</volume><fpage>1286</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000316</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baindara</surname><given-names>P</given-names></name><name><surname>Gautam</surname><given-names>A</given-names></name><name><surname>Raghava</surname><given-names>GPS</given-names></name><name><surname>Korpole</surname><given-names>S</given-names></name></person-group><article-title>Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>46541</fpage><pub-id pub-id-type="doi">10.1038/srep46541</pub-id><?supplied-pmid 28422156?><pub-id pub-id-type="pmid">28422156</pub-id>
</element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baindara</surname><given-names>P</given-names></name><name><surname>Korpole</surname><given-names>S</given-names></name><name><surname>Grover</surname><given-names>V</given-names></name></person-group><article-title>Bacteriocins: perspective for the development of novel anticancer drugs</article-title><source>Appl Microbiol Biotechnol</source><year>2018</year><volume>102</volume><fpage>10393</fpage><lpage>10408</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-9420-8</pub-id><?supplied-pmid 30338356?><pub-id pub-id-type="pmid">30338356</pub-id>
</element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balcik-Ercin</surname><given-names>P</given-names></name><name><surname>Sever</surname><given-names>B</given-names></name></person-group><article-title>An investigation of bacteriocin nisin anti-cancer effects and FZD7 protein interactions in liver cancer cells</article-title><source>Chem Biol Interact</source><year>2022</year><volume>366</volume><fpage>110152</fpage><pub-id pub-id-type="doi">10.1016/j.cbi.2022.110152</pub-id><?supplied-pmid 36084725?><pub-id pub-id-type="pmid">36084725</pub-id>
</element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bali</surname><given-names>V</given-names></name><name><surname>Panesar</surname><given-names>PS</given-names></name><name><surname>Bera</surname><given-names>MB</given-names></name><name><surname>Kennedy</surname><given-names>JF</given-names></name></person-group><article-title>Bacteriocins: recent trends and potential applications</article-title><source>Crit Rev Food Sci Nutr</source><year>2016</year><volume>56</volume><fpage>817</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1080/10408398.2012.729231</pub-id><?supplied-pmid 25117970?><pub-id pub-id-type="pmid">25117970</pub-id>
</element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balty</surname><given-names>C</given-names></name><name><surname>Guillot</surname><given-names>A</given-names></name><name><surname>Fradale</surname><given-names>L</given-names></name><etal/></person-group><article-title>Ruminococcin C, an anti-clostridial sactipeptide produced by a prominent member of the human microbiota <italic>Ruminococcus gnavus</italic></article-title><source>J Biol Chem</source><year>2019</year><volume>294</volume><fpage>14512</fpage><lpage>14525</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.009416</pub-id><?supplied-pmid 31337708?><pub-id pub-id-type="pmid">31337708</pub-id>
</element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ba&#x000f1;os</surname><given-names>A</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>JD</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>C</given-names></name><etal/></person-group><article-title>Subchronic toxicity study in BALBc mice of enterocin AS-48, an anti-microbial peptide produced by <italic>Enterococcus faecalis</italic> UGRA10</article-title><source>Food Chem Toxicol</source><year>2019</year><volume>132</volume><fpage>110667</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110667</pub-id><?supplied-pmid 31288051?><pub-id pub-id-type="pmid">31288051</pub-id>
</element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>F</given-names></name><name><surname>Lanza</surname><given-names>VF</given-names></name><name><surname>Baquero</surname><given-names>M-R</given-names></name><etal/></person-group><article-title>Microcins in Enterobacteriaceae: peptide antimicrobials in the eco-active intestinal chemosphere</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>2261</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.02261</pub-id><?supplied-pmid 31649628?><pub-id pub-id-type="pmid">31649628</pub-id>
</element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>F</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>JL</given-names></name><name><surname>Lanza</surname><given-names>F</given-names></name><name><surname>V,</surname></name><etal/></person-group><article-title>Evolutionary pathways and trajectories in antibiotic resistance</article-title><source>Clin Microbiol Rev</source><year>2021</year><volume>34</volume><fpage>e0005019</fpage><pub-id pub-id-type="doi">10.1128/CMR.00050-19</pub-id><?supplied-pmid 34190572?><pub-id pub-id-type="pmid">34190572</pub-id>
</element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>F</given-names></name><name><surname>Beis</surname><given-names>K</given-names></name><name><surname>Craik</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>The pearl jubilee of microcin J25: thirty years of research on an exceptional lasso peptide</article-title><source>Nat Prod Rep</source><year>2024</year><pub-id pub-id-type="doi">10.1039/d3np00046j</pub-id><?supplied-pmid 38164764?><pub-id pub-id-type="pmid">38164764</pub-id>
</element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>CC</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Small molecule natural products in human nasal/oral microbiota</article-title><source>J Ind Microbiol Biotechnol</source><year>2021</year><volume>48</volume><fpage>kuab010</fpage><pub-id pub-id-type="doi">10.1093/jimb/kuab010</pub-id><?supplied-pmid 33945611?><pub-id pub-id-type="pmid">33945611</pub-id>
</element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbiroli</surname><given-names>A</given-names></name><name><surname>Musatti</surname><given-names>A</given-names></name><name><surname>Capretti</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sakacin-A antimicrobial packaging for decreasing <italic>Listeria</italic> contamination in thin-cut meat: preliminary assessment</article-title><source>J Sci Food Agric</source><year>2017</year><volume>97</volume><fpage>1042</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1002/jsfa.8120</pub-id><?supplied-pmid 27790709?><pub-id pub-id-type="pmid">27790709</pub-id>
</element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>AAT</given-names></name><name><surname>Silva de Ara&#x000fa;jo</surname><given-names>HG</given-names></name><name><surname>Matos</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Effects of nisin-incorporated films on the microbiological and physicochemical quality of minimally processed mangoes</article-title><source>Int J Food Microbiol</source><year>2013</year><volume>164</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.04.004</pub-id><?supplied-pmid 23673058?><pub-id pub-id-type="pmid">23673058</pub-id>
</element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barboza-Corona</surname><given-names>JE</given-names></name><name><surname>de la Fuente-Salcido</surname><given-names>N</given-names></name><name><surname>Alva-Murillo</surname><given-names>N</given-names></name><etal/></person-group><article-title>Activity of bacteriocins synthesized by <italic>Bacillus thuringiensis</italic> against <italic>Staphylococcus aureus</italic> isolates associated to bovine mastitis</article-title><source>Vet Microbiol</source><year>2009</year><volume>138</volume><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2009.03.018</pub-id><?supplied-pmid 19359107?><pub-id pub-id-type="pmid">19359107</pub-id>
</element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barman</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>C</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><etal/></person-group><article-title>In vivo acute toxicity and therapeutic potential of a synthetic peptide, DP1 in a <italic>Staphylococcus aureus</italic> infected murine wound excision model</article-title><source>Probiotics Antimicrob Proteins</source><year>2023</year><pub-id pub-id-type="doi">10.1007/s12602-023-10176-1</pub-id><?supplied-pmid 37910332?><pub-id pub-id-type="pmid">37910332</pub-id>
</element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname><given-names>MCF</given-names></name><name><surname>Ceotto</surname><given-names>H</given-names></name><name><surname>Coelho</surname><given-names>MLV</given-names></name><name><surname>Nascimento</surname><given-names>JS</given-names></name></person-group><article-title>Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications</article-title><source>Curr Pharm Biotechnol</source><year>2009</year><volume>10</volume><fpage>38</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.2174/138920109787048580</pub-id><?supplied-pmid 19149589?><pub-id pub-id-type="pmid">19149589</pub-id>
</element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname><given-names>MDCDF</given-names></name><name><surname>Coelho</surname><given-names>MLV</given-names></name><name><surname>Santos</surname><given-names>OCDS</given-names></name></person-group><article-title>Resistance to bacteriocins produced by Gram-positive bacteria</article-title><source>Microbiology (Reading, Engl)</source><year>2015</year><volume>161</volume><fpage>683</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1099/mic.0.082289-0</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;uerl</surname><given-names>C</given-names></name><name><surname>Umu</surname><given-names>&#x000d6;CO</given-names></name><name><surname>Hernandez</surname><given-names>PE</given-names></name><etal/></person-group><article-title>A method to assess bacteriocin effects on the gut microbiota of mice</article-title><source>J vis Exp</source><year>2017</year><pub-id pub-id-type="doi">10.3791/56053</pub-id><?supplied-pmid 28784971?><pub-id pub-id-type="pmid">28784971</pub-id>
</element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;dard</surname><given-names>F</given-names></name><name><surname>Biron</surname><given-names>E</given-names></name></person-group><article-title>Recent progress in the chemical synthesis of Class II and S-glycosylated bacteriocins</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1048</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01048</pub-id><?supplied-pmid 29875754?><pub-id pub-id-type="pmid">29875754</pub-id>
</element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;dard</surname><given-names>F</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Zirah</surname><given-names>S</given-names></name><etal/></person-group><article-title>Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>9029</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-27225-3</pub-id><?supplied-pmid 29899567?><pub-id pub-id-type="pmid">29899567</pub-id>
</element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belfiore</surname><given-names>C</given-names></name><name><surname>Castellano</surname><given-names>P</given-names></name><name><surname>Vignolo</surname><given-names>G</given-names></name></person-group><article-title>Reduction of <italic>Escherichia coli</italic> population following treatment with bacteriocins from lactic acid bacteria and chelators</article-title><source>Food Microbiol</source><year>2007</year><volume>24</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2006.05.006</pub-id><?supplied-pmid 17188201?><pub-id pub-id-type="pmid">17188201</pub-id>
</element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Lagha</surname><given-names>A</given-names></name><name><surname>Haas</surname><given-names>B</given-names></name><name><surname>Gottschalk</surname><given-names>M</given-names></name><name><surname>Grenier</surname><given-names>D</given-names></name></person-group><article-title>Antimicrobial potential of bacteriocins in poultry and swine production</article-title><source>Vet Res</source><year>2017</year><volume>48</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1186/s13567-017-0425-6</pub-id><?supplied-pmid 28399941?><pub-id pub-id-type="pmid">28399941</pub-id>
</element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Said</surname><given-names>L</given-names></name><name><surname>Emond-Rheault</surname><given-names>J-G</given-names></name><name><surname>Soltani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phenomic and genomic approaches to studying the inhibition of multiresistant <italic>Salmonella enterica</italic> by microcin J25</article-title><source>Environ Microbiol</source><year>2020</year><volume>22</volume><fpage>2907</fpage><lpage>2920</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.15045</pub-id><?supplied-pmid 32363677?><pub-id pub-id-type="pmid">32363677</pub-id>
</element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benabbou</surname><given-names>R</given-names></name><name><surname>Subirade</surname><given-names>M</given-names></name><name><surname>Desbiens</surname><given-names>M</given-names></name><name><surname>Fliss</surname><given-names>I</given-names></name></person-group><article-title>Divergicin M35-chitosan film: development and characterization</article-title><source>Probiotics Antimicrob Proteins</source><year>2020</year><volume>12</volume><fpage>1562</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1007/s12602-020-09660-9</pub-id><?supplied-pmid 32430585?><pub-id pub-id-type="pmid">32430585</pub-id>
</element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>T</given-names></name><name><surname>L&#x000f6;nn</surname><given-names>J</given-names></name><name><surname>Khalaf</surname><given-names>H</given-names></name><name><surname>Palm</surname><given-names>E</given-names></name></person-group><article-title>The lantibiotic gallidermin acts bactericidal against <italic>Staphylococcus epidermidis</italic> and <italic>Staphylococcus aureus</italic> and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts</article-title><source>Microbiologyopen</source><year>2018</year><volume>7</volume><fpage>e00606</fpage><pub-id pub-id-type="doi">10.1002/mbo3.606</pub-id><?supplied-pmid 29536668?><pub-id pub-id-type="pmid">29536668</pub-id>
</element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>T</given-names></name><name><surname>Seleg&#x000e5;rd</surname><given-names>R</given-names></name><name><surname>Musa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Plantaricin NC8 &#x003b1;&#x003b2; exerts potent antimicrobial activity against <italic>Staphylococcus</italic> spp. and enhances the effects of antibiotics</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><fpage>3580</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-60570-w</pub-id><?supplied-pmid 32107445?><pub-id pub-id-type="pmid">32107445</pub-id>
</element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben&#x000ed;tez-Chao</surname><given-names>DF</given-names></name><name><surname>Le&#x000f3;n-Buitimea</surname><given-names>A</given-names></name><name><surname>Lerma-Escalera</surname><given-names>JA</given-names></name><name><surname>Morones-Ram&#x000ed;rez</surname><given-names>JR</given-names></name></person-group><article-title>Bacteriocins: an overview of antimicrobial, toxicity, and biosafety assessment by in vivo models</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>630695</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.630695</pub-id><?supplied-pmid 33935991?><pub-id pub-id-type="pmid">33935991</pub-id>
</element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkirane</surname><given-names>G</given-names></name><name><surname>Ananou</surname><given-names>S</given-names></name><name><surname>Dumas</surname><given-names>E</given-names></name><etal/></person-group><article-title>Moroccan traditional fermented dairy products: current processing practices and physicochemical and microbiological properties&#x02014;a review</article-title><source>JMBFS</source><year>2022</year><pub-id pub-id-type="doi">10.55251/jmbfs.5636</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>S</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><name><surname>Lacasse</surname><given-names>P</given-names></name><etal/></person-group><article-title>Susceptibility to nisin, bactofencin, pediocin and reuterin of multidrug resistant <italic>Staphylococcus aureus</italic>, <italic>Streptococcus dysgalactiae</italic> and <italic>Streptococcus uberis</italic> causing bovine mastitis</article-title><source>Antibiotics (Basel).</source><year>2021</year><pub-id pub-id-type="doi">10.3390/antibiotics10111418</pub-id><?supplied-pmid 34827356?><pub-id pub-id-type="pmid">34827356</pub-id>
</element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>S</given-names></name><name><surname>Fliss</surname><given-names>I</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><etal/></person-group><article-title>Efficacy of bacteriocin-based formula for reducing staphylococci, streptococci, and total bacterial counts on teat skin of dairy cows</article-title><source>J Dairy Sci</source><year>2022</year><volume>105</volume><fpage>4498</fpage><lpage>4507</lpage><pub-id pub-id-type="doi">10.3168/jds.2021-21381</pub-id><?supplied-pmid 35346465?><pub-id pub-id-type="pmid">35346465</pub-id>
</element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>A</given-names></name><name><surname>Stacy</surname><given-names>A</given-names></name><name><surname>Bashey</surname><given-names>F</given-names></name></person-group><article-title>Suppression of bacteriocin resistance using live, heterospecific competitors</article-title><source>Evol Appl</source><year>2019</year><volume>12</volume><fpage>1191</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1111/eva.12797</pub-id><?supplied-pmid 31293631?><pub-id pub-id-type="pmid">31293631</pub-id>
</element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bier</surname><given-names>K</given-names></name><name><surname>Schittek</surname><given-names>B</given-names></name></person-group><article-title>Beneficial effects of coagulase-negative Staphylococci on <italic>Staphylococcus aureus</italic> skin colonization</article-title><source>Exp Dermatol</source><year>2021</year><volume>30</volume><fpage>1442</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1111/exd.14381</pub-id><?supplied-pmid 33960019?><pub-id pub-id-type="pmid">33960019</pub-id>
</element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birri</surname><given-names>DJ</given-names></name><name><surname>Brede</surname><given-names>DA</given-names></name><name><surname>Nes</surname><given-names>IF</given-names></name></person-group><article-title>Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from <italic>Streptococcus salivarius</italic> 5M6c isolated from a healthy infant</article-title><source>Appl Environ Microbiol</source><year>2012</year><volume>78</volume><fpage>402</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1128/AEM.06588-11</pub-id><?supplied-pmid 22101034?><pub-id pub-id-type="pmid">22101034</pub-id>
</element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitschar</surname><given-names>K</given-names></name><name><surname>Sauer</surname><given-names>B</given-names></name><name><surname>Focken</surname><given-names>J</given-names></name><etal/></person-group><article-title>Lugdunin amplifies innate immune responses in the skin in synergy with host- and microbiota-derived factors</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>2730</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-10646-7</pub-id><?supplied-pmid 31227691?><pub-id pub-id-type="pmid">31227691</pub-id>
</element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasche</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Mars</surname><given-names>RAT</given-names></name><etal/></person-group><article-title>Metabolic cooperation and spatiotemporal niche partitioning in a kefir microbial community</article-title><source>Nat Microbiol</source><year>2021</year><volume>6</volume><fpage>196</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-00816-5</pub-id><?supplied-pmid 33398099?><pub-id pub-id-type="pmid">33398099</pub-id>
</element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K</given-names></name><name><surname>Medema</surname><given-names>MH</given-names></name><name><surname>Kazempour</surname><given-names>D</given-names></name><etal/></person-group><article-title>antiSMASH 2.0&#x02014;a versatile platform for genome mining of secondary metabolite producers</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>W204</fpage><lpage>W212</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt449</pub-id><?supplied-pmid 23737449?><pub-id pub-id-type="pmid">23737449</pub-id>
</element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>DE</given-names></name><name><surname>Black</surname><given-names>S</given-names></name><name><surname>Salisbury</surname><given-names>D</given-names></name><name><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title>Antimicrobial resistance and the role of vaccines</article-title><source>Proc Natl Acad Sci USA</source><year>2018</year><volume>115</volume><fpage>12868</fpage><lpage>12871</lpage><pub-id pub-id-type="doi">10.1073/pnas.1717157115</pub-id><?supplied-pmid 30559204?><pub-id pub-id-type="pmid">30559204</pub-id>
</element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boakes</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>WJ</given-names></name><name><surname>Vinson</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models</article-title><source>J Antibiot</source><year>2016</year><volume>69</volume><fpage>850</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1038/ja.2016.47</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolocan</surname><given-names>AS</given-names></name><name><surname>Pennone</surname><given-names>V</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Inhibition of <italic>Listeria monocytogenes</italic> biofilms by bacteriocin-producing bacteria isolated from mushroom substrate</article-title><source>J Appl Microbiol</source><year>2017</year><volume>122</volume><fpage>279</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1111/jam.13337</pub-id><?supplied-pmid 27797439?><pub-id pub-id-type="pmid">27797439</pub-id>
</element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonham</surname><given-names>KS</given-names></name><name><surname>Wolfe</surname><given-names>BE</given-names></name><name><surname>Dutton</surname><given-names>RJ</given-names></name></person-group><article-title>Extensive horizontal gene transfer in cheese-associated bacteria</article-title><source>Elife</source><year>2017</year><pub-id pub-id-type="doi">10.7554/eLife.22144</pub-id><?supplied-pmid 28644126?><pub-id pub-id-type="pmid">28644126</pub-id>
</element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos&#x000e1;k</surname><given-names>J</given-names></name><name><surname>Laiblov&#x000e1;</surname><given-names>P</given-names></name><name><surname>Smarda</surname><given-names>J</given-names></name><etal/></person-group><article-title>Novel colicin Fy of <italic>Yersinia frederiksenii</italic> inhibits pathogenic <italic>Yersinia</italic> strains via YiuR-mediated reception, TonB import, and cell membrane pore formation</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>1950</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1128/JB.05885-11</pub-id><?supplied-pmid 22343298?><pub-id pub-id-type="pmid">22343298</pub-id>
</element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos&#x000e1;k</surname><given-names>J</given-names></name><name><surname>Micenkov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Hrala</surname><given-names>M</given-names></name><etal/></person-group><article-title>Colicin FY inhibits pathogenic <italic>Yersinia enterocolitica</italic> in mice</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>12242</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-30729-7</pub-id><?supplied-pmid 30115964?><pub-id pub-id-type="pmid">30115964</pub-id>
</element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos&#x000e1;k</surname><given-names>J</given-names></name><name><surname>Hrala</surname><given-names>M</given-names></name><name><surname>Micenkov&#x000e1;</surname><given-names>L</given-names></name><name><surname>&#x00160;majs</surname><given-names>D</given-names></name></person-group><article-title>Non-antibiotic antibacterial peptides and proteins of <italic>Escherichia coli</italic>: efficacy and potency of bacteriocins</article-title><source>Expert Rev Anti Infect Ther</source><year>2021</year><volume>19</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1080/14787210.2020.1816824</pub-id><?supplied-pmid 32856960?><pub-id pub-id-type="pmid">32856960</pub-id>
</element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;ttger</surname><given-names>R</given-names></name><name><surname>Hoffmann</surname><given-names>R</given-names></name><name><surname>Knappe</surname><given-names>D</given-names></name></person-group><article-title>Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><fpage>e0178943</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0178943</pub-id><?supplied-pmid 28575099?><pub-id pub-id-type="pmid">28575099</pub-id>
</element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bountra</surname><given-names>K</given-names></name><name><surname>Hagelueken</surname><given-names>G</given-names></name><name><surname>Choudhury</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Structural basis for antibacterial peptide self-immunity by the bacterial ABC transporter McjD</article-title><source>EMBO J</source><year>2017</year><volume>36</volume><fpage>3062</fpage><lpage>3079</lpage><pub-id pub-id-type="doi">10.15252/embj.201797278</pub-id><?supplied-pmid 28864543?><pub-id pub-id-type="pmid">28864543</pub-id>
</element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AM</given-names></name><name><surname>de Kwaadsteniet</surname><given-names>M</given-names></name><name><surname>Dicks</surname><given-names>LMT</given-names></name></person-group><article-title>The ability of nisin F to control <italic>Staphylococcus aureus</italic> infection in the peritoneal cavity, as studied in mice</article-title><source>Lett Appl Microbiol</source><year>2010</year><volume>51</volume><fpage>645</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2010.02948.x</pub-id><?supplied-pmid 21029139?><pub-id pub-id-type="pmid">21029139</pub-id>
</element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name></person-group><article-title>The role of bacterial interference in otitis, sinusitis and tonsillitis</article-title><source>Otolaryngol Head Neck Surg</source><year>2005</year><volume>133</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.otohns.2005.03.012</pub-id><?supplied-pmid 16025067?><pub-id pub-id-type="pmid">16025067</pub-id>
</element-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000f6;tz</surname><given-names>H</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name><name><surname>Leopold</surname><given-names>K</given-names></name><etal/></person-group><article-title>The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II</article-title><source>Antimicrob Agents Chemother</source><year>1998</year><volume>42</volume><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1128/AAC.42.1.154</pub-id><?supplied-pmid 9449277?><pub-id pub-id-type="pmid">9449277</pub-id>
</element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broughton</surname><given-names>LJ</given-names></name><name><surname>Crow</surname><given-names>C</given-names></name><name><surname>Maraveyas</surname><given-names>A</given-names></name><name><surname>Madden</surname><given-names>LA</given-names></name></person-group><article-title>Duramycin-induced calcium release in cancer cells</article-title><source>Anticancer Drugs</source><year>2016</year><volume>27</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1097/CAD.0000000000000313</pub-id><?supplied-pmid 26512767?><pub-id pub-id-type="pmid">26512767</pub-id>
</element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>JP</given-names></name><name><surname>Chilcott</surname><given-names>CN</given-names></name><name><surname>Moore</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>A preliminary study of the effect of probiotic <italic>Streptococcus salivarius</italic> K12 on oral malodour parameters</article-title><source>J Appl Microbiol</source><year>2006</year><volume>100</volume><fpage>754</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2006.02837.x</pub-id><?supplied-pmid 16553730?><pub-id pub-id-type="pmid">16553730</pub-id>
</element-citation></ref><ref id="CR95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>JP</given-names></name><name><surname>Wescombe</surname><given-names>PA</given-names></name><name><surname>Moore</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Safety assessment of the oral cavity probiotic <italic>Streptococcus salivarius</italic> K12</article-title><source>Appl Environ Microbiol</source><year>2006</year><volume>72</volume><fpage>3050</fpage><lpage>3053</lpage><pub-id pub-id-type="doi">10.1128/AEM.72.4.3050-3053.2006</pub-id><?supplied-pmid 16598017?><pub-id pub-id-type="pmid">16598017</pub-id>
</element-citation></ref><ref id="CR96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero G&#x000f3;mez</surname><given-names>N</given-names></name><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>Grande</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Combined treatments of enterocin AS-48 with biocides to improve the inactivation of methicillin-sensitive and methicillin-resistant <italic>Staphylococcus aureus</italic> planktonic and sessile cells</article-title><source>Int J Food Microbiol</source><year>2013</year><volume>163</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.02.018</pub-id><?supplied-pmid 23558192?><pub-id pub-id-type="pmid">23558192</pub-id>
</element-citation></ref><ref id="CR97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campion</surname><given-names>A</given-names></name><name><surname>Casey</surname><given-names>PG</given-names></name><name><surname>Field</surname><given-names>D</given-names></name><etal/></person-group><article-title>In vivo activity of nisin A and nisin V against <italic>Listeria monocytogenes</italic> in mice</article-title><source>BMC Microbiol</source><year>2013</year><volume>13</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-13-23</pub-id><?supplied-pmid 23374279?><pub-id pub-id-type="pmid">23374279</pub-id>
</element-citation></ref><ref id="CR98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>LT</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name><name><surname>Xie</surname><given-names>F</given-names></name><etal/></person-group><article-title>Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows</article-title><source>J Dairy Sci</source><year>2007</year><volume>90</volume><fpage>3980</fpage><lpage>3985</lpage><pub-id pub-id-type="doi">10.3168/jds.2007-0153</pub-id><?supplied-pmid 17639009?><pub-id pub-id-type="pmid">17639009</pub-id>
</element-citation></ref><ref id="CR99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlin Fagundes</surname><given-names>P</given-names></name><name><surname>Miceli de Farias</surname><given-names>F</given-names></name><name><surname>da Silva</surname><given-names>C</given-names></name><name><surname>Santos</surname><given-names>O</given-names></name><etal/></person-group><article-title>The four-component aureocin A70 as a promising agent for food biopreservation</article-title><source>Int J Food Microbiol</source><year>2016</year><volume>237</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2016.08.017</pub-id><?supplied-pmid 27543814?><pub-id pub-id-type="pmid">27543814</pub-id>
</element-citation></ref><ref id="CR100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona-Cruz</surname><given-names>S</given-names></name><name><surname>Orozco-Covarrubias</surname><given-names>L</given-names></name><name><surname>S&#x000e1;ez-de-Ocariz</surname><given-names>M</given-names></name></person-group><article-title>The human skin microbiome in selected cutaneous diseases</article-title><source>Front Cell Infect Microbiol</source><year>2022</year><volume>12</volume><fpage>834135</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.834135</pub-id><?supplied-pmid 35321316?><pub-id pub-id-type="pmid">35321316</pub-id>
</element-citation></ref><ref id="CR101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnio</surname><given-names>MC</given-names></name><name><surname>H&#x000f6;ltzel</surname><given-names>A</given-names></name><name><surname>Rudolf</surname><given-names>M</given-names></name><etal/></person-group><article-title>The macrocyclic peptide antibiotic micrococcin P(1) is secreted by the food-borne bacterium <italic>Staphylococcus equorum</italic> WS 2733 and inhibits <italic>Listeria monocytogenes</italic> on soft cheese</article-title><source>Appl Environ Microbiol</source><year>2000</year><volume>66</volume><fpage>2378</fpage><lpage>2384</lpage><pub-id pub-id-type="doi">10.1128/AEM.66.6.2378-2384.2000</pub-id><?supplied-pmid 10831414?><pub-id pub-id-type="pmid">10831414</pub-id>
</element-citation></ref><ref id="CR102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>J</given-names></name><name><surname>Draper</surname><given-names>LA</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria</article-title><source>Int J Antimicrob Agents</source><year>2010</year><volume>36</volume><fpage>132</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.03.029</pub-id><?supplied-pmid 20547041?><pub-id pub-id-type="pmid">20547041</pub-id>
</element-citation></ref><ref id="CR103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellano</surname><given-names>P</given-names></name><name><surname>Vignolo</surname><given-names>G</given-names></name></person-group><article-title>Inhibition of <italic>Listeria innocua</italic> and <italic>Brochothrix thermosphacta</italic> in vacuum-packaged meat by addition of bacteriocinogenic <italic>Lactobacillus curvatus</italic> CRL705 and its bacteriocins</article-title><source>Lett Appl Microbiol</source><year>2006</year><volume>43</volume><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2006.01933.x</pub-id><?supplied-pmid 16869904?><pub-id pub-id-type="pmid">16869904</pub-id>
</element-citation></ref><ref id="CR104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavicchioli</surname><given-names>VQ</given-names></name><name><surname>de Carvalho</surname><given-names>OV</given-names></name><name><surname>de Paiva</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Inhibition of herpes simplex virus 1 (HSV-1) and poliovirus (PV-1) by bacteriocins from <italic>Lactococcus lactis</italic> subsp. lactis and <italic>Enterococcus durans</italic> strains isolated from goat milk</article-title><source>Int J Antimicrob Agents</source><year>2018</year><volume>51</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.04.020</pub-id><?supplied-pmid 28668682?><pub-id pub-id-type="pmid">28668682</pub-id>
</element-citation></ref><ref id="CR105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cebri&#x000e1;n</surname><given-names>R</given-names></name><name><surname>Rodr&#x000ed;guez-Cabezas</surname><given-names>ME</given-names></name><name><surname>Mart&#x000ed;n-Escolano</surname><given-names>R</given-names></name><etal/></person-group><article-title>Preclinical studies of toxicity and safety of the AS-48 bacteriocin</article-title><source>J Adv Res</source><year>2019</year><volume>20</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2019.06.003</pub-id><?supplied-pmid 31360546?><pub-id pub-id-type="pmid">31360546</pub-id>
</element-citation></ref><ref id="CR106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cebri&#x000e1;n</surname><given-names>R</given-names></name><name><surname>Mart&#x000ed;nez-Garc&#x000ed;a</surname><given-names>M</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Advances in the preclinical characterization of the antimicrobial peptide AS-48</article-title><source>Front Microbiol</source><year>2023</year><volume>14</volume><fpage>1110360</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2023.1110360</pub-id><?supplied-pmid 36819031?><pub-id pub-id-type="pmid">36819031</pub-id>
</element-citation></ref><ref id="CR107"><mixed-citation publication-type="other">Centers for Disease Control and Prevention CDC (2018) CDC core elements to help resource-limited settings improve antibiotic use | CDC. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/drugresistance/solutions-initiative/stories/core-elements-resource-limited-settings.html">https://www.cdc.gov/drugresistance/solutions-initiative/stories/core-elements-resource-limited-settings.html</ext-link>. Accessed 31 Aug 2023.</mixed-citation></ref><ref id="CR108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesa-Luna</surname><given-names>C</given-names></name><name><surname>Alatorre-Cruz</surname><given-names>J-M</given-names></name><name><surname>Carre&#x000f1;o-L&#x000f3;pez</surname><given-names>R</given-names></name><etal/></person-group><article-title>Emerging applications of bacteriocins as antimicrobials, anticancer drugs, and modulators of the gastrointestinal microbiota</article-title><source>Pol J Microbiol</source><year>2021</year><volume>70</volume><fpage>143</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.33073/pjm-2021-020</pub-id><?supplied-pmid 34349808?><pub-id pub-id-type="pmid">34349808</pub-id>
</element-citation></ref><ref id="CR109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrakasan</surname><given-names>G</given-names></name><name><surname>Rodr&#x000ed;guez-Hern&#x000e1;ndez</surname><given-names>A-I</given-names></name><name><surname>Del Roc&#x000ed;o</surname><given-names>L-C</given-names></name><etal/></person-group><article-title>Bacteriocin encapsulation for food and pharmaceutical applications: advances in the past 20 years</article-title><source>Biotechnol Lett</source><year>2019</year><volume>41</volume><fpage>453</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1007/s10529-018-02635-5</pub-id><?supplied-pmid 30739282?><pub-id pub-id-type="pmid">30739282</pub-id>
</element-citation></ref><ref id="CR110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S-W</given-names></name><name><surname>Liu</surname><given-names>C-H</given-names></name><name><surname>Hu</surname><given-names>S-Y</given-names></name></person-group><article-title>Dietary administration of probiotic <italic>Paenibacillus ehimensis</italic> NPUST1 with bacteriocin-like activity improves growth performance and immunity against <italic>Aeromonas hydrophila</italic> and <italic>Streptococcus iniae</italic> in Nile tilapia (<italic>Oreochromis niloticus</italic>)</article-title><source>Fish Shellfish Immunol</source><year>2019</year><volume>84</volume><fpage>695</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2018.10.059</pub-id><?supplied-pmid 30368025?><pub-id pub-id-type="pmid">30368025</pub-id>
</element-citation></ref><ref id="CR111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>WN</given-names></name><name><surname>Han</surname><given-names>SG</given-names></name></person-group><article-title>Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments&#x02014;a review</article-title><source>Asian-Australas J Anim Sci</source><year>2020</year><volume>33</volume><fpage>1699</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.5713/ajas.20.0156</pub-id><?supplied-pmid 32777908?><pub-id pub-id-type="pmid">32777908</pub-id>
</element-citation></ref><ref id="CR112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherif</surname><given-names>A</given-names></name><name><surname>Ouzari</surname><given-names>H</given-names></name><name><surname>Daffonchio</surname><given-names>D</given-names></name><etal/></person-group><article-title>Thuricin 7: a novel bacteriocin produced by <italic>Bacillus thuringiensis</italic> BMG1.7, a new strain isolated from soil</article-title><source>Lett Appl Microbiol</source><year>2001</year><volume>32</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1046/j.1472-765x.2001.00898.x</pub-id><?supplied-pmid 11298934?><pub-id pub-id-type="pmid">11298934</pub-id>
</element-citation></ref><ref id="CR113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherif</surname><given-names>A</given-names></name><name><surname>Rezgui</surname><given-names>W</given-names></name><name><surname>Raddadi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization and partial purification of entomocin 110, a newly identified bacteriocin from <italic>Bacillus thuringiensis</italic> subsp. Entomocidus HD110</article-title><source>Microbiol Res</source><year>2008</year><volume>163</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2006.10.005</pub-id><?supplied-pmid 19216106?><pub-id pub-id-type="pmid">19216106</pub-id>
</element-citation></ref><ref id="CR114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chifiriuc</surname><given-names>M</given-names></name><name><surname>Grumezescu</surname><given-names>A</given-names></name><name><surname>Lazar</surname><given-names>V</given-names></name><etal/></person-group><article-title>Contribution of antimicrobial peptides to the development of new and efficient antimicrobial strategies</article-title><source>CP</source><year>2014</year><volume>11</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.2174/157016461102140917121943</pub-id></element-citation></ref><ref id="CR115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikindas</surname><given-names>ML</given-names></name><name><surname>Weeks</surname><given-names>R</given-names></name><name><surname>Drider</surname><given-names>D</given-names></name><etal/></person-group><article-title>Functions and emerging applications of bacteriocins</article-title><source>Curr Opin Biotechnol</source><year>2018</year><volume>49</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2017.07.011</pub-id><?supplied-pmid 28787641?><pub-id pub-id-type="pmid">28787641</pub-id>
</element-citation></ref><ref id="CR116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiumento</surname><given-names>S</given-names></name><name><surname>Roblin</surname><given-names>C</given-names></name><name><surname>Kieffer-Jaquinod</surname><given-names>S</given-names></name><etal/></person-group><article-title>Ruminococcin C, a promising antibiotic produced by a human gut symbiont</article-title><source>Sci Adv</source><year>2019</year><volume>5</volume><fpage>eaaw9969</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaw9969</pub-id><?supplied-pmid 31579822?><pub-id pub-id-type="pmid">31579822</pub-id>
</element-citation></ref><ref id="CR117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Kumar Jena</surname><given-names>K</given-names></name><name><surname>Sahoo</surname><given-names>DK</given-names></name></person-group><article-title>Sonorensin: a new bacteriocin with potential of an anti-biofilm agent and a food biopreservative</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>13412</fpage><pub-id pub-id-type="doi">10.1038/srep13412</pub-id><?supplied-pmid 26292786?><pub-id pub-id-type="pmid">26292786</pub-id>
</element-citation></ref><ref id="CR118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>SP</given-names></name><name><surname>Hartmann</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Borriss</surname><given-names>R</given-names></name></person-group><article-title>Biocontrol mechanism by root-associated <italic>Bacillus amyloliquefaciens</italic> FZB42&#x02014;a review</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>780</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00780</pub-id><?supplied-pmid 26284057?><pub-id pub-id-type="pmid">26284057</pub-id>
</element-citation></ref><ref id="CR119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirkovic</surname><given-names>I</given-names></name><name><surname>Bozic</surname><given-names>DD</given-names></name><name><surname>Draganic</surname><given-names>V</given-names></name><etal/></person-group><article-title>Licheniocin 50.2 and Bacteriocins from <italic>Lactococcus lactis</italic> subsp. lactis biovar. diacetylactis BGBU1&#x02013;4 inhibit biofilms of coagulase negative Staphylococci and <italic>Listeria monocytogenes</italic> clinical isolates</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0167995</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0167995</pub-id><?supplied-pmid 27930711?><pub-id pub-id-type="pmid">27930711</pub-id>
</element-citation></ref><ref id="CR120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claesen</surname><given-names>J</given-names></name><name><surname>Bibb</surname><given-names>M</given-names></name></person-group><article-title>Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>16297</fpage><lpage>16302</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008608107</pub-id><?supplied-pmid 20805503?><pub-id pub-id-type="pmid">20805503</pub-id>
</element-citation></ref><ref id="CR121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coburn</surname><given-names>PS</given-names></name><name><surname>Gilmore</surname><given-names>MS</given-names></name></person-group><article-title>The <italic>Enterococcus faecalis</italic> cytolysin: a novel toxin active against eukaryotic and prokaryotic cells</article-title><source>Cell Microbiol</source><year>2003</year><volume>5</volume><fpage>661</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1046/j.1462-5822.2003.00310.x</pub-id><?supplied-pmid 12969372?><pub-id pub-id-type="pmid">12969372</pub-id>
</element-citation></ref><ref id="CR122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colagiorgi</surname><given-names>A</given-names></name><name><surname>Bruini</surname><given-names>I</given-names></name><name><surname>Di Ciccio</surname><given-names>PA</given-names></name><etal/></person-group><article-title><italic>Listeria monocytogenes</italic> biofilms in the Wonderland of Food Industry</article-title><source>Pathogens</source><year>2017</year><pub-id pub-id-type="doi">10.3390/pathogens6030041</pub-id><?supplied-pmid 28869552?><pub-id pub-id-type="pmid">28869552</pub-id>
</element-citation></ref><ref id="CR123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>B</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>The ABC transporter AnrAB contributes to the innate resistance of <italic>Listeria monocytogenes</italic> to nisin, bacitracin, and various beta-lactam antibiotics</article-title><source>Antimicrob Agents Chemother</source><year>2010</year><volume>54</volume><fpage>4416</fpage><lpage>4423</lpage><pub-id pub-id-type="doi">10.1128/AAC.00503-10</pub-id><?supplied-pmid 20643901?><pub-id pub-id-type="pmid">20643901</pub-id>
</element-citation></ref><ref id="CR124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>B</given-names></name><name><surname>Guinane</surname><given-names>CM</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Assessing the contributions of the LiaS histidine kinase to the innate resistance of <italic>Listeria monocytogenes</italic> to nisin, cephalosporins, and disinfectants</article-title><source>Appl Environ Microbiol</source><year>2012</year><volume>78</volume><fpage>2923</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1128/AEM.07402-11</pub-id><?supplied-pmid 22327581?><pub-id pub-id-type="pmid">22327581</pub-id>
</element-citation></ref><ref id="CR125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contente</surname><given-names>D</given-names></name><name><surname>D&#x000ed;az-Rosales</surname><given-names>P</given-names></name><name><surname>Feito</surname><given-names>J</given-names></name><etal/></person-group><article-title>Immunomodulatory effects of bacteriocinogenic and non-bacteriocinogenic <italic>Lactococcus cremoris</italic> of aquatic origin on rainbow trout (<italic>Oncorhynchus mykiss</italic>, Walbaum)</article-title><source>Front Immunol</source><year>2023</year><volume>14</volume><fpage>1178462</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2023.1178462</pub-id><?supplied-pmid 37153602?><pub-id pub-id-type="pmid">37153602</pub-id>
</element-citation></ref><ref id="CR126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbin</surname><given-names>A</given-names></name><name><surname>Pitts</surname><given-names>B</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name></person-group><article-title>Antimicrobial penetration and efficacy in an in vitro oral biofilm model</article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><fpage>3338</fpage><lpage>3344</lpage><pub-id pub-id-type="doi">10.1128/AAC.00206-11</pub-id><?supplied-pmid 21537022?><pub-id pub-id-type="pmid">21537022</pub-id>
</element-citation></ref><ref id="CR127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Riedel</surname><given-names>CU</given-names></name><etal/></person-group><article-title>Bacteriocin production as a mechanism for the antiinfective activity of <italic>Lactobacillus salivarius</italic> UCC118</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>7617</fpage><lpage>7621</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700440104</pub-id><?supplied-pmid 17456596?><pub-id pub-id-type="pmid">17456596</pub-id>
</element-citation></ref><ref id="CR128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortesi</surname><given-names>ML</given-names></name><name><surname>Panebianco</surname><given-names>A</given-names></name><name><surname>Giuffrida</surname><given-names>A</given-names></name><name><surname>Anastasio</surname><given-names>A</given-names></name></person-group><article-title>Innovations in seafood preservation and storage</article-title><source>Vet Res Commun</source><year>2009</year><volume>33</volume><issue>Suppl 1</issue><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s11259-009-9241-4</pub-id><?supplied-pmid 19585263?><pub-id pub-id-type="pmid">19585263</pub-id>
</element-citation></ref><ref id="CR129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>RL</given-names></name><name><surname>Moreira</surname><given-names>J</given-names></name><name><surname>Lorenzo</surname><given-names>A</given-names></name><name><surname>Lamas</surname><given-names>CC</given-names></name></person-group><article-title>Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series</article-title><source>BMC Complement Altern Med</source><year>2018</year><volume>18</volume><fpage>329</fpage><pub-id pub-id-type="doi">10.1186/s12906-018-2394-3</pub-id><?supplied-pmid 30541524?><pub-id pub-id-type="pmid">30541524</pub-id>
</element-citation></ref><ref id="CR130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name></person-group><article-title>Bacteriocins: developing innate immunity for food</article-title><source>Nat Rev Microbiol</source><year>2005</year><volume>3</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1273</pub-id><?supplied-pmid 16205711?><pub-id pub-id-type="pmid">16205711</pub-id>
</element-citation></ref><ref id="CR131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>Bacteriocins&#x02014;a viable alternative to antibiotics?</article-title><source>Nat Rev Microbiol</source><year>2013</year><volume>11</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2937</pub-id><?supplied-pmid 23268227?><pub-id pub-id-type="pmid">23268227</pub-id>
</element-citation></ref><ref id="CR132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>CR</given-names></name><name><surname>Coburn</surname><given-names>PS</given-names></name><name><surname>Gilmore</surname><given-names>MS</given-names></name></person-group><article-title>Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells</article-title><source>Curr Protein Pept Sci</source><year>2005</year><volume>6</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.2174/1389203053027557</pub-id><?supplied-pmid 15638770?><pub-id pub-id-type="pmid">15638770</pub-id>
</element-citation></ref><ref id="CR133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruchet</surname><given-names>S</given-names></name><name><surname>Obregon</surname><given-names>MC</given-names></name><name><surname>Salazar</surname><given-names>G</given-names></name><etal/></person-group><article-title>Effect of the ingestion of a dietary product containing <italic>Lactobacillus johnsonii</italic> La1 on <italic>Helicobacter pylori</italic> colonization in children</article-title><source>Nutrition</source><year>2003</year><volume>19</volume><fpage>716</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/S0899-9007(03)00109-6</pub-id><?supplied-pmid 12921879?><pub-id pub-id-type="pmid">12921879</pub-id>
</element-citation></ref><ref id="CR134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cursino</surname><given-names>L</given-names></name><name><surname>Smajs</surname><given-names>D</given-names></name><name><surname>Smarda</surname><given-names>J</given-names></name><etal/></person-group><article-title>Exoproducts of the <italic>Escherichia coli</italic> strain H22 inhibiting some enteric pathogens both in vitro and in vivo</article-title><source>J Appl Microbiol</source><year>2006</year><volume>100</volume><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2006.02834.x</pub-id><?supplied-pmid 16553738?><pub-id pub-id-type="pmid">16553738</pub-id>
</element-citation></ref><ref id="CR135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>SA</given-names></name><name><surname>Lonergan</surname><given-names>SM</given-names></name><name><surname>Cornick</surname><given-names>N</given-names></name><etal/></person-group><article-title>Dietary inclusion of colicin e1 is effective in preventing postweaning diarrhea caused by F18-positive <italic>Escherichia coli</italic> in pigs</article-title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>3830</fpage><lpage>3835</lpage><pub-id pub-id-type="doi">10.1128/AAC.00360-07</pub-id><?supplied-pmid 17724148?><pub-id pub-id-type="pmid">17724148</pub-id>
</element-citation></ref><ref id="CR136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cz&#x000e1;r&#x000e1;n</surname><given-names>TL</given-names></name><name><surname>Hoekstra</surname><given-names>RF</given-names></name><name><surname>Pagie</surname><given-names>L</given-names></name></person-group><article-title>Chemical warfare between microbes promotes biodiversity</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1073/pnas.012399899</pub-id><?supplied-pmid 11792831?><pub-id pub-id-type="pmid">11792831</pub-id>
</element-citation></ref><ref id="CR137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daba</surname><given-names>GM</given-names></name><name><surname>Elkhateeb</surname><given-names>WA</given-names></name></person-group><article-title>Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: current applications and future prospects</article-title><source>Biocatal Agric Biotechnol</source><year>2020</year><volume>28</volume><fpage>101750</fpage><pub-id pub-id-type="doi">10.1016/j.bcab.2020.101750</pub-id></element-citation></ref><ref id="CR138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabour</surname><given-names>N</given-names></name><name><surname>Zihler</surname><given-names>A</given-names></name><name><surname>Kheadr</surname><given-names>E</given-names></name><etal/></person-group><article-title>In vivo study on the effectiveness of pediocin PA-1 and <italic>Pediococcus acidilactici</italic> UL5 at inhibiting <italic>Listeria monocytogenes</italic></article-title><source>Int J Food Microbiol</source><year>2009</year><volume>133</volume><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.05.005</pub-id><?supplied-pmid 19541383?><pub-id pub-id-type="pmid">19541383</pub-id>
</element-citation></ref><ref id="CR139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahiya</surname><given-names>DK</given-names></name><name><surname>Renuka</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>563</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00563</pub-id><?supplied-pmid 28421057?><pub-id pub-id-type="pmid">28421057</pub-id>
</element-citation></ref><ref id="CR140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal Bello</surname><given-names>B</given-names></name><name><surname>Cocolin</surname><given-names>L</given-names></name><name><surname>Zeppa</surname><given-names>G</given-names></name><etal/></person-group><article-title>Technological characterization of bacteriocin producing <italic>Lactococcus lactis</italic> strains employed to control <italic>Listeria monocytogenes</italic> in cottage cheese</article-title><source>Int J Food Microbiol</source><year>2012</year><volume>153</volume><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2011.10.016</pub-id><pub-id pub-id-type="pmid">22104121</pub-id>
</element-citation></ref><ref id="CR141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darbandi</surname><given-names>A</given-names></name><name><surname>Asadi</surname><given-names>A</given-names></name><name><surname>Mahdizade Ari</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bacteriocins: properties and potential use as antimicrobials</article-title><source>J Clin Lab Anal</source><year>2022</year><volume>36</volume><fpage>e24093</fpage><pub-id pub-id-type="doi">10.1002/jcla.24093</pub-id><?supplied-pmid 34851542?><pub-id pub-id-type="pmid">34851542</pub-id>
</element-citation></ref><ref id="CR142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Goyal</surname><given-names>A</given-names></name></person-group><article-title>Characterization of a noncytotoxic bacteriocin from probiotic <italic>Lactobacillus plantarum</italic> DM5 with potential as a food preservative</article-title><source>Food Funct</source><year>2014</year><volume>5</volume><fpage>2453</fpage><lpage>2462</lpage><pub-id pub-id-type="doi">10.1039/c4fo00481g</pub-id><?supplied-pmid 25103206?><pub-id pub-id-type="pmid">25103206</pub-id>
</element-citation></ref><ref id="CR143"><mixed-citation publication-type="other">David OM, Onifade OE (2018) Effects of partially purified enterocins from <italic>Enterococcus faecalis</italic> strains on the growth of some phytopathogenic fungi. Ruhuna J Sci 9(2):160&#x02013;168. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.rjs.ruh.ac.lk/index.php/rjs/article/view/236">https://www.rjs.ruh.ac.lk/index.php/rjs/article/view/236</ext-link></mixed-citation></ref><ref id="CR144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carvalho</surname><given-names>AAT</given-names></name><name><surname>Mantovani</surname><given-names>HC</given-names></name><name><surname>Vanetti</surname><given-names>MCD</given-names></name></person-group><article-title>Bactericidal effect of bovicin HC5 and nisin against <italic>Clostridium tyrobutyricum</italic> isolated from spoiled mango pulp</article-title><source>Lett Appl Microbiol</source><year>2007</year><volume>45</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2007.02150.x</pub-id><?supplied-pmid 17594463?><pub-id pub-id-type="pmid">17594463</pub-id>
</element-citation></ref><ref id="CR145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Kwaadsteniet</surname><given-names>M</given-names></name><name><surname>van Reenen</surname><given-names>CA</given-names></name><name><surname>Dicks</surname><given-names>LMT</given-names></name></person-group><article-title>Evaluation of nisin F in the treatment of subcutaneous skin infections, as monitored by using a bioluminescent strain of <italic>Staphylococcus aureus</italic></article-title><source>Probiotics Antimicrob Proteins</source><year>2010</year><volume>2</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s12602-009-9017-8de</pub-id><?supplied-pmid 26781114?><pub-id pub-id-type="pmid">26781114</pub-id>
</element-citation></ref><ref id="CR146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vuyst</surname><given-names>L</given-names></name><name><surname>Leroy</surname><given-names>F</given-names></name></person-group><article-title>Bacteriocins from lactic acid bacteria: production, purification, and food applications</article-title><source>J Mol Microbiol Biotechnol</source><year>2007</year><volume>13</volume><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1159/000104752</pub-id><?supplied-pmid 17827969?><pub-id pub-id-type="pmid">17827969</pub-id>
</element-citation></ref><ref id="CR147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Giani</surname><given-names>A</given-names></name><name><surname>Bovio</surname><given-names>F</given-names></name><name><surname>Forcella</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of a bacteriocin-like compound from <italic>Lactobacillus plantarum</italic> with antimicrobial activity and effects on normal and cancerogenic human intestinal cells</article-title><source>AMB Express</source><year>2019</year><volume>9</volume><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/s13568-019-0813-6</pub-id><?supplied-pmid 31209580?><pub-id pub-id-type="pmid">31209580</pub-id>
</element-citation></ref><ref id="CR148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Kwaadsteniet</surname><given-names>M</given-names></name><name><surname>Doeschate</surname><given-names>KT</given-names></name><name><surname>Dicks</surname><given-names>LMT</given-names></name></person-group><article-title>Nisin F in the treatment of respiratory tract infections caused by <italic>Staphylococcus aureus</italic></article-title><source>Lett Appl Microbiol</source><year>2009</year><volume>48</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2008.02488.x</pub-id><?supplied-pmid 19018962?><pub-id pub-id-type="pmid">19018962</pub-id>
</element-citation></ref><ref id="CR149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deegan</surname><given-names>LH</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>P</given-names></name></person-group><article-title>Bacteriocins: biological tools for bio-preservation and shelf-life extension</article-title><source>Int Dairy J</source><year>2006</year><volume>16</volume><fpage>1058</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2005.10.026</pub-id></element-citation></ref><ref id="CR150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Viel</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name></person-group><article-title>Synthesis and characterization of heterodimers and fluorescent nisin species by incorporation of methionine analogues and subsequent click chemistry</article-title><source>ACS Synth Biol</source><year>2020</year><volume>9</volume><fpage>2525</fpage><lpage>2536</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.0c00308</pub-id><?supplied-pmid 32786360?><pub-id pub-id-type="pmid">32786360</pub-id>
</element-citation></ref><ref id="CR151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desiderato</surname><given-names>CK</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>C</given-names></name><name><surname>Schretzmeier</surname><given-names>A</given-names></name><etal/></person-group><article-title>Optimized recombinant production of the bacteriocin garvicin Q by <italic>Corynebacterium glutamicum</italic></article-title><source>Front Microbiol</source><year>2023</year><volume>14</volume><fpage>1254882</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2023.1254882</pub-id><?supplied-pmid 38260893?><pub-id pub-id-type="pmid">38260893</pub-id>
</element-citation></ref><ref id="CR152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deslouches</surname><given-names>B</given-names></name><name><surname>Montelaro</surname><given-names>RC</given-names></name><name><surname>Urish</surname><given-names>KL</given-names></name><name><surname>Di</surname><given-names>YP</given-names></name></person-group><article-title>Engineered cationic antimicrobial peptides (eCAPs) to combat multidrug-resistant bacteria</article-title><source>Pharmaceutics</source><year>2020</year><pub-id pub-id-type="doi">10.3390/pharmaceutics12060501</pub-id><?supplied-pmid 32486228?><pub-id pub-id-type="pmid">32486228</pub-id>
</element-citation></ref><ref id="CR153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>D</given-names></name><name><surname>Ema</surname><given-names>TI</given-names></name><name><surname>Biswas</surname><given-names>P</given-names></name><etal/></person-group><article-title>Antiviral effects of bacteriocin against animal-to-human transmittable mutated SARS-COV-2: a systematic review</article-title><source>Front Agric Sci Eng</source><year>2021</year><volume>8</volume><fpage>603</fpage><pub-id pub-id-type="doi">10.15302/J-FASE-2021397</pub-id></element-citation></ref><ref id="CR154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Limitone</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cell-cell communication in sourdough lactic acid bacteria: a proteomic study in <italic>Lactobacillus sanfranciscensis</italic> CB1</article-title><source>Proteomics</source><year>2007</year><volume>7</volume><fpage>2430</fpage><lpage>2446</lpage><pub-id pub-id-type="doi">10.1002/pmic.200700143</pub-id><?supplied-pmid 17623302?><pub-id pub-id-type="pmid">17623302</pub-id>
</element-citation></ref><ref id="CR155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dierksen</surname><given-names>KP</given-names></name><name><surname>Moore</surname><given-names>CJ</given-names></name><name><surname>Inglis</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effect of ingestion of milk supplemented with salivaricin A-producing <italic>Streptococcus salivarius</italic> on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue</article-title><source>FEMS Microbiol Ecol</source><year>2007</year><volume>59</volume><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2006.00228.x</pub-id><?supplied-pmid 17069620?><pub-id pub-id-type="pmid">17069620</pub-id>
</element-citation></ref><ref id="CR156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;ez</surname><given-names>L</given-names></name><name><surname>Rojo-Bezares</surname><given-names>B</given-names></name><name><surname>Zarazaga</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antimicrobial activity of pediocin PA-1 against <italic>Oenococcus oeni</italic> and other wine bacteria</article-title><source>Food Microbiol</source><year>2012</year><volume>31</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2012.03.006</pub-id><?supplied-pmid 22608220?><pub-id pub-id-type="pmid">22608220</pub-id>
</element-citation></ref><ref id="CR157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrzy&#x00144;ska</surname><given-names>I</given-names></name><name><surname>Szachowicz-Petelska</surname><given-names>B</given-names></name><name><surname>Sulkowski</surname><given-names>S</given-names></name><name><surname>Figaszewski</surname><given-names>Z</given-names></name></person-group><article-title>Changes in electric charge and phospholipids composition in human colorectal cancer cells</article-title><source>Mol Cell Biochem</source><year>2005</year><volume>276</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1007/s11010-005-3557-3</pub-id><?supplied-pmid 16132692?><pub-id pub-id-type="pmid">16132692</pub-id>
</element-citation></ref><ref id="CR158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>A</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>Bacteriocin production: a probiotic trait?</article-title><source>Appl Environ Microbiol</source><year>2012</year><volume>78</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1128/AEM.05576-11</pub-id><?supplied-pmid 22038602?><pub-id pub-id-type="pmid">22038602</pub-id>
</element-citation></ref><ref id="CR159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donia</surname><given-names>MS</given-names></name><name><surname>Cimermancic</surname><given-names>P</given-names></name><name><surname>Schulze</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics</article-title><source>Cell</source><year>2014</year><volume>158</volume><fpage>1402</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.032</pub-id><?supplied-pmid 25215495?><pub-id pub-id-type="pmid">25215495</pub-id>
</element-citation></ref><ref id="CR160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doron</surname><given-names>S</given-names></name><name><surname>Snydman</surname><given-names>DR</given-names></name></person-group><article-title>Risk and safety of probiotics</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><issue>Suppl 2</issue><fpage>S129</fpage><lpage>S134</lpage><pub-id pub-id-type="doi">10.1093/cid/civ085</pub-id><?supplied-pmid 25922398?><pub-id pub-id-type="pmid">25922398</pub-id>
</element-citation></ref><ref id="CR161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doshi</surname><given-names>MN</given-names></name><name><surname>Nair</surname><given-names>K</given-names></name><name><surname>Hassan</surname><given-names>ZU</given-names></name><name><surname>Jaoua</surname><given-names>S</given-names></name></person-group><article-title>Pyocin QDD1: a highly thermostable bacteriocin produced by <italic>Pseudomonas aeruginosa</italic> QDD1 for the biocontrol of foodborne pathogens <italic>Staphylococcus aureus</italic> and <italic>Bacillus cereus</italic></article-title><source>Bioresour Technol Rep</source><year>2022</year><volume>18</volume><fpage>101106</fpage><pub-id pub-id-type="doi">10.1016/j.biteb.2022.101106</pub-id></element-citation></ref><ref id="CR162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dover</surname><given-names>SE</given-names></name><name><surname>Aroutcheva</surname><given-names>AA</given-names></name><name><surname>Faro</surname><given-names>S</given-names></name><name><surname>Chikindas</surname><given-names>ML</given-names></name></person-group><article-title>Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal <italic>Lactobacillus rhamnosus</italic></article-title><source>Infect Dis Obstet Gynecol</source><year>2007</year><volume>2007</volume><fpage>78248</fpage><pub-id pub-id-type="doi">10.1155/2007/78248</pub-id><?supplied-pmid 18273406?><pub-id pub-id-type="pmid">18273406</pub-id>
</element-citation></ref><ref id="CR163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drissi</surname><given-names>F</given-names></name><name><surname>Buffet</surname><given-names>S</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name><name><surname>Merhej</surname><given-names>V</given-names></name></person-group><article-title>Common occurrence of antibacterial agents in human intestinal microbiota</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>441</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00441</pub-id><?supplied-pmid 25999943?><pub-id pub-id-type="pmid">25999943</pub-id>
</element-citation></ref><ref id="CR164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du Toit</surname><given-names>M</given-names></name><name><surname>Franz</surname><given-names>CM</given-names></name><name><surname>Dicks</surname><given-names>LM</given-names></name><name><surname>Holzapfel</surname><given-names>WH</given-names></name></person-group><article-title>Preliminary characterization of bacteriocins produced by <italic>Enterococcus faecium</italic> and <italic>Enterococcus faecalis</italic> isolated from pig faeces</article-title><source>J Appl Microbiol</source><year>2000</year><volume>88</volume><fpage>482</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2000.00986.x</pub-id><?supplied-pmid 10747229?><pub-id pub-id-type="pmid">10747229</pub-id>
</element-citation></ref><ref id="CR165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>AFDS</given-names></name><name><surname>Ceotto-Vigoder</surname><given-names>H</given-names></name><name><surname>Barrias</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Hyicin 4244, the first sactibiotic described in staphylococci, exhibits an anti-staphylococcal biofilm activity</article-title><source>Int J Antimicrob Agents</source><year>2018</year><volume>51</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.06.025</pub-id><?supplied-pmid 28705677?><pub-id pub-id-type="pmid">28705677</pub-id>
</element-citation></ref><ref id="CR166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000fc;ndar</surname><given-names>H</given-names></name></person-group><article-title>Bacteriocinogenic potential of <italic>Enterococcus faecium</italic> isolated from wine</article-title><source>Probiotics Antimicrob Proteins</source><year>2016</year><volume>8</volume><fpage>150</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1007/s12602-016-9222-1</pub-id><?supplied-pmid 27406790?><pub-id pub-id-type="pmid">27406790</pub-id>
</element-citation></ref><ref id="CR167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsayed</surname><given-names>SS</given-names></name><name><surname>Trusch</surname><given-names>F</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Chaxapeptin, a lasso peptide from extremotolerant <italic>Streptomyces leeuwenhoekii</italic> strain C58 from the hyperarid atacama desert</article-title><source>J Org Chem</source><year>2015</year><volume>80</volume><fpage>10252</fpage><lpage>10260</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.5b01878</pub-id><?supplied-pmid 26402731?><pub-id pub-id-type="pmid">26402731</pub-id>
</element-citation></ref><ref id="CR168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ermolenko</surname><given-names>EI</given-names></name><name><surname>Desheva</surname><given-names>YA</given-names></name><name><surname>Kolobov</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Anti-influenza activity of enterocin B in vitro and protective effect of bacteriocinogenic enterococcal probiotic strain on influenza infection in mouse model</article-title><source>Probiotics Antimicrob Proteins</source><year>2019</year><volume>11</volume><fpage>705</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1007/s12602-018-9457-0</pub-id><?supplied-pmid 30143997?><pub-id pub-id-type="pmid">30143997</pub-id>
</element-citation></ref><ref id="CR169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar</surname><given-names>V</given-names></name><name><surname>Scaramozzino</surname><given-names>N</given-names></name><name><surname>Vidic</surname><given-names>J</given-names></name><etal/></person-group><article-title>Recent advances on peptide-based biosensors and electronic noses for foodborne pathogen detection</article-title><source>Biosensors (Basel)</source><year>2023</year><pub-id pub-id-type="doi">10.3390/bios13020258</pub-id><?supplied-pmid 37887128?><pub-id pub-id-type="pmid">37887128</pub-id>
</element-citation></ref><ref id="CR170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etayash</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Thundat</surname><given-names>T</given-names></name><name><surname>Kaur</surname><given-names>K</given-names></name></person-group><article-title>Impedimetric detection of pathogenic Gram-positive bacteria using an antimicrobial peptide from Class IIa bacteriocins</article-title><source>Anal Chem</source><year>2014</year><volume>86</volume><fpage>1693</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1021/ac4034938</pub-id><?supplied-pmid 24400685?><pub-id pub-id-type="pmid">24400685</pub-id>
</element-citation></ref><ref id="CR171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etayash</surname><given-names>H</given-names></name><name><surname>Norman</surname><given-names>L</given-names></name><name><surname>Thundat</surname><given-names>T</given-names></name><etal/></person-group><article-title>Surface-conjugated antimicrobial peptide leucocin a displays high binding to pathogenic Gram-positive bacteria</article-title><source>ACS Appl Mater Interfaces</source><year>2014</year><volume>6</volume><fpage>1131</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1021/am404729c</pub-id><?supplied-pmid 24359454?><pub-id pub-id-type="pmid">24359454</pub-id>
</element-citation></ref><ref id="CR172"><mixed-citation publication-type="other">European Commission (2005) Ban on antibiotics as growth promoters in animal feed. Available at: <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/commission/presscorner/detail/en/IP_05_1687">https://ec.europa.eu/commission/presscorner/detail/en/IP_05_1687</ext-link>. Accessed 31 Aug 2023</mixed-citation></ref><ref id="CR173"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>European Food Safety Authority (EFSA)</collab></person-group><article-title>Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to the use of nisin (E 234) as a food additive</article-title><source>EFSA J</source><year>2006</year><volume>4</volume><fpage>314</fpage><pub-id pub-id-type="doi">10.2903/j.efsa.2006.314</pub-id></element-citation></ref><ref id="CR174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Betsi</surname><given-names>GI</given-names></name><name><surname>Athanasiou</surname><given-names>S</given-names></name></person-group><article-title>Probiotics for the treatment of women with bacterial vaginosis</article-title><source>Clin Microbiol Infect</source><year>2007</year><volume>13</volume><fpage>657</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01688.x</pub-id><?supplied-pmid 17633390?><pub-id pub-id-type="pmid">17633390</pub-id>
</element-citation></ref><ref id="CR175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farha</surname><given-names>MA</given-names></name><name><surname>Verschoor</surname><given-names>CP</given-names></name><name><surname>Bowdish</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>ED</given-names></name></person-group><article-title>Collapsing the proton motive force to identify synergistic combinations against <italic>Staphylococcus aureus</italic></article-title><source>Chem Biol</source><year>2013</year><volume>20</volume><fpage>1168</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.07.006</pub-id><?supplied-pmid 23972939?><pub-id pub-id-type="pmid">23972939</pub-id>
</element-citation></ref><ref id="CR176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feito</surname><given-names>J</given-names></name><name><surname>Contente</surname><given-names>D</given-names></name><name><surname>Ponce-Alonso</surname><given-names>M</given-names></name><etal/></person-group><article-title>Draft genome sequence of <italic>Lactococcus lactis</italic> subsp. cremoris WA2-67: a promising nisin-producing probiotic strain isolated from the rearing environment of a Spanish Rainbow Trout (<italic>Oncorhynchus mykiss</italic>, Walbaum) farm</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><fpage>521</fpage><pub-id pub-id-type="doi">10.3390/microorganisms10030521</pub-id><?supplied-pmid 35336097?><pub-id pub-id-type="pmid">35336097</pub-id>
</element-citation></ref><ref id="CR177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feito</surname><given-names>J</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>C</given-names></name><name><surname>Arbulu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Design of <italic>Lactococcus lactis</italic> strains producing garvicin A and/or garvicin Q, either alone or together with nisin A or nisin Z and high antimicrobial activity against <italic>Lactococcus garvieae</italic></article-title><source>Foods</source><year>2023</year><volume>12</volume><fpage>1063</fpage><pub-id pub-id-type="doi">10.3390/foods12051063</pub-id><?supplied-pmid 36900581?><pub-id pub-id-type="pmid">36900581</pub-id>
</element-citation></ref><ref id="CR178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felicio</surname><given-names>BA</given-names></name><name><surname>Pinto</surname><given-names>MS</given-names></name><name><surname>Oliveira</surname><given-names>FS</given-names></name><etal/></person-group><article-title>Effects of nisin on <italic>Staphylococcus aureus</italic> count and physicochemical properties of Minas Frescal cheese</article-title><source>J Dairy Sci</source><year>2015</year><volume>98</volume><fpage>4364</fpage><lpage>4369</lpage><pub-id pub-id-type="doi">10.3168/jds.2015-9520</pub-id><?supplied-pmid 25981063?><pub-id pub-id-type="pmid">25981063</pub-id>
</element-citation></ref><ref id="CR179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000e9;rir</surname><given-names>G</given-names></name><name><surname>Petrova</surname><given-names>MI</given-names></name><name><surname>Andrei</surname><given-names>G</given-names></name><etal/></person-group><article-title>The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e64010</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0064010</pub-id><?supplied-pmid 23724015?><pub-id pub-id-type="pmid">23724015</pub-id>
</element-citation></ref><ref id="CR180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000e9;rir</surname><given-names>G</given-names></name><name><surname>Petrova</surname><given-names>MI</given-names></name><name><surname>Andrei</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dual anti-HSV and anti-HIV activity of the lantibiotic Labyrinthopeptin A1</article-title><source>BMC Infect Dis</source><year>2014</year><pub-id pub-id-type="doi">10.1186/1471-2334-14-S2-P79</pub-id></element-citation></ref><ref id="CR181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>L</given-names></name><name><surname>Delgado</surname><given-names>S</given-names></name><name><surname>Herrero</surname><given-names>H</given-names></name><etal/></person-group><article-title>The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation</article-title><source>J Hum Lact</source><year>2008</year><volume>24</volume><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1177/0890334408317435</pub-id><?supplied-pmid 18689718?><pub-id pub-id-type="pmid">18689718</pub-id>
</element-citation></ref><ref id="CR182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>B</given-names></name><name><surname>Le Lay</surname><given-names>C</given-names></name><name><surname>Jean</surname><given-names>J</given-names></name><name><surname>Fliss</surname><given-names>I</given-names></name></person-group><article-title>Growth, acid production and bacteriocin production by probiotic candidates under simulated colonic conditions</article-title><source>J Appl Microbiol</source><year>2013</year><volume>114</volume><fpage>877</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1111/jam.12081</pub-id><?supplied-pmid 23167818?><pub-id pub-id-type="pmid">23167818</pub-id>
</element-citation></ref><ref id="CR183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Eguiz&#x000e1;bal</surname><given-names>P</given-names></name><etal/></person-group><article-title>Bacteriocin-like inhibitory substances in Staphylococci of different origins and species with activity against relevant pathogens</article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><fpage>870510</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.870510</pub-id><?supplied-pmid 35558130?><pub-id pub-id-type="pmid">35558130</pub-id>
</element-citation></ref><ref id="CR184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Ruiz-Ripa</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antimicrobial resistance and antimicrobial activity of <italic>Staphylococcus lugdunensis</italic> obtained from two Spanish hospitals</article-title><source>Microorganisms</source><year>2022</year><pub-id pub-id-type="doi">10.3390/microorganisms10081480</pub-id><?supplied-pmid 35893538?><pub-id pub-id-type="pmid">35893538</pub-id>
</element-citation></ref><ref id="CR185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Abdullahi</surname><given-names>IN</given-names></name><name><surname>Gonz&#x000e1;lez-Azcona</surname><given-names>C</given-names></name><etal/></person-group><article-title>Detection of antimicrobial producing <italic>Staphylococcus</italic> from migratory birds: potential role in nasotracheal microbiota modulation</article-title><source>Front Microbiol</source><year>2023</year><volume>14</volume><fpage>1144975</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2023.1144975</pub-id><?supplied-pmid 37113241?><pub-id pub-id-type="pmid">37113241</pub-id>
</element-citation></ref><ref id="CR186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Elsherbini</surname><given-names>AMA</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genomic analysis of bacteriocin-producing Staphylococci: high prevalence of lanthipeptides and the Micrococcin P1 biosynthetic gene clusters</article-title><source>Probiotics Antimicrob Proteins</source><year>2023</year><pub-id pub-id-type="doi">10.1007/s12602-023-10119-w</pub-id><?supplied-pmid 37632676?><pub-id pub-id-type="pmid">37632676</pub-id>
</element-citation></ref><ref id="CR187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Fern&#x000e1;ndez-P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>Zarazaga</surname><given-names>M</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Krismer</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name></person-group><article-title>Detection and evaluation of the antimicrobial activity of Micrococcin P1 isolated from commensal and environmental staphylococcal isolates against MRSA</article-title><source>Intl J Antimicrob Agents</source><year>2023</year><volume>65</volume><fpage>106965</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2023.106965</pub-id></element-citation></ref><ref id="CR188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Reuben</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Comprehensive approaches for the search and characterization of staphylococcins</article-title><source>Microorganisms</source><year>2023</year><pub-id pub-id-type="doi">10.3390/microorganisms11051329</pub-id><?supplied-pmid 37317303?><pub-id pub-id-type="pmid">37317303</pub-id>
</element-citation></ref><ref id="CR189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>Y</given-names></name><name><surname>Rojo-Bezares</surname><given-names>B</given-names></name><etal/></person-group><article-title>Production and antimicrobial activity of nisin under enological conditions</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1918</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01918</pub-id><?supplied-pmid 30233504?><pub-id pub-id-type="pmid">30233504</pub-id>
</element-citation></ref><ref id="CR190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraz</surname><given-names>MP</given-names></name></person-group><article-title>An overview of the relevance of human gut and skin microbiome in disease: the influence on atopic dermatitis</article-title><source>Appl Sci</source><year>2023</year><volume>13</volume><fpage>10540</fpage><pub-id pub-id-type="doi">10.3390/app131810540</pub-id></element-citation></ref><ref id="CR191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name></person-group><article-title>Bioengineering lantibiotics for therapeutic success</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>1363</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.01363</pub-id><?supplied-pmid 26640466?><pub-id pub-id-type="pmid">26640466</pub-id>
</element-citation></ref><ref id="CR192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Blake</surname><given-names>T</given-names></name><name><surname>Mathur</surname><given-names>H</given-names></name><etal/></person-group><article-title>Bioengineering nisin to overcome the nisin resistance protein</article-title><source>Mol Microbiol</source><year>2019</year><volume>111</volume><fpage>717</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1111/mmi.14183</pub-id><?supplied-pmid 30537404?><pub-id pub-id-type="pmid">30537404</pub-id>
</element-citation></ref><ref id="CR193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Considine</surname><given-names>K</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Bio-engineered nisin with increased anti-<italic>Staphylococcus</italic> and selectively reduced anti-<italic>Lactococcus</italic> activity for treatment of bovine mastitis</article-title><source>Int J Mol Sci</source><year>2021</year><pub-id pub-id-type="doi">10.3390/ijms22073480</pub-id><?supplied-pmid 33801752?><pub-id pub-id-type="pmid">33801752</pub-id>
</element-citation></ref><ref id="CR194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Fernandez de Ullivarri</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>After a century of nisin research&#x02014;where are we now?</article-title><source>FEMS Microbiol Rev</source><year>2023</year><pub-id pub-id-type="doi">10.1093/femsre/fuad023</pub-id><?supplied-pmid 37300874?><pub-id pub-id-type="pmid">37300874</pub-id>
</element-citation></ref><ref id="CR195"><element-citation publication-type="data"><name><surname>Fischer</surname><given-names>SW</given-names></name><name><surname>Titgemeyer</surname><given-names>F</given-names></name><year>2023</year><data-title>Protective cultures in food products: from science to market</data-title><source>Foods</source><pub-id pub-id-type="doi">10.3390/foods12071541</pub-id></element-citation></ref><ref id="CR196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flemming</surname><given-names>H-C</given-names></name><name><surname>Wingender</surname><given-names>J</given-names></name><name><surname>Szewzyk</surname><given-names>U</given-names></name><etal/></person-group><article-title>Biofilms: an emergent form of bacterial life</article-title><source>Nat Rev Microbiol</source><year>2016</year><volume>14</volume><fpage>563</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2016.94</pub-id><?supplied-pmid 27510863?><pub-id pub-id-type="pmid">27510863</pub-id>
</element-citation></ref><ref id="CR197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J</given-names></name><name><surname>Mallen</surname><given-names>S</given-names></name><name><surname>Durack</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mesoporous matrices for the delivery of the broad spectrum bacteriocin, nisin A</article-title><source>J Colloid Interface Sci</source><year>2019</year><volume>537</volume><fpage>396</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2018.11.037</pub-id><?supplied-pmid 30465975?><pub-id pub-id-type="pmid">30465975</pub-id>
</element-citation></ref><ref id="CR198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Hudson</surname><given-names>SP</given-names></name></person-group><article-title>Synergistic antimicrobial interactions of nisin A with biopolymers and solubilising agents for oral drug delivery</article-title><source>Eur J Pharm Biopharm</source><year>2022</year><volume>171</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2021.12.010</pub-id><?supplied-pmid 34986413?><pub-id pub-id-type="pmid">34986413</pub-id>
</element-citation></ref><ref id="CR199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francino</surname><given-names>MP</given-names></name></person-group><article-title>Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>1543</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.01543</pub-id><?supplied-pmid 26793178?><pub-id pub-id-type="pmid">26793178</pub-id>
</element-citation></ref><ref id="CR200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Ruan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Preservation of large yellow croaker (<italic>Pseudosciaena crocea</italic>) by Coagulin L1208, a novel bacteriocin produced by <italic>Bacillus coagulans</italic> L1208</article-title><source>Int J Food Microbiol</source><year>2018</year><volume>266</volume><fpage>60</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2017.11.012</pub-id><?supplied-pmid 29179097?><pub-id pub-id-type="pmid">29179097</pub-id>
</element-citation></ref><ref id="CR201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fugaban</surname><given-names>JII</given-names></name><name><surname>Holzapfel</surname><given-names>WH</given-names></name><name><surname>Todorov</surname><given-names>SD</given-names></name></person-group><article-title>Probiotic potential and safety assessment of bacteriocinogenic <italic>Enterococcus faecium</italic> strains with antibacterial activity against <italic>Listeria</italic> and vancomycin-resistant enterococci</article-title><source>Curr Res Microbial Sci</source><year>2021</year><volume>2</volume><fpage>100070</fpage><pub-id pub-id-type="doi">10.1016/j.crmicr.2021.100070</pub-id></element-citation></ref><ref id="CR202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fugaban</surname><given-names>JII</given-names></name><name><surname>Vazquez Bucheli</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><etal/></person-group><article-title>Safety and beneficial properties of bacteriocinogenic <italic>Pediococcus acidilactici</italic> and <italic>Pediococcus pentosaceus</italic> isolated from silage</article-title><source>Lett Appl Microbiol</source><year>2021</year><volume>73</volume><fpage>725</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1111/lam.13562</pub-id><?supplied-pmid 34549812?><pub-id pub-id-type="pmid">34549812</pub-id>
</element-citation></ref><ref id="CR203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuochi</surname><given-names>V</given-names></name><name><surname>Cardile</surname><given-names>V</given-names></name><name><surname>Petronio Petronio</surname><given-names>G</given-names></name><name><surname>Furneri</surname><given-names>PM</given-names></name></person-group><article-title>Biological properties and production of bacteriocins-like-inhibitory substances by <italic>Lactobacillus</italic> sp. strains from human vagina</article-title><source>J Appl Microbiol</source><year>2019</year><volume>126</volume><fpage>1541</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1111/jam.14164</pub-id><?supplied-pmid 30499608?><pub-id pub-id-type="pmid">30499608</pub-id>
</element-citation></ref><ref id="CR204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000e1;lvez</surname><given-names>A</given-names></name><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>RL</given-names></name><name><surname>Ben Omar</surname><given-names>N</given-names></name></person-group><article-title>Bacteriocin-based strategies for food biopreservation</article-title><source>Int J Food Microbiol</source><year>2007</year><volume>120</volume><fpage>51</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.06.001</pub-id><?supplied-pmid 17614151?><pub-id pub-id-type="pmid">17614151</pub-id>
</element-citation></ref><ref id="CR205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gutierrez</surname><given-names>E</given-names></name><name><surname>Mayer</surname><given-names>MJ</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Narbad</surname><given-names>A</given-names></name></person-group><article-title>Gut microbiota as a source of novel antimicrobials</article-title><source>Gut Microbes</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/19490976.2018.1455790</pub-id><?supplied-pmid 29584555?><pub-id pub-id-type="pmid">29584555</pub-id>
</element-citation></ref><ref id="CR206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-L&#x000f3;pez</surname><given-names>JD</given-names></name><name><surname>Teso-P&#x000e9;rez</surname><given-names>C</given-names></name><name><surname>Mart&#x000ed;n-Platero</surname><given-names>AM</given-names></name><etal/></person-group><article-title><italic>Lactiplantibacillus paraplantarum</italic> BPF2 and <italic>Pediococcus acidilactici</italic> ST6, two bacteriocinogenic isolated strains from andalusian spontaneous fermented sausages</article-title><source>Foods</source><year>2023</year><volume>12</volume><fpage>2445</fpage><pub-id pub-id-type="doi">10.3390/foods12132445</pub-id><?supplied-pmid 37444181?><pub-id pub-id-type="pmid">37444181</pub-id>
</element-citation></ref><ref id="CR207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Vela</surname><given-names>S</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><name><surname>Soltani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Targeting enterococci with antimicrobial activity against <italic>Clostridium perfringens</italic> from poultry</article-title><source>Antibiotics (Basel)</source><year>2023</year><pub-id pub-id-type="doi">10.3390/antibiotics12020231</pub-id><?supplied-pmid 36830142?><pub-id pub-id-type="pmid">36830142</pub-id>
</element-citation></ref><ref id="CR208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Vela</surname><given-names>S</given-names></name><name><surname>Guay</surname><given-names>L-D</given-names></name><name><surname>Rahman</surname><given-names>MRT</given-names></name><etal/></person-group><article-title>Antimicrobial activity of synthetic enterocins A, B, P, SEK4, and L50, alone and in combinations, against <italic>Clostridium perfringens</italic></article-title><source>Int J Mol Sci</source><year>2024</year><volume>25</volume><fpage>1597</fpage><pub-id pub-id-type="doi">10.3390/ijms25031597</pub-id><?supplied-pmid 38338877?><pub-id pub-id-type="pmid">38338877</pub-id>
</element-citation></ref><ref id="CR209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garsa</surname><given-names>AK</given-names></name><name><surname>Kumariya</surname><given-names>R</given-names></name><name><surname>Sood</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Bacteriocin production and different strategies for their recovery and purification</article-title><source>Probiotics Antimicrob Proteins</source><year>2014</year><volume>6</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s12602-013-9153-z</pub-id><?supplied-pmid 24676767?><pub-id pub-id-type="pmid">24676767</pub-id>
</element-citation></ref><ref id="CR210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavrish</surname><given-names>E</given-names></name><name><surname>Sit</surname><given-names>CS</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Lassomycin, a ribosomally synthesized cyclic peptide, kills <italic>Mycobacterium tuberculosis</italic> by targeting the ATP-dependent protease ClpC1P1P2</article-title><source>Chem Biol</source><year>2014</year><volume>21</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2014.01.014</pub-id><?supplied-pmid 24684906?><pub-id pub-id-type="pmid">24684906</pub-id>
</element-citation></ref><ref id="CR211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhart</surname><given-names>D</given-names></name><name><surname>Lok</surname><given-names>S</given-names></name><name><surname>Clare</surname><given-names>S</given-names></name><etal/></person-group><article-title>A modified R-type bacteriocin specifically targeting <italic>Clostridium difficile</italic> prevents colonization of mice without affecting gut microbiota diversity</article-title><source>Mbio</source><year>2015</year><volume>6</volume><fpage>e02368</fpage><lpage>e2414</lpage><pub-id pub-id-type="doi">10.1128/mBio.02368-14</pub-id><?supplied-pmid 25805733?><pub-id pub-id-type="pmid">25805733</pub-id>
</element-citation></ref><ref id="CR212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghapanvari</surname><given-names>P</given-names></name><name><surname>Taheri</surname><given-names>M</given-names></name><name><surname>Jalilian</surname><given-names>FA</given-names></name><etal/></person-group><article-title>The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of <italic>Staphylococcus aureus</italic> and <italic>Pseudomonas aeruginosa</italic></article-title><source>Eur J Med Res</source><year>2022</year><volume>27</volume><fpage>173</fpage><pub-id pub-id-type="doi">10.1186/s40001-022-00804-x</pub-id><?supplied-pmid 36076252?><pub-id pub-id-type="pmid">36076252</pub-id>
</element-citation></ref><ref id="CR213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharsallaoui</surname><given-names>A</given-names></name><name><surname>Oulahal</surname><given-names>N</given-names></name><name><surname>Joly</surname><given-names>C</given-names></name><name><surname>Degraeve</surname><given-names>P</given-names></name></person-group><article-title>Nisin as a food preservative: part 1: physicochemical properties, antimicrobial activity, and main uses</article-title><source>Crit Rev Food Sci Nutr</source><year>2016</year><volume>56</volume><fpage>1262</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1080/10408398.2013.763765</pub-id><?supplied-pmid 25675115?><pub-id pub-id-type="pmid">25675115</pub-id>
</element-citation></ref><ref id="CR214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghobrial</surname><given-names>OG</given-names></name><name><surname>Derendorf</surname><given-names>H</given-names></name><name><surname>Hillman</surname><given-names>JD</given-names></name></person-group><article-title>Pharmacodynamic activity of the lantibiotic MU1140</article-title><source>Int J Antimicrob Agents</source><year>2009</year><volume>33</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.07.028</pub-id><?supplied-pmid 18835136?><pub-id pub-id-type="pmid">18835136</pub-id>
</element-citation></ref><ref id="CR215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghodhbane</surname><given-names>H</given-names></name><name><surname>Elaidi</surname><given-names>S</given-names></name><name><surname>Sabatier</surname><given-names>J-M</given-names></name><etal/></person-group><article-title>Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections</article-title><source>IDDT</source><year>2015</year><volume>15</volume><fpage>2</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.2174/1871526514666140522113337</pub-id></element-citation></ref><ref id="CR216"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gillor</surname><given-names>O</given-names></name><name><surname>Kirkup</surname><given-names>BC</given-names></name><name><surname>Riley</surname><given-names>MA</given-names></name></person-group><source>Colicins and microcins: the next generation antimicrobials</source><year>2004</year><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>129</fpage><lpage>146</lpage></element-citation></ref><ref id="CR217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillor</surname><given-names>O</given-names></name><name><surname>Etzion</surname><given-names>A</given-names></name><name><surname>Riley</surname><given-names>MA</given-names></name></person-group><article-title>The dual role of bacteriocins as anti- and probiotics</article-title><source>Appl Microbiol Biotechnol</source><year>2008</year><volume>81</volume><fpage>591</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1007/s00253-008-1726-5</pub-id><?supplied-pmid 18853155?><pub-id pub-id-type="pmid">18853155</pub-id>
</element-citation></ref><ref id="CR218"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatthardt</surname><given-names>T</given-names></name><name><surname>Lima</surname><given-names>RD</given-names></name><name><surname>de Mattos</surname><given-names>RM</given-names></name><name><surname>Ferreira</surname><given-names>RBR</given-names></name></person-group><article-title>Microbe interactions within the skin microbiome</article-title><source>Antibiotics (Basel)</source><year>2024</year><volume>13</volume><fpage>10049</fpage><pub-id pub-id-type="doi">10.3390/antibiotics13010049</pub-id></element-citation></ref><ref id="CR219"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldbeck</surname><given-names>O</given-names></name><name><surname>Desef</surname><given-names>DN</given-names></name><name><surname>Ovchinnikov</surname><given-names>KV</given-names></name><etal/></person-group><article-title>Establishing recombinant production of pediocin PA-1 in <italic>Corynebacterium glutamicum</italic></article-title><source>Metab Eng</source><year>2021</year><pub-id pub-id-type="doi">10.1016/j.ymben.2021.09.002</pub-id><?supplied-pmid 34492380?><pub-id pub-id-type="pmid">34492380</pub-id>
</element-citation></ref><ref id="CR220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>B</given-names></name></person-group><article-title>Activity of nisin against <italic>Streptococcus pneumoniae</italic>, in vitro, and in a mouse infection model</article-title><source>J Antimicrob Chemother</source><year>1998</year><volume>42</volume><fpage>277</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1093/jac/42.2.277</pub-id><?supplied-pmid 9738856?><pub-id pub-id-type="pmid">9738856</pub-id>
</element-citation></ref><ref id="CR221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomaa</surname><given-names>AI</given-names></name><name><surname>Martinent</surname><given-names>C</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><etal/></person-group><article-title>Dual coating of liposomes as encapsulating matrix of antimicrobial peptides: development and characterization</article-title><source>Front Chem</source><year>2017</year><volume>5</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.3389/fchem.2017.00103</pub-id><?supplied-pmid 29204423?><pub-id pub-id-type="pmid">29204423</pub-id>
</element-citation></ref><ref id="CR222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez</surname><given-names>NC</given-names></name><name><surname>Abriouel</surname><given-names>H</given-names></name><name><surname>Grande</surname><given-names>MAJ</given-names></name><etal/></person-group><article-title>Effect of enterocin AS-48 in combination with biocides on planktonic and sessile <italic>Listeria monocytogenes</italic></article-title><source>Food Microbiol</source><year>2012</year><volume>30</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2011.12.013</pub-id><?supplied-pmid 22265283?><pub-id pub-id-type="pmid">22265283</pub-id>
</element-citation></ref><ref id="CR223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez-Sala</surname><given-names>B</given-names></name><name><surname>Mu&#x000f1;oz-Atienza</surname><given-names>E</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bacteriocin production by lactic acid bacteria isolated from fish, seafood and fish products</article-title><source>Eur Food Res Technol</source><year>2015</year><volume>241</volume><fpage>341</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1007/s00217-015-2465-3</pub-id></element-citation></ref><ref id="CR224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>A</given-names></name><name><surname>Mozafarpoor</surname><given-names>S</given-names></name><name><surname>Bodaghabadi</surname><given-names>M</given-names></name><name><surname>Mohamadi</surname><given-names>M</given-names></name></person-group><article-title>The potential of probiotics for treating acne vulgaris: a review of literature on acne and microbiota</article-title><source>Dermatol Ther</source><year>2020</year><volume>33</volume><fpage>e13279</fpage><pub-id pub-id-type="doi">10.1111/dth.13279</pub-id><?supplied-pmid 32266790?><pub-id pub-id-type="pmid">32266790</pub-id>
</element-citation></ref><ref id="CR225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotteland</surname><given-names>M</given-names></name></person-group><article-title>Suppressive effect of frequent ingestion of <italic>Lactobacillus johnsonii</italic> La1 on <italic>Helicobacter pylori</italic> colonization in asymptomatic volunteers</article-title><source>J Antimicrob Chemother</source><year>2003</year><volume>51</volume><fpage>1317</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1093/jac/dkg227</pub-id><?supplied-pmid 12697639?><pub-id pub-id-type="pmid">12697639</pub-id>
</element-citation></ref><ref id="CR226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gough</surname><given-names>R</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Rea</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Simulated gastrointestinal digestion of nisin and interaction between nisin and bile</article-title><source>LWT</source><year>2017</year><volume>86</volume><fpage>530</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2017.08.031</pub-id></element-citation></ref><ref id="CR227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gough</surname><given-names>R</given-names></name><name><surname>Cabrera Rubio</surname><given-names>R</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Oral delivery of nisin in resistant starch based matrices alters the gut microbiota in mice</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1186</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01186</pub-id><?supplied-pmid 29963017?><pub-id pub-id-type="pmid">29963017</pub-id>
</element-citation></ref><ref id="CR228"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gradisteanu Pircalabioru</surname><given-names>G</given-names></name><name><surname>Popa</surname><given-names>LI</given-names></name><name><surname>Marutescu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Bacteriocins in the era of antibiotic resistance: rising to the challenge</article-title><source>Pharmaceutics</source><year>2021</year><pub-id pub-id-type="doi">10.3390/pharmaceutics13020196</pub-id><?supplied-pmid 33540560?><pub-id pub-id-type="pmid">33540560</pub-id>
</element-citation></ref><ref id="CR229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grasemann</surname><given-names>H</given-names></name><name><surname>Stehling</surname><given-names>F</given-names></name><name><surname>Brunar</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhalation of Moli 1901 in patients with cystic fibrosis</article-title><source>Chest</source><year>2007</year><volume>131</volume><fpage>1461</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1378/chest.06-2085</pub-id><?supplied-pmid 17494794?><pub-id pub-id-type="pmid">17494794</pub-id>
</element-citation></ref><ref id="CR230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grein</surname><given-names>F</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Sahl</surname><given-names>H-G</given-names></name></person-group><article-title>Docking on lipid II-A widespread mechanism for potent bactericidal activities of antibiotic peptides</article-title><source>J Mol Biol</source><year>2019</year><volume>431</volume><fpage>3520</fpage><lpage>3530</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.05.014</pub-id><?supplied-pmid 31100388?><pub-id pub-id-type="pmid">31100388</pub-id>
</element-citation></ref><ref id="CR231"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>EA</given-names></name></person-group><article-title>The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease</article-title><source>Semin Cutan Med Surg</source><year>2014</year><volume>33</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.12788/j.sder.0087</pub-id><?supplied-pmid 25085669?><pub-id pub-id-type="pmid">25085669</pub-id>
</element-citation></ref><ref id="CR232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grilli</surname><given-names>E</given-names></name><name><surname>Messina</surname><given-names>MR</given-names></name><name><surname>Catelli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Pediocin A improves growth performance of broilers challenged with <italic>Clostridium perfringens</italic></article-title><source>Poult Sci</source><year>2009</year><volume>88</volume><fpage>2152</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.3382/ps.2009-00160</pub-id><?supplied-pmid 19762869?><pub-id pub-id-type="pmid">19762869</pub-id>
</element-citation></ref><ref id="CR233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinter</surname><given-names>R</given-names></name><name><surname>Milner</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>D</given-names></name></person-group><article-title>Bacteriocins active against plant pathogenic bacteria</article-title><source>Biochem Soc Trans</source><year>2012</year><volume>40</volume><fpage>1498</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1042/BST20120206</pub-id><?supplied-pmid 23176505?><pub-id pub-id-type="pmid">23176505</pub-id>
</element-citation></ref><ref id="CR234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinane</surname><given-names>CM</given-names></name><name><surname>Lawton</surname><given-names>EM</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>The bacteriocin bactofencin A subtly modulates gut microbial populations</article-title><source>Anaerobe</source><year>2016</year><volume>40</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.anaerobe.2016.05.001</pub-id><?supplied-pmid 27154638?><pub-id pub-id-type="pmid">27154638</pub-id>
</element-citation></ref><ref id="CR235"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumienna</surname><given-names>M</given-names></name><name><surname>G&#x000f3;rna</surname><given-names>B</given-names></name></person-group><article-title>Antimicrobial food packaging with biodegradable polymers and bacteriocins</article-title><source>Molecules</source><year>2021</year><pub-id pub-id-type="doi">10.3390/molecules26123735</pub-id><?supplied-pmid 34207426?><pub-id pub-id-type="pmid">34207426</pub-id>
</element-citation></ref><ref id="CR236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;nther</surname><given-names>V</given-names></name><name><surname>Allahqoli</surname><given-names>L</given-names></name><name><surname>Watrowski</surname><given-names>R</given-names></name><etal/></person-group><article-title>Vaginal microbiome in reproductive medicine</article-title><source>Diagnostics (Basel)</source><year>2022</year><pub-id pub-id-type="doi">10.3390/diagnostics12081948</pub-id><?supplied-pmid 36428831?><pub-id pub-id-type="pmid">36428831</pub-id>
</element-citation></ref><ref id="CR237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name></person-group><article-title>Antimicrobial therapy in resource-limited settings with high antimicrobial resistance: a case-based approach</article-title><source>Infez Med</source><year>2022</year><volume>30</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.53854/liim-3001-8</pub-id><?supplied-pmid 35350265?><pub-id pub-id-type="pmid">35350265</pub-id>
</element-citation></ref><ref id="CR238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn-L&#x000f6;bmann</surname><given-names>S</given-names></name><name><surname>Stephan</surname><given-names>A</given-names></name><name><surname>Schulz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Colicins and salmocins&#x02014;new classes of plant-made non-antibiotic food antibacterials</article-title><source>Front Plant Sci</source><year>2019</year><volume>10</volume><fpage>437</fpage><pub-id pub-id-type="doi">10.3389/fpls.2019.00437</pub-id><?supplied-pmid 31024601?><pub-id pub-id-type="pmid">31024601</pub-id>
</element-citation></ref><ref id="CR239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammami</surname><given-names>I</given-names></name><name><surname>Rhouma</surname><given-names>A</given-names></name><name><surname>Jaouadi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Optimization and biochemical characterization of a bacteriocin from a newly isolated <italic>Bacillus subtilis</italic> strain 14B for biocontrol of <italic>Agrobacterium</italic> spp. strains</article-title><source>Lett Appl Microbiol</source><year>2009</year><volume>48</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2008.02524.x</pub-id><?supplied-pmid 19196444?><pub-id pub-id-type="pmid">19196444</pub-id>
</element-citation></ref><ref id="CR240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Zouhir</surname><given-names>A</given-names></name><name><surname>Le Lay</surname><given-names>C</given-names></name><etal/></person-group><article-title>BACTIBASE second release: a database and tool platform for bacteriocin characterization</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-10-22</pub-id><?supplied-pmid 20105292?><pub-id pub-id-type="pmid">20105292</pub-id>
</element-citation></ref><ref id="CR241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Fliss</surname><given-names>I</given-names></name><name><surname>Corsetti</surname><given-names>A</given-names></name></person-group><article-title>Editorial: application of protective cultures and bacteriocins for food biopreservation</article-title><source>Front Microbiol</source><year>2019</year><pub-id pub-id-type="doi">10.3389/fmicb.2019.01561</pub-id><?supplied-pmid 31333638?><pub-id pub-id-type="pmid">31333638</pub-id>
</element-citation></ref><ref id="CR242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanchi</surname><given-names>H</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Fernandez</surname><given-names>B</given-names></name><etal/></person-group><article-title>Simultaneous production of formylated and nonformylated enterocins L50A and L50B as well as 61A, a new glycosylated durancin, by <italic>Enterococcus durans</italic> 61A, a strain isolated from artisanal fermented milk in Tunisia</article-title><source>J Agric Food Chem</source><year>2016</year><volume>64</volume><fpage>3584</fpage><lpage>3590</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.6b00700</pub-id><?supplied-pmid 27111259?><pub-id pub-id-type="pmid">27111259</pub-id>
</element-citation></ref><ref id="CR243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanchi</surname><given-names>H</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Gingras</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhibition of MRSA and of <italic>Clostridium difficile</italic> by durancin 61A: synergy with bacteriocins and antibiotics</article-title><source>Future Microbiol</source><year>2017</year><volume>12</volume><fpage>205</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.2217/fmb-2016-0113</pub-id><?supplied-pmid 28262046?><pub-id pub-id-type="pmid">28262046</pub-id>
</element-citation></ref><ref id="CR244"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanny</surname><given-names>ELL</given-names></name><name><surname>Mustopa</surname><given-names>AZ</given-names></name><name><surname>Budiarti</surname><given-names>S</given-names></name><etal/></person-group><article-title>Efficacy, toxicity study and antioxidant properties of plantaricin E and F recombinants against enteropathogenic <italic>Escherichia coli</italic> K1.1 (EPEC K1.1)</article-title><source>Mol Biol Rep</source><year>2019</year><volume>46</volume><fpage>6501</fpage><lpage>6512</lpage><pub-id pub-id-type="doi">10.1007/s11033-019-05096-9</pub-id><?supplied-pmid 31583564?><pub-id pub-id-type="pmid">31583564</pub-id>
</element-citation></ref><ref id="CR245"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heeney</surname><given-names>DD</given-names></name><name><surname>Zhai</surname><given-names>Z</given-names></name><name><surname>Bendiks</surname><given-names>Z</given-names></name><etal/></person-group><article-title><italic>Lactobacillus plantarum</italic> bacteriocin is associated with intestinal and systemic improvements in diet-induced obese mice and maintains epithelial barrier integrity in vitro</article-title><source>Gut Microbes</source><year>2019</year><volume>10</volume><fpage>382</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1080/19490976.2018.1534513</pub-id><?supplied-pmid 30409105?><pub-id pub-id-type="pmid">30409105</pub-id>
</element-citation></ref><ref id="CR246"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilbronner</surname><given-names>S</given-names></name><name><surname>Krismer</surname><given-names>B</given-names></name><name><surname>Br&#x000f6;tz-Oesterhelt</surname><given-names>H</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><article-title>The microbiome-shaping roles of bacteriocins</article-title><source>Nat Rev Microbiol</source><year>2021</year><volume>19</volume><fpage>726</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1038/s41579-021-00569-w</pub-id><?supplied-pmid 34075213?><pub-id pub-id-type="pmid">34075213</pub-id>
</element-citation></ref><ref id="CR247"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzinger</surname><given-names>LR</given-names></name><name><surname>Pugh</surname><given-names>AR</given-names></name><name><surname>Wagner</surname><given-names>JA</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name></person-group><article-title>Evaluating the translational potential of bacteriocins as an alternative treatment for <italic>Staphylococcus aureus</italic> infections in animals and humans</article-title><source>Antibiotics (Basel)</source><year>2023</year><pub-id pub-id-type="doi">10.3390/antibiotics12081256</pub-id><?supplied-pmid 37627676?><pub-id pub-id-type="pmid">37627676</pub-id>
</element-citation></ref><ref id="CR248"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henker</surname><given-names>J</given-names></name><name><surname>Laass</surname><given-names>M</given-names></name><name><surname>Blokhin</surname><given-names>BM</given-names></name><etal/></person-group><article-title>The probiotic <italic>Escherichia coli</italic> strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers</article-title><source>Eur J Pediatr</source><year>2007</year><volume>166</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1007/s00431-007-0419-x</pub-id><?supplied-pmid 17287932?><pub-id pub-id-type="pmid">17287932</pub-id>
</element-citation></ref><ref id="CR249"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C</given-names></name><name><surname>Bono</surname><given-names>MR</given-names></name><name><surname>Barros</surname><given-names>LF</given-names></name><name><surname>Lagos</surname><given-names>R</given-names></name></person-group><article-title>Microcin E492, a channel-forming bacteriocin from <italic>Klebsiella pneumoniae</italic>, induces apoptosis in some human cell lines</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>2696</fpage><lpage>2701</lpage><pub-id pub-id-type="doi">10.1073/pnas.052709699</pub-id><?supplied-pmid 11880624?><pub-id pub-id-type="pmid">11880624</pub-id>
</element-citation></ref><ref id="CR250"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name><etal/></person-group><article-title>Expert consensus document. The International Scientific Association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2014</year><volume>11</volume><fpage>506</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2014.66</pub-id><?supplied-pmid 24912386?><pub-id pub-id-type="pmid">24912386</pub-id>
</element-citation></ref><ref id="CR251"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillman</surname><given-names>JD</given-names></name><name><surname>Dzuback</surname><given-names>AL</given-names></name><name><surname>Andrews</surname><given-names>SW</given-names></name></person-group><article-title>Colonization of the human oral cavity by a <italic>Streptococcus mutans</italic> mutant producing increased bacteriocin</article-title><source>J Dent Res</source><year>1987</year><volume>66</volume><fpage>1092</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1177/00220345870660060101</pub-id><?supplied-pmid 3476580?><pub-id pub-id-type="pmid">3476580</pub-id>
</element-citation></ref><ref id="CR252"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillman</surname><given-names>JD</given-names></name><name><surname>Brooks</surname><given-names>TA</given-names></name><name><surname>Michalek</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Construction and characterization of an effector strain of <italic>Streptococcus mutans</italic> for replacement therapy of dental caries</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.2.543-549.2000</pub-id><?supplied-pmid 10639415?><pub-id pub-id-type="pmid">10639415</pub-id>
</element-citation></ref><ref id="CR253"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>P</given-names></name><name><surname>Tagirdzhanov</surname><given-names>A</given-names></name><name><surname>Kushnareva</surname><given-names>A</given-names></name><etal/></person-group><article-title>ABC-HuMi: the Atlas of biosynthetic gene clusters in the human microbiome</article-title><source>Nucleic Acids Res</source><year>2024</year><volume>52</volume><fpage>D579</fpage><lpage>D585</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad1086</pub-id><?supplied-pmid 37994699?><pub-id pub-id-type="pmid">37994699</pub-id>
</element-citation></ref><ref id="CR254"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcapkova</surname><given-names>P</given-names></name><name><surname>Hurajova</surname><given-names>A</given-names></name><name><surname>Bazant</surname><given-names>P</given-names></name><etal/></person-group><article-title>Thermal stability of bacteriocin nisin in polylactide-based films</article-title><source>Polym Degrad Stab</source><year>2018</year><volume>158</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.polymdegradstab.2018.10.019</pub-id></element-citation></ref><ref id="CR255"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hols</surname><given-names>P</given-names></name><name><surname>Ledesma-Garc&#x000ed;a</surname><given-names>L</given-names></name><name><surname>Gabant</surname><given-names>P</given-names></name><name><surname>Mignolet</surname><given-names>J</given-names></name></person-group><article-title>Mobilization of microbiota commensals and their bacteriocins for therapeutics</article-title><source>Trends Microbiol</source><year>2019</year><volume>27</volume><fpage>690</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.03.007</pub-id><?supplied-pmid 30987817?><pub-id pub-id-type="pmid">30987817</pub-id>
</element-citation></ref><ref id="CR256"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homayouni Rad</surname><given-names>A</given-names></name><name><surname>Aghebati Maleki</surname><given-names>L</given-names></name><name><surname>Samadi Kafil</surname><given-names>H</given-names></name><name><surname>Abbasi</surname><given-names>A</given-names></name></person-group><article-title>Postbiotics: a novel strategy in food allergy treatment</article-title><source>Crit Rev Food Sci Nutr</source><year>2021</year><volume>61</volume><fpage>492</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1080/10408398.2020.1738333</pub-id><?supplied-pmid 32160762?><pub-id pub-id-type="pmid">32160762</pub-id>
</element-citation></ref><ref id="CR257"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horz</surname><given-names>HP</given-names></name><name><surname>Meinelt</surname><given-names>A</given-names></name><name><surname>Houben</surname><given-names>B</given-names></name><name><surname>Conrads</surname><given-names>G</given-names></name></person-group><article-title>Distribution and persistence of probiotic <italic>Streptococcus salivarius</italic> K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction</article-title><source>Oral Microbiol Immunol</source><year>2007</year><volume>22</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1111/j.1399-302X.2007.00334.x</pub-id><?supplied-pmid 17311636?><pub-id pub-id-type="pmid">17311636</pub-id>
</element-citation></ref><ref id="CR258"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskin</surname><given-names>DW</given-names></name><name><surname>Ramamoorthy</surname><given-names>A</given-names></name></person-group><article-title>Studies on anticancer activities of antimicrobial peptides</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1778</volume><fpage>357</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2007.11.008</pub-id><?supplied-pmid 18078805?><pub-id pub-id-type="pmid">18078805</pub-id>
</element-citation></ref><ref id="CR259"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>SS</given-names></name><name><surname>Hajikhani</surname><given-names>B</given-names></name><name><surname>Faghihloo</surname><given-names>E</given-names></name><name><surname>Goudarzi</surname><given-names>H</given-names></name></person-group><article-title>Increased expression of caspase genes in colorectal cancer cell line by nisin</article-title><source>Arch Clin Infect Dis</source><year>2020</year><pub-id pub-id-type="doi">10.5812/archcid.97734</pub-id></element-citation></ref><ref id="CR260"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Z-X</given-names></name><name><surname>Chen</surname><given-names>X-Y</given-names></name><etal/></person-group><article-title>Microbiota in health and diseases</article-title><source>Signal Transduct Target Ther</source><year>2022</year><volume>7</volume><fpage>135</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-00974-4</pub-id><?supplied-pmid 35461318?><pub-id pub-id-type="pmid">35461318</pub-id>
</element-citation></ref><ref id="CR261"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>TH</given-names></name><name><surname>Fiorellini</surname><given-names>JP</given-names></name><name><surname>Blackburn</surname><given-names>P</given-names></name><etal/></person-group><article-title>The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs</article-title><source>J Clin Periodontol</source><year>1993</year><volume>20</volume><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051x.1993.tb00369.x</pub-id><?supplied-pmid 8501273?><pub-id pub-id-type="pmid">8501273</pub-id>
</element-citation></ref><ref id="CR262"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrabalikova</surname><given-names>M</given-names></name><name><surname>Holcapkova</surname><given-names>P</given-names></name><name><surname>Suly</surname><given-names>P</given-names></name><name><surname>Sedlarik</surname><given-names>V</given-names></name></person-group><article-title>Immobilization of bacteriocin nisin into a poly(vinyl alcohol) polymer matrix crosslinked with nontoxic dicarboxylic acid</article-title><source>J Appl Polym Sci</source><year>2016</year><pub-id pub-id-type="doi">10.1002/app.43674</pub-id></element-citation></ref><ref id="CR263"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>2151</fpage><pub-id pub-id-type="doi">10.1038/ncomms3151</pub-id><?supplied-pmid 23877117?><pub-id pub-id-type="pmid">23877117</pub-id>
</element-citation></ref><ref id="CR264"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Mao</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Biotechnical paving of recombinant enterocin A as the candidate of anti-<italic>Listeria</italic> agent</article-title><source>BMC Microbiol</source><year>2014</year><volume>14</volume><fpage>220</fpage><pub-id pub-id-type="doi">10.1186/s12866-014-0220-8</pub-id><?supplied-pmid 25163588?><pub-id pub-id-type="pmid">25163588</pub-id>
</element-citation></ref><ref id="CR265"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A microbiota-derived bacteriocin targets the host to confer diarrhea resistance in early-weaned piglets</article-title><source>Cell Host Microbe</source><year>2018</year><volume>24</volume><fpage>817</fpage><lpage>832.e8</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.11.006</pub-id><?supplied-pmid 30543777?><pub-id pub-id-type="pmid">30543777</pub-id>
</element-citation></ref><ref id="CR267"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>MF</given-names></name><name><surname>Ambreen</surname><given-names>G</given-names></name><etal/></person-group><article-title>An antibiotic stewardship program in a surgical ICU of a resource-limited country: financial impact with improved clinical outcomes</article-title><source>J Pharm Policy Pract</source><year>2020</year><volume>13</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/s40545-020-00272-w</pub-id><?supplied-pmid 33042557?><pub-id pub-id-type="pmid">33042557</pub-id>
</element-citation></ref><ref id="CR268"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussien</surname><given-names>H</given-names></name><name><surname>Abd-Rabou</surname><given-names>HS</given-names></name><name><surname>Saad</surname><given-names>MA</given-names></name></person-group><article-title>The impact of incorporating <italic>Lactobacillus acidophilus</italic> bacteriocin with inulin and FOS on yogurt quality</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><fpage>13401</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-17633-x</pub-id><?supplied-pmid 35927320?><pub-id pub-id-type="pmid">35927320</pub-id>
</element-citation></ref><ref id="CR269"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibraheim</surname><given-names>HK</given-names></name><name><surname>Madhi</surname><given-names>KS</given-names></name><name><surname>Baqer</surname><given-names>GK</given-names></name><name><surname>Gharban</surname><given-names>HAJ</given-names></name></person-group><article-title>Effectiveness of raw bacteriocin produced from lactic acid bacteria on biofilm of methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Vet World</source><year>2023</year><volume>16</volume><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2023.491-499</pub-id><?supplied-pmid 37041833?><pub-id pub-id-type="pmid">37041833</pub-id>
</element-citation></ref><ref id="CR270"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilinskaya</surname><given-names>ON</given-names></name><name><surname>Ulyanova</surname><given-names>VV</given-names></name><name><surname>Yarullina</surname><given-names>DR</given-names></name><name><surname>Gataullin</surname><given-names>IG</given-names></name></person-group><article-title>Secretome of intestinal bacilli: a natural guard against pathologies</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>1666</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01666</pub-id><?supplied-pmid 28919884?><pub-id pub-id-type="pmid">28919884</pub-id>
</element-citation></ref><ref id="CR271"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperial</surname><given-names>ICVJ</given-names></name><name><surname>Ibana</surname><given-names>JA</given-names></name></person-group><article-title>Addressing the antibiotic resistance problem with probiotics: reducing the risk of its double-edged sword effect</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>1983</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.01983</pub-id><?supplied-pmid 28018315?><pub-id pub-id-type="pmid">28018315</pub-id>
</element-citation></ref><ref id="CR272"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imran</surname><given-names>M</given-names></name><name><surname>Revol-Junelles</surname><given-names>A-M</given-names></name><name><surname>de Bruin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Fluorescent labeling of nisin Z and assessment of anti-listerial action</article-title><source>J Microbiol Methods</source><year>2013</year><volume>95</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2013.07.009</pub-id><?supplied-pmid 23892059?><pub-id pub-id-type="pmid">23892059</pub-id>
</element-citation></ref><ref id="CR273"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglis</surname><given-names>RF</given-names></name><name><surname>Scanlan</surname><given-names>P</given-names></name><name><surname>Buckling</surname><given-names>A</given-names></name></person-group><article-title>Iron availability shapes the evolution of bacteriocin resistance in <italic>Pseudomonas aeruginosa</italic></article-title><source>ISME J</source><year>2016</year><volume>10</volume><fpage>2060</fpage><lpage>2066</lpage><pub-id pub-id-type="doi">10.1038/ismej.2016.15</pub-id><?supplied-pmid 26905630?><pub-id pub-id-type="pmid">26905630</pub-id>
</element-citation></ref><ref id="CR274"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MA</given-names></name><name><surname>Hassen</surname><given-names>WM</given-names></name><name><surname>Tayabali</surname><given-names>AF</given-names></name><name><surname>Dubowski</surname><given-names>JJ</given-names></name></person-group><article-title>Short ligand, cysteine-modified warnericin RK antimicrobial peptides favor highly sensitive detection of <italic>Legionella pneumophila</italic></article-title><source>ACS Omega</source><year>2021</year><volume>6</volume><fpage>1299</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1021/acsomega.0c04753</pub-id><?supplied-pmid 33490789?><pub-id pub-id-type="pmid">33490789</pub-id>
</element-citation></ref><ref id="CR275"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MA</given-names></name><name><surname>Hassen</surname><given-names>WM</given-names></name><name><surname>Ishika</surname><given-names>I</given-names></name><etal/></person-group><article-title>Selective detection of <italic>Legionella pneumophila</italic> serogroup 1 and 5 with a digital photocorrosion biosensor using antimicrobial peptide-antibody sandwich strategy</article-title><source>Biosensors (Basel)</source><year>2022</year><pub-id pub-id-type="doi">10.3390/bios12020105</pub-id><?supplied-pmid 36354455?><pub-id pub-id-type="pmid">36354455</pub-id>
</element-citation></ref><ref id="CR276"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo</surname><given-names>E</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Marchioni</surname><given-names>E</given-names></name><etal/></person-group><article-title>Enterocin 96, a novel class II bacteriocin produced by <italic>Enterococcus faecalis</italic> WHE 96, isolated from Munster cheese</article-title><source>Appl Environ Microbiol</source><year>2009</year><volume>75</volume><fpage>4273</fpage><lpage>4276</lpage><pub-id pub-id-type="doi">10.1128/AEM.02772-08</pub-id><?supplied-pmid 19411428?><pub-id pub-id-type="pmid">19411428</pub-id>
</element-citation></ref><ref id="CR277"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jab&#x000e9;s</surname><given-names>D</given-names></name><name><surname>Brunati</surname><given-names>C</given-names></name><name><surname>Candiani</surname><given-names>G</given-names></name><etal/></person-group><article-title>Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens</article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><fpage>1671</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1128/AAC.01288-10</pub-id><?supplied-pmid 21220527?><pub-id pub-id-type="pmid">21220527</pub-id>
</element-citation></ref><ref id="CR278"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaumaux</surname><given-names>F</given-names></name><name><surname>Petit</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Selective bacteriocins: a promising treatment for <italic>Staphylococcus aureus</italic> skin infections reveals insights into resistant mutants, vancomycin resistance, and cell wall alterations</article-title><source>Antibiotics (Basel)</source><year>2023</year><pub-id pub-id-type="doi">10.3390/antibiotics12060947</pub-id><?supplied-pmid 37370267?><pub-id pub-id-type="pmid">37370267</pub-id>
</element-citation></ref><ref id="CR279"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>S</given-names></name><name><surname>Thangavel</surname><given-names>G</given-names></name><name><surname>Kurian</surname><given-names>H</given-names></name><etal/></person-group><article-title><italic>Bacillus subtilis</italic> PB6 improves intestinal health of broiler chickens challenged with <italic>Clostridium perfringens</italic>-induced necrotic enteritis</article-title><source>Poult Sci</source><year>2013</year><volume>92</volume><fpage>370</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.3382/ps.2012-02528</pub-id><?supplied-pmid 23300303?><pub-id pub-id-type="pmid">23300303</pub-id>
</element-citation></ref><ref id="CR280"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Bao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Effect of nisin on microbiome-brain-gut axis neurochemicals by <italic>Escherichia coli</italic>-induced diarrhea in mice</article-title><source>Microb Pathog</source><year>2018</year><volume>119</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.005</pub-id><?supplied-pmid 29649517?><pub-id pub-id-type="pmid">29649517</pub-id>
</element-citation></ref><ref id="CR281"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Purification, characterization, and mode of action of pentocin JL-1, a novel bacteriocin isolated from <italic>Lactobacillus pentosus</italic>, against drug-resistant <italic>Staphylococcus aureus</italic></article-title><source>Biomed Res Int</source><year>2017</year><volume>2017</volume><fpage>7657190</fpage><pub-id pub-id-type="doi">10.1155/2017/7657190</pub-id><?supplied-pmid 29333451?><pub-id pub-id-type="pmid">29333451</pub-id>
</element-citation></ref><ref id="CR282"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y-H</given-names></name><name><surname>Xin</surname><given-names>W-G</given-names></name><name><surname>Yang</surname><given-names>L-Y</given-names></name><etal/></person-group><article-title>A novel bacteriocin against <italic>Staphylococcus aureus</italic> from <italic>Lactobacillus paracasei</italic> isolated from Yunnan traditional fermented yogurt: purification, antibacterial characterization, and antibiofilm activity</article-title><source>J Dairy Sci</source><year>2022</year><volume>105</volume><fpage>2094</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.3168/jds.2021-21126</pub-id><?supplied-pmid 35180941?><pub-id pub-id-type="pmid">35180941</pub-id>
</element-citation></ref><ref id="CR283"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><etal/></person-group><article-title>The clinical and experimental research on the treatment of endometriosis with thiostrepton</article-title><source>Anticancer Agents Med Chem</source><year>2019</year><volume>19</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.2174/1871520618666180108100211</pub-id><?supplied-pmid 29308746?><pub-id pub-id-type="pmid">29308746</pub-id>
</element-citation></ref><ref id="CR284"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Jung</surname><given-names>DY-G</given-names></name><name><surname>Jin</surname><given-names>DY-Y</given-names></name><etal/></person-group><article-title>Bacteriocins as food preservatives: challenges and emerging horizons</article-title><source>Crit Rev Food Sci Nutr</source><year>2018</year><volume>58</volume><fpage>2743</fpage><lpage>2767</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1340870</pub-id><?supplied-pmid 28880573?><pub-id pub-id-type="pmid">28880573</pub-id>
</element-citation></ref><ref id="CR285"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>NE</given-names></name><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>Kamarajan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1</article-title><source>Cancer Med</source><year>2012</year><volume>1</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1002/cam4.35</pub-id><?supplied-pmid 23342279?><pub-id pub-id-type="pmid">23342279</pub-id>
</element-citation></ref><ref id="CR286"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>B</given-names></name><name><surname>Dhas</surname><given-names>B</given-names></name><name><surname>Hena</surname><given-names>V</given-names></name><name><surname>Raj</surname><given-names>J</given-names></name></person-group><article-title>Bacteriocin from <italic>Bacillus subtilis</italic> as a novel drug against diabetic foot ulcer bacterial pathogens</article-title><source>Asian Pac J Trop Biomed</source><year>2013</year><volume>3</volume><fpage>942</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(13)60183-5</pub-id><?supplied-pmid 24093784?><pub-id pub-id-type="pmid">24093784</pub-id>
</element-citation></ref><ref id="CR287"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000f3;zefiak</surname><given-names>D</given-names></name><name><surname>Kiero&#x00144;czyk</surname><given-names>B</given-names></name><name><surname>Ju&#x0015b;kiewicz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Dietary nisin modulates the gastrointestinal microbial ecology and enhances growth performance of the broiler chickens</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e85347</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0085347</pub-id><?supplied-pmid 24376878?><pub-id pub-id-type="pmid">24376878</pub-id>
</element-citation></ref><ref id="CR288"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juarez Tom&#x000e1;s</surname><given-names>MS</given-names></name><name><surname>Bru</surname><given-names>E</given-names></name><name><surname>Wiese</surname><given-names>B</given-names></name><etal/></person-group><article-title>Influence of pH, temperature and culture media on the growth and bacteriocin production by vaginal <italic>Lactobacillus salivarius</italic> CRL 1328</article-title><source>J Appl Microbiol</source><year>2002</year><volume>93</volume><fpage>714</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2002.01753.x</pub-id><?supplied-pmid 12234356?><pub-id pub-id-type="pmid">12234356</pub-id>
</element-citation></ref><ref id="CR289"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juturu</surname><given-names>V</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name></person-group><article-title>Microbial production of bacteriocins: latest research development and applications</article-title><source>Biotechnol Adv</source><year>2018</year><volume>36</volume><fpage>2187</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.10.007</pub-id><?supplied-pmid 30385277?><pub-id pub-id-type="pmid">30385277</pub-id>
</element-citation></ref><ref id="CR290"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaewnopparat</surname><given-names>S</given-names></name><name><surname>Dangmanee</surname><given-names>N</given-names></name><name><surname>Kaewnopparat</surname><given-names>N</given-names></name><etal/></person-group><article-title>In vitro probiotic properties of <italic>Lactobacillus fermentum</italic> SK5 isolated from vagina of a healthy woman</article-title><source>Anaerobe</source><year>2013</year><volume>22</volume><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.04.009</pub-id><?supplied-pmid 23624069?><pub-id pub-id-type="pmid">23624069</pub-id>
</element-citation></ref><ref id="CR291"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaewsrichan</surname><given-names>J</given-names></name><name><surname>Peeyananjarassri</surname><given-names>K</given-names></name><name><surname>Kongprasertkit</surname><given-names>J</given-names></name></person-group><article-title>Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens</article-title><source>FEMS Immunol Med Microbiol</source><year>2006</year><volume>48</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2006.00124.x</pub-id><?supplied-pmid 16965354?><pub-id pub-id-type="pmid">16965354</pub-id>
</element-citation></ref><ref id="CR292"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000e5;hrstr&#x000f6;m</surname><given-names>CT</given-names></name></person-group><article-title>Antimicrobials: targeting of <italic>C. difficile</italic> made easy</article-title><source>Nat Rev Microbiol</source><year>2015</year><volume>13</volume><fpage>250</fpage><pub-id pub-id-type="doi">10.1038/nrmicro3481</pub-id><?supplied-pmid 25895936?><pub-id pub-id-type="pmid">25895936</pub-id>
</element-citation></ref><ref id="CR293"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamarajan</surname><given-names>P</given-names></name><name><surname>Hayami</surname><given-names>T</given-names></name><name><surname>Matte</surname><given-names>B</given-names></name><etal/></person-group><article-title>Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0131008</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0131008</pub-id><?supplied-pmid 26132406?><pub-id pub-id-type="pmid">26132406</pub-id>
</element-citation></ref><ref id="CR294"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>BS</given-names></name><name><surname>Seo</surname><given-names>J-G</given-names></name><name><surname>Lee</surname><given-names>G-S</given-names></name><etal/></person-group><article-title>Antimicrobial activity of enterocins from <italic>Enterococcus faecalis</italic> SL-5 against <italic>Propionibacterium acnes</italic>, the causative agent in acne vulgaris, and its therapeutic effect</article-title><source>J Microbiol</source><year>2009</year><volume>47</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s12275-008-0179-y</pub-id><?supplied-pmid 19229497?><pub-id pub-id-type="pmid">19229497</pub-id>
</element-citation></ref><ref id="CR295"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanmani</surname><given-names>P</given-names></name><name><surname>Satish Kumar</surname><given-names>R</given-names></name><name><surname>Yuvaraj</surname><given-names>N</given-names></name><etal/></person-group><article-title>Probiotics and its functionally valuable products&#x02014;a review</article-title><source>Crit Rev Food Sci Nutr</source><year>2013</year><volume>53</volume><fpage>641</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1080/10408398.2011.553752</pub-id><?supplied-pmid 23627505?><pub-id pub-id-type="pmid">23627505</pub-id>
</element-citation></ref><ref id="CR296"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassaa</surname><given-names>IA</given-names></name><name><surname>Rafei</surname><given-names>R</given-names></name><name><surname>Moukhtar</surname><given-names>M</given-names></name><etal/></person-group><article-title>LABiocin database: a new database designed specifically for lactic acid bacteria bacteriocins</article-title><source>Int J Antimicrob Agents</source><year>2019</year><volume>54</volume><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2019.07.012</pub-id><?supplied-pmid 31374334?><pub-id pub-id-type="pmid">31374334</pub-id>
</element-citation></ref><ref id="CR297"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassem</surname><given-names>MA</given-names></name><name><surname>Saafan</surname><given-names>AE</given-names></name><name><surname>Bayomy</surname><given-names>F</given-names></name><name><surname>El-Gendy</surname><given-names>AO</given-names></name></person-group><article-title>Exploring clinically isolated <italic>Staphylococcus</italic> sp. bacteriocins revealed the production of amonabactin, micrococcin, and &#x003b1;-circulocin</article-title><source>Iran J Microbiol</source><year>2021</year><volume>13</volume><fpage>212</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.18502/ijm.v13i2.5983</pub-id><?supplied-pmid 34540157?><pub-id pub-id-type="pmid">34540157</pub-id>
</element-citation></ref><ref id="CR298"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name></person-group><article-title>Bacteriocins as potential anticancer agents</article-title><source>Front Pharmacol</source><year>2015</year><volume>6</volume><fpage>272</fpage><pub-id pub-id-type="doi">10.3389/fphar.2015.00272</pub-id><?supplied-pmid 26617524?><pub-id pub-id-type="pmid">26617524</pub-id>
</element-citation></ref><ref id="CR299"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaveh</surname><given-names>S</given-names></name><name><surname>Hashemi</surname><given-names>SMB</given-names></name><name><surname>Abedi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Bio-preservation of meat and fermented meat products by lactic acid bacteria strains and their antibacterial metabolites</article-title><source>Sustainability</source><year>2023</year><volume>15</volume><fpage>10154</fpage><pub-id pub-id-type="doi">10.3390/su151310154</pub-id></element-citation></ref><ref id="CR300"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>I</given-names></name><name><surname>Miskeen</surname><given-names>S</given-names></name><name><surname>Khalil</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Foodborne pathogens: <italic>Staphylococcus aureus</italic> and <italic>Listeria monocytogenes</italic> an unsolved problem of the food industry</article-title><source>Pak J Nutr</source><year>2016</year><volume>15</volume><fpage>505</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.3923/pjn.2016.505.514</pub-id></element-citation></ref><ref id="CR301"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>HA</given-names></name><name><surname>Baig</surname><given-names>FK</given-names></name><name><surname>Mehboob</surname><given-names>R</given-names></name></person-group><article-title>Nosocomial infections: epidemiology, prevention, control and surveillance</article-title><source>Asian Pac J Trop Biomed</source><year>2017</year><volume>7</volume><fpage>478</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2017.01.019</pub-id></element-citation></ref><ref id="CR302"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheadr</surname><given-names>E</given-names></name><name><surname>Zihler</surname><given-names>A</given-names></name><name><surname>Dabour</surname><given-names>N</given-names></name><etal/></person-group><article-title>Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model</article-title><source>J Appl Microbiol</source><year>2010</year><volume>109</volume><fpage>54</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2009.04644.x</pub-id><?supplied-pmid 20059619?><pub-id pub-id-type="pmid">20059619</pub-id>
</element-citation></ref><ref id="CR303"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khorshidian</surname><given-names>N</given-names></name><name><surname>Khanniri</surname><given-names>E</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antibacterial activity of pediocin and pediocin-producing bacteria against <italic>Listeria monocytogenes</italic> in meat products</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>709959</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.709959</pub-id><?supplied-pmid 34603234?><pub-id pub-id-type="pmid">34603234</pub-id>
</element-citation></ref><ref id="CR304"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Koo</surname><given-names>HC</given-names></name><etal/></person-group><article-title>In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by <italic>Staphylococcus</italic> species isolated from bovine mastitis</article-title><source>J Dairy Sci</source><year>2010</year><volume>93</volume><fpage>3610</fpage><lpage>3615</lpage><pub-id pub-id-type="doi">10.3168/jds.2010-3129</pub-id><?supplied-pmid 20655430?><pub-id pub-id-type="pmid">20655430</pub-id>
</element-citation></ref><ref id="CR305"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Ku</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Safety evaluations of <italic>Bifidobacterium bifidum</italic> BGN4 and <italic>Bifidobacterium longum</italic> BORI</article-title><source>Int J Mol Sci</source><year>2018</year><pub-id pub-id-type="doi">10.3390/ijms19051422</pub-id><?supplied-pmid 30597956?><pub-id pub-id-type="pmid">30597956</pub-id>
</element-citation></ref><ref id="CR306"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Hanh</surname><given-names>BTB</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><etal/></person-group><article-title>Thiostrepton: a novel therapeutic drug candidate for <italic>Mycobacterium abscessus</italic> infection</article-title><source>Molecules</source><year>2019</year><pub-id pub-id-type="doi">10.3390/molecules24244511</pub-id><?supplied-pmid 31905820?><pub-id pub-id-type="pmid">31905820</pub-id>
</element-citation></ref><ref id="CR307"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirtonia</surname><given-names>K</given-names></name><name><surname>Salauddin</surname><given-names>M</given-names></name><name><surname>Bharadwaj</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Bacteriocin: a new strategic antibiofilm agent in food industries</article-title><source>Biocatal Agric Biotechnol</source><year>2021</year><volume>36</volume><fpage>102141</fpage><pub-id pub-id-type="doi">10.1016/j.bcab.2021.102141</pub-id></element-citation></ref><ref id="CR308"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjos</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Slager</surname><given-names>J</given-names></name><etal/></person-group><article-title>Expression of <italic>Streptococcus pneumoniae</italic> bacteriocins is induced by antibiotics via regulatory interplay with the competence system</article-title><source>PLoS Pathog</source><year>2016</year><volume>12</volume><fpage>e1005422</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005422</pub-id><?supplied-pmid 26840404?><pub-id pub-id-type="pmid">26840404</pub-id>
</element-citation></ref><ref id="CR309"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaenhammer</surname><given-names>TR</given-names></name></person-group><article-title>Bacteriocins of lactic acid bacteria</article-title><source>Biochimie</source><year>1988</year><volume>70</volume><fpage>337</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/0300-9084(88)90206-4</pub-id><?supplied-pmid 3139051?><pub-id pub-id-type="pmid">3139051</pub-id>
</element-citation></ref><ref id="CR310"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaenhammer</surname><given-names>TR</given-names></name></person-group><article-title>Genetics of bacteriocins produced by lactic acid bacteria</article-title><source>FEMS Microbiol Rev</source><year>1993</year><volume>12</volume><fpage>39</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.1993.tb00012.x</pub-id><?supplied-pmid 8398217?><pub-id pub-id-type="pmid">8398217</pub-id>
</element-citation></ref><ref id="CR311"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klostermann</surname><given-names>K</given-names></name><name><surname>Crispie</surname><given-names>F</given-names></name><name><surname>Flynn</surname><given-names>J</given-names></name><etal/></person-group><article-title>Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis</article-title><source>J Dairy Res</source><year>2010</year><volume>77</volume><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1017/S0022029909990239</pub-id><?supplied-pmid 19785910?><pub-id pub-id-type="pmid">19785910</pub-id>
</element-citation></ref><ref id="CR312"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knorr</surname><given-names>D</given-names></name></person-group><article-title>Technology aspects related to microorganisms in functional foods</article-title><source>Trends Food Sci Technol</source><year>1998</year><volume>9</volume><fpage>295</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/S0924-2244(98)00051-X</pub-id></element-citation></ref><ref id="CR313"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohoutova</surname><given-names>D</given-names></name><name><surname>Smajs</surname><given-names>D</given-names></name><name><surname>Moravkova</surname><given-names>P</given-names></name><etal/></person-group><article-title><italic>Escherichia coli</italic> strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia</article-title><source>BMC Infect Dis</source><year>2014</year><volume>14</volume><fpage>733</fpage><pub-id pub-id-type="doi">10.1186/s12879-014-0733-7</pub-id><?supplied-pmid 25540872?><pub-id pub-id-type="pmid">25540872</pub-id>
</element-citation></ref><ref id="CR314"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondrotiene</surname><given-names>K</given-names></name><name><surname>Kasnauskyte</surname><given-names>N</given-names></name><name><surname>Serniene</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characterization and application of newly isolated nisin producing <italic>Lactococcus lactis</italic> strains for control of <italic>Listeria monocytogenes</italic> growth in fresh cheese</article-title><source>LWT Food Sci Technol</source><year>2018</year><volume>87</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2017.09.021</pub-id></element-citation></ref><ref id="CR315"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kongsema</surname><given-names>M</given-names></name><name><surname>Wongkhieo</surname><given-names>S</given-names></name><name><surname>Khongkow</surname><given-names>M</given-names></name><etal/></person-group><article-title>Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells</article-title><source>Oncol Rep</source><year>2019</year><volume>42</volume><fpage>953</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.3892/or.2019.7225</pub-id><?supplied-pmid 31322278?><pub-id pub-id-type="pmid">31322278</pub-id>
</element-citation></ref><ref id="CR316"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kothari</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S-K</given-names></name></person-group><article-title>Probiotic supplements might not be universally-effective and safe: a review</article-title><source>Biomed Pharmacother</source><year>2019</year><volume>111</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.12.104</pub-id><?supplied-pmid 30597307?><pub-id pub-id-type="pmid">30597307</pub-id>
</element-citation></ref><ref id="CR317"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Zipperer</surname><given-names>A</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Secretion of and self-resistance to the novel fibupeptide antimicrobial lugdunin by distinct ABC transporters in <italic>Staphylococcus lugdunensis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2020</year><pub-id pub-id-type="doi">10.1128/AAC.01734-20</pub-id><?supplied-pmid 33106269?><pub-id pub-id-type="pmid">33106269</pub-id>
</element-citation></ref><ref id="CR318"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krulwich</surname><given-names>TA</given-names></name><name><surname>Sachs</surname><given-names>G</given-names></name><name><surname>Padan</surname><given-names>E</given-names></name></person-group><article-title>Molecular aspects of bacterial pH sensing and homeostasis</article-title><source>Nat Rev Microbiol</source><year>2011</year><volume>9</volume><fpage>330</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2549</pub-id><?supplied-pmid 21464825?><pub-id pub-id-type="pmid">21464825</pub-id>
</element-citation></ref><ref id="CR319"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruszewska</surname><given-names>D</given-names></name><name><surname>Sahl</surname><given-names>H-G</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mersacidin eradicates methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) in a mouse rhinitis model</article-title><source>J Antimicrob Chemother</source><year>2004</year><volume>54</volume><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1093/jac/dkh387</pub-id><?supplied-pmid 15282239?><pub-id pub-id-type="pmid">15282239</pub-id>
</element-citation></ref><ref id="CR320"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>B</given-names></name></person-group><article-title>In vitro cytotoxicity of native and Rec-Pediocin CP2 against cancer cell lines: a comparative study</article-title><source>Pharm Anal Acta</source><year>2012</year><pub-id pub-id-type="doi">10.4172/2153-2435.1000183</pub-id></element-citation></ref><ref id="CR321"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumariya</surname><given-names>R</given-names></name><name><surname>Sood</surname><given-names>SK</given-names></name><name><surname>Rajput</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Increased membrane surface positive charge and altered membrane fluidity leads to cationic antimicrobial peptide resistance in <italic>Enterococcus faecalis</italic></article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1848</volume><fpage>1367</fpage><lpage>1375</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2015.03.007</pub-id><?supplied-pmid 25782727?><pub-id pub-id-type="pmid">25782727</pub-id>
</element-citation></ref><ref id="CR322"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumariya</surname><given-names>R</given-names></name><name><surname>Garsa</surname><given-names>AK</given-names></name><name><surname>Rajput</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Bacteriocins: classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria</article-title><source>Microb Pathog</source><year>2019</year><volume>128</volume><fpage>171</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2019.01.002</pub-id><?supplied-pmid 30610901?><pub-id pub-id-type="pmid">30610901</pub-id>
</element-citation></ref><ref id="CR323"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuniyoshi</surname><given-names>TM</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Lawton</surname><given-names>E</given-names></name><etal/></person-group><article-title>An oxidation resistant pediocin PA-1 derivative and penocin A display effective anti-Listeria activity in a model human gut environment</article-title><source>Gut Microbes</source><year>2022</year><volume>14</volume><fpage>2004071</fpage><pub-id pub-id-type="doi">10.1080/19490976.2021.2004071</pub-id><?supplied-pmid 35104196?><pub-id pub-id-type="pmid">35104196</pub-id>
</element-citation></ref><ref id="CR324"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>JM-M</given-names></name><name><surname>Myatt</surname><given-names>SS</given-names></name><name><surname>Marson</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression</article-title><source>Mol Cancer Ther</source><year>2008</year><volume>7</volume><fpage>2022</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-08-0188</pub-id><?supplied-pmid 18645012?><pub-id pub-id-type="pmid">18645012</pub-id>
</element-citation></ref><ref id="CR325"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshminarayanan</surname><given-names>B</given-names></name><name><surname>Guinane</surname><given-names>CM</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects</article-title><source>J Appl Microbiol</source><year>2013</year><volume>114</volume><fpage>886</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1111/jam.12085</pub-id><?supplied-pmid 23181509?><pub-id pub-id-type="pmid">23181509</pub-id>
</element-citation></ref><ref id="CR326"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange-Starke</surname><given-names>A</given-names></name><name><surname>Petereit</surname><given-names>A</given-names></name><name><surname>Truyen</surname><given-names>U</given-names></name><etal/></person-group><article-title>Antiviral potential of selected starter cultures, bacteriocins and <sc>d</sc>, <sc>l</sc>-lactic acid</article-title><source>Food Environ Virol</source><year>2014</year><volume>6</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1007/s12560-013-9135-z</pub-id><?supplied-pmid 24297091?><pub-id pub-id-type="pmid">24297091</pub-id>
</element-citation></ref><ref id="CR327"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lategan</surname><given-names>MJ</given-names></name><name><surname>Gibson</surname><given-names>LF</given-names></name></person-group><article-title>Antagonistic activity of <italic>Aeromonas</italic> media strain A199 against <italic>Saprolegnia</italic> sp., an opportunistic pathogen of the eel, <italic>Anguilla australis</italic> Richardson</article-title><source>J Fish Dis</source><year>2003</year><volume>26</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2761.2003.00443.x</pub-id><?supplied-pmid 12962224?><pub-id pub-id-type="pmid">12962224</pub-id>
</element-citation></ref><ref id="CR328"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latham</surname><given-names>RD</given-names></name><name><surname>Gell</surname><given-names>DA</given-names></name><name><surname>Fairbairn</surname><given-names>RL</given-names></name><etal/></person-group><article-title>An isolate of <italic>Haemophilus haemolyticus</italic> produces a bacteriocin-like substance that inhibits the growth of nontypeable <italic>Haemophilus influenzae</italic></article-title><source>Int J Antimicrob Agents</source><year>2017</year><volume>49</volume><fpage>503</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2016.12.010</pub-id><?supplied-pmid 28242259?><pub-id pub-id-type="pmid">28242259</pub-id>
</element-citation></ref><ref id="CR329"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laux</surname><given-names>C</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Krismer</surname><given-names>B</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> colonization of the human nose and interaction with other microbiome members</article-title><source>Microbiol Spectr</source><year>2019</year><pub-id pub-id-type="doi">10.1128/microbiolspec.GPP3-0029-2018</pub-id><?supplied-pmid 31004422?><pub-id pub-id-type="pmid">31004422</pub-id>
</element-citation></ref><ref id="CR330"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavermicocca</surname><given-names>P</given-names></name><name><surname>Lonigro</surname><given-names>SL</given-names></name><name><surname>Valerio</surname><given-names>F</given-names></name><etal/></person-group><article-title>Reduction of olive knot disease by a bacteriocin from <italic>Pseudomonas syringae</italic> pv. ciccaronei</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>68</volume><fpage>1403</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.3.1403-1407.2002</pub-id><?supplied-pmid 11872493?><pub-id pub-id-type="pmid">11872493</pub-id>
</element-citation></ref><ref id="CR331"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lay</surname><given-names>CL</given-names></name><name><surname>Dridi</surname><given-names>L</given-names></name><name><surname>Bergeron</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Nisin is an effective inhibitor of <italic>Clostridium difficile</italic> vegetative cells and spore germination</article-title><source>J Med Microbiol</source><year>2016</year><volume>65</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.000202</pub-id><?supplied-pmid 26555543?><pub-id pub-id-type="pmid">26555543</pub-id>
</element-citation></ref><ref id="CR332"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>C</given-names></name><etal/></person-group><article-title>Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired <italic>Klebsiella pneumoniae</italic> infections in Guangzhou</article-title><source>China Antimicrob Resist Infect Control</source><year>2021</year><volume>10</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s13756-021-00910-1</pub-id><?supplied-pmid 33632338?><pub-id pub-id-type="pmid">33632338</pub-id>
</element-citation></ref><ref id="CR333"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>MN-T</given-names></name><name><surname>Nguyen</surname><given-names>TH-H</given-names></name><name><surname>Trinh</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Comprehensive analysis of bacteriocins produced by the hypermucoviscous <italic>Klebsiella pneumoniae</italic> species complex</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><fpage>e0086323</fpage><pub-id pub-id-type="doi">10.1128/spectrum.00863-23</pub-id><?supplied-pmid 37154746?><pub-id pub-id-type="pmid">37154746</pub-id>
</element-citation></ref><ref id="CR334"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DG</given-names></name><name><surname>Hahm</surname><given-names>K-S</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Functional and structural characteristics of anticancer peptide Pep27 analogues</article-title><source>Cancer Cell Int</source><year>2005</year><volume>5</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1475-2867-5-21</pub-id><?supplied-pmid 16004618?><pub-id pub-id-type="pmid">16004618</pub-id>
</element-citation></ref><ref id="CR335"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H-T</given-names></name><name><surname>Lee</surname><given-names>C-C</given-names></name><name><surname>Yang</surname><given-names>J-R</given-names></name><etal/></person-group><article-title>A large-scale structural classification of antimicrobial peptides</article-title><source>Biomed Res Int</source><year>2015</year><volume>2015</volume><fpage>475062</fpage><pub-id pub-id-type="doi">10.1155/2015/475062</pub-id><?supplied-pmid 26000295?><pub-id pub-id-type="pmid">26000295</pub-id>
</element-citation></ref><ref id="CR336"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><etal/></person-group><article-title>Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner</article-title><source>Antiviral Res</source><year>2016</year><volume>132</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.07.002</pub-id><?supplied-pmid 27387825?><pub-id pub-id-type="pmid">27387825</pub-id>
</element-citation></ref><ref id="CR337"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J-Z</given-names></name><name><surname>Zhou</surname><given-names>L-Y</given-names></name><name><surname>Peng</surname><given-names>Y-L</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name></person-group><article-title><italic>Pseudomonas</italic> bacteriocin syringacin M released upon desiccation suppresses the growth of sensitive bacteria in plant necrotic lesions</article-title><source>Microb Biotechnol</source><year>2020</year><volume>13</volume><fpage>134</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13367</pub-id><?supplied-pmid 30672132?><pub-id pub-id-type="pmid">30672132</pub-id>
</element-citation></ref><ref id="CR338"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Xing</surname><given-names>D</given-names></name></person-group><article-title>The current and future perspectives of postbiotics</article-title><source>Probiotics Antimicrob Proteins</source><year>2023</year><pub-id pub-id-type="doi">10.1007/s12602-023-10045-x</pub-id><?supplied-pmid 37639209?><pub-id pub-id-type="pmid">37639209</pub-id>
</element-citation></ref><ref id="CR339"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name><name><surname>Wu</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Screening and characterization of LAB-produced bacteriocin-like substances from the intestine of grey mullet (<italic>Mugil cephalus</italic> L.) as potential biocontrol agents in aquaculture</article-title><source>J Appl Microbiol</source><year>2013</year><volume>114</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1111/jam.12041</pub-id><?supplied-pmid 23075097?><pub-id pub-id-type="pmid">23075097</pub-id>
</element-citation></ref><ref id="CR340"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linares-Morales</surname><given-names>JR</given-names></name><name><surname>Cuellar-Nev&#x000e1;rez</surname><given-names>GE</given-names></name><name><surname>Rivera-Chavira</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Selection of lactic acid bacteria isolated from fresh fruits and vegetables based on their antimicrobial and enzymatic activities</article-title><source>Foods</source><year>2020</year><volume>9</volume><fpage>1399</fpage><pub-id pub-id-type="doi">10.3390/foods9101399</pub-id><?supplied-pmid 33023126?><pub-id pub-id-type="pmid">33023126</pub-id>
</element-citation></ref><ref id="CR341"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Lv</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><etal/></person-group><article-title>Pentocin 31&#x02013;1, an anti-<italic>Listeria</italic> bacteriocin produced by <italic>Lactobacillus pentosus</italic> 31&#x02013;1 isolated from Xuan-Wei Ham, a traditional China fermented meat product</article-title><source>Food Control</source><year>2008</year><volume>19</volume><fpage>353</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2007.04.010</pub-id></element-citation></ref><ref id="CR342"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Skin microbiota analysis-inspired development of novel anti-infectives</article-title><source>Microbiome</source><year>2020</year><volume>8</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s40168-020-00866-1</pub-id><?supplied-pmid 32503672?><pub-id pub-id-type="pmid">32503672</pub-id>
</element-citation></ref><ref id="CR343"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Nie</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title><italic>Bacillus subtilis</italic> BS-15 effectively improves plantaricin production and the regulatory biosynthesis in <italic>Lactiplantibacillus plantarum</italic> RX-8</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>772546</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.772546</pub-id><?supplied-pmid 35154024?><pub-id pub-id-type="pmid">35154024</pub-id>
</element-citation></ref><ref id="CR344"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>van Heel</surname><given-names>AJ</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name></person-group><article-title>Leader- and terminal residue requirements for circularin A biosynthesis probed by systematic mutational analyses</article-title><source>ACS Synth Biol</source><year>2023</year><volume>12</volume><fpage>852</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.2c00661</pub-id><?supplied-pmid 36857413?><pub-id pub-id-type="pmid">36857413</pub-id>
</element-citation></ref><ref id="CR345"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Verso</surname><given-names>L</given-names></name><name><surname>Lessard</surname><given-names>M</given-names></name><name><surname>Talbot</surname><given-names>G</given-names></name><etal/></person-group><article-title>Isolation and selection of potential probiotic bacteria from the pig gastrointestinal tract</article-title><source>Probiotics Antimicrob Proteins</source><year>2018</year><volume>10</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/s12602-017-9309-3</pub-id><?supplied-pmid 28744832?><pub-id pub-id-type="pmid">28744832</pub-id>
</element-citation></ref><ref id="CR346"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohans</surname><given-names>CT</given-names></name><name><surname>Vederas</surname><given-names>JC</given-names></name></person-group><article-title>Development of class iia bacteriocins as therapeutic agents</article-title><source>Int J Microbiol</source><year>2012</year><volume>2012</volume><fpage>386410</fpage><pub-id pub-id-type="doi">10.1155/2012/386410</pub-id><?supplied-pmid 22187559?><pub-id pub-id-type="pmid">22187559</pub-id>
</element-citation></ref><ref id="CR347"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopetuso</surname><given-names>LR</given-names></name><name><surname>Giorgio</surname><given-names>ME</given-names></name><name><surname>Saviano</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bacteriocins and bacteriophages: therapeutic weapons for gastrointestinal diseases?</article-title><source>Int J Mol Sci</source><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20010183</pub-id><?supplied-pmid 30621339?><pub-id pub-id-type="pmid">30621339</pub-id>
</element-citation></ref><ref id="CR348"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Gonz&#x000e1;lez</surname><given-names>MJ</given-names></name><name><surname>Campelo</surname><given-names>AB</given-names></name><name><surname>Picon</surname><given-names>A</given-names></name><etal/></person-group><article-title>Resistance to bacteriocin Lcn972 improves oxygen tolerance of <italic>Lactococcus lactis</italic> IPLA947 without compromising its performance as a dairy starter</article-title><source>BMC Microbiol</source><year>2018</year><volume>18</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s12866-018-1222-8</pub-id><?supplied-pmid 30029618?><pub-id pub-id-type="pmid">30029618</pub-id>
</element-citation></ref><ref id="CR349"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Jie</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Purification and antibacterial mechanism of fish-borne bacteriocin and its application in shrimp (<italic>Penaeus vanname</italic>i) for inhibiting <italic>Vibrio parahaemolyticus</italic></article-title><source>World J Microbiol Biotechnol</source><year>2017</year><volume>33</volume><fpage>156</fpage><pub-id pub-id-type="doi">10.1007/s11274-017-2320-8</pub-id><?supplied-pmid 28702797?><pub-id pub-id-type="pmid">28702797</pub-id>
</element-citation></ref><ref id="CR350"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>D</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Identification and characterisation of capidermicin, a novel bacteriocin produced by <italic>Staphylococcus capitis</italic></article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><fpage>e0223541</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0223541</pub-id><?supplied-pmid 31618225?><pub-id pub-id-type="pmid">31618225</pub-id>
</element-citation></ref><ref id="CR351"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>I</given-names></name><name><surname>Schwille-Kiuntke</surname><given-names>J</given-names></name><name><surname>Mazurak</surname><given-names>N</given-names></name><etal/></person-group><article-title>A nonviable probiotic in irritable bowel syndrome: a randomized, double-blind, placebo-controlled, multicenter study</article-title><source>Clin Gastroenterol Hepatol</source><year>2022</year><volume>20</volume><fpage>1039</fpage><lpage>1047.e9</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2021.06.028</pub-id><?supplied-pmid 34214682?><pub-id pub-id-type="pmid">34214682</pub-id>
</element-citation></ref><ref id="CR352"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magana</surname><given-names>M</given-names></name><name><surname>Pushpanathan</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>AL</given-names></name><etal/></person-group><article-title>The value of antimicrobial peptides in the age of resistance</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><fpage>e216</fpage><lpage>e230</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30327-3</pub-id><?supplied-pmid 32653070?><pub-id pub-id-type="pmid">32653070</pub-id>
</element-citation></ref><ref id="CR353"><mixed-citation publication-type="other">Mahdavi M, Jalali M, Kasra Kermanshahi R (2007) The effect of nisin on biofilm forming foodborne bacteria using microtiter plate method. Res Pharma Sci 2(2):113&#x02013;118. Available at: <ext-link ext-link-type="uri" xlink:href="http://rps.mui.ac.ir/index.php/jrps/article/view/35/33">http://rps.mui.ac.ir/index.php/jrps/article/view/35/33</ext-link></mixed-citation></ref><ref id="CR354"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahdi</surname><given-names>LH</given-names></name><name><surname>Jabbar</surname><given-names>HS</given-names></name><name><surname>Auda</surname><given-names>IG</given-names></name></person-group><article-title>Antibacterial immunomodulatory and antibiofilm triple effect of salivaricin LHM against <italic>Pseudomonas aeruginosa</italic> urinary tract infection model</article-title><source>Int J Biol Macromol</source><year>2019</year><volume>134</volume><fpage>1132</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.05.181</pub-id><?supplied-pmid 31136751?><pub-id pub-id-type="pmid">31136751</pub-id>
</element-citation></ref><ref id="CR355"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majeed</surname><given-names>H</given-names></name><name><surname>Gillor</surname><given-names>O</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Riley</surname><given-names>MA</given-names></name></person-group><article-title>Competitive interactions in <italic>Escherichia coli</italic> populations: the role of bacteriocins</article-title><source>ISME J</source><year>2011</year><volume>5</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/ismej.2010.90</pub-id><?supplied-pmid 20664553?><pub-id pub-id-type="pmid">20664553</pub-id>
</element-citation></ref><ref id="CR356"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado-Barrag&#x000e1;n</surname><given-names>A</given-names></name><name><surname>Caballero-Guerrero</surname><given-names>B</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>V</given-names></name><etal/></person-group><article-title>Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from <italic>Lactobacillus gasser</italic>i EV1461 isolated from the vagina of a healthy woman</article-title><source>BMC Microbiol</source><year>2016</year><volume>16</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.1186/s12866-016-0663-1</pub-id><?supplied-pmid 26969428?><pub-id pub-id-type="pmid">26969428</pub-id>
</element-citation></ref><ref id="CR357"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>HC</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Worobo</surname><given-names>RW</given-names></name><name><surname>Russell</surname><given-names>JB</given-names></name></person-group><article-title>Bovicin HC5, a bacteriocin from <italic>Streptococcus bovis</italic> HC5</article-title><source>Microbiology (Reading, Engl)</source><year>2002</year><volume>148</volume><fpage>3347</fpage><lpage>3352</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-11-3347</pub-id></element-citation></ref><ref id="CR358"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ed;n-Cevada</surname><given-names>V</given-names></name><name><surname>Mu&#x000f1;oz-Rojas</surname><given-names>J</given-names></name><name><surname>Caballero-Mellado</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antagonistic interactions among bacteria inhabiting pineapple</article-title><source>Appl Soil Ecol</source><year>2012</year><volume>61</volume><fpage>230</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.apsoil.2011.11.014</pub-id></element-citation></ref><ref id="CR359"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Bland</surname><given-names>MJ</given-names></name><name><surname>Rodriguez-Villalobos</surname><given-names>H</given-names></name><etal/></person-group><article-title>Promising antimicrobial activity and synergy of bacteriocins against <italic>Mycobacterium tuberculosis</italic></article-title><source>Microb Drug Resist</source><year>2023</year><volume>29</volume><fpage>165</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1089/mdr.2021.0429</pub-id><?supplied-pmid 35852864?><pub-id pub-id-type="pmid">35852864</pub-id>
</element-citation></ref><ref id="CR360"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>RCR</given-names></name><name><surname>Staliano</surname><given-names>CD</given-names></name><name><surname>Vieira</surname><given-names>ADS</given-names></name><etal/></person-group><article-title>Bacteriocin production and inhibition of <italic>Listeria monocytogenes</italic> by <italic>Lactobacillus sakei</italic> subsp. sakei 2a in a potentially synbiotic cheese spread</article-title><source>Food Microbiol</source><year>2015</year><volume>48</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2014.12.010</pub-id><?supplied-pmid 25791002?><pub-id pub-id-type="pmid">25791002</pub-id>
</element-citation></ref><ref id="CR361"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>J</given-names></name><name><surname>Vasconcelos</surname><given-names>V</given-names></name></person-group><article-title>Cyanobactins from cyanobacteria: current genetic and chemical state of knowledge</article-title><source>Mar Drugs</source><year>2015</year><volume>13</volume><fpage>6910</fpage><lpage>6946</lpage><pub-id pub-id-type="doi">10.3390/md13116910</pub-id><?supplied-pmid 26580631?><pub-id pub-id-type="pmid">26580631</pub-id>
</element-citation></ref><ref id="CR362"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>J</given-names></name><name><surname>Leikoski</surname><given-names>N</given-names></name><name><surname>Wahlsten</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sphaerocyclamide, a prenylated cyanobactin from the cyanobacterium <italic>Sphaerospermopsis</italic> sp. LEGE 00249</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>14537</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-32618-5</pub-id><?supplied-pmid 30266955?><pub-id pub-id-type="pmid">30266955</pub-id>
</element-citation></ref><ref id="CR363"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathur</surname><given-names>H</given-names></name><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Rea</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Fighting biofilms with lantibiotics and other groups of bacteriocins</article-title><source>Npj Biofilms Microbiomes</source><year>2018</year><volume>4</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1038/s41522-018-0053-6</pub-id><?supplied-pmid 29707229?><pub-id pub-id-type="pmid">29707229</pub-id>
</element-citation></ref><ref id="CR364"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mba</surname><given-names>IE</given-names></name><name><surname>Nweze</surname><given-names>EI</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Hameed</surname><given-names>S</given-names></name><name><surname>Rehman</surname><given-names>S</given-names></name></person-group><article-title>Application of nanotechnology in the treatment of infectious diseases: an overview</article-title><source>Nanotechnology for infectious diseases</source><year>2022</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer Singapore</publisher-name><fpage>25</fpage><lpage>51</lpage></element-citation></ref><ref id="CR365"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAllister</surname><given-names>TA</given-names></name><name><surname>Beauchemin</surname><given-names>KA</given-names></name><name><surname>Alazzeh</surname><given-names>AY</given-names></name><etal/></person-group><article-title>Review: The use of direct fed microbials to mitigate pathogens and enhance production in cattle</article-title><source>Can J Anim Sci</source><year>2011</year><volume>91</volume><fpage>193</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.4141/cjas10047</pub-id></element-citation></ref><ref id="CR366"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaughey</surname><given-names>LC</given-names></name><name><surname>Ritchie</surname><given-names>ND</given-names></name><name><surname>Douce</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Efficacy of species-specific protein antibiotics in a murine model of acute <italic>Pseudomonas aeruginosa</italic> lung infection</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>30201</fpage><pub-id pub-id-type="doi">10.1038/srep30201</pub-id><?supplied-pmid 27444885?><pub-id pub-id-type="pmid">27444885</pub-id>
</element-citation></ref><ref id="CR367"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Md Sidek</surname><given-names>NL</given-names></name><name><surname>Halim</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Stability of bacteriocin-like inhibitory substance (BLIS) produced by <italic>Pediococcus acidilactici</italic> kp10 at different extreme conditions</article-title><source>Biomed Res Int</source><year>2018</year><volume>2018</volume><fpage>5973484</fpage><pub-id pub-id-type="doi">10.1155/2018/5973484</pub-id><?supplied-pmid 30363649?><pub-id pub-id-type="pmid">30363649</pub-id>
</element-citation></ref><ref id="CR368"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meade</surname><given-names>E</given-names></name><name><surname>Slattery</surname><given-names>MA</given-names></name><name><surname>Garvey</surname><given-names>M</given-names></name></person-group><article-title>Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile?</article-title><source>Antibiotics (Basel)</source><year>2020</year><pub-id pub-id-type="doi">10.3390/antibiotics9010032</pub-id><?supplied-pmid 31963311?><pub-id pub-id-type="pmid">31963311</pub-id>
</element-citation></ref><ref id="CR369"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RR</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Taylor</surname><given-names>BN</given-names></name><etal/></person-group><article-title>A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt</article-title><source>Angiogenesis</source><year>2011</year><volume>14</volume><fpage>355</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s10456-011-9220-6</pub-id><?supplied-pmid 21667138?><pub-id pub-id-type="pmid">21667138</pub-id>
</element-citation></ref><ref id="CR370"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meira</surname><given-names>SMM</given-names></name><name><surname>Zehetmeyer</surname><given-names>G</given-names></name><name><surname>Scheibel</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Starch-halloysite nanocomposites containing nisin: characterization and inhibition of <italic>Listeria monocytogenes</italic> in soft cheese</article-title><source>LWT Food Sci Technol</source><year>2016</year><volume>68</volume><fpage>226</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2015.12.006</pub-id></element-citation></ref><ref id="CR371"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melian</surname><given-names>C</given-names></name><name><surname>Segli</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>R</given-names></name><etal/></person-group><article-title>Lactocin AL705 as quorum sensing inhibitor to control <italic>Listeria monocytogenes</italic> biofilm formation</article-title><source>J Appl Microbiol</source><year>2019</year><volume>127</volume><fpage>911</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1111/jam.14348</pub-id><?supplied-pmid 31206966?><pub-id pub-id-type="pmid">31206966</pub-id>
</element-citation></ref><ref id="CR372"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesa-Pereira</surname><given-names>B</given-names></name><name><surname>Rea</surname><given-names>MC</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Heterologous expression of biopreservative bacteriocins with a view to low cost production</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1654</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01654</pub-id><?supplied-pmid 30093889?><pub-id pub-id-type="pmid">30093889</pub-id>
</element-citation></ref><ref id="CR373"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mihailovskaya</surname><given-names>VS</given-names></name><name><surname>Sutormin</surname><given-names>DA</given-names></name><name><surname>Karipova</surname><given-names>MO</given-names></name><etal/></person-group><article-title>Bacteriocin-producing <italic>Escherichia coli</italic> Q5 and C41 with potential probiotic properties: in silico, in vitro, and in vivo studies</article-title><source>Int J Mol Sci</source><year>2023</year><pub-id pub-id-type="doi">10.3390/ijms241612636</pub-id><?supplied-pmid 37628817?><pub-id pub-id-type="pmid">37628817</pub-id>
</element-citation></ref><ref id="CR374"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millette</surname><given-names>M</given-names></name><name><surname>Cornut</surname><given-names>G</given-names></name><name><surname>Dupont</surname><given-names>C</given-names></name><etal/></person-group><article-title>Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci</article-title><source>Appl Environ Microbiol</source><year>2008</year><volume>74</volume><fpage>1997</fpage><lpage>2003</lpage><pub-id pub-id-type="doi">10.1128/AEM.02150-07</pub-id><?supplied-pmid 18245231?><pub-id pub-id-type="pmid">18245231</pub-id>
</element-citation></ref><ref id="CR375"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>S</given-names></name><name><surname>Serrano</surname><given-names>LM</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Inhibitory activity of <italic>Lactobacillus plantarum</italic> LMG P-26358 against <italic>Listeria innocua</italic> when used as an adjunct starter in the manufacture of cheese</article-title><source>Microb Cell Fact</source><year>2011</year><volume>10</volume><issue>Suppl 1</issue><fpage>S7</fpage><pub-id pub-id-type="doi">10.1186/1475-2859-10-S1-S7</pub-id><?supplied-pmid 21995443?><pub-id pub-id-type="pmid">21995443</pub-id>
</element-citation></ref><ref id="CR376"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>S</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology</article-title><source>FEMS Microbiol Rev</source><year>2017</year><volume>41</volume><fpage>S129</fpage><lpage>S153</lpage><pub-id pub-id-type="doi">10.1093/femsre/fux022</pub-id><?supplied-pmid 28830091?><pub-id pub-id-type="pmid">28830091</pub-id>
</element-citation></ref><ref id="CR377"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ming</surname><given-names>X</given-names></name><name><surname>Weber</surname><given-names>GH</given-names></name><name><surname>Ayres</surname><given-names>JW</given-names></name><name><surname>Sandine</surname><given-names>WE</given-names></name></person-group><article-title>Bacteriocins applied to food packaging materials to inhibit <italic>Listeria monocytogenes</italic> on meats</article-title><source>J Food Sci</source><year>1997</year><volume>62</volume><fpage>413</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2621.1997.tb04015.x</pub-id></element-citation></ref><ref id="CR378"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzaee</surname><given-names>H</given-names></name><name><surname>Neira Peralta</surname><given-names>NL</given-names></name><name><surname>Carvalhais</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Plant-produced bacteriocins inhibit plant pathogens and confer disease resistance in tomato</article-title><source>N Biotechnol</source><year>2021</year><volume>63</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.nbt.2021.03.003</pub-id><?supplied-pmid 33766789?><pub-id pub-id-type="pmid">33766789</pub-id>
</element-citation></ref><ref id="CR379"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>BC</given-names></name><name><surname>Biswas</surname><given-names>SR</given-names></name></person-group><article-title>Potential application of the nisin Z preparation of <italic>Lactococcus lactis</italic> W8 in preservation of milk</article-title><source>Lett Appl Microbiol</source><year>2011</year><volume>53</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2011.03075.x</pub-id><?supplied-pmid 21554339?><pub-id pub-id-type="pmid">21554339</pub-id>
</element-citation></ref><ref id="CR380"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyauchi</surname><given-names>E</given-names></name><name><surname>O&#x02019;Callaghan</surname><given-names>J</given-names></name><name><surname>Butt&#x000f3;</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Mechanism of protection of transepithelial barrier function by <italic>Lactobacillus salivarius</italic>: strain dependence and attenuation by bacteriocin production</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2012</year><volume>303</volume><fpage>G1029</fpage><lpage>G1041</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00003.2012</pub-id><?supplied-pmid 22961803?><pub-id pub-id-type="pmid">22961803</pub-id>
</element-citation></ref><ref id="CR381"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokoena</surname><given-names>MP</given-names></name></person-group><article-title>Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review</article-title><source>Molecules</source><year>2017</year><pub-id pub-id-type="doi">10.3390/molecules22081255</pub-id><?supplied-pmid 28933759?><pub-id pub-id-type="pmid">28933759</pub-id>
</element-citation></ref><ref id="CR382"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molujin</surname><given-names>AM</given-names></name><name><surname>Abbasiliasi</surname><given-names>S</given-names></name><name><surname>Nurdin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bacteriocins as potential therapeutic approaches in the treatment of various cancers: a review of in vitro studies</article-title><source>Cancers (Basel)</source><year>2022</year><pub-id pub-id-type="doi">10.3390/cancers14194758</pub-id><?supplied-pmid 36230679?><pub-id pub-id-type="pmid">36230679</pub-id>
</element-citation></ref><ref id="CR383"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>SM</given-names></name><name><surname>Galvin</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>Evaluation of a spray-dried lacticin 3147 powder for the control of <italic>Listeria monocytogenes</italic> and <italic>Bacillus cereus</italic> in a range of food systems</article-title><source>Lett Appl Microbiol</source><year>2001</year><volume>33</volume><fpage>387</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1046/j.1472-765x.2001.01016.x</pub-id><?supplied-pmid 11696102?><pub-id pub-id-type="pmid">11696102</pub-id>
</element-citation></ref><ref id="CR384"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mota-Meira</surname><given-names>M</given-names></name><name><surname>LaPointe</surname><given-names>G</given-names></name><name><surname>Lacroix</surname><given-names>C</given-names></name><name><surname>Lavoie</surname><given-names>MC</given-names></name></person-group><article-title>MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens</article-title><source>Antimicrob Agents Chemother</source><year>2000</year><volume>44</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1128/AAC.44.1.24-29.2000</pub-id><?supplied-pmid 10602718?><pub-id pub-id-type="pmid">10602718</pub-id>
</element-citation></ref><ref id="CR385"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mota-Meira</surname><given-names>M</given-names></name><name><surname>Morency</surname><given-names>H</given-names></name><name><surname>Lavoie</surname><given-names>MC</given-names></name></person-group><article-title>In vivo activity of mutacin B-Ny266</article-title><source>J Antimicrob Chemother</source><year>2005</year><volume>56</volume><fpage>869</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1093/jac/dki295</pub-id><?supplied-pmid 16155061?><pub-id pub-id-type="pmid">16155061</pub-id>
</element-citation></ref><ref id="CR386"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouritzen</surname><given-names>MV</given-names></name><name><surname>Andrea</surname><given-names>A</given-names></name><name><surname>Qvist</surname><given-names>K</given-names></name><etal/></person-group><article-title>Immunomodulatory potential of nisin A with application in wound healing</article-title><source>Wound Repair Regen</source><year>2019</year><volume>27</volume><fpage>650</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1111/wrr.12743</pub-id><?supplied-pmid 31287619?><pub-id pub-id-type="pmid">31287619</pub-id>
</element-citation></ref><ref id="CR387"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousavi Khaneghah</surname><given-names>A</given-names></name><name><surname>Hashemi</surname><given-names>SMB</given-names></name><name><surname>Limbo</surname><given-names>S</given-names></name></person-group><article-title>Antimicrobial agents and packaging systems in antimicrobial active food packaging: an overview of approaches and interactions</article-title><source>Food Bioprod Process</source><year>2018</year><volume>111</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.fbp.2018.05.001</pub-id></element-citation></ref><ref id="CR388"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>C-Z</given-names></name><etal/></person-group><article-title>Antibacterial activity and action mode of crude bacteriocin C2&#x02013;1 from <italic>Ligilactobacillus salivarius</italic> C2&#x02013;1 against <italic>Listeria monocytogenes</italic> CICC 21633</article-title><source>LWT</source><year>2024</year><volume>193</volume><fpage>115765</fpage><pub-id pub-id-type="doi">10.1016/j.lwt.2024.115765</pub-id></element-citation></ref><ref id="CR389"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>A</given-names></name><name><surname>Maqueda</surname><given-names>M</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biocontrol of psychrotrophic enterotoxigenic <italic>Bacillus cereus</italic> in a nonfat hard cheese by an enterococcal strain-producing enterocin AS-48</article-title><source>J Food Prot</source><year>2004</year><volume>67</volume><fpage>1517</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.4315/0362-028x-67.7.1517</pub-id><?supplied-pmid 15270513?><pub-id pub-id-type="pmid">15270513</pub-id>
</element-citation></ref><ref id="CR390"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>A</given-names></name><name><surname>Ananou</surname><given-names>S</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Inhibition of <italic>Staphylococcus aureus</italic> in dairy products by enterocin AS-48 produced in situ and ex situ: bactericidal synergism with heat</article-title><source>Int Dairy J</source><year>2007</year><volume>17</volume><fpage>760</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2006.09.006</pub-id></element-citation></ref><ref id="CR391"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>EF</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Hogan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity</article-title><source>Gut</source><year>2013</year><volume>62</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2011-300705</pub-id><?supplied-pmid 22345653?><pub-id pub-id-type="pmid">22345653</pub-id>
</element-citation></ref><ref id="CR392"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naimi</surname><given-names>S</given-names></name><name><surname>Zirah</surname><given-names>S</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><etal/></person-group><article-title>Fate and biological activity of the antimicrobial lasso peptide microcin J25 under gastrointestinal tract conditions</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1764</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01764</pub-id><?supplied-pmid 30123205?><pub-id pub-id-type="pmid">30123205</pub-id>
</element-citation></ref><ref id="CR393"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naimi</surname><given-names>S</given-names></name><name><surname>Zirah</surname><given-names>S</given-names></name><name><surname>Greppi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impact of microcin J25 on the porcine microbiome in a continuous culture model</article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><fpage>930392</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.930392</pub-id><?supplied-pmid 35992668?><pub-id pub-id-type="pmid">35992668</pub-id>
</element-citation></ref><ref id="CR394"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naskar</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name></person-group><article-title>Potential novel food-related and biomedical applications of nanomaterials combined with bacteriocins</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><fpage>86</fpage><pub-id pub-id-type="doi">10.3390/pharmaceutics13010086</pub-id><?supplied-pmid 33440722?><pub-id pub-id-type="pmid">33440722</pub-id>
</element-citation></ref><ref id="CR395"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>L</given-names></name><name><surname>Zarazaga</surname><given-names>M</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bacteriocin production by lactic acid bacteria isolated from Rioja red wines</article-title><source>J Appl Microbiol</source><year>2000</year><volume>88</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2000.00865.x</pub-id><?supplied-pmid 10735242?><pub-id pub-id-type="pmid">10735242</pub-id>
</element-citation></ref><ref id="CR396"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>S</given-names></name><name><surname>Abla</surname><given-names>H</given-names></name><name><surname>Colmer-Hamood</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Under conditions closely mimicking vaginal fluid, <italic>Lactobacillus jensenii</italic> strain 62B produces a bacteriocin-like inhibitory substance that targets and eliminates <italic>Gardnerella</italic> species</article-title><source>Microbiology (Reading, Engl)</source><year>2023</year><pub-id pub-id-type="doi">10.1099/mic.0.001409</pub-id></element-citation></ref><ref id="CR397"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naveen</surname><given-names>SV</given-names></name><name><surname>Kalaivani</surname><given-names>K</given-names></name></person-group><article-title>Cancer stem cells and evolving novel therapies: a paradigm shift</article-title><source>Stem Cell Investig</source><year>2018</year><volume>5</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.21037/sci.2018.01.03</pub-id><?supplied-pmid 29430460?><pub-id pub-id-type="pmid">29430460</pub-id>
</element-citation></ref><ref id="CR398"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazari</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name></person-group><article-title>A PGPR-produced bacteriocin for sustainable agriculture: a review of thuricin 17 characteristics and applications</article-title><source>Front Plant Sci</source><year>2020</year><volume>11</volume><fpage>916</fpage><pub-id pub-id-type="doi">10.3389/fpls.2020.00916</pub-id><?supplied-pmid 32733506?><pub-id pub-id-type="pmid">32733506</pub-id>
</element-citation></ref><ref id="CR399"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negash</surname><given-names>AW</given-names></name><name><surname>Tsehai</surname><given-names>BA</given-names></name></person-group><article-title>Current applications of bacteriocin</article-title><source>Int J Microbiol</source><year>2020</year><volume>2020</volume><fpage>4374891</fpage><pub-id pub-id-type="doi">10.1155/2020/4374891</pub-id><?supplied-pmid 33488719?><pub-id pub-id-type="pmid">33488719</pub-id>
</element-citation></ref><ref id="CR400"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>ZJ</given-names></name><name><surname>Zarin</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Tan</surname><given-names>JS</given-names></name></person-group><article-title>Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review</article-title><source>RSC Adv</source><year>2020</year><volume>10</volume><fpage>38937</fpage><lpage>38964</lpage><pub-id pub-id-type="doi">10.1039/D0RA06161A</pub-id><?supplied-pmid 35518417?><pub-id pub-id-type="pmid">35518417</pub-id>
</element-citation></ref><ref id="CR401"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholas-Haizelden</surname><given-names>K</given-names></name><name><surname>Murphy</surname><given-names>B</given-names></name><name><surname>Hoptroff</surname><given-names>M</given-names></name><name><surname>Horsburgh</surname><given-names>MJ</given-names></name></person-group><article-title>Bioprospecting the skin microbiome: advances in therapeutics and personal care products</article-title><source>Microorganisms</source><year>2023</year><pub-id pub-id-type="doi">10.3390/microorganisms11081899</pub-id><?supplied-pmid 37630459?><pub-id pub-id-type="pmid">37630459</pub-id>
</element-citation></ref><ref id="CR402"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norouzi</surname><given-names>Z</given-names></name><name><surname>Salimi</surname><given-names>A</given-names></name><name><surname>Halabian</surname><given-names>R</given-names></name><name><surname>Fahimi</surname><given-names>H</given-names></name></person-group><article-title>Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines</article-title><source>Microb Pathog</source><year>2018</year><volume>123</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.07.006</pub-id><?supplied-pmid 30017942?><pub-id pub-id-type="pmid">30017942</pub-id>
</element-citation></ref><ref id="CR403"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>GE</given-names></name><name><surname>Patchett</surname><given-names>ML</given-names></name></person-group><article-title>The glycocins: in a class of their own</article-title><source>Curr Opin Struct Biol</source><year>2016</year><volume>40</volume><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2016.09.003</pub-id><?supplied-pmid 27662231?><pub-id pub-id-type="pmid">27662231</pub-id>
</element-citation></ref><ref id="CR404"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>RF</given-names></name></person-group><article-title>Bacterial vaginosis: many questions&#x02014;any answers?</article-title><source>Curr Opin Pediatr</source><year>2005</year><volume>17</volume><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1097/01.mop.0000170516.35272.45</pub-id><?supplied-pmid 16012258?><pub-id pub-id-type="pmid">16012258</pub-id>
</element-citation></ref><ref id="CR405"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name></person-group><article-title>Antimicrobial antagonists against food pathogens: a bacteriocin perspective</article-title><source>Curr Opin Food Sci</source><year>2015</year><volume>2</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.cofs.2015.01.004</pub-id></element-citation></ref><ref id="CR406"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>EF</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>The potency of the broad&#x000a0;spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>11833</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-30271-6</pub-id><?supplied-pmid 30087409?><pub-id pub-id-type="pmid">30087409</pub-id>
</element-citation></ref><ref id="CR407"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Kuniyoshi</surname><given-names>TM</given-names></name><name><surname>Oliveira</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Antimicrobials for food and feed; a bacteriocin perspective</article-title><source>Curr Opin Biotechnol</source><year>2020</year><volume>61</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2019.12.023</pub-id><?supplied-pmid 31968296?><pub-id pub-id-type="pmid">31968296</pub-id>
</element-citation></ref><ref id="CR408"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Mahony</surname><given-names>T</given-names></name><name><surname>Rekhif</surname><given-names>N</given-names></name><name><surname>Cavadini</surname><given-names>C</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name></person-group><article-title>The application of a fermented food ingredient containing &#x0201c;variacin&#x0201d;, a novel antimicrobial produced by <italic>Kocuria varians</italic>, to control the growth of <italic>Bacillus cereus</italic> in chilled dairy products</article-title><source>J Appl Microbiol</source><year>2001</year><volume>90</volume><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2001.01222.x</pub-id><?supplied-pmid 11155129?><pub-id pub-id-type="pmid">11155129</pub-id>
</element-citation></ref><ref id="CR409"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Reilly</surname><given-names>C</given-names></name><name><surname>Grimaud</surname><given-names>GM</given-names></name><name><surname>Coakley</surname><given-names>M</given-names></name><etal/></person-group><article-title>Modulation of the gut microbiome with nisin</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>7899</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-34586-x</pub-id><?supplied-pmid 37193715?><pub-id pub-id-type="pmid">37193715</pub-id>
</element-citation></ref><ref id="CR410"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>L</given-names></name><name><surname>Ryan</surname><given-names>MP</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name></person-group><article-title>Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481</article-title><source>Appl Environ Microbiol</source><year>2003</year><volume>69</volume><fpage>3681</fpage><lpage>3685</lpage><pub-id pub-id-type="doi">10.1128/AEM.69.6.3681-3685.2003</pub-id><?supplied-pmid 12788782?><pub-id pub-id-type="pmid">12788782</pub-id>
</element-citation></ref><ref id="CR411"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>JN</given-names></name><name><surname>Rea</surname><given-names>MC</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens</article-title><source>FEMS Microbiol Ecol</source><year>2019</year><pub-id pub-id-type="doi">10.1093/femsec/fiy241</pub-id><?supplied-pmid 30590567?><pub-id pub-id-type="pmid">30590567</pub-id>
</element-citation></ref><ref id="CR412"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogunbanwo</surname><given-names>ST</given-names></name><name><surname>Sanni</surname><given-names>AI</given-names></name><name><surname>Onilude</surname><given-names>AA</given-names></name></person-group><article-title>Influence of bacteriocin in the control of <italic>Escherichia coli</italic> infection of broiler chickens in Nigeria</article-title><source>World J Microbiol Biotechnol</source><year>2004</year><volume>20</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1023/B:WIBI.0000013311.43842.74</pub-id></element-citation></ref><ref id="CR413"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>MM</given-names></name><name><surname>Ramos</surname><given-names>ETA</given-names></name><name><surname>Drechsel</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Gluconacin from <italic>Gluconacetobacter diazotrophicus</italic> PAL5 is an active bacteriocin against phytopathogenic and beneficial sugarcane bacteria</article-title><source>J Appl Microbiol</source><year>2018</year><pub-id pub-id-type="doi">10.1111/jam.14074</pub-id><?supplied-pmid 30142702?><pub-id pub-id-type="pmid">30142702</pub-id>
</element-citation></ref><ref id="CR414"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oman</surname><given-names>TJ</given-names></name><name><surname>van der Donk</surname><given-names>WA</given-names></name></person-group><article-title>Insights into the mode of action of the two-peptide lantibiotic haloduracin</article-title><source>ACS Chem Biol</source><year>2009</year><volume>4</volume><fpage>865</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1021/cb900194x</pub-id><?supplied-pmid 19678697?><pub-id pub-id-type="pmid">19678697</pub-id>
</element-citation></ref><ref id="CR415"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongey</surname><given-names>EL</given-names></name><name><surname>Neubauer</surname><given-names>P</given-names></name></person-group><article-title>Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production</article-title><source>Microb Cell Fact</source><year>2016</year><volume>15</volume><fpage>97</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0502-y</pub-id><?supplied-pmid 27267232?><pub-id pub-id-type="pmid">27267232</pub-id>
</element-citation></ref><ref id="CR416"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongey</surname><given-names>EL</given-names></name><name><surname>Yassi</surname><given-names>H</given-names></name><name><surname>Pflugmacher</surname><given-names>S</given-names></name><name><surname>Neubauer</surname><given-names>P</given-names></name></person-group><article-title>Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies</article-title><source>Biotechnol Lett</source><year>2017</year><volume>39</volume><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1007/s10529-016-2279-9</pub-id><?supplied-pmid 28044226?><pub-id pub-id-type="pmid">28044226</pub-id>
</element-citation></ref><ref id="CR417"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opsata</surname><given-names>M</given-names></name><name><surname>Nes</surname><given-names>IF</given-names></name><name><surname>Holo</surname><given-names>H</given-names></name></person-group><article-title>Class IIa bacteriocin resistance in <italic>Enterococcus faecalis</italic> V583: the mannose PTS operon mediates global transcriptional responses</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>224</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-10-224</pub-id><?supplied-pmid 20738841?><pub-id pub-id-type="pmid">20738841</pub-id>
</element-citation></ref><ref id="CR418"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ormaasen</surname><given-names>I</given-names></name><name><surname>Rudi</surname><given-names>K</given-names></name><name><surname>Diep</surname><given-names>DB</given-names></name><name><surname>Snipen</surname><given-names>L</given-names></name></person-group><article-title>Metagenome-mining indicates an association between bacteriocin presence and strain diversity in the infant gut</article-title><source>BMC Genomics</source><year>2023</year><volume>24</volume><fpage>295</fpage><pub-id pub-id-type="doi">10.1186/s12864-023-09388-0</pub-id><?supplied-pmid 37259063?><pub-id pub-id-type="pmid">37259063</pub-id>
</element-citation></ref><ref id="CR419"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oumer</surname><given-names>A</given-names></name><name><surname>Garde</surname><given-names>S</given-names></name><name><surname>Gaya</surname><given-names>P</given-names></name><etal/></person-group><article-title>The effects of cultivating lactic starter cultures with bacteriocin-producing lactic acid bacteria</article-title><source>J Food Prot</source><year>2001</year><volume>64</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.4315/0362-028x-64.1.81</pub-id><?supplied-pmid 11198445?><pub-id pub-id-type="pmid">11198445</pub-id>
</element-citation></ref><ref id="CR420"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovchinnikov</surname><given-names>KV</given-names></name><name><surname>Kranjec</surname><given-names>C</given-names></name><name><surname>Thorstensen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Successful development of bacteriocins into therapeutic formulation for treatment of MRSA skin infection in a murine model</article-title><source>Antimicrob Agents Chemother</source><year>2020</year><volume>64</volume><fpage>e00829</fpage><lpage>e920</lpage><pub-id pub-id-type="doi">10.1128/AAC.00829-20</pub-id><?supplied-pmid 32958719?><pub-id pub-id-type="pmid">32958719</pub-id>
</element-citation></ref><ref id="CR421"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovchinnikov</surname><given-names>KV</given-names></name><name><surname>Kranjec</surname><given-names>C</given-names></name><name><surname>Telke</surname><given-names>A</given-names></name><etal/></person-group><article-title>A strong synergy between the thiopeptide bacteriocin micrococcin P1 and rifampicin against MRSA in a murine skin infection model</article-title><source>Front Immunol</source><year>2021</year><volume>12</volume><fpage>676534</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2021.676534</pub-id><?supplied-pmid 34276663?><pub-id pub-id-type="pmid">34276663</pub-id>
</element-citation></ref><ref id="CR422"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pablo</surname><given-names>MA</given-names></name><name><surname>Gaforio</surname><given-names>JJ</given-names></name><name><surname>Gallego</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Evaluation of immunomodulatory effects of nisin-containing diets on mice</article-title><source>FEMS Immunol Med Microbiol</source><year>1999</year><volume>24</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.1999.tb01262.x</pub-id><?supplied-pmid 10340710?><pub-id pub-id-type="pmid">10340710</pub-id>
</element-citation></ref><ref id="CR423"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>AD</given-names></name><name><surname>de Oliveira</surname><given-names>MD</given-names></name><name><surname>de Paula</surname><given-names>SO</given-names></name><etal/></person-group><article-title>Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity</article-title><source>Microbiology (Reading, Engl)</source><year>2012</year><volume>158</volume><fpage>2851</fpage><lpage>2858</lpage><pub-id pub-id-type="doi">10.1099/mic.0.062190-0</pub-id></element-citation></ref><ref id="CR424"><mixed-citation publication-type="other">Pan American Health Organization/World Health Organization (PAHO/WHO) Ten threats to global health in 2019. Available at: <ext-link ext-link-type="uri" xlink:href="https://www3.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=14916:ten-threats-to-global-health-in-2019&#x00026;Itemid=0&#x00026;lang=en#gsc.tab=0">https://www3.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=14916:ten-threats-to-global-health-in-2019&#x00026;Itemid=0&#x00026;lang=en#gsc.tab=0</ext-link>. Accessed 1 Sept 2023</mixed-citation></ref><ref id="CR425"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pararajasingam</surname><given-names>A</given-names></name><name><surname>Uwagwu</surname><given-names>J</given-names></name></person-group><article-title><italic>Lactobacillus</italic>: the not so friendly bacteria</article-title><source>BMJ Case Rep</source><year>2017</year><pub-id pub-id-type="doi">10.1136/bcr-2016-218423</pub-id><?supplied-pmid 28903972?><pub-id pub-id-type="pmid">28903972</pub-id>
</element-citation></ref><ref id="CR426"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parret</surname><given-names>AHA</given-names></name><name><surname>Temmerman</surname><given-names>K</given-names></name><name><surname>De Mot</surname><given-names>R</given-names></name></person-group><article-title>Novel lectin-like bacteriocins of biocontrol strain <italic>Pseudomonas fluorescens</italic> Pf-5</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><fpage>5197</fpage><lpage>5207</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.9.5197-5207.2005</pub-id><?supplied-pmid 16151105?><pub-id pub-id-type="pmid">16151105</pub-id>
</element-citation></ref><ref id="CR427"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>LM</given-names></name><name><surname>Daniele</surname><given-names>MB</given-names></name><name><surname>Giordano</surname><given-names>W</given-names></name><etal/></person-group><article-title>Purification and partial characterization of novel bacteriocin L23 produced by <italic>Lactobacillus fermentum</italic> L23</article-title><source>Curr Microbiol</source><year>2008</year><volume>56</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1007/s00284-007-9094-4</pub-id><?supplied-pmid 18172715?><pub-id pub-id-type="pmid">18172715</pub-id>
</element-citation></ref><ref id="CR428"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattanayaiying</surname><given-names>R</given-names></name><name><surname>H-Kittikun</surname><given-names>A</given-names></name><name><surname>Cutter</surname><given-names>CN</given-names></name></person-group><article-title>Incorporation of nisin Z and lauric arginate into pullulan films to inhibit foodborne pathogens associated with fresh and ready-to-eat muscle foods</article-title><source>Int J Food Microbiol</source><year>2015</year><volume>207</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2015.04.045</pub-id><?supplied-pmid 26001063?><pub-id pub-id-type="pmid">26001063</pub-id>
</element-citation></ref><ref id="CR429"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pendharkar</surname><given-names>S</given-names></name><name><surname>Skafte-Holm</surname><given-names>A</given-names></name><name><surname>Simsek</surname><given-names>G</given-names></name><name><surname>Haahr</surname><given-names>T</given-names></name></person-group><article-title>Lactobacilli and their probiotic effects in the vagina of reproductive age women</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><fpage>636</fpage><pub-id pub-id-type="doi">10.3390/microorganisms11030636</pub-id><?supplied-pmid 36985210?><pub-id pub-id-type="pmid">36985210</pub-id>
</element-citation></ref><ref id="CR430"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>RH</given-names></name><name><surname>Zendo</surname><given-names>T</given-names></name><name><surname>Sonomoto</surname><given-names>K</given-names></name></person-group><article-title>Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications</article-title><source>Microb Cell Fact</source><year>2014</year><volume>13</volume><issue>Suppl 1</issue><fpage>S3</fpage><pub-id pub-id-type="doi">10.1186/1475-2859-13-S1-S3</pub-id><?supplied-pmid 25186038?><pub-id pub-id-type="pmid">25186038</pub-id>
</element-citation></ref><ref id="CR431"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>RH</given-names></name><name><surname>Zendo</surname><given-names>T</given-names></name><name><surname>Sonomoto</surname><given-names>K</given-names></name></person-group><article-title>Circular and leaderless bacteriocins: biosynthesis, mode of action, applications, and prospects</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>2085</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02085</pub-id><?supplied-pmid 30233551?><pub-id pub-id-type="pmid">30233551</pub-id>
</element-citation></ref><ref id="CR432"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Cobas</surname><given-names>AE</given-names></name><name><surname>Rodr&#x000ed;guez-Beltr&#x000e1;n</surname><given-names>J</given-names></name><name><surname>Baquero</surname><given-names>F</given-names></name><name><surname>Coque</surname><given-names>TM</given-names></name></person-group><article-title>Ecology of the respiratory tract microbiome</article-title><source>Trends Microbiol</source><year>2023</year><volume>31</volume><fpage>972</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2023.04.006</pub-id><?supplied-pmid 37173205?><pub-id pub-id-type="pmid">37173205</pub-id>
</element-citation></ref><ref id="CR433"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Ibarreche</surname><given-names>M</given-names></name><name><surname>Castellano</surname><given-names>P</given-names></name><name><surname>Leclercq</surname><given-names>A</given-names></name><name><surname>Vignolo</surname><given-names>G</given-names></name></person-group><article-title>Control of <italic>Listeria monocytogenes</italic> biofilms on industrial surfaces by the bacteriocin-producing <italic>Lactobacillus sakei</italic> CRL1862</article-title><source>FEMS Microbiol Lett</source><year>2016</year><pub-id pub-id-type="doi">10.1093/femsle/fnw118</pub-id><?supplied-pmid 27190146?><pub-id pub-id-type="pmid">27190146</pub-id>
</element-citation></ref><ref id="CR434"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phongphakdee</surname><given-names>K</given-names></name><name><surname>Nitisinprasert</surname><given-names>S</given-names></name></person-group><article-title>Combination inhibition activity of nisin and ethanol on the growth inhibition of pathogenic gram negative bacteria and their application as disinfectant solution</article-title><source>J Food Sci</source><year>2015</year><volume>80</volume><fpage>M2241</fpage><lpage>M2246</lpage><pub-id pub-id-type="doi">10.1111/1750-3841.13015</pub-id><?supplied-pmid 26409058?><pub-id pub-id-type="pmid">26409058</pub-id>
</element-citation></ref><ref id="CR435"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieterse</surname><given-names>R</given-names></name><name><surname>Todorov</surname><given-names>SD</given-names></name><name><surname>Dicks</surname><given-names>LMT</given-names></name></person-group><article-title>Mode of action and in vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin</article-title><source>Braz J Microbiol</source><year>2010</year><volume>41</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822010000100020</pub-id><?supplied-pmid 24031473?><pub-id pub-id-type="pmid">24031473</pub-id>
</element-citation></ref><ref id="CR436"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieterse</surname><given-names>R</given-names></name><name><surname>Todorov</surname><given-names>SD</given-names></name><name><surname>Leon</surname><given-names>MTD</given-names></name></person-group><article-title>Mode of action and In vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin</article-title><source>Braz J Microbiol</source><year>2010</year><volume>41</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1590/S1517-838220100001000020</pub-id><?supplied-pmid 24031473?><pub-id pub-id-type="pmid">24031473</pub-id>
</element-citation></ref><ref id="CR437"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>AL</given-names></name><name><surname>Fernandes</surname><given-names>M</given-names></name><name><surname>Pinto</surname><given-names>C</given-names></name><etal/></person-group><article-title>Characterization of anti-<italic>Listeria</italic> bacteriocins isolated from shellfish: potential antimicrobials to control non-fermented seafood</article-title><source>Int J Food Microbiol</source><year>2009</year><volume>129</volume><fpage>50</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.11.005</pub-id><?supplied-pmid 19081155?><pub-id pub-id-type="pmid">19081155</pub-id>
</element-citation></ref><ref id="CR438"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piper</surname><given-names>C</given-names></name><name><surname>Draper</surname><given-names>LA</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>A comparison of the activities of lacticin 3147 and nisin against drug-resistant <italic>Staphylococcus aureus</italic> and <italic>Enterococcus</italic> species</article-title><source>J Antimicrob Chemother</source><year>2009</year><volume>64</volume><fpage>546</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1093/jac/dkp221</pub-id><?supplied-pmid 19561147?><pub-id pub-id-type="pmid">19561147</pub-id>
</element-citation></ref><ref id="CR439"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pog&#x000e1;ny Simonov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Chrastinov&#x000e1;</surname><given-names>&#x0013d;</given-names></name><name><surname>&#x00160;&#x0010d;erbov&#x000e1;</surname><given-names>J</given-names></name><etal/></person-group><article-title>Preventive potential of dipeptide enterocin A/P on rabbit health and its effect on growth, microbiota, and immune response</article-title><source>Animals (Basel)</source><year>2022</year><pub-id pub-id-type="doi">10.3390/ani12091108</pub-id><?supplied-pmid 36009700?><pub-id pub-id-type="pmid">36009700</pub-id>
</element-citation></ref><ref id="CR440"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polak</surname><given-names>K</given-names></name><name><surname>Jobb&#x000e1;gy</surname><given-names>A</given-names></name><name><surname>Muszy&#x00144;ski</surname><given-names>T</given-names></name><etal/></person-group><article-title>Microbiome modulation as a therapeutic approach in chronic skin diseases</article-title><source>Biomedicines</source><year>2021</year><pub-id pub-id-type="doi">10.3390/biomedicines9101436</pub-id><?supplied-pmid 34680552?><pub-id pub-id-type="pmid">34680552</pub-id>
</element-citation></ref><ref id="CR441"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prescott</surname><given-names>J</given-names></name></person-group><article-title>Veterinary antimicrobial stewardship in australia</article-title><source>Can Vet J</source><year>2019</year><volume>60</volume><fpage>246</fpage><lpage>248</lpage><?supplied-pmid 30872846?><pub-id pub-id-type="pmid">30872846</pub-id>
</element-citation></ref><ref id="CR442"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pr&#x000ed;ncipe</surname><given-names>A</given-names></name><name><surname>Fernandez</surname><given-names>M</given-names></name><name><surname>Torasso</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effectiveness of tailocins produced by <italic>Pseudomonas fluorescens</italic> SF4c in controlling the bacterial-spot disease in tomatoes caused by <italic>Xanthomonas vesicatoria</italic></article-title><source>Microbiol Res</source><year>2018</year><volume>212&#x02013;213</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2018.05.010</pub-id><?supplied-pmid 29853172?><pub-id pub-id-type="pmid">29853172</pub-id>
</element-citation></ref><ref id="CR443"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Promrug</surname><given-names>D</given-names></name><name><surname>Wittayacom</surname><given-names>K</given-names></name><name><surname>Nathapanan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cocultures of <italic>Enterococcus faecium</italic> and <italic>Aeromonas veronii</italic> induce the secretion of bacteriocin-like substances against aeromonas</article-title><source>J Agric Food Chem</source><year>2023</year><volume>71</volume><fpage>16194</fpage><lpage>16203</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.3c04019</pub-id><?supplied-pmid 37779478?><pub-id pub-id-type="pmid">37779478</pub-id>
</element-citation></ref><ref id="CR444"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudent</surname><given-names>M</given-names></name><name><surname>Salon</surname><given-names>C</given-names></name><name><surname>Souleimanov</surname><given-names>A</given-names></name><etal/></person-group><article-title>Soybean is less impacted by water stress using <italic>Bradyrhizobium japonicum</italic> and thuricin-17 from <italic>Bacillus thuringiensis</italic></article-title><source>Agron Sust Dev</source><year>2015</year><volume>35</volume><fpage>749</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1007/s13593-014-0256-z</pub-id></element-citation></ref><ref id="CR445"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Hang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><etal/></person-group><article-title>A Class IIb bacteriocin plantaricin NC8 modulates gut microbiota of different enterotypes in vitro</article-title><source>Front Nutr</source><year>2022</year><volume>9</volume><fpage>877948</fpage><pub-id pub-id-type="doi">10.3389/fnut.2022.877948</pub-id><?supplied-pmid 35845772?><pub-id pub-id-type="pmid">35845772</pub-id>
</element-citation></ref><ref id="CR446"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puls</surname><given-names>J-S</given-names></name><name><surname>Winnerling</surname><given-names>B</given-names></name><name><surname>Power</surname><given-names>JJ</given-names></name><etal/></person-group><article-title><italic>Staphylococcus epidermidis</italic> bacteriocin A37 kills natural competitors with a unique mechanism of action</article-title><source>ISME J</source><year>2024</year><pub-id pub-id-type="doi">10.1093/ismejo/wrae044</pub-id><?supplied-pmid 38470311?><pub-id pub-id-type="pmid">38470311</pub-id>
</element-citation></ref><ref id="CR447"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulse</surname><given-names>ME</given-names></name><name><surname>Weiss</surname><given-names>WJ</given-names></name><name><surname>Kers</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Pharmacological, toxicological, and dose range assessment of OG716, a novel lantibiotic for the treatment of <italic>Clostridium difficile</italic>-associated infection</article-title><source>Antimicrob Agents Chemother</source><year>2019</year><pub-id pub-id-type="doi">10.1128/AAC.01904-18</pub-id><?supplied-pmid 31636067?><pub-id pub-id-type="pmid">31636067</pub-id>
</element-citation></ref><ref id="CR448"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quereda</surname><given-names>JJ</given-names></name><name><surname>Dussurget</surname><given-names>O</given-names></name><name><surname>Nahori</surname><given-names>M-A</given-names></name><etal/></person-group><article-title>Bacteriocin from epidemic <italic>Listeria</italic> strains alters the host intestinal microbiota to favor infection</article-title><source>Proc Natl Acad Sci USA</source><year>2016</year><volume>113</volume><fpage>5706</fpage><lpage>5711</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523899113</pub-id><?supplied-pmid 27140611?><pub-id pub-id-type="pmid">27140611</pub-id>
</element-citation></ref><ref id="CR449"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>VM</given-names></name><name><surname>Torres</surname><given-names>NI</given-names></name><name><surname>Wachsman</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin</article-title><source>J Appl Microbiol</source><year>2014</year><volume>117</volume><fpage>1253</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1111/jam.12618</pub-id><?supplied-pmid 25087911?><pub-id pub-id-type="pmid">25087911</pub-id>
</element-citation></ref><ref id="CR450"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>H</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Rasool</surname><given-names>SA</given-names></name></person-group><article-title>Coliphage HSA as a model for antiviral studies/spectrum by some indigenous bacteriocin like inhibitory substances (BLIS)</article-title><source>Pak J Pharm Sci</source><year>2006</year><volume>19</volume><fpage>182</fpage><lpage>185</lpage><?supplied-pmid 16935823?><pub-id pub-id-type="pmid">16935823</pub-id>
</element-citation></ref><ref id="CR451"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raheel</surname><given-names>I</given-names></name><name><surname>Mohammed</surname><given-names>AN</given-names></name><name><surname>Mohamed</surname><given-names>AA</given-names></name></person-group><article-title>The efficacy of bacteriocins against biofilm-producing bacteria causing bovine clinical mastitis in dairy farms: a new strategy</article-title><source>Curr Microbiol</source><year>2023</year><volume>80</volume><fpage>229</fpage><pub-id pub-id-type="doi">10.1007/s00284-023-03324-x</pub-id><?supplied-pmid 37256384?><pub-id pub-id-type="pmid">37256384</pub-id>
</element-citation></ref><ref id="CR452"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>M</given-names></name><name><surname>Ambalam</surname><given-names>P</given-names></name><name><surname>Doble</surname><given-names>M</given-names></name></person-group><source>Probiotics and bioactive carbohydrates in colon cancer management</source><year>2016</year><publisher-loc>New Delhi</publisher-loc><publisher-name>Springer India</publisher-name></element-citation></ref><ref id="CR453"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramu</surname><given-names>R</given-names></name><name><surname>Shirahatti</surname><given-names>PS</given-names></name><name><surname>Devi</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Bacteriocins and their applications in food preservation</article-title><source>Crit Rev Food Sci Nutr</source><year>2015</year><pub-id pub-id-type="doi">10.1080/10408398.2015.1020918</pub-id></element-citation></ref><ref id="CR454"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>P</given-names></name><name><surname>Tiwari</surname><given-names>SK</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sobti</surname><given-names>RC</given-names></name><name><surname>Kuhad</surname><given-names>RC</given-names></name><name><surname>Lal</surname><given-names>R</given-names></name><name><surname>Rishi</surname><given-names>P</given-names></name></person-group><article-title>Role of bacteriocins in modulation of microbiome in human diseases</article-title><source>Role of microbes in sustainable development: human health and diseases</source><year>2023</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer Nature Singapore</publisher-name><fpage>395</fpage><lpage>408</lpage></element-citation></ref><ref id="CR455"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasch</surname><given-names>M</given-names></name><name><surname>Kn&#x000f8;chel</surname><given-names>S</given-names></name></person-group><article-title>Variations in tolerance of <italic>Listeria monocytogenes</italic> to nisin, pediocin PA-1 and bavaricin A</article-title><source>Lett Appl Microbiol</source><year>1998</year><volume>27</volume><fpage>275</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1046/j.1472-765x.1998.t01-6-00449.x</pub-id><?supplied-pmid 9830144?><pub-id pub-id-type="pmid">9830144</pub-id>
</element-citation></ref><ref id="CR456"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>MC</given-names></name><name><surname>Clayton</surname><given-names>E</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Antimicrobial activity of lacticin 3,147 against clinical <italic>Clostridium difficile</italic> strains</article-title><source>J Med Microbiol</source><year>2007</year><volume>56</volume><fpage>940</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.47085-0</pub-id><?supplied-pmid 17577060?><pub-id pub-id-type="pmid">17577060</pub-id>
</element-citation></ref><ref id="CR457"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>MC</given-names></name><name><surname>Sit</surname><given-names>CS</given-names></name><name><surname>Clayton</surname><given-names>E</given-names></name><etal/></person-group><article-title>Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against <italic>Clostridium difficile</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>9352</fpage><lpage>9357</lpage><pub-id pub-id-type="doi">10.1073/pnas.0913554107</pub-id><?supplied-pmid 20435915?><pub-id pub-id-type="pmid">20435915</pub-id>
</element-citation></ref><ref id="CR458"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>MC</given-names></name><name><surname>Alemayehu</surname><given-names>D</given-names></name><name><surname>Casey</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract</article-title><source>Microbiology (Reading, Engl)</source><year>2014</year><volume>160</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1099/mic.0.068767-0</pub-id></element-citation></ref><ref id="CR459"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redero</surname><given-names>M</given-names></name><name><surname>L&#x000f3;pez-Causap&#x000e9;</surname><given-names>C</given-names></name><name><surname>Aznar</surname><given-names>J</given-names></name><etal/></person-group><article-title>Susceptibility to R-pyocins of <italic>Pseudomonas aeruginosa</italic> clinical isolates from cystic fibrosis patients</article-title><source>J Antimicrob Chemother</source><year>2018</year><volume>73</volume><fpage>2770</fpage><lpage>2776</lpage><pub-id pub-id-type="doi">10.1093/jac/dky261</pub-id><?supplied-pmid 30052973?><pub-id pub-id-type="pmid">30052973</pub-id>
</element-citation></ref><ref id="CR460"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinseth</surname><given-names>I</given-names></name><name><surname>Diep</surname><given-names>DB</given-names></name><name><surname>Kjos</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exploring the feasibility of bacteriocins EntK1 and EntEJ97s in treatment of systemic VRE infections in mice</article-title><source>J Appl Microbiol</source><year>2024</year><pub-id pub-id-type="doi">10.1093/jambio/lxae054</pub-id><?supplied-pmid 38439668?><pub-id pub-id-type="pmid">38439668</pub-id>
</element-citation></ref><ref id="CR461"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>RC</given-names></name><name><surname>Roy</surname><given-names>PC</given-names></name><name><surname>Sarkar</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Isolation, characterization, and assessment of lactic acid bacteria toward their selection as poultry probiotics</article-title><source>BMC Microbiol</source><year>2019</year><volume>19</volume><fpage>253</fpage><pub-id pub-id-type="doi">10.1186/s12866-019-1626-0</pub-id><?supplied-pmid 31718570?><pub-id pub-id-type="pmid">31718570</pub-id>
</element-citation></ref><ref id="CR462"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>RC</given-names></name><name><surname>Roy</surname><given-names>PC</given-names></name><name><surname>Sarkar</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Characterization and evaluation of lactic acid bacteria from indigenous raw milk for potential probiotic properties</article-title><source>J Dairy Sci</source><year>2020</year><volume>103</volume><fpage>1223</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-17092</pub-id><?supplied-pmid 31759592?><pub-id pub-id-type="pmid">31759592</pub-id>
</element-citation></ref><ref id="CR463"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>RC</given-names></name><name><surname>Sarkar</surname><given-names>SL</given-names></name><name><surname>Ibnat</surname><given-names>H</given-names></name><etal/></person-group><article-title>Novel multi-strain probiotics reduces <italic>Pasteurella multocida</italic> induced fowl cholera mortality in broilers</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><fpage>8885</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-88299-0</pub-id><?supplied-pmid 33903662?><pub-id pub-id-type="pmid">33903662</pub-id>
</element-citation></ref><ref id="CR464"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>RC</given-names></name><name><surname>Sarkar</surname><given-names>SL</given-names></name><name><surname>Ibnat</surname><given-names>H</given-names></name><etal/></person-group><article-title>Novel mono- and multi-strain probiotics supplementation modulates growth, intestinal microflora composition and haemato-biochemical parameters in broiler chickens</article-title><source>Vet Med Sci</source><year>2022</year><pub-id pub-id-type="doi">10.1002/vms3.709</pub-id><?supplied-pmid 35014219?><pub-id pub-id-type="pmid">35014219</pub-id>
</element-citation></ref><ref id="CR465"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>RC</given-names></name><name><surname>Beugnon</surname><given-names>R</given-names></name><name><surname>Jurburg</surname><given-names>SD</given-names></name></person-group><article-title>COVID-19 alters human microbiomes: a meta-analysis</article-title><source>Front Cell Infect Microbiol</source><year>2023</year><volume>13</volume><fpage>1211348</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2023.1211348</pub-id><?supplied-pmid 37600938?><pub-id pub-id-type="pmid">37600938</pub-id>
</element-citation></ref><ref id="CR466"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>SC</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>PM</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><etal/></person-group><article-title>An anti-listerial <italic>Lactococcus lactis</italic> strain isolated from Azorean Pico cheese produces lacticin 481</article-title><source>Int Dairy J</source><year>2016</year><volume>63</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2016.07.017</pub-id></element-citation></ref><ref id="CR467"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riboulet-Bisson</surname><given-names>E</given-names></name><name><surname>Sturme</surname><given-names>MHJ</given-names></name><name><surname>Jeffery</surname><given-names>IB</given-names></name><etal/></person-group><article-title>Effect of <italic>Lactobacillus salivarius</italic> bacteriocin Abp118 on the mouse and pig intestinal microbiota</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e31113</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0031113</pub-id><?supplied-pmid 22363561?><pub-id pub-id-type="pmid">22363561</pub-id>
</element-citation></ref><ref id="CR468"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>K</given-names></name><name><surname>Wohlrab</surname><given-names>J</given-names></name></person-group><article-title>Impact of preservatives in topicals on the cutaneous microbiota</article-title><source>Dermatologie (heidelb)</source><year>2023</year><volume>74</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1007/s00105-023-05112-x</pub-id><?supplied-pmid 36729161?><pub-id pub-id-type="pmid">36729161</pub-id>
</element-citation></ref><ref id="CR469"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>MA</given-names></name></person-group><article-title>Molecular mechanisms of bacteriocin evolution</article-title><source>Annu Rev Genet</source><year>1998</year><volume>32</volume><fpage>255</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.32.1.255</pub-id><?supplied-pmid 9928481?><pub-id pub-id-type="pmid">9928481</pub-id>
</element-citation></ref><ref id="CR470"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>MA</given-names></name><name><surname>Gordon</surname><given-names>DM</given-names></name></person-group><article-title>The ecological role of bacteriocins in bacterial competition</article-title><source>Trends Microbiol</source><year>1999</year><volume>7</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/s0966-842x(99)01459-6</pub-id><?supplied-pmid 10203843?><pub-id pub-id-type="pmid">10203843</pub-id>
</element-citation></ref><ref id="CR471"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>MA</given-names></name><name><surname>Wertz</surname><given-names>JE</given-names></name></person-group><article-title>Bacteriocins: evolution, ecology, and application</article-title><source>Annu Rev Microbiol</source><year>2002</year><volume>56</volume><fpage>117</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.56.012302.161024</pub-id><?supplied-pmid 12142491?><pub-id pub-id-type="pmid">12142491</pub-id>
</element-citation></ref><ref id="CR472"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ring&#x000f8;</surname><given-names>E</given-names></name><name><surname>Hoseinifar</surname><given-names>SH</given-names></name><name><surname>Ghosh</surname><given-names>K</given-names></name><etal/></person-group><article-title>Lactic acid bacteria in finfish&#x02014;an update</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1818</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01818</pub-id><?supplied-pmid 30147679?><pub-id pub-id-type="pmid">30147679</pub-id>
</element-citation></ref><ref id="CR473"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000ed;os Colombo</surname><given-names>NS</given-names></name><name><surname>Perez-Ibarreche</surname><given-names>M</given-names></name><name><surname>Draper</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Impact of bacteriocin-producing strains on bacterial community composition in a simplified human intestinal microbiota</article-title><source>Front Microbiol</source><year>2023</year><pub-id pub-id-type="doi">10.3389/fmicb.2023.1290697</pub-id><?supplied-pmid 38143858?><pub-id pub-id-type="pmid">38143858</pub-id>
</element-citation></ref><ref id="CR474"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Hern&#x000e1;ndez</surname><given-names>L</given-names></name><name><surname>Chavarr&#x000ed;a-Hern&#x000e1;ndez</surname><given-names>N</given-names></name><name><surname>L&#x000f3;pez Cuellar</surname><given-names>MDR</given-names></name><etal/></person-group><article-title>Pectin-gellan films intended for active food packaging: release kinetics of nisin and physico-mechanical characterization</article-title><source>J Food Sci Technol</source><year>2021</year><volume>58</volume><fpage>2973</fpage><lpage>2981</lpage><pub-id pub-id-type="doi">10.1007/s13197-020-04800-z</pub-id><?supplied-pmid 34294959?><pub-id pub-id-type="pmid">34294959</pub-id>
</element-citation></ref><ref id="CR475"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodnina</surname><given-names>MV</given-names></name><name><surname>Savelsbergh</surname><given-names>A</given-names></name><name><surname>Matassova</surname><given-names>NB</given-names></name><etal/></person-group><article-title>Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>9586</fpage><lpage>9590</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9586</pub-id><?supplied-pmid 10449736?><pub-id pub-id-type="pmid">10449736</pub-id>
</element-citation></ref><ref id="CR476"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojo-Bezares</surname><given-names>B</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>Y</given-names></name><name><surname>Navarro</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characterization of a new organization of the plantaricin locus in the inducible bacteriocin-producing <italic>Lactobacillus plantarum</italic> J23 of grape must origin</article-title><source>Arch Microbiol</source><year>2008</year><volume>189</volume><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1007/s00203-007-0342-6</pub-id><?supplied-pmid 18193201?><pub-id pub-id-type="pmid">18193201</pub-id>
</element-citation></ref><ref id="CR477"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolhion</surname><given-names>N</given-names></name><name><surname>Chassaing</surname><given-names>B</given-names></name><name><surname>Nahori</surname><given-names>M-A</given-names></name><etal/></person-group><article-title>A <italic>Listeria monocytogenes</italic> bacteriocin can target the commensal <italic>Prevotella copri</italic> and modulate intestinal infection</article-title><source>Cell Host Microbe</source><year>2019</year><volume>26</volume><fpage>691</fpage><lpage>701.e5</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.10.016</pub-id><?supplied-pmid 31726031?><pub-id pub-id-type="pmid">31726031</pub-id>
</element-citation></ref><ref id="CR478"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooney</surname><given-names>WM</given-names></name><name><surname>Grinter</surname><given-names>RW</given-names></name><name><surname>Correia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Engineering bacteriocin-mediated resistance against the plant pathogen <italic>Pseudomonas syringae</italic></article-title><source>Plant Biotechnol J</source><year>2020</year><volume>18</volume><fpage>1296</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1111/pbi.13294</pub-id><?supplied-pmid 31705720?><pub-id pub-id-type="pmid">31705720</pub-id>
</element-citation></ref><ref id="CR479"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>CC</given-names></name><name><surname>Ahmad</surname><given-names>F</given-names></name><name><surname>Giambiagi-deMarval</surname><given-names>M</given-names></name></person-group><article-title><italic>Staphylococcus haemolyticus</italic>: an updated review on nosocomial infections, antimicrobial resistance, virulence, genetic traits, and strategies for combating this emerging opportunistic pathogen</article-title><source>Microbiol Res</source><year>2024</year><volume>282</volume><fpage>127652</fpage><pub-id pub-id-type="doi">10.1016/j.micres.2024.127652</pub-id><?supplied-pmid 38432015?><pub-id pub-id-type="pmid">38432015</pub-id>
</element-citation></ref><ref id="CR480"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>KA</given-names></name><name><surname>Jayaraman</surname><given-names>T</given-names></name><name><surname>Daly</surname><given-names>P</given-names></name><etal/></person-group><article-title>Isolation of lactobacilli with probiotic properties from the human stomach</article-title><source>Lett Appl Microbiol</source><year>2008</year><volume>47</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765x.2008.02416.x</pub-id><?supplied-pmid 19241519?><pub-id pub-id-type="pmid">19241519</pub-id>
</element-citation></ref><ref id="CR481"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybalchenko</surname><given-names>OV</given-names></name><name><surname>Bondarenko</surname><given-names>VM</given-names></name><name><surname>Orlova</surname><given-names>OG</given-names></name><etal/></person-group><article-title>Inhibitory effects of <italic>Lactobacillus fermentum</italic> on microbial growth and biofilm formation</article-title><source>Arch Microbiol</source><year>2015</year><volume>197</volume><fpage>1027</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1007/s00203-015-1140-1</pub-id><?supplied-pmid 26267163?><pub-id pub-id-type="pmid">26267163</pub-id>
</element-citation></ref><ref id="CR482"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sa&#x000e1; Ibusquiza</surname><given-names>P</given-names></name><name><surname>Herrera</surname><given-names>JJR</given-names></name><name><surname>Cabo</surname><given-names>ML</given-names></name></person-group><article-title>Resistance to benzalkonium chloride, peracetic acid and nisin during formation of mature biofilms by <italic>Listeria monocytogenes</italic></article-title><source>Food Microbiol</source><year>2011</year><volume>28</volume><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2010.09.014</pub-id><?supplied-pmid 21356446?><pub-id pub-id-type="pmid">21356446</pub-id>
</element-citation></ref><ref id="CR483"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sada</surname><given-names>RM</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Motooka</surname><given-names>D</given-names></name><etal/></person-group><article-title><italic>Clostridium butyricum</italic> bacteremia associated with probiotic use, Japan</article-title><source>Emerging Infect Dis</source><year>2024</year><pub-id pub-id-type="doi">10.3201/eid3004.231633</pub-id></element-citation></ref><ref id="CR484"><mixed-citation publication-type="other">Saeed S, Rasool SA, Ahmad S, Zaidi SE, Rehmanii S (2007) Antiviral activity of Staphylococcin 188: a purified bacteriocin like inhibitory substance isolated from <italic>Staphylococcus aureus</italic> AB188. Available at: <ext-link ext-link-type="uri" xlink:href="https://scialert.net/fulltext/?doi=jm.2007.796.806">https://scialert.net/fulltext/?doi=jm.2007.796.806</ext-link></mixed-citation></ref><ref id="CR485"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saelao</surname><given-names>S</given-names></name><name><surname>Maneerat</surname><given-names>S</given-names></name><name><surname>Kaewsuwan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inhibition of <italic>Staphylococcus aureus</italic> in vitro by bacteriocinogenic <italic>Lactococcus lactis</italic> KTH0-1S isolated from Thai fermented shrimp (Kung-som) and safety evaluation</article-title><source>Arch Microbiol</source><year>2017</year><volume>199</volume><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1007/s00203-016-1324-3</pub-id><?supplied-pmid 28058488?><pub-id pub-id-type="pmid">28058488</pub-id>
</element-citation></ref><ref id="CR486"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahoo</surname><given-names>TK</given-names></name><name><surname>Jena</surname><given-names>PK</given-names></name><name><surname>Prajapati</surname><given-names>B</given-names></name><etal/></person-group><article-title>In vivo assessment of immunogenicity and toxicity of the bacteriocin TSU4 in balb/c mice</article-title><source>Probiotics Antimicrob Proteins</source><year>2017</year><volume>9</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1007/s12602-016-9249-3</pub-id><?supplied-pmid 28063116?><pub-id pub-id-type="pmid">28063116</pub-id>
</element-citation></ref><ref id="CR487"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saising</surname><given-names>J</given-names></name><name><surname>Dube</surname><given-names>L</given-names></name><name><surname>Ziebandt</surname><given-names>A-K</given-names></name><etal/></person-group><article-title>Activity of gallidermin on <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic> biofilms</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>5804</fpage><lpage>5810</lpage><pub-id pub-id-type="doi">10.1128/AAC.01296-12</pub-id><?supplied-pmid 22926575?><pub-id pub-id-type="pmid">22926575</pub-id>
</element-citation></ref><ref id="CR488"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakayori</surname><given-names>Y</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name><name><surname>Hanada</surname><given-names>S</given-names></name><etal/></person-group><article-title>Characterization of <italic>Enterococcus faecium</italic> mutants resistant to mundticin KS, a class IIa bacteriocin</article-title><source>Microbiology (Reading, Engl)</source><year>2003</year><volume>149</volume><fpage>2901</fpage><lpage>2908</lpage><pub-id pub-id-type="doi">10.1099/mic.0.26435-0</pub-id></element-citation></ref><ref id="CR489"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar-Marroqu&#x000ed;n</surname><given-names>EL</given-names></name><name><surname>Gal&#x000e1;n-Wong</surname><given-names>LJ</given-names></name><name><surname>Moreno-Medina</surname><given-names>VR</given-names></name><etal/></person-group><article-title>Bacteriocins synthesized by <italic>Bacillus thuringiensis</italic>: generalities and potential applications</article-title><source>Rev Med Microbiol</source><year>2016</year><volume>27</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1097/MRM.0000000000000076</pub-id><?supplied-pmid 27340340?><pub-id pub-id-type="pmid">27340340</pub-id>
</element-citation></ref><ref id="CR490"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvucci</surname><given-names>E</given-names></name><name><surname>Saavedra</surname><given-names>L</given-names></name><name><surname>Hebert</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Enterocin CRL35 inhibits <italic>Listeria monocytogenes</italic> in a murine model</article-title><source>Foodborne Pathog Dis</source><year>2012</year><volume>9</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1089/fpd.2011.0972</pub-id><?supplied-pmid 22011041?><pub-id pub-id-type="pmid">22011041</pub-id>
</element-citation></ref><ref id="CR491"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez</surname><given-names>J</given-names></name><name><surname>Diep</surname><given-names>DB</given-names></name><name><surname>Herranz</surname><given-names>C</given-names></name><etal/></person-group><article-title>Amino acid and nucleotide sequence, adjacent genes, and heterologous expression of hiracin JM79, a sec-dependent bacteriocin produced by <italic>Enterococcus hirae</italic> DCH5, isolated from Mallard ducks (<italic>Anas platyrhynchos</italic>)</article-title><source>FEMS Microbiol Lett</source><year>2007</year><volume>270</volume><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00673.x</pub-id><?supplied-pmid 17326750?><pub-id pub-id-type="pmid">17326750</pub-id>
</element-citation></ref><ref id="CR492"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Rodriguez</surname><given-names>E</given-names></name><name><surname>Egea-Zorrilla</surname><given-names>A</given-names></name><name><surname>Plaza-D&#x000ed;az</surname><given-names>J</given-names></name><etal/></person-group><article-title>The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases</article-title><source>Nutrients</source><year>2020</year><pub-id pub-id-type="doi">10.3390/nu12030605</pub-id><?supplied-pmid 32110880?><pub-id pub-id-type="pmid">32110880</pub-id>
</element-citation></ref><ref id="CR493"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sand</surname><given-names>SL</given-names></name><name><surname>Nissen-Meyer</surname><given-names>J</given-names></name><name><surname>Sand</surname><given-names>O</given-names></name><name><surname>Haug</surname><given-names>TM</given-names></name></person-group><article-title>Plantaricin A, a cationic peptide produced by <italic>Lactobacillus plantarum</italic>, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins</article-title><source>Biochim Biophys Acta</source><year>2013</year><volume>1828</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2012.11.001</pub-id><?supplied-pmid 23142566?><pub-id pub-id-type="pmid">23142566</pub-id>
</element-citation></ref><ref id="CR494"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanguyo</surname><given-names>FHC</given-names></name><name><surname>Angeles</surname><given-names>FLA</given-names></name><name><surname>Deborde</surname><given-names>SMV</given-names></name><etal/></person-group><article-title>Bacteriocin and its current application as a food packaging film component against spoilage: a narrative review</article-title><source>AJBLS</source><year>2021</year><volume>10</volume><fpage>325</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.5530/ajbls.2021.10.45</pub-id></element-citation></ref><ref id="CR495"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>JCP</given-names></name><name><surname>Sousa</surname><given-names>RCS</given-names></name><name><surname>Otoni</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Nisin and other antimicrobial peptides: production, mechanisms of action, and application in active food packaging</article-title><source>Innov Food Sci Emerg Technol</source><year>2018</year><volume>48</volume><fpage>179</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.ifset.2018.06.008</pub-id></element-citation></ref><ref id="CR496"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarika</surname><given-names>AR</given-names></name><name><surname>Lipton</surname><given-names>AP</given-names></name><name><surname>Aishwarya</surname><given-names>MS</given-names></name><name><surname>Dhivya</surname><given-names>RS</given-names></name></person-group><article-title>Isolation of a bacteriocin-producing <italic>Lactococcus lactis</italic> and application of its bacteriocin to manage spoilage bacteria in high-value marine fish under different storage temperatures</article-title><source>Appl Biochem Biotechnol</source><year>2012</year><volume>167</volume><fpage>1280</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1007/s12010-012-9701-0</pub-id><?supplied-pmid 22555500?><pub-id pub-id-type="pmid">22555500</pub-id>
</element-citation></ref><ref id="CR497"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarika</surname><given-names>AR</given-names></name><name><surname>Lipton</surname><given-names>AP</given-names></name><name><surname>Aishwarya</surname><given-names>MS</given-names></name></person-group><article-title>Biopreservative efficacy of bacteriocin GP1 of <italic>Lactobacillus rhamnosus</italic> GP1 on stored fish filets</article-title><source>Front Nutr</source><year>2019</year><volume>6</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.3389/fnut.2019.00029</pub-id><?supplied-pmid 30968026?><pub-id pub-id-type="pmid">30968026</pub-id>
</element-citation></ref><ref id="CR498"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassone-Corsi</surname><given-names>M</given-names></name><name><surname>Nuccio</surname><given-names>S-P</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Microcins mediate competition among Enterobacteriaceae in the inflamed gut</article-title><source>Nature</source><year>2016</year><volume>540</volume><fpage>280</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1038/nature20557</pub-id><?supplied-pmid 27798599?><pub-id pub-id-type="pmid">27798599</pub-id>
</element-citation></ref><ref id="CR499"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satish Kumar</surname><given-names>R</given-names></name><name><surname>Kanmani</surname><given-names>P</given-names></name><name><surname>Yuvaraj</surname><given-names>N</given-names></name><etal/></person-group><article-title>Purification and characterization of enterocin MC13 produced by a potential aquaculture probiont <italic>Enterococcus faecium</italic> MC13 isolated from the gut of <italic>Mugil cephalus</italic></article-title><source>Can J Microbiol</source><year>2011</year><volume>57</volume><fpage>993</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1139/w11-092</pub-id><?supplied-pmid 22112158?><pub-id pub-id-type="pmid">22112158</pub-id>
</element-citation></ref><ref id="CR500"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Nikolovski</surname><given-names>J</given-names></name><name><surname>Gould</surname><given-names>R</given-names></name><etal/></person-group><article-title>Skin surface biomarkers are associated with future development of atopic dermatitis in children with family history of allergic disease</article-title><source>Skin Res Technol</source><year>2023</year><volume>29</volume><fpage>e13470</fpage><pub-id pub-id-type="doi">10.1111/srt.13470</pub-id><?supplied-pmid 37881058?><pub-id pub-id-type="pmid">37881058</pub-id>
</element-citation></ref><ref id="CR501"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saur</surname><given-names>JS</given-names></name><name><surname>Wirtz</surname><given-names>SN</given-names></name><name><surname>Schilling</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Distinct lugdunins from a new efficient synthesis and broad exploitation of its MRSA-antimicrobial structure</article-title><source>J Med Chem</source><year>2021</year><volume>64</volume><fpage>4034</fpage><lpage>4058</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c02170</pub-id><?supplied-pmid 33779184?><pub-id pub-id-type="pmid">33779184</pub-id>
</element-citation></ref><ref id="CR502"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawa</surname><given-names>N</given-names></name><name><surname>Zendo</surname><given-names>T</given-names></name><name><surname>Kiyofuji</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by <italic>Lactococcus</italic> sp. strain QU 12</article-title><source>Appl Environ Microbiol</source><year>2009</year><volume>75</volume><fpage>1552</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1128/AEM.02299-08</pub-id><?supplied-pmid 19139222?><pub-id pub-id-type="pmid">19139222</pub-id>
</element-citation></ref><ref id="CR503"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaffaro</surname><given-names>R</given-names></name><name><surname>Botta</surname><given-names>L</given-names></name><name><surname>Marineo</surname><given-names>S</given-names></name><name><surname>Puglia</surname><given-names>AM</given-names></name></person-group><article-title>Incorporation of nisin in poly (ethylene-<italic>co</italic>-vinyl acetate) films by melt processing: a study on the antimicrobial properties</article-title><source>J Food Prot</source><year>2011</year><volume>74</volume><fpage>1137</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.4315/0362-028X.JFP-10-383</pub-id><?supplied-pmid 21740716?><pub-id pub-id-type="pmid">21740716</pub-id>
</element-citation></ref><ref id="CR504"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scannell</surname><given-names>AG</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Development of bioactive food packaging materials using immobilised bacteriocins lacticin 3147 and nisaplin</article-title><source>Int J Food Microbiol</source><year>2000</year><volume>60</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/s0168-1605(00)00314-7</pub-id><?supplied-pmid 11016613?><pub-id pub-id-type="pmid">11016613</pub-id>
</element-citation></ref><ref id="CR505"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelegueda</surname><given-names>LI</given-names></name><name><surname>Vallejo</surname><given-names>M</given-names></name><name><surname>Gliemmo</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Synergistic antimicrobial action and potential application for fish preservation of a bacteriocin produced by <italic>Enterococcus mundtii</italic> isolated from <italic>Odontesthes platensis</italic></article-title><source>LWT Food Sci Technol</source><year>2015</year><volume>64</volume><fpage>794</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2015.06.017</pub-id></element-citation></ref><ref id="CR506"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Hahn-L&#x000f6;bmann</surname><given-names>S</given-names></name><name><surname>Stephan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Plant-made <italic>Salmonella</italic> bacteriocins salmocins for control of <italic>Salmonella</italic> pathovars</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>4078</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-22465-9</pub-id><?supplied-pmid 29511259?><pub-id pub-id-type="pmid">29511259</pub-id>
</element-citation></ref><ref id="CR507"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholl</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>DW</given-names></name></person-group><article-title>Antibacterial efficacy of R-type pyocins towards <italic>Pseudomonas aeruginosa</italic> in a murine peritonitis model</article-title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><fpage>1647</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1128/AAC.01479-07</pub-id><?supplied-pmid 18332164?><pub-id pub-id-type="pmid">18332164</pub-id>
</element-citation></ref><ref id="CR508"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholz</surname><given-names>R</given-names></name><name><surname>Vater</surname><given-names>J</given-names></name><name><surname>Budiharjo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Amylocyclicin, a novel circular bacteriocin produced by <italic>Bacillus amyloliquefaciens</italic> FZB42</article-title><source>J Bacteriol</source><year>2014</year><volume>196</volume><fpage>1842</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1128/JB.01474-14</pub-id><?supplied-pmid 24610713?><pub-id pub-id-type="pmid">24610713</pub-id>
</element-citation></ref><ref id="CR509"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sequeiros</surname><given-names>C</given-names></name><name><surname>Garc&#x000e9;s</surname><given-names>ME</given-names></name><name><surname>Vallejo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Potential aquaculture probiont <italic>Lactococcus lactis</italic> TW34 produces nisin Z and inhibits the fish pathogen <italic>Lactococcus garvieae</italic></article-title><source>Arch Microbiol</source><year>2015</year><volume>197</volume><fpage>449</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1007/s00203-014-1076-x</pub-id><?supplied-pmid 25549984?><pub-id pub-id-type="pmid">25549984</pub-id>
</element-citation></ref><ref id="CR510"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J</given-names></name><name><surname>Danova</surname><given-names>S</given-names></name><name><surname>Ivanova</surname><given-names>I</given-names></name></person-group><article-title>Antiinfluenza virus activity of a bacteriocin produced by <italic>Lactobacillus delbrueckii</italic></article-title><source>Appl Biochem Biotechnol</source><year>2000</year><volume>88</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1385/ABAB:88:1-3:285</pub-id></element-citation></ref><ref id="CR511"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevim</surname><given-names>B</given-names></name><name><surname>G&#x000fc;ne&#x0015f; Altunta&#x0015f;</surname><given-names>E</given-names></name></person-group><article-title>Molecular dynamic study on the structure and thermal stability of mutant pediocin PA-1 peptides engineered with cysteine substitutions</article-title><source>Probiotics Antimicrob Proteins</source><year>2024</year><pub-id pub-id-type="doi">10.1007/s12602-024-10225-3</pub-id><?supplied-pmid 38424320?><pub-id pub-id-type="pmid">38424320</pub-id>
</element-citation></ref><ref id="CR512"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafique</surname><given-names>B</given-names></name><name><surname>Ranjha</surname><given-names>MMAN</given-names></name><name><surname>Murtaza</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Recent trends and applications of nanoencapsulated bacteriocins against microbes in food quality and safety</article-title><source>Microorganisms</source><year>2022</year><pub-id pub-id-type="doi">10.3390/microorganisms11010085</pub-id><?supplied-pmid 36677377?><pub-id pub-id-type="pmid">36677377</pub-id>
</element-citation></ref><ref id="CR513"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanks</surname><given-names>RMQ</given-names></name><name><surname>Dashiff</surname><given-names>A</given-names></name><name><surname>Alster</surname><given-names>JS</given-names></name><name><surname>Kadouri</surname><given-names>DE</given-names></name></person-group><article-title>Isolation and identification of a bacteriocin with antibacterial and antibiofilm activity from <italic>Citrobacter freundii</italic></article-title><source>Arch Microbiol</source><year>2012</year><volume>194</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1007/s00203-012-0793-2</pub-id><?supplied-pmid 22290290?><pub-id pub-id-type="pmid">22290290</pub-id>
</element-citation></ref><ref id="CR514"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Chadha</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Anticancer and antimicrobial potential of enterocin 12a from <italic>Enterococcus faecium</italic></article-title><source>BMC Microbiol</source><year>2021</year><volume>21</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/s12866-021-02086-5</pub-id><?supplied-pmid 33541292?><pub-id pub-id-type="pmid">33541292</pub-id>
</element-citation></ref><ref id="CR515"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Vashist</surname><given-names>S</given-names></name><name><surname>Lamba</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Novel strategies in the treatment of acne: a review</article-title><source>IJPI</source><year>2022</year><volume>12</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.5530/ijpi.2022.2.23</pub-id></element-citation></ref><ref id="CR516"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>C</given-names></name><name><surname>Bray</surname><given-names>J</given-names></name><name><surname>Housden</surname><given-names>NG</given-names></name><etal/></person-group><article-title>Diversity and distribution of nuclease bacteriocins in bacterial genomes revealed using hidden Markov models</article-title><source>PLoS Comput Biol</source><year>2017</year><volume>13</volume><fpage>e1005652</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005652</pub-id><?supplied-pmid 28715501?><pub-id pub-id-type="pmid">28715501</pub-id>
</element-citation></ref><ref id="CR517"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheoran</surname><given-names>P</given-names></name><name><surname>Tiwari</surname><given-names>SK</given-names></name></person-group><article-title>Synergistically-acting enterocin LD3 and plantaricin LD4 against Gram-positive and Gram-negative pathogenic bacteria</article-title><source>Probiotics Antimicrob Proteins</source><year>2021</year><volume>13</volume><fpage>542</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1007/s12602-020-09708-w</pub-id><?supplied-pmid 32918678?><pub-id pub-id-type="pmid">32918678</pub-id>
</element-citation></ref><ref id="CR518"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>JM</given-names></name><name><surname>Gwak</surname><given-names>JW</given-names></name><name><surname>Kamarajan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Biomedical applications of nisin</article-title><source>J Appl Microbiol</source><year>2016</year><volume>120</volume><fpage>1449</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1111/jam.13033</pub-id><?supplied-pmid 26678028?><pub-id pub-id-type="pmid">26678028</pub-id>
</element-citation></ref><ref id="CR519"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>CCG</given-names></name><name><surname>Silva</surname><given-names>SPM</given-names></name><name><surname>Ribeiro</surname><given-names>SC</given-names></name></person-group><article-title>Application of bacteriocins and protective cultures in dairy food preservation</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>594</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.00594</pub-id><?supplied-pmid 29686652?><pub-id pub-id-type="pmid">29686652</pub-id>
</element-citation></ref><ref id="CR520"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>A</given-names></name><name><surname>Alhanout</surname><given-names>K</given-names></name><name><surname>Duval</surname><given-names>RE</given-names></name></person-group><article-title>Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria</article-title><source>Microorganisms</source><year>2020</year><pub-id pub-id-type="doi">10.3390/microorganisms8050639</pub-id><?supplied-pmid 32349409?><pub-id pub-id-type="pmid">32349409</pub-id>
</element-citation></ref><ref id="CR521"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siragusa</surname><given-names>GR</given-names></name></person-group><article-title>Production of bacteriocin inhibitory to <italic>Listeria</italic> species by <italic>Enterococcus hirae</italic></article-title><source>Appl Environ Microbiol</source><year>1992</year><volume>58</volume><fpage>3508</fpage><lpage>3513</lpage><pub-id pub-id-type="doi">10.1128/aem.58.11.3508-3513.1992</pub-id><?supplied-pmid 1482176?><pub-id pub-id-type="pmid">1482176</pub-id>
</element-citation></ref><ref id="CR522"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siragusa</surname><given-names>GR</given-names></name><name><surname>Cutter</surname><given-names>CN</given-names></name><name><surname>Willett</surname><given-names>JL</given-names></name></person-group><article-title>Incorporation of bacteriocin in plastic retains activity and inhibits surface growth of bacteria on meat</article-title><source>Food Microbiol</source><year>1999</year><volume>16</volume><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1006/fmic.1998.0239</pub-id></element-citation></ref><ref id="CR523"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015a;mia&#x00142;ek-Bartyzel</surname><given-names>J</given-names></name><name><surname>Bzowska</surname><given-names>M</given-names></name><name><surname>M&#x00119;&#x0017c;yk-Kope&#x00107;</surname><given-names>R</given-names></name><etal/></person-group><article-title>BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer</article-title><source>Inflamm Res</source><year>2023</year><volume>72</volume><fpage>915</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1007/s00011-023-01721-3</pub-id><?supplied-pmid 36964784?><pub-id pub-id-type="pmid">36964784</pub-id>
</element-citation></ref><ref id="CR524"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimanpour</surname><given-names>S</given-names></name><name><surname>Hasanian</surname><given-names>SM</given-names></name><name><surname>Avan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bacteriotherapy in gastrointestinal cancer</article-title><source>Life Sci</source><year>2020</year><volume>254</volume><fpage>117754</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.117754</pub-id><?supplied-pmid 32389833?><pub-id pub-id-type="pmid">32389833</pub-id>
</element-citation></ref><ref id="CR525"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>W</given-names></name><name><surname>Bhattacharjee</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>K</given-names></name></person-group><article-title>Adsorption of an antimicrobial peptide on self-assembled monolayers by molecular dynamics simulation</article-title><source>J Phys Chem B</source><year>2010</year><volume>114</volume><fpage>11292</fpage><lpage>11302</lpage><pub-id pub-id-type="doi">10.1021/jp104024d</pub-id><?supplied-pmid 20690694?><pub-id pub-id-type="pmid">20690694</pub-id>
</element-citation></ref><ref id="CR526"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>S</given-names></name><name><surname>Hammami</surname><given-names>R</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations</article-title><source>FEMS Microbiol Rev</source><year>2021</year><pub-id pub-id-type="doi">10.1093/femsre/fuaa039</pub-id><?supplied-pmid 32876664?><pub-id pub-id-type="pmid">32876664</pub-id>
</element-citation></ref><ref id="CR527"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>S</given-names></name><name><surname>Zirah</surname><given-names>S</given-names></name><name><surname>Rebuffat</surname><given-names>S</given-names></name><etal/></person-group><article-title>Gastrointestinal stability and cytotoxicity of bacteriocins from Gram-positive and Gram-negative bacteria: a comparative in vitro study</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>780355</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.780355</pub-id><?supplied-pmid 35145490?><pub-id pub-id-type="pmid">35145490</pub-id>
</element-citation></ref><ref id="CR528"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>S</given-names></name><name><surname>Biron</surname><given-names>E</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><etal/></person-group><article-title>Bacteriocin-based synergetic consortia: a promising strategy to enhance antimicrobial activity and broaden the spectrum of inhibition</article-title><source>Microbiol Spectr</source><year>2022</year><volume>10</volume><fpage>e0040621</fpage><pub-id pub-id-type="doi">10.1128/spectrum.00406-21</pub-id><?supplied-pmid 35170996?><pub-id pub-id-type="pmid">35170996</pub-id>
</element-citation></ref><ref id="CR529"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>S</given-names></name><name><surname>Boutin</surname><given-names>Y</given-names></name><name><surname>Couture</surname><given-names>F</given-names></name><etal/></person-group><article-title>In vitro assessment of skin sensitization, irritability and toxicity of bacteriocins and reuterin for possible topical applications</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><fpage>4570</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-08441-4</pub-id><?supplied-pmid 35301365?><pub-id pub-id-type="pmid">35301365</pub-id>
</element-citation></ref><ref id="CR530"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosunov</surname><given-names>V</given-names></name><name><surname>Mischenko</surname><given-names>V</given-names></name><name><surname>Eruslanov</surname><given-names>B</given-names></name><etal/></person-group><article-title>Antimycobacterial activity of bacteriocins and their complexes with liposomes</article-title><source>J Antimicrob Chemother</source><year>2007</year><volume>59</volume><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1093/jac/dkm053</pub-id><?supplied-pmid 17347179?><pub-id pub-id-type="pmid">17347179</pub-id>
</element-citation></ref><ref id="CR531"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spano</surname><given-names>G</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name><name><surname>Lonvaud-Funel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biogenic amines in fermented foods</article-title><source>Eur J Clin Nutr</source><year>2010</year><volume>64</volume><issue>Suppl 3</issue><fpage>S95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2010.218</pub-id><?supplied-pmid 21045859?><pub-id pub-id-type="pmid">21045859</pub-id>
</element-citation></ref><ref id="CR532"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srionnual</surname><given-names>S</given-names></name><name><surname>Yanagida</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>L-H</given-names></name><etal/></person-group><article-title>Weissellicin 110, a newly discovered bacteriocin from <italic>Weissella cibaria</italic> 110, isolated from plaa-som, a fermented fish product from Thailand</article-title><source>Appl Environ Microbiol</source><year>2007</year><volume>73</volume><fpage>2247</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1128/AEM.02484-06</pub-id><?supplied-pmid 17293526?><pub-id pub-id-type="pmid">17293526</pub-id>
</element-citation></ref><ref id="CR533"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavric</surname><given-names>S</given-names></name><name><surname>D&#x02019;Aoust</surname><given-names>JY</given-names></name></person-group><article-title>Undefined and defined bacterial preparations for the competitive exclusion of <italic>Salmonella</italic> in poultry&#x02014;a review</article-title><source>J Food Prot</source><year>1993</year><volume>56</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.4315/0362-028X-56.2.173</pub-id><?supplied-pmid 31084112?><pub-id pub-id-type="pmid">31084112</pub-id>
</element-citation></ref><ref id="CR534"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>I</given-names></name><name><surname>Errhalt</surname><given-names>P</given-names></name><name><surname>Kubesch</surname><given-names>K</given-names></name><etal/></person-group><article-title>Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2008</year><volume>378</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1007/s00210-008-0293-8</pub-id><?supplied-pmid 18500510?><pub-id pub-id-type="pmid">18500510</pub-id>
</element-citation></ref><ref id="CR535"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stentiford</surname><given-names>GD</given-names></name><name><surname>Peeler</surname><given-names>EJ</given-names></name><name><surname>Tyler</surname><given-names>CR</given-names></name><etal/></person-group><article-title>A seafood risk tool for assessing and mitigating chemical and pathogen hazards in the aquaculture supply chain</article-title><source>Nat Food</source><year>2022</year><volume>3</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/s43016-022-00465-3</pub-id><?supplied-pmid 37117966?><pub-id pub-id-type="pmid">37117966</pub-id>
</element-citation></ref><ref id="CR536"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>NJ</given-names></name><name><surname>Svetoch</surname><given-names>EA</given-names></name><name><surname>Eruslanov</surname><given-names>BV</given-names></name><etal/></person-group><article-title><italic>Paenibacillus polymyxa</italic> purified bacteriocin to control <italic>Campylobacter jejuni</italic> in chickens</article-title><source>J Food Prot</source><year>2005</year><volume>68</volume><fpage>1450</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.4315/0362-028x-68.7.1450</pub-id><?supplied-pmid 16013385?><pub-id pub-id-type="pmid">16013385</pub-id>
</element-citation></ref><ref id="CR537"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>P</given-names></name><name><surname>Henriksson</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>H</given-names></name></person-group><article-title>Survival and retention of the probiotic <italic>Lactobacillus casei</italic> LAFTI L26 in the gastrointestinal tract of the mouse</article-title><source>Lett Appl Microbiol</source><year>2007</year><volume>44</volume><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2006.02063.x</pub-id><?supplied-pmid 17257248?><pub-id pub-id-type="pmid">17257248</pub-id>
</element-citation></ref><ref id="CR538"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name></person-group><article-title>Bacteriocins from the rhizosphere microbiome&#x02014;from an agriculture perspective</article-title><source>Front Plant Sci</source><year>2015</year><volume>6</volume><fpage>909</fpage><pub-id pub-id-type="doi">10.3389/fpls.2015.00909</pub-id><?supplied-pmid 26579159?><pub-id pub-id-type="pmid">26579159</pub-id>
</element-citation></ref><ref id="CR539"><mixed-citation publication-type="other">Sudarsanan SE, Thangappan B (2017) Antimicrobial activity and anti-aflatoxigenic activity of bacteriocin isolated from <italic>Pediococcus acidilactici</italic> from fish wastes. Biotech Res 3:104&#x02013;125. <ext-link ext-link-type="uri" xlink:href="http://br.biomedpress.org/index.php/br/article/view/757">http://br.biomedpress.org/index.php/br/article/view/757</ext-link></mixed-citation></ref><ref id="CR540"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><etal/></person-group><article-title><italic>Bifidobacterium</italic> alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade</article-title><source>Proc Natl Acad Sci USA</source><year>2020</year><volume>117</volume><fpage>27509</fpage><lpage>27515</lpage><pub-id pub-id-type="doi">10.1073/pnas.1921223117</pub-id><?supplied-pmid 33077598?><pub-id pub-id-type="pmid">33077598</pub-id>
</element-citation></ref><ref id="CR541"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>WS</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>C-H</given-names></name><etal/></person-group><article-title>Mode of antibacterial action of a signal peptide, Pep27 from <italic>Streptococcus pneumoniae</italic></article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>363</volume><fpage>806</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.041</pub-id><?supplied-pmid 17900534?><pub-id pub-id-type="pmid">17900534</pub-id>
</element-citation></ref><ref id="CR542"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutyak</surname><given-names>KE</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Dover</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Spermicidal activity of the safe natural antimicrobial peptide subtilosin</article-title><source>Infect Dis Obstet Gynecol</source><year>2008</year><volume>2008</volume><fpage>540758</fpage><pub-id pub-id-type="doi">10.1155/2008/540758</pub-id><?supplied-pmid 18923673?><pub-id pub-id-type="pmid">18923673</pub-id>
</element-citation></ref><ref id="CR543"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutyak</surname><given-names>KE</given-names></name><name><surname>Wirawan</surname><given-names>RE</given-names></name><name><surname>Aroutcheva</surname><given-names>AA</given-names></name><name><surname>Chikindas</surname><given-names>ML</given-names></name></person-group><article-title>Isolation of the <italic>Bacillus subtilis</italic> antimicrobial peptide subtilosin from the dairy product-derived <italic>Bacillus amyloliquefaciens</italic></article-title><source>J Appl Microbiol</source><year>2008</year><volume>104</volume><fpage>1067</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2007.03626.x</pub-id><?supplied-pmid 17976171?><pub-id pub-id-type="pmid">17976171</pub-id>
</element-citation></ref><ref id="CR544"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svetoch</surname><given-names>EA</given-names></name><name><surname>Eruslanov</surname><given-names>BV</given-names></name><name><surname>Kovalev</surname><given-names>YN</given-names></name><etal/></person-group><article-title>Antimicrobial activities of bacteriocins E 50&#x02013;52 and B 602 against antibiotic-resistant strains involved in nosocomial infections</article-title><source>Probiotics Antimicrob Proteins</source><year>2009</year><volume>1</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1007/s12602-009-9027-6</pub-id><?supplied-pmid 26783168?><pub-id pub-id-type="pmid">26783168</pub-id>
</element-citation></ref><ref id="CR545"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telhig</surname><given-names>S</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evaluating the potential and synergetic effects of microcins against multidrug-resistant enterobacteriaceae</article-title><source>Microbiol Spectr</source><year>2022</year><volume>10</volume><fpage>e0275221</fpage><pub-id pub-id-type="doi">10.1128/spectrum.02752-21</pub-id><?supplied-pmid 35543514?><pub-id pub-id-type="pmid">35543514</pub-id>
</element-citation></ref><ref id="CR546"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Teneva-Angelova</surname><given-names>T</given-names></name><name><surname>Hristova</surname><given-names>I</given-names></name><name><surname>Pavlov</surname><given-names>A</given-names></name><name><surname>Beshkova</surname><given-names>D</given-names></name></person-group><article-title>Lactic acid bacteria&#x02014;from nature through food to health</article-title><source>Advances in biotechnology for food industry</source><year>2018</year><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>91</fpage><lpage>133</lpage></element-citation></ref><ref id="CR547"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Food and gut originated bacteriocins involved in gut microbe-host interactions</article-title><source>Crit Rev Microbiol</source><year>2023</year><volume>49</volume><fpage>515</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2022.2082860</pub-id><?supplied-pmid 35713699?><pub-id pub-id-type="pmid">35713699</pub-id>
</element-citation></ref><ref id="CR548"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorov</surname><given-names>SD</given-names></name></person-group><article-title>Bacteriocin production by <italic>Lactobacillus plantarum</italic> AMA-K isolated from Amasi, a Zimbabwean fermented milk product and study of the adsorption of bacteriocin AMA-K to <italic>Listeria</italic> sp.</article-title><source>Braz J Microbiol</source><year>2008</year><volume>39</volume><fpage>178</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822008000100035</pub-id><?supplied-pmid 24031200?><pub-id pub-id-type="pmid">24031200</pub-id>
</element-citation></ref><ref id="CR549"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorov</surname><given-names>SD</given-names></name><name><surname>Wachsman</surname><given-names>MB</given-names></name><name><surname>Knoetze</surname><given-names>H</given-names></name><etal/></person-group><article-title>An antibacterial and antiviral peptide produced by <italic>Enterococcus mundtii</italic> ST4V isolated from soya beans</article-title><source>Int J Antimicrob Agents</source><year>2005</year><volume>25</volume><fpage>508</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.02.005</pub-id><?supplied-pmid 15869868?><pub-id pub-id-type="pmid">15869868</pub-id>
</element-citation></ref><ref id="CR550"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorov</surname><given-names>SD</given-names></name><name><surname>Wachsman</surname><given-names>M</given-names></name><name><surname>Tom&#x000e9;</surname><given-names>E</given-names></name><etal/></person-group><article-title>Characterisation of an antiviral pediocin-like bacteriocin produced by <italic>Enterococcus faecium</italic></article-title><source>Food Microbiol</source><year>2010</year><volume>27</volume><fpage>869</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2010.05.001</pub-id><?supplied-pmid 20688228?><pub-id pub-id-type="pmid">20688228</pub-id>
</element-citation></ref><ref id="CR551"><element-citation publication-type="data"><name><surname>Todorov</surname><given-names>SD</given-names></name><name><surname>Popov</surname><given-names>I</given-names></name><name><surname>Weeks</surname><given-names>R</given-names></name><name><surname>Chikindas</surname><given-names>ML</given-names></name><year>2022</year><data-title>Use of bacteriocins and bacteriocinogenic beneficial organisms in food products: benefits, challenges, concerns</data-title><source>Foods</source><pub-id pub-id-type="doi">10.3390/foods11193145</pub-id></element-citation></ref><ref id="CR552"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Ni</surname><given-names>L</given-names></name><name><surname>Ling</surname><given-names>J</given-names></name></person-group><article-title>Antibacterial peptide nisin: a potential role in the inhibition of oral pathogenic bacteria</article-title><source>Peptides</source><year>2014</year><volume>60</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2014.07.020</pub-id><?supplied-pmid 25088158?><pub-id pub-id-type="pmid">25088158</pub-id>
</element-citation></ref><ref id="CR553"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>NI</given-names></name><name><surname>Noll</surname><given-names>KS</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1</article-title><source>Probiotics Antimicrob Proteins</source><year>2013</year><volume>5</volume><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s12602-012-9123-x</pub-id><?supplied-pmid 23637711?><pub-id pub-id-type="pmid">23637711</pub-id>
</element-citation></ref><ref id="CR554"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>C</given-names></name><name><surname>Alonso</surname><given-names>CA</given-names></name><name><surname>Ruiz-Ripa</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antimicrobial resistance in <italic>Enterococcus</italic> spp. of animal origin</article-title><source>Microbiol Spectr</source><year>2018</year><pub-id pub-id-type="doi">10.1128/microbiolspec.ARBA-0032-2018</pub-id><?supplied-pmid 30051804?><pub-id pub-id-type="pmid">30051804</pub-id>
</element-citation></ref><ref id="CR555"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>C</given-names></name><name><surname>Horyanto</surname><given-names>D</given-names></name><name><surname>Stanley</surname><given-names>D</given-names></name><etal/></person-group><article-title>Antimicrobial properties of <italic>Bacillus</italic> probiotics as animal growth promoters</article-title><source>Antibiotics (Basel)</source><year>2023</year><volume>12</volume><fpage>407</fpage><pub-id pub-id-type="doi">10.3390/antibiotics12020407</pub-id><?supplied-pmid 36830317?><pub-id pub-id-type="pmid">36830317</pub-id>
</element-citation></ref><ref id="CR556"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumbarski</surname><given-names>Y</given-names></name><name><surname>Lante</surname><given-names>A</given-names></name><name><surname>Krastanov</surname><given-names>A</given-names></name></person-group><article-title>Immobilization of bacteriocins from lactic acid bacteria and possibilities for application in food biopreservation</article-title><source>Open Biotechnol J</source><year>2018</year><volume>12</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.2174/1874070701812010025</pub-id></element-citation></ref><ref id="CR557"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turovskiy</surname><given-names>Y</given-names></name><name><surname>Ludescher</surname><given-names>RD</given-names></name><name><surname>Aroutcheva</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Lactocin 160, a bacteriocin produced by vaginal <italic>Lactobacillus rhamnosus</italic>, targets cytoplasmic membranes of the vaginal pathogen, <italic>Gardnerella vaginalis</italic></article-title><source>Probiotics Antimicrob Proteins</source><year>2009</year><volume>1</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s12602-008-9003-6</pub-id><?supplied-pmid 20445810?><pub-id pub-id-type="pmid">20445810</pub-id>
</element-citation></ref><ref id="CR558"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udompijitkul</surname><given-names>P</given-names></name><name><surname>Paredes-Sabja</surname><given-names>D</given-names></name><name><surname>Sarker</surname><given-names>MR</given-names></name></person-group><article-title>Inhibitory effects of nisin against <italic>Clostridium perfringens</italic> food poisoning and nonfood-borne isolates</article-title><source>J Food Sci</source><year>2012</year><volume>77</volume><fpage>M51</fpage><lpage>M56</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2011.02475.x</pub-id><?supplied-pmid 22132724?><pub-id pub-id-type="pmid">22132724</pub-id>
</element-citation></ref><ref id="CR559"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ukuku</surname><given-names>DO</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Sommers</surname><given-names>C</given-names></name></person-group><article-title>Efficacy of sanitizer treatments on survival and growth parameters of <italic>Escherichia coli</italic> O157:H7, <italic>Salmonella</italic>, and <italic>Listeria monocytogenes</italic> on fresh-cut pieces of cantaloupe during storage</article-title><source>J Food Prot</source><year>2015</year><volume>78</volume><fpage>1288</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.4315/0362-028X.JFP-14-233</pub-id><?supplied-pmid 26197279?><pub-id pub-id-type="pmid">26197279</pub-id>
</element-citation></ref><ref id="CR560"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Um</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y-J</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sungsanpin, a lasso peptide from a deep-sea streptomycete</article-title><source>J Nat Prod</source><year>2013</year><volume>76</volume><fpage>873</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1021/np300902g</pub-id><?supplied-pmid 23662937?><pub-id pub-id-type="pmid">23662937</pub-id>
</element-citation></ref><ref id="CR561"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umair</surname><given-names>M</given-names></name><name><surname>Jabbar</surname><given-names>S</given-names></name><name><surname>Zhaoxin</surname><given-names>L</given-names></name><etal/></person-group><article-title>Probiotic-based bacteriocin: immunity supplementation against viruses. An updated review</article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><fpage>876058</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.876058</pub-id><?supplied-pmid 36033850?><pub-id pub-id-type="pmid">36033850</pub-id>
</element-citation></ref><ref id="CR562"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umu</surname><given-names>&#x000d6;CO</given-names></name><name><surname>B&#x000e4;uerl</surname><given-names>C</given-names></name><name><surname>Oostindjer</surname><given-names>M</given-names></name><etal/></person-group><article-title>The potential of class II bacteriocins to modify gut microbiota to improve host health</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0164036</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0164036</pub-id><?supplied-pmid 27695121?><pub-id pub-id-type="pmid">27695121</pub-id>
</element-citation></ref><ref id="CR563"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadyvaloo</surname><given-names>V</given-names></name><name><surname>Hastings</surname><given-names>JW</given-names></name><name><surname>van der Merwe</surname><given-names>MJ</given-names></name><name><surname>Rautenbach</surname><given-names>M</given-names></name></person-group><article-title>Membranes of class IIa bacteriocin-resistant <italic>Listeria monocytogenes</italic> cells contain increased levels of desaturated and short-acyl-chain phosphatidylglycerols</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>68</volume><fpage>5223</fpage><lpage>5230</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.11.5223-5230.2002</pub-id><?supplied-pmid 12406708?><pub-id pub-id-type="pmid">12406708</pub-id>
</element-citation></ref><ref id="CR564"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahedi Shahandashti</surname><given-names>R</given-names></name><name><surname>Kasra Kermanshahi</surname><given-names>R</given-names></name><name><surname>Ghadam</surname><given-names>P</given-names></name></person-group><article-title>The inhibitory effect of bacteriocin produced by <italic>Lactobacillus acidophilus</italic> ATCC 4356 and <italic>Lactobacillus plantarum</italic> ATCC 8014 on planktonic cells and biofilms of Serratia marcescens</article-title><source>Turk J Med Sci</source><year>2016</year><volume>46</volume><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.3906/sag-1505-51</pub-id><?supplied-pmid 27513424?><pub-id pub-id-type="pmid">27513424</pub-id>
</element-citation></ref><ref id="CR565"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valledor</surname><given-names>SJD</given-names></name><name><surname>Dioso</surname><given-names>CM</given-names></name><name><surname>Bucheli</surname><given-names>JEV</given-names></name><etal/></person-group><article-title>Characterization and safety evaluation of two beneficial, enterocin-producing <italic>Enterococcus faecium</italic> strains isolated from kimchi, a Korean fermented cabbage</article-title><source>Food Microbiol</source><year>2022</year><volume>102</volume><fpage>103886</fpage><pub-id pub-id-type="doi">10.1016/j.fm.2021.103886</pub-id><?supplied-pmid 34809929?><pub-id pub-id-type="pmid">34809929</pub-id>
</element-citation></ref><ref id="CR566"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Heel</surname><given-names>AJ</given-names></name><name><surname>de Jong</surname><given-names>A</given-names></name><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M</given-names></name><etal/></person-group><article-title>BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>W448</fpage><lpage>W453</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt391</pub-id><?supplied-pmid 23677608?><pub-id pub-id-type="pmid">23677608</pub-id>
</element-citation></ref><ref id="CR567"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Staden</surname><given-names>ADP</given-names></name><name><surname>Heunis</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><etal/></person-group><article-title>Efficacy of lantibiotic treatment of <italic>Staphylococcus aureus</italic>-induced skin infections, monitored by in vivo bioluminescent imaging</article-title><source>Antimicrob Agents Chemother</source><year>2016</year><volume>60</volume><fpage>3948</fpage><lpage>3955</lpage><pub-id pub-id-type="doi">10.1128/AAC.02938-15</pub-id><?supplied-pmid 27067340?><pub-id pub-id-type="pmid">27067340</pub-id>
</element-citation></ref><ref id="CR568"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varas</surname><given-names>MA</given-names></name><name><surname>Mu&#x000f1;oz-Montecinos</surname><given-names>C</given-names></name><name><surname>Kallens</surname><given-names>V</given-names></name><etal/></person-group><article-title>Exploiting zebrafish xenografts for testing the in vivo antitumorigenic activity of microcin E492 against human colorectal cancer cells</article-title><source>Front Microbiol</source><year>2020</year><volume>11</volume><fpage>405</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00405</pub-id><?supplied-pmid 32265865?><pub-id pub-id-type="pmid">32265865</pub-id>
</element-citation></ref><ref id="CR569"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;squez</surname><given-names>A</given-names></name><name><surname>Jakobsson</surname><given-names>T</given-names></name><name><surname>Ahrn&#x000e9;</surname><given-names>S</given-names></name><etal/></person-group><article-title>Vaginal <italic>Lactobacillus</italic> flora of healthy Swedish women</article-title><source>J Clin Microbiol</source><year>2002</year><volume>40</volume><fpage>2746</fpage><lpage>2749</lpage><pub-id pub-id-type="doi">10.1128/JCM.40.8.2746-2749.2002</pub-id><?supplied-pmid 12149323?><pub-id pub-id-type="pmid">12149323</pub-id>
</element-citation></ref><ref id="CR570"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vel&#x000e1;zquez-Su&#x000e1;rez</surname><given-names>C</given-names></name><name><surname>Cebri&#x000e1;n</surname><given-names>R</given-names></name><name><surname>Gasca-Capote</surname><given-names>C</given-names></name><etal/></person-group><article-title>Antimicrobial activity of the circular bacteriocin AS-48 against clinical multidrug-resistant <italic>Staphylococcus aureus</italic></article-title><source>Antibiotics (Basel)</source><year>2021</year><pub-id pub-id-type="doi">10.3390/antibiotics10080925</pub-id><?supplied-pmid 34438974?><pub-id pub-id-type="pmid">34438974</pub-id>
</element-citation></ref><ref id="CR571"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera Pingitore</surname><given-names>E</given-names></name><name><surname>H&#x000e9;bert</surname><given-names>EM</given-names></name><name><surname>Nader-Mac&#x000ed;as</surname><given-names>ME</given-names></name><name><surname>Sesma</surname><given-names>F</given-names></name></person-group><article-title>Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by <italic>Lactobacillus salivarius</italic> CRL 1328 isolated from the human vagina</article-title><source>Res Microbiol</source><year>2009</year><volume>160</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2009.06.009</pub-id><?supplied-pmid 19591924?><pub-id pub-id-type="pmid">19591924</pub-id>
</element-citation></ref><ref id="CR572"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieco-Saiz</surname><given-names>N</given-names></name><name><surname>Belguesmia</surname><given-names>Y</given-names></name><name><surname>Raspoet</surname><given-names>R</given-names></name><etal/></person-group><article-title>Benefits and inputs from lactic acid bacteria and their bacteriocins as alternatives to antibiotic growth promoters during food-animal production</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00057</pub-id><?supplied-pmid 30804896?><pub-id pub-id-type="pmid">30804896</pub-id>
</element-citation></ref><ref id="CR573"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayabaskar</surname><given-names>P</given-names></name><name><surname>Somasundaram</surname><given-names>ST</given-names></name></person-group><article-title>Isolation of bacteriocin producing lactic acid bacteria from fish gut and probiotic activity against common fresh water fish pathogen <italic>Aeromonas hydrophila</italic></article-title><source>Biotechnology</source><year>2008</year><volume>7</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.3923/biotech.2008.124.128</pub-id></element-citation></ref><ref id="CR574"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villarante</surname><given-names>KI</given-names></name><name><surname>Elegado</surname><given-names>FB</given-names></name><name><surname>Iwatani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Purification, characterization and in vitro cytotoxicity of the bacteriocin from <italic>Pediococcus acidilactici</italic> K2a2&#x02013;3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells</article-title><source>World J Microbiol Biotechnol</source><year>2011</year><volume>27</volume><fpage>975</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1007/s11274-010-0541-1</pub-id></element-citation></ref><ref id="CR575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachsman</surname><given-names>MB</given-names></name><name><surname>Far&#x000ed;as</surname><given-names>ME</given-names></name><name><surname>Takeda</surname><given-names>E</given-names></name><etal/></person-group><article-title>Antiviral activity of enterocin CRL35 against herpesviruses</article-title><source>Int J Antimicrob Agents</source><year>1999</year><volume>12</volume><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/s0924-8579(99)00078-3</pub-id><?supplied-pmid 10493605?><pub-id pub-id-type="pmid">10493605</pub-id>
</element-citation></ref><ref id="CR576"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachsman</surname><given-names>MB</given-names></name><name><surname>Castilla</surname><given-names>V</given-names></name><name><surname>de Ruiz Holgado</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro</article-title><source>Antiviral Res</source><year>2003</year><volume>58</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/s0166-3542(02)00099-2</pub-id><?supplied-pmid 12719003?><pub-id pub-id-type="pmid">12719003</pub-id>
</element-citation></ref><ref id="CR577"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>T</given-names></name><name><surname>Power</surname><given-names>D</given-names></name><name><surname>Tagg</surname><given-names>J</given-names></name></person-group><article-title>Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?</article-title><source>J Med Microbiol</source><year>2003</year><volume>52</volume><fpage>829</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.05259-0</pub-id><?supplied-pmid 12909662?><pub-id pub-id-type="pmid">12909662</pub-id>
</element-citation></ref><ref id="CR578"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>AM</given-names></name><name><surname>Leech</surname><given-names>J</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><etal/></person-group><article-title>Integrated molecular approaches for fermented food microbiome research</article-title><source>FEMS Microbiol Rev</source><year>2023</year><pub-id pub-id-type="doi">10.1093/femsre/fuad001</pub-id><?supplied-pmid 36725208?><pub-id pub-id-type="pmid">36725208</pub-id>
</element-citation></ref><ref id="CR579"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Prevention of cyclophosphamide-induced immunosuppression in mice with the antimicrobial peptide sublancin</article-title><source>J Immunol Res</source><year>2018</year><volume>2018</volume><fpage>4353580</fpage><pub-id pub-id-type="doi">10.1155/2018/4353580</pub-id><?supplied-pmid 29854837?><pub-id pub-id-type="pmid">29854837</pub-id>
</element-citation></ref><ref id="CR580"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><article-title>Current developments of bacteriocins, screening methods and their application in aquaculture and aquatic products</article-title><source>Biocatal Agric Biotechnol</source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.bcab.2019.101395</pub-id></element-citation></ref><ref id="CR581"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Enhancement of macrophage function by the antimicrobial peptide sublancin protects mice from methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>J Immunol Res</source><year>2019</year><volume>2019</volume><fpage>3979352</fpage><pub-id pub-id-type="doi">10.1155/2019/3979352</pub-id><?supplied-pmid 31583256?><pub-id pub-id-type="pmid">31583256</pub-id>
</element-citation></ref><ref id="CR582"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Garcia-Gutierrez</surname><given-names>E</given-names></name><etal/></person-group><article-title><italic>Lactobacillus acidophilus</italic> JCM 1132 strain and its mutant with different bacteriocin-producing behaviour have various in situ effects on the gut microbiota of healthy mice</article-title><source>Microorganisms</source><year>2019</year><pub-id pub-id-type="doi">10.3390/microorganisms8010049</pub-id><?supplied-pmid 31888104?><pub-id pub-id-type="pmid">31888104</pub-id>
</element-citation></ref><ref id="CR583"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C-H</given-names></name><name><surname>Hsieh</surname><given-names>Y-H</given-names></name><name><surname>Powers</surname><given-names>ZM</given-names></name><name><surname>Kao</surname><given-names>C-Y</given-names></name></person-group><article-title>Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era</article-title><source>Int J Mol Sci</source><year>2020</year><pub-id pub-id-type="doi">10.3390/ijms21031061</pub-id><?supplied-pmid 33396869?><pub-id pub-id-type="pmid">33396869</pub-id>
</element-citation></ref><ref id="CR584"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of antimicrobial peptide microcin J25 on growth performance, immune regulation, and intestinal microbiota in broiler chickens challenged with <italic>Escherichia coli</italic> and <italic>Salmonella</italic></article-title><source>Animals (Basel)</source><year>2020</year><pub-id pub-id-type="doi">10.3390/ani10020345</pub-id><?supplied-pmid 33383762?><pub-id pub-id-type="pmid">33383762</pub-id>
</element-citation></ref><ref id="CR585"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name><name><surname>Breukink</surname><given-names>E</given-names></name></person-group><article-title>Non-lipid II targeting lantibiotics</article-title><source>Biochim Biophys Acta Biomembr</source><year>2020</year><volume>1862</volume><fpage>183244</fpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2020.183244</pub-id><?supplied-pmid 32126235?><pub-id pub-id-type="pmid">32126235</pub-id>
</element-citation></ref><ref id="CR586"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Haqmal</surname><given-names>MA</given-names></name><name><surname>Liang</surname><given-names>Y-D</given-names></name><etal/></person-group><article-title>Antibacterial activity and cytotoxicity of a novel bacteriocin isolated from <italic>Pseudomonas</italic> sp. strain 166</article-title><source>Microb Biotechnol</source><year>2022</year><volume>15</volume><fpage>2337</fpage><lpage>2350</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.14096</pub-id><?supplied-pmid 35849816?><pub-id pub-id-type="pmid">35849816</pub-id>
</element-citation></ref><ref id="CR587"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hao</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Secondary metabolites of <italic>Bacillus subtilis</italic> L2 show antiviral activity against pseudorabies virus</article-title><source>Front Microbiol</source><year>2023</year><pub-id pub-id-type="doi">10.3389/fmicb.2023.1277782</pub-id><?supplied-pmid 38420214?><pub-id pub-id-type="pmid">38420214</pub-id>
</element-citation></ref><ref id="CR588"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wholey</surname><given-names>W-Y</given-names></name><name><surname>Abu-Khdeir</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Characterization of the competitive pneumocin peptides of <italic>Streptococcus pneumoniae</italic></article-title><source>Front Cell Infect Microbiol</source><year>2019</year><volume>9</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2019.00055</pub-id><?supplied-pmid 30915281?><pub-id pub-id-type="pmid">30915281</pub-id>
</element-citation></ref><ref id="CR589"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiman</surname><given-names>E</given-names></name><name><surname>Zattarin</surname><given-names>E</given-names></name><name><surname>Aili</surname><given-names>D</given-names></name><etal/></person-group><article-title>Development of novel broad-spectrum antimicrobial lipopeptides derived from plantaricin NC8 &#x003b2;</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>4104</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-31185-8</pub-id><?supplied-pmid 36914718?><pub-id pub-id-type="pmid">36914718</pub-id>
</element-citation></ref><ref id="CR590"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkowski</surname><given-names>K</given-names></name><name><surname>Montville</surname><given-names>TJ</given-names></name></person-group><article-title>Use of meat isolate, <italic>Lactobacillus bavaricus</italic> mn, to inhibit <italic>Listeria monocytogenes</italic> growth in a model meat gravy system</article-title><source>J Food Saf</source><year>1992</year><volume>13</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/j.1745-4565.1992.tb00091.x</pub-id></element-citation></ref><ref id="CR591"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolden</surname><given-names>R</given-names></name><name><surname>Ovchinnikov</surname><given-names>KV</given-names></name><name><surname>Venter</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>The novel bacteriocin romsacin from <italic>Staphylococcus haemolyticus</italic> inhibits Gram-positive WHO priority pathogens</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><fpage>e0086923</fpage><pub-id pub-id-type="doi">10.1128/spectrum.00869-23</pub-id><?supplied-pmid 37905822?><pub-id pub-id-type="pmid">37905822</pub-id>
</element-citation></ref><ref id="CR592"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>BE</given-names></name></person-group><article-title>Using cultivated microbial communities to dissect microbiome assembly: challenges, limitations, and the path ahead</article-title><source>mSystems</source><year>2018</year><volume>3</volume><fpage>e00161</fpage><lpage>e171</lpage><pub-id pub-id-type="doi">10.1128/mSystems.00161-17</pub-id><?supplied-pmid 29629414?><pub-id pub-id-type="pmid">29629414</pub-id>
</element-citation></ref><ref id="CR593"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>BE</given-names></name></person-group><article-title>Are fermented foods an overlooked reservoir of antimicrobial resistance?</article-title><source>Curr Opin Food Sci</source><year>2023</year><volume>51</volume><fpage>101018</fpage><pub-id pub-id-type="doi">10.1016/j.cofs.2023.101018</pub-id></element-citation></ref><ref id="CR594"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>BE</given-names></name><name><surname>Button</surname><given-names>JE</given-names></name><name><surname>Santarelli</surname><given-names>M</given-names></name><name><surname>Dutton</surname><given-names>RJ</given-names></name></person-group><article-title>Cheese rind communities provide tractable systems for in situ and in vitro studies of microbial diversity</article-title><source>Cell</source><year>2014</year><volume>158</volume><fpage>422</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.041</pub-id><?supplied-pmid 25036636?><pub-id pub-id-type="pmid">25036636</pub-id>
</element-citation></ref><ref id="CR595"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woraprayote</surname><given-names>W</given-names></name><name><surname>Malila</surname><given-names>Y</given-names></name><name><surname>Sorapukdee</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bacteriocins from lactic acid bacteria and their applications in meat and meat products</article-title><source>Meat Sci</source><year>2016</year><volume>120</volume><fpage>118</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.meatsci.2016.04.004</pub-id><?supplied-pmid 27118166?><pub-id pub-id-type="pmid">27118166</pub-id>
</element-citation></ref><ref id="CR596"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woraprayote</surname><given-names>W</given-names></name><name><surname>Pumpuang</surname><given-names>L</given-names></name><name><surname>Tosukhowong</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antimicrobial biodegradable food packaging impregnated with bacteriocin 7293 for control of pathogenic bacteria in pangasius fish fillets</article-title><source>LWT</source><year>2018</year><volume>89</volume><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2017.10.026</pub-id></element-citation></ref><ref id="CR597"><mixed-citation publication-type="other">World Health Organization (WHO) (2021) 10 global health issues to track in 2021. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021">https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021</ext-link>. Accessed 1 Sept 2023</mixed-citation></ref><ref id="CR598"><mixed-citation publication-type="other">World Organization for Animal Health (WOAH) (2023) Annual report for antimicrobial agents intended for use in animals, 7th edn. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.woah.org/app/uploads/2023/05/a-seventh-annual-report-amu-final.pdf">https://www.woah.org/app/uploads/2023/05/a-seventh-annual-report-amu-final.pdf</ext-link>. Accessed 19 Sept 2023</mixed-citation></ref><ref id="CR599"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>EE</given-names></name></person-group><article-title>Preliminary characterization of a nisin Z bacteriocin with activity against the fish pathogen <italic>Streptococcus iniae</italic></article-title><source>OFOAJ</source><year>2017</year><pub-id pub-id-type="doi">10.19080/OFOAJ.2017.03.555610</pub-id></element-citation></ref><ref id="CR600"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>Y-Z</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y-P</given-names></name><etal/></person-group><article-title>Inhibitory effect of a new bacteriocin RSQ04 purified from <italic>Lactococcus lactis</italic> on <italic>Listeria monocytogenes</italic> and its application on model food systems</article-title><source>LWT</source><year>2022</year><volume>164</volume><fpage>113626</fpage><pub-id pub-id-type="doi">10.1016/j.lwt.2022.113626</pub-id></element-citation></ref><ref id="CR601"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name></person-group><article-title>Heterologous expression of Class IIb bacteriocin plantaricin JK in <italic>Lactococcus lactis</italic></article-title><source>Protein Expr Purif</source><year>2019</year><volume>159</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2019.02.013</pub-id><?supplied-pmid 30807850?><pub-id pub-id-type="pmid">30807850</pub-id>
</element-citation></ref><ref id="CR602"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Mehta</surname><given-names>RR</given-names></name><name><surname>Lekmine</surname><given-names>F</given-names></name><etal/></person-group><article-title>A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells</article-title><source>Mol Cancer Ther</source><year>2009</year><volume>8</volume><fpage>2947</fpage><lpage>2958</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-09-0444</pub-id><?supplied-pmid 19808975?><pub-id pub-id-type="pmid">19808975</pub-id>
</element-citation></ref><ref id="CR603"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Action mode of bacteriocin BM1829 against <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic></article-title><source>Food Biosci</source><year>2021</year><volume>39</volume><fpage>100794</fpage><pub-id pub-id-type="doi">10.1016/j.fbio.2020.100794</pub-id></element-citation></ref><ref id="CR604"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Influence of culture media, pH and temperature on growth and bacteriocin production of bacteriocinogenic lactic acid bacteria</article-title><source>AMB Express</source><year>2018</year><volume>8</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s13568-018-0536-0</pub-id><?supplied-pmid 29368243?><pub-id pub-id-type="pmid">29368243</pub-id>
</element-citation></ref><ref id="CR605"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Bacterial peptides and bacteriocins as novel treatment for prostate cancer</article-title><source>Int J Pept Res Ther</source><year>2023</year><volume>29</volume><fpage>78</fpage><pub-id pub-id-type="doi">10.1007/s10989-023-10544-z</pub-id></element-citation></ref><ref id="CR606"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Y&#x00131;ld&#x00131;r&#x00131;m</surname><given-names>Z</given-names></name><name><surname>Yerlikaya</surname><given-names>S</given-names></name><name><surname>&#x000d6;nc&#x000fc;l</surname><given-names>N</given-names></name><name><surname>Sakin</surname><given-names>T</given-names></name></person-group><article-title>Inhibitory effect of lactococcin BZ against <italic>Listeria innocua</italic> and indigenous microbiota of fresh beef</article-title><source>Food Technol Biotechnol</source><year>2016</year><volume>54</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.17113/ftb.54.03.16.4373</pub-id><?supplied-pmid 27956863?><pub-id pub-id-type="pmid">27956863</pub-id>
</element-citation></ref><ref id="CR607"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>J-P</given-names></name><name><surname>Fu</surname><given-names>C-M</given-names></name><name><surname>Wu</surname><given-names>Y-C</given-names></name><etal/></person-group><article-title>Combined analysis of transcriptomics and metabolomics provide insights into the antibacterial mechanism of bacteriocin XJS01 against multidrug-resistant <italic>Staphylococcus aureus</italic></article-title><source>Sci Total Environ</source><year>2024</year><volume>917</volume><fpage>170412</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2024.170412</pub-id><?supplied-pmid 38281634?><pub-id pub-id-type="pmid">38281634</pub-id>
</element-citation></ref><ref id="CR608"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>WH</given-names></name><name><surname>Park</surname><given-names>HD</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Hwang</surname><given-names>BD</given-names></name></person-group><article-title>Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells</article-title><source>Biochem Biophys Res Commun</source><year>1996</year><volume>222</volume><fpage>694</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1996.0806</pub-id><?supplied-pmid 8651907?><pub-id pub-id-type="pmid">8651907</pub-id>
</element-citation></ref><ref id="CR609"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Shang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Protective ability of biogenic antimicrobial peptide microcin J25 against enterotoxigenic <italic>Escherichia coli</italic>-induced intestinal epithelial dysfunction and inflammatory responses IPEC-J2 cells</article-title><source>Front Cell Infect Microbiol</source><year>2018</year><volume>8</volume><fpage>242</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2018.00242</pub-id><?supplied-pmid 30057893?><pub-id pub-id-type="pmid">30057893</pub-id>
</element-citation></ref><ref id="CR610"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><etal/></person-group><article-title>A comprehensive antimicrobial activity evaluation of the recombinant microcin J25 against the foodborne pathogens salmonella and <italic>E. coli</italic> O157:H7 by using a matrix of conditions</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>1954</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01954</pub-id><?supplied-pmid 31507565?><pub-id pub-id-type="pmid">31507565</pub-id>
</element-citation></ref><ref id="CR611"><element-citation publication-type="data"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/><year>2023</year><data-title>Potential impact of combined inhibition by bacteriocins and chemical substances of foodborne pathogenic and spoilage bacteria: a review</data-title><source>Foods</source><pub-id pub-id-type="doi">10.3390/foods12163128</pub-id></element-citation></ref><ref id="CR612"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharof</surname><given-names>MP</given-names></name><name><surname>Lovitt</surname><given-names>RW</given-names></name></person-group><article-title>Bacteriocins produced by lactic acid bacteria a review article</article-title><source>APCBEE Proc</source><year>2012</year><volume>2</volume><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.apcbee.2012.06.010</pub-id></element-citation></ref><ref id="CR613"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zainodini</surname><given-names>N</given-names></name><name><surname>Hassanshahi</surname><given-names>G</given-names></name><name><surname>Hajizadeh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nisin induces cytotoxicity and apoptosis in human asterocytoma cell line (SW1088)</article-title><source>Asian Pac J Cancer Prev</source><year>2018</year><volume>19</volume><fpage>2217</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.22034/APJCP.2018.19.8.2217</pub-id><?supplied-pmid 30139228?><pub-id pub-id-type="pmid">30139228</pub-id>
</element-citation></ref><ref id="CR614"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalewska</surname><given-names>M</given-names></name><name><surname>Churey</surname><given-names>JJ</given-names></name><name><surname>Worobo</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Isolation of bacteriocin-producing <italic>Staphylococcus</italic> spp. strains from human skin wounds, soft tissue infections and bovine mastitis</article-title><source>Pol J Microbiol</source><year>2018</year><volume>67</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.21307/pjm-2018-018</pub-id><?supplied-pmid 30015454?><pub-id pub-id-type="pmid">30015454</pub-id>
</element-citation></ref><ref id="CR615"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Development and antilisterial activity of PE-based biological preservative films incorporating plantaricin BM-1</article-title><source>FEMS Microbiol Lett</source><year>2017</year><pub-id pub-id-type="doi">10.1093/femsle/fnw283</pub-id><?supplied-pmid 29155937?><pub-id pub-id-type="pmid">29155937</pub-id>
</element-citation></ref><ref id="CR616"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Suksanpaisan</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dual-isotope SPECT imaging with NIS reporter gene and duramycin to visualize tumor susceptibility to oncolytic virus infection</article-title><source>Mol Ther Oncolytics</source><year>2019</year><volume>15</volume><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.omto.2019.10.002</pub-id><?supplied-pmid 31890867?><pub-id pub-id-type="pmid">31890867</pub-id>
</element-citation></ref><ref id="CR617"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A novel bacteriocin PE-ZYB1 produced by <italic>Pediococcus pentosaceus</italic> zy-B isolated from intestine of Mimachlamys nobilis: purification, identification and its anti-listerial action</article-title><source>LWT</source><year>2020</year><volume>118</volume><fpage>108760</fpage><pub-id pub-id-type="doi">10.1016/j.lwt.2019.108760</pub-id></element-citation></ref><ref id="CR618"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ben Said</surname><given-names>L</given-names></name><name><surname>Herv&#x000e9;</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effects of drinking water supplementation with <italic>Lactobacillus reuteri</italic>, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens</article-title><source>J Anim Sci Biotechnol</source><year>2022</year><volume>13</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/s40104-022-00683-6</pub-id><?supplied-pmid 35246239?><pub-id pub-id-type="pmid">35246239</pub-id>
</element-citation></ref><ref id="CR619"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-M</given-names></name><name><surname>Jiang</surname><given-names>Y-H</given-names></name><name><surname>Li</surname><given-names>H-W</given-names></name><etal/></person-group><article-title>Purification and characterization of <italic>Lactobacillus plantarum</italic>-derived bacteriocin with activity against <italic>Staphylococcus argenteus</italic> planktonic cells and biofilm</article-title><source>J Food Sci</source><year>2022</year><volume>87</volume><fpage>2718</fpage><lpage>2731</lpage><pub-id pub-id-type="doi">10.1111/1750-3841.16148</pub-id><?supplied-pmid 35470896?><pub-id pub-id-type="pmid">35470896</pub-id>
</element-citation></ref><ref id="CR620"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antimicrobial kinetics of nisin and grape seed extract against inoculated <italic>Listeria monocytogenes</italic> on cooked shrimps: survival and residual effects</article-title><source>Food Control</source><year>2020</year><volume>115</volume><fpage>107278</fpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2020.107278</pub-id></element-citation></ref><ref id="CR621"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Klebicin E, a pore-forming bacteriocin of <italic>Klebsiella pneumoniae</italic>, exploits the porin OmpC and the Ton system for translocation</article-title><source>J Biol Chem</source><year>2024</year><volume>300</volume><fpage>105694</fpage><pub-id pub-id-type="doi">10.1016/j.jbc.2024.105694</pub-id><?supplied-pmid 38301890?><pub-id pub-id-type="pmid">38301890</pub-id>
</element-citation></ref><ref id="CR622"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>T</given-names></name><name><surname>Xiong</surname><given-names>P</given-names></name><etal/></person-group><article-title>Characterization of the oral microbiome and gut microbiome of dental caries and extrinsic black stain in preschool children</article-title><source>Front Microbiol</source><year>2023</year><volume>14</volume><fpage>1081629</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2023.1081629</pub-id><?supplied-pmid 37065128?><pub-id pub-id-type="pmid">37065128</pub-id>
</element-citation></ref><ref id="CR623"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Structural basis of pore formation in the mannose phosphotransferase system by pediocin PA-1</article-title><source>Appl Environ Microbiol</source><year>2022</year><volume>88</volume><fpage>e0199221</fpage><pub-id pub-id-type="doi">10.1128/AEM.01992-21</pub-id><?supplied-pmid 34851716?><pub-id pub-id-type="pmid">34851716</pub-id>
</element-citation></ref><ref id="CR624"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Imre</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mechanisms of probiotic <italic>Bacillus</italic> against enteric bacterial infections</article-title><source>One Health Adv</source><year>2023</year><volume>1</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s44280-023-00020-0</pub-id></element-citation></ref><ref id="CR625"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zieli&#x00144;ska</surname><given-names>D</given-names></name><name><surname>Kolo&#x0017c;yn-Krajewska</surname><given-names>D</given-names></name></person-group><article-title>Food-origin lactic acid bacteria may exhibit probiotic properties: review</article-title><source>Biomed Res Int</source><year>2018</year><volume>2018</volume><fpage>5063185</fpage><pub-id pub-id-type="doi">10.1155/2018/5063185</pub-id><?supplied-pmid 30402482?><pub-id pub-id-type="pmid">30402482</pub-id>
</element-citation></ref><ref id="CR626"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimina</surname><given-names>M</given-names></name><name><surname>Babich</surname><given-names>O</given-names></name><name><surname>Prosekov</surname><given-names>A</given-names></name><etal/></person-group><article-title>Overview of global trends in classification, methods of preparation and application of bacteriocins</article-title><source>Antibiotics (Basel)</source><year>2020</year><volume>9</volume><fpage>553</fpage><pub-id pub-id-type="doi">10.3390/antibiotics9090553</pub-id><?supplied-pmid 32872235?><pub-id pub-id-type="pmid">32872235</pub-id>
</element-citation></ref><ref id="CR627"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipperer</surname><given-names>A</given-names></name><name><surname>Konnerth</surname><given-names>MC</given-names></name><name><surname>Laux</surname><given-names>C</given-names></name><etal/></person-group><article-title>Human commensals producing a novel antibiotic impair pathogen colonization</article-title><source>Nature</source><year>2016</year><volume>535</volume><fpage>511</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/nature18634</pub-id><?supplied-pmid 27466123?><pub-id pub-id-type="pmid">27466123</pub-id>
</element-citation></ref></ref-list></back></article>